fixss

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

for the fiscal year ended December 31, 20182021

or

Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from to .

Commission file number 0-21810

 

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

Michigan

 

95-4318554

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

21680 Haggerty Road, Northville, MI

 

48167

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (248) 504-0500

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Nameof each exchange on which registered

Common Stock, no par value

THRM

The Nasdaq Global Select Stock Market

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes      No  

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes      No  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K    

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

 

 

 

Non-accelerated filer

 

  

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

 

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes      No  

The aggregate market value of the registrant’s Common Stock held by non-affiliates of the registrant, computed by reference to the closing price of such Common Stock on The Nasdaq Global Select Stock Market as of the last business day of the registrant’s most recently completed second fiscal quarter, June 29, 2018,30, 2021, was $1,066,320,000.$2,342,097,813. For purposes of this computation, the registrant has excluded the market value of all shares of its Common Stock reported as being beneficially owned by executive officers and directors and holders of more than 10% of the Common Stock on a fully diluted basis of the registrant;directors; such exclusion shall not, however, be deemed to constitute an admission that any such person is an “affiliate” of the registrant.

As of February 25, 2019,14, 2022, there were 34,989,34933,021,536 issued and outstanding shares of Common Stock of the registrant.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the proxy statement for the 20192022 annual meeting of shareholders are incorporated by reference into Part III of this Annual Report to the extent described herein.

 

 


TABLE OF CONTENTS

 

Part I

 

 

 

Item 1:

 

Business

  34

 

 

Item 1A:

 

Risk Factors

  1317

 

 

Item 1B:

 

Unresolved Staff Comments

29

 

 

Item 2:

 

Properties

  3029

 

 

Item 3:

 

Legal Proceedings

  3029

 

 

Item 4:

 

Mine Safety Disclosures

  3029

 

 

Part II

  3130

 

 

Item 5:

 

Market for the Registrant’s Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities

  3130

 

 

Item 6:

 

Selected Financial DataReserved

  3230

 

 

Item 7:

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  3331

 

 

Item 7A:

 

Quantitative and Qualitative Disclosures About Market Risk

  5144

 

 

Item 8:

 

Financial Statements and Supplementary Data

  5446

 

 

Item 9:

 

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

  5446

 

 

Item 9A:

 

Controls and Procedures

  5446

 

 

Item 9B:

 

Other Information

46

 56

Item 9C:

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

47

 

 

Part III

  5748

 

 

Item 10:

 

Directors, Executive Officers and Corporate Governance

  5748

 

 

Item 11:

 

Executive Compensation

  5748

 

 

Item 12:

 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

  5748

 

 

Item 13:

 

Certain Relationships and Related Transactions and Director Independence

  5748

 

 

Item 14:

 

Principal Accounting Fees and Services

  5748

 

 

Part IV

  5849

 

 

Item 15:

 

Exhibits and Financial Statement Schedules

49

 58

Item 16:

Form 10-K Summary

52

 

 

 

 


GENTHERM INCORPORATED

PART I

 

ITEM 1.

BUSINESS

Unless otherwise indicated, references to “Gentherm”, “the Company”, “we”, “our” and “us” in thisForward-Looking Statements

This Annual Report on Form 10-K refer to Gentherm Incorporated and its consolidated subsidiaries.

Except tofor the extent expressly noted herein, the content of our website or the websites of other third parties noted herein are not incorporated by reference in this Report.

Forward-Looking Statements

This Reportyear ended December 31, 2021 (this “Annual Report”) contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as the impact of the COVID-19 pandemic and other current macroeconomic conditions, including supply chain disruptions, labor shortages and inflationary pressures, on our financial statements, liquidity, and business as well as the global economy, our ability to execute our new strategic plan, our ability to finance sufficient working capital, the amount of availability under our credit facility, our ability to continue to maintain or increase sales and profits of our operations, andgrow current production levels, the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs.needs, our ability to finance sufficient working capital, and our ability to execute our strategic plan.  Reference is made in particular to forward-looking statements included in “Item 1. Business,”, “Item 1A. Risk Factors” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms.

The forward-looking statements included in this Annual Report are made as of the date hereof or as of the date specified and are based on management’s reasonable expectations and beliefs.  Such forward-looking statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors which are set forththat may cause the Company’s actual results or performance to differ materially from that described in “Item 1A. Risk Factors” and elsewhere in this Report, and subsequent reports filed with or furnished toindicated by the Securities and Exchange Commission, and whichforward-looking statements. Important factors that could cause actual results to differ materially from that describedthose in the forward looking statements.forward-looking statements include, but are not limited to those summarized below:

the COVID-19 pandemic and its direct and indirect adverse impacts on the automobile and medical industries and global economy, which had, and are likely to continue to have, an adverse effect on, among other things, the Company’s results of operations, financial condition, cash flows, liquidity, business operations and stock price;

the current supply-constrained environment we are facing involving component shortages, manufacturing disruptions, logistics challenges and inflationary pressures, and any future material delays in the supply chain of the Company or the automotive original equipment manufacturers (“OEMs”) or first tier suppliers (“Tier 1s”) supplied by the Company;  

the period of sustained price increases for various material components and shipping costs currently experienced in the automotive industry, which may continue for longer than we expect;

the impact of industry or consumer behaviors on future automotive vehicle production, including the development and use of autonomous and electric vehicles and increasing use of car- and ride-sharing and on-demand transportation as a service, as well as related regulations;

borrowing availability under the Company’s revolving credit facility;

the Company’s failure to be in compliance with covenants under its debt agreements, which could result in the amounts outstanding thereunder being accelerated and becoming immediately due and payable;

the Company’s ability to obtain additional financing by accessing the capital markets, which may not be available on acceptable terms or at all;

the macroeconomic environment, including its impact on the automotive industry, which is cyclical;

any significant declines in automobile production;

market acceptance of the Company’s existing or new products, and new or improved competing products developed by competitors with greater resources;

shifting customer preferences, including shifts due to the evolving use of automobiles and technology;

the Company’s ability to project future sales volumes, based on which the Company manages its business;

reductions in new business awards due to the macroeconomic environment, COVID-19 and related uncertainties;

the Company’s ability to convert new business awards into product revenues;

3


the loss or insolvency of any of the Company’s key customers, including due to M&A or other market consolidation of OEMs and Tier 1s;

the loss of any key suppliers;

the impact of price downs in the ordinary course, or additional increased pricing pressures from the Company’s customers;

the feasibility of Company’s development of new products on a timely, cost effective basis, or at all;

security breaches and other disruptions to the Company’s IT systems;

labor shortages, wage inflation and work stoppages impacting the Company, its suppliers or customers;

changes in free trade agreements or the implementation of additional tariffs, and the Company’s ability to pass-through tariff costs;

unfavorable changes to currency exchange rates;

the Company’s ability to protect its intellectual property in certain jurisdictions;

the Company’s ability to effectively implement ongoing restructuring and other cost-savings measures or realize the full amount of estimated savings;

compliance with, and increased costs related to, domestic and international regulations, including potential climate change regulations;

changes in government leadership and laws, political instability and economic tensions between governments;

severe weather conditions and natural disasters and any resultant disruptions on the supply or production of goods or services or customer demands; and

other risks, uncertainties, and other factors set forth in “Item 1A. Risk Factors” and elsewhere in this Annual Report, and subsequent reports filed with or furnished to the Securities and Exchange Commission.  

In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s business and financial results.  Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

General

ITEM 1.

BUSINESS

Unless otherwise indicated, references to “Gentherm”, “the Company”, “we”, “our” and “us” in this Annual Report refer to Gentherm Incorporated and its consolidated subsidiaries.

Except to the extent expressly noted herein, the content of our website or the websites of other third parties noted herein are not incorporated by reference in this Annual Report.

Overview

Gentherm Incorporated is a global technologydeveloper, manufacturer and industry leader in the design, development, and manufacturingmarketer of innovative thermal management technologies.  Ourtechnologies for a broad range of heating and cooling and temperature control applications in the automotive and medical industries. Within the automotive industry, our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management remote power generation,and cell connecting systems. Within the medical industry our products provide patient temperature management and other consumer and industrial temperature control needs.solutions. Our automotive products can be found on the vehicles ofmanufactured by nearly all the major automotive manufacturersOEMs operating in North America and Europe, and several major OEMs in Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the developmentcapabilities. The Company is also developing a number of new technologies and new applications fromproducts that are expected to enable improvements to existing technologiesproducts and to create product and market opportunities for a wide array of thermal management solutions.  

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial.

Automotive

The Automotive reporting segment is comprised of the results from our global automotive businesses. Operating results from our climate comfort systems, specialized automotive cable systems, battery thermal management, and automotive electronic and software systems are all reported in the Automotive segment because of their complementary focus on automotive content, passenger thermal comfort and convenience.  The operating results of Etratech, a business acquired in November 2017 (see “Recent Acquisition and Dispositions” below) are included within Gentherm’s Automotive segment due to the concentration ofnew product applications within the automotive, RVfor existing and marine industries.new markets.

Climate comfort system solutions include seat heaters, variable temperature Climate Control Seats (“CCS”) designed to provide individualized thermal comfort to automobile passengers, and integrated electronic components, such as blowers and electronic control units and that utilize our proprietary electronics technology and software.  Other climate comfort system solutions include

34


steering wheel heaters, neck climate control systems and surface climate control system products for doors, armrests, cupholders and storage bins.

Industrial

The Industrial reporting segment represents the combined results from our remote power generation systems business, our patient temperature management systems business, our environmental testing equipment business and our advanced research and product development division.  Our remote power generation systems business is managed by our subsidiary Gentherm Global Power Technologies (“GPT”) and our patient temperature management and environment test equipment businesses are managed by our subsidiary Cincinnati Sub-Zero (“CSZ”). The advanced research and product development division is engaged in projects to improve the efficiency and functionality of thermal management technologies and to develop, market, and distribute products based on these new technologies.  The operating results from these businesses and division are presented together as one reporting segment because of their joint concentration on identifying new markets and product applications based on thermal management technologies.

In June 2018, as part of a new strategic plan intended to improve business performance and position the Company to deliver above-market growth and improved profitability to its shareholders, Gentherm launched the Fit-for-Growth cost-savings initiative. One key objective for Fit-for-Growth is to eliminate non-core areas of investment within the industrial reporting segment, including elimination of our investment in GPT, Cincinnati Sub-Zero’s industrial chamber business (“CSZ-IC”), and our battery management systems division in Irvine, California. We also completed the site consolidation plan for our advanced research and development operations and vacated two leased facilities in Azusa, California. See Note 1 of the consolidated financial statements for more information about the new strategic plan and Fit-for-Growth.  

See Note 9 of the consolidated financial statements for information regarding the Company’s segment revenues from external customers, including geographic composition, operating income, depreciation and amortization, and goodwill. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at the segment level.

Corporate Information

We are incorporated under the laws of the State of Michigan. We were originally incorporated in California in 1991 and we reincorporated in Michigan in 2005. Our internet website is www.gentherm.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are made available free of charge through our website, www.gentherm.com, as soon as reasonably practicable after we electronically file them with or furnish them to the Securities and Exchange Commission.Commission (“SEC”). These reports are also available on the SecuritiesSEC’s website, www.sec.gov.

Impact of COVID-19, Supply Chain Disruptions and Exchange Commission’s website, www.sec.gov.Other Matters

The macroeconomic effects of the COVID-19 pandemic continue to cause significant volatility in the global economy, including within the automotive market and our business. Our sales are driven by the number of vehicles produced by the automotive manufacturers, which is ultimately dependent on consumer demand for automotive vehicles, and our content per vehicle, and other factors that may limit or otherwise impact production by us, our supply chain and our customers. According to the forecasting firm IHS Markit (February 2022 release), global light vehicle production in 2021 in the Company’s key markets of North America, Europe, China, Japan and Korea, was up 0.3%, as compared to 2020. The lack of significant growth in 2021 was primarily due to the impacts of global supply chain disruptions, including the worldwide semiconductor supply shortage, and follows the significant decrease in vehicle production in 2020 which was driven by the adverse impacts of the COVID-19 pandemic. Light vehicle production remains well below recent historic levels and consumer demand.

In 2021, the Company's semiconductor suppliers, along with most automotive component supply companies that use semiconductors, including Gentherm, were unable to fully meet the vehicle production demands of the OEMs largely due to events outside the control of the Company and its suppliers and customers, as well as the automotive industry generally. Supply shortages of semiconductor chips and other components not only resulted in decreased global automotive vehicle production but also caused significant volatility in customer vehicle production schedules. Sudden changes in the production schedules of OEMs and Tier 1s resulted in operating inefficiencies which adversely affect our profitability and results of operations. In addition, we experienced inflationary cost increases in certain component parts, raw materials, labor and transportation as a result of the supply-constrained environment and general economic conditions. These broad-based operational and inflationary impacts negatively impacted the Company’s financial condition, results of operations and cash flows for the fiscal year ended December 31, 2021.

In response to the global supply chain instability and inflationary cost increases the Company has taken several actions to minimize any potential and actual adverse impacts by working closely with its suppliers and customers to closely monitor the availability of semiconductor microchips and other component parts and raw materials, customer vehicle production schedules and any other supply chain inefficiencies that may arise. We expect global supply chain instability will continue to have an adverse impact on our business and financial performance for the foreseeable future, and such adverse impact may be material. The consequences of the pandemic, global supply chain instability and inflationary cost increases and their adverse impact to the global economy continue to evolve. Accordingly, the significance of the future adverse impact on our business and financial statements remains subject to significant uncertainty.

See further discussion of the COVID-19 pandemic and related risks in Item 1A, “Risk Factors” and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Annual Report.

Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Medical.

Automotive

The Automotive reporting segment is comprised of the results from our global automotive businesses, including the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems.

Climate comfort systems include seat heaters, blowers and thermoelectric devices for variable temperature Climate Control Seats® (“CCS”) and steering wheel heaters designed to provide individualized thermal comfort to automobile passengers, and integrated electronic components, such as electronic control units that utilize our proprietary electronics technology and software. Other climate comfort systems include neck and shoulder conditioners and climate control system products for door panels, armrests, cupholders and storage bins.

5


Battery performance solutions consist of cell connecting devices and battery cable technologies used for various types of automotive batteries and thermal management products for heating and cooling 12 volts, 48 volts and high voltage batteries and battery modules.

Automotive electronic and software systems include electronic control units for climate comfort systems, electronic control units for memory seat modules and other devices.

Medical

The Medical reporting segment is comprised of the results from the patient temperature management business in the medical industry.

Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute care, ambulatory, clinics and home health.

Business Strategy

Across the globe,Globally, we producedevelop, manufacture, and deliver advancedextraordinary thermal solutions for automotive and patient thermal management markets that positively impact lives. make meaningful differences in everyday life by improving health, wellness, comfort and energy efficiency.

To achieve our goals and capitalize on opportunities within the automotive and patient thermal management segments,markets, in mid-2018, we are implementinglaunched and continue to implement four primary strategies:

Focus Growth

The focused growth strategy includes of four key areas:goals:

Accelerate growth in our core automotive climate and comfort businesses by leveraging human thermophysiology to offer personalized passenger comfort and improve efficiency,

Accelerate growth in our core automotive climate and comfort businesses by leveraging human thermophysiology and smart control algorithms to increase personalized passenger comfort and improve energy efficiency;

 

Introduce an innovative microclimate solution, ClimateSenseTM, thatwhich offers personalized thermal comfort in one intelligent and integrated system,system;

Drive battery thermal management with increased focus on active battery heating and cooling, passive battery cooling, battery heaters, and cell connecting board solutions, and

Drive battery performance solutions with increased focus on active battery heating and cooling, passive battery cooling, battery heaters, and cell connecting board solutions; and

Expand patient thermal solutions that leverage synergies between our automotive climate and comfort businesses.

Expand patient thermal management solutions that leverage our expertise in thermophysiology and drive synergies from our automotive climate and comfort businesses.

4


These areas of the focused growth strategy are underpinned and enabled by electronicsour electronic and software systems.systems business.

Extend Technology Leadership

ContinueWe continue to expand our technology leadership with focused investments in key core technologies and competencies, including thermophysiology, software and electronics, simulation, thermal engines and integration.  

Expand Gross Margin and Return on Invested Capital

StrengthenWe continue to build a culture of performance that includes a focus on high-return growth opportunities. During 2018 and 2019, we exited several non-core product categories. Additionally, we undertook restructuring actions to reduce global overhead costs to improve Selling, general and administrative expenses. We are continuing to strengthen our operational discipline and execution to expand gross margin and return on invested capital. This strategy centers around building a culture of performance that includes a focus on high-return growth opportunities, the Fit-for-Growth cost rationalization program, and divestiture of non-core investments.

Optimize Capital Allocation

OptimizeWe are optimizing our capital allocation to drive shareholder returns, while also allowing us to reinvestfocusing on reinvesting in our business to drive continued growth. Make investments to grow our businessesgrowth through capital expenditure projects, and focused research and development investments, while opportunistically utilizing our authorized stock repurchase program. Further, we continuously evaluate acquisition and potential acquisitionsinvestment opportunities that will enhance other business strategies.

Recent Acquisitions6


Research, Development and Dispositions

As part of our plan to make strategic acquisitions and dispositions, we have completed the following significant acquisitions and dispositions in the recent past:

On April 1, 2016, we acquired Cincinnati Sub-Zero Products, LLC to expand our temperature management activities into the medical, industrial and testing fields. In June 2018, we determined CSZ’s industrial chamber and testing business and our GPT business were not aligned with the Company’s strategic growth plan and should be eliminated. Both businesses were classified as held for sale as of December 31, 2018. On February 1, 2019, we completed the sale of CSZ’s industrial chamber and testing business and the CSZ headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million.

On November 1, 2017, we acquired Etratech Enterprises Inc. to expand our electronics capabilities, including in the automotive, consumer and commercial markets.

Research and DevelopmentPartnerships

Our research, development and developmentpartnerships activities are an essential part of our efforts to develop new or improved innovative products and introduce them to the market.products.  Through both internal and external research and development programs, we are working to develop a comprehensive knowledge of thermal management systems that can demonstratedemonstrates functionality and performance.  These activities are critical to optimizingoptimize energy utilization and production efficiencies, improvingimprove effectiveness in our products and minimizingminimize the cost to integrate our products with those of our customers.

We perform advanced research and development on thermal management systems, including those that utilize new proprietary comfort software algorithms, to enhance the efficiency and functionality of our automotive heating and cooling products. We believe there are substantial opportunities to integrate innovative thermal management systems into current and future product applications.

ResearchTo offer our customers cutting-edge products and development activities are expensed as incurred. These expenses include direct expenses for wages, materialstechnologies, our strategy includes partnering with key technology leaders in our industry.  Our advanced partnership with global automakers and services associated with particular engineering activities, netmanufactures address and work to solve industry preferences of reimbursements from customerstoday and research sponsors.  Any related reimbursements for costs, whether for advanced research or a specific product application, are accounted for as a reduction of research and development expense.  tomorrow by leveraging our expertise in human thermophysiology.

Research and development is conducted around the globe, includingglobally and predominantly at our world headquarters in Northville, Michigan, our test laboratoryTechnology Center in Farmington Hills, Michigan, our European research facilitiesfacility in Odelzhausen, Germany and Budapest, Hungary, our Asian research facility in Langfang, China, our industrial application research facility in Calgary, Canada, our medical application research facility in Cincinnati, Ohio and our electronicsShanghai, China.

Product design and advanced testing facilities in Shanghai, China and Burlington,

5


Canada.  During 2018, as part of the Fit-for-Growth cost-savings initiative, Gentherm completed a sale of the advanced battery research facility in Irvine, California and vacated advanced materials research facilities in Azusa, California.  See Note 1 of the consolidated financial statement for more information about the new strategic plan, Fit-for-Growth and other restructuring activities undertaken by the Company.  

Additional product development is also performed at all of our manufacturing facilities to support our geographically diverse customers.  We believe the localized development model employed at our global design and manufacturing facilities improves our ability to effectively serve our customers and increases our innovative capacity in the future.

Net research and development expense in 2018, 2017 and 2016 was $79,900,000, $82,478,000, and $72,923,000, respectively. Because of changing levels of research and development activity, our research and development expenses fluctuate from period to period.capacity.

Core Technologies

Gentherm’s expertise in thermal management is focused on two general areas: managing the thermal conditions of people and objects and managing the thermal energy conversion to electrical energy.objects.  

Thermoelectric Technologies

Many of our thermal products manage the thermal conditions of people and objects using our internally developed advanced thermoelectric device technology (“TED”). A TED is a solid-state circuit that has the capability to produce both hot and cold thermal conditions by use of the Peltier effect. The advantages of advanced TEDs over conventional compressed gas systems are that they are environmentally friendly and less complex as they have no moving parts and are compact and light weight.  For the last 18 years, our work on this technology has yielded great improvements in areas of efficiency, durability and performance.

Resistive Heaters

Resistive heater technologies are comprised of wire, carbon fiber or positive thermal coefficient (“PTC”) heating elements which quickly and effectively deliver heat to people and objects.  Wire heating elements are designed from stainless steel, copper, our proprietary carbon fiber woven lattice technology called Carbotex® or printed circuit PTC heaters based on the specifications for a particular product application.ClimateSenseTM

ClimateSenseTM

ClimateSense is an integrated comfort system designedwe are designing to create a personalized microclimate for passengers using localized convective, conductive and radiative heating and cooling products.  Using self-regulating sensingautomatic regulation technology and cloud data management,in combination with our unique occupant-centric control algorithm, ClimateSenseTM offers the ability to personalize and improve overall occupant thermal comfort, improve time to comfort with (all-electric) pre-conditioning, provide comfort with less energy consumption thereby lowering carbon dioxide emissions by conventional internal combustion and extendinghybrid powertrains, and extend range for electrified powertrains through a reduction in central HVACheating, ventilation and air conditioning (“HVAC”) system usage.  In July 2021, we received first production vehicle award for our ClimateSenseTM technology on an all-new 2024 model year electric vehicle with a global automaker.

Electronics

Gentherm manufactures and suppliesThe electronics toin our core climate comfort solution products.products is manufactured by us.  We also supply electronics for products outside this core set and have a contract to supply value-added electronic products to third parties for adjacent areas within the automotive interior, which is scheduledinterior.  In addition, Gentherm manufacturers and supplies electronic control units for memory seat modules that include electric motor position sensing technology. This technology further applies to launch in 2019.  Our 2017 acquisition of Canadian-based Etratech Enterprises expanded our electronics capabilities in automotive and consumer products.

Automotive Cable Systems

Gentherm produces automotive cable systems used to connect automotive components to sources of power. The automotive cable systems are an important element in the production of virtually all of our products and form a significant component in how we generate value to our customers by being an efficient, low-cost and high-quality manufacturer. We offer cable systems as integrated parts of our products and also as stand-alone components for other automotive applications, such as oxygen sensors.  Our cable

6


systems business includes both ready-made individual cables and ready-to-install cable networks. Sales of products that utilize our automotive cable systems technology represented 9% of our total product revenues for each of the twelve-month periods ending December 31, 2018, 2017 and 2016.requiring fine motor controls.

Air Moving Devices

Our highly durable and quiet air moving devices, includingsome of which include our proprietary blower and fan designs, are essential to all of our products that require air movement. ProductionWe have a strong portfolio of integrated air moving devices is an examplethese products, tailored to various automotive application, including seat ventilation and electric vehicle battery cooling.

7


Thermoelectric Technologies

Many of our expanding manufacturing capabilitiesthermal products manage the thermal conditions of people and objects using our internally developed advanced thermoelectric device technology (“TED”). A TED is an important step towarda solid-state circuit that has the capability to produce both hot and cold thermal conditions by use of the Peltier effect. The advantages of advanced TED over conventional compressed gas systems are that they are environmentally friendly and less complex as they have no moving parts and are compact and light weight.  Our work on this technology has yielded improvements in areas of functionality, efficiency, durability and performance.

Resistive Heaters

Resistive heater technologies are comprised of wire, carbon fiber or positive thermal coefficient (“PTC”) heating elements that quickly and effectively deliver heat to people and objects.  Wire heating elements are designed from stainless steel, copper, our goal of becomingproprietary carbon fiber woven lattice technology called Carbotex® or printed circuit PTC heaters based on the specifications for a full-service provider of sub-systems.particular product application.  Resistive heaters have multiple automotive applications, including seat heating, steering wheel heating, interior panel heating, and battery heating.

Products

Climate Comfort Solutions – Seat Comfort

Climate Control Seat® (“CCS”)CCS

OurGentherm offers a range of CCS products utilize exclusive patented technology to regulateutilizing proprietary technologies for regulating temperature and enhanceenhancing the comfort of vehicle passengers. The most advancedOur ventilated CCS models use one or moreproducts move air through the seat to provide conditioning. Our active CCS products utilize TEDs to generate heating or cooling depending uponheat and cool air used to condition the direction of the current applied to the device.

A TED is the heart of a compact heat pump used in our active CCS products. Air is forced through the heat pump and thermally conditioned in response to electronic switch input from the seat occupant.seat. The conditionedconditioning air circulates by one of our specially designed air moving devices through a proprietaryan air distribution system installed in the seat cushion and seat back, so that the seat surface can be heated, ventilated or cooled. Each seat has individual electronic controls to adjust the level of heating, ventilating or cooling. ActiveOur CCS products substantially improve comfort compared with conventional vehicle cabin air conditioners by focusing heating and cooling directly on the passenger through the seat rather than waiting until ambient air cools the seat surface beneath the passenger.  A heated and ventilated variant of theseat. Our CCS utilizes ambient cabin air to provide cooling comfort instead of a TED to actively cool the seat. In the heating mode, the vent-only system is supplementedproducts can be combined with our resistive heating elements.  elements to increase heating capacity and reduce time to comfort.

Heated and ventilated CCS products provide a lower level of cooling capability than our active CCS solution, but at a lower price. By offering different models of the CCS product, our customers have the opportunity to purchase a wider range of climate control products at different price points. Sales of CCS products, primarily ventilated CCS products, contributed 36%38%, 39%38% and 45%37% to our total product revenues for the twelve-month periods endingyears ended December 31, 2018, 20172021, 2020 and 2016,2019, respectively.

Heated Seat

Heated seats, based on our resistive heater core technology, are seamlessly integrated into automotive seat designs, and are constructed using materials that offer the best capacity, installation characteristics and durability.  Our design and manufacturing capabilities allow customers to choose among a variety of resistive heater materials based on their individual vehicle specifications. Sales of heated seat products contributed 29%26%, 31%27% and 32%29% to our total product revenues for the twelve-month periods endingyears ended December 31, 2018, 20172021, 2020 and 2016,2019, respectively.  

Neck Climate Control Systems

Neck climate control systems ventilate warm or temperature-controlled air directly onto the passenger’s neck and shoulder area. The system combines electronics, air moving device technologies and a heating element into a compact, integrated headrest design that can be adjusted to suit the body size of the passenger.  

Climate Comfort Solutions – Surface Climate Control Systems

Heated Steering Wheel

Heated steering wheels deliver heating comfort to automobile drivers through resistive elements. This product can be applied to both leather and wood steering wheels.  A solution for drivers in cold and mild weather climates, the heated steering wheel is designed for the global automotive market.  

78


Heated Surfaces

Gentherm’s thermally conductive or radiative surfaces, such as door panel armrest and center console armrest products, are powered by our core technologies. The system is thermally managed by a heating control system which can be discretely located in the door panel or seat of the vehicle.  Heated door panels and armrests complement our climate-controlled seat and steering wheel products and provide a superior level of thermal comfort to the driving experience.  

Electronics Solutions

Memory Seat Modules

Gentherm has developed a unique way to control certain electrical motors in a vehicle.  Our Intelligent Positioning System, IPS® product suite utilizes proprietary software to determine the position of a power seat and control the memory seat module.

Hands-On Detection

All vehicles manufactured with autonomous driving level 2 or higher capabilities are required to ensure that the driver stays in control of the vehicle during operation.  In order to accomplish this task, Gentherm developed PilotSenseTM – a sensor integrated into the steering wheel that monitors whether the driver’s hands are maintaining contact with the steering wheel.  This product is available for both heated and non-heated steering wheels.

Battery Sub-SystemsPerformance Solutions

Cell Connecting Systems

Cell connecting systems provide secure connections between advanced automotive batteries to transmit a continuous flow of information about battery temperature and cell voltage during the charging and discharging process to monitor battery system performance. Gentherm has developed a range of cell connecting system products, including flexible foil cell connecting boards that offer improved packaging, weight and functionality. We offer these products in a variety of materials to cover customers’ requirements.

Thermoelectric Battery Thermal Management (BTM)

Thermal management is critically important for the long-term operation of advanced automotive batteries.  The expansion of electrified vehicle applications, such as 48-volt electrical networks, start-stop systems, regenerative braking systemselectric vehicles, plug-in hybrids and other micro-hybrid battery implementations,mild hybrids, have drastically increased the demand for BTMbattery thermal management(“BTM”) systems solutions whichthat enable wider operating temperature ranges, enhanced driving range and prolonged life of the battery.  Gentherm’s BTM system can provide precision battery cooling of 48-volt mild hybrid systems on pack or cell-level using patented TED technology.  The BTM system maintains the temperature of the lithium-ion battery or other advanced chemistry battery within an acceptable temperature range without the use of chilled liquids or refrigerant loops, making it a light weight, highly scalable, compact solution ideal for automotive applications. Gentherm’s proprietary BTM system is compact and energy efficient, resulting in a minimal energy budget,usage, which is important for an electrified vehicle.  The performance improvements realized with this product have been validated through the award

Aside from battery cooling, Gentherm’s BTM portfolio includes battery heating applications.  Based on our proprietary technology, we offer solutions to our customers that enable efficient heating of production BTM systems by two flagship original equipment manufacturers (“OEMs”). We are currently working with other OEMs in an effort to secure more production contracts.lithium-ion batteries for most electrified vehicles.

Cell Connecting Systems

Cell connecting systems provide secure connections between advanced automotive batteries to transmit a continuous flow of information about battery temperature and cell voltage during the charging and discharging process to monitor battery system performance.

Climate Comfort Solutions – Thermal Convenience

TrueThermTM Cup Holder

The TrueTherm cup holderTM Cup Holder applies Gentherm’s patented TED technologies to keep beverages of automobile drivers and passengers either warm or cool.  We have developed a range of cup holder models with varying degrees of functionality, designed to be packagedmanufactured in multiple configurations to accommodate different console environments.  Our dual independent design provides separate temperature settings in each holder allowing the driver and passenger to individually maintain a heated or cooled beverage.  

9


TrueThermTM Storage Unit

Gentherm’s TrueThermTM Storage Unit

Gentherm’s TrueTherm storage units provide for food or beverage cooling for the global automotive market.  Using patented TED or refrigeration technologies, the TrueTherm cool storage unitTM Storage Unit provides temperature control independently from a vehicle’s heating and air conditioning system.  It can be custom designed to accommodate tight interior spaces, such as the front floor console of a sport utility vehicle (SUV) and provide additional cooling capacity to those who have long work commutes or transport multiple passengers.  

Remote Power GenerationAutomotive Cable Systems

Gentherm ismanufactures automotive cable systems used to connect automotive components to power sources. The automotive cable systems are an important element in the production of many of our products and form a leading provider of remote electric power generation systems, primarily serving large upstream and midstream oil and gas markets.  Using our unique industrial TEG technologies, our generation systems deliver ultra-reliable power for long-term unattended operationsignificant component in geographically remote applications that are criticalhow we generate value to our customers’ operations,customers by being an efficient, low-cost and high-quality manufacturer. We offer cable systems as integrated parts of our products and also as stand-alone components for other automotive applications, such as wellhead automation, valve automationoxygen sensors.  Our cable systems business includes both ready-made individual cables and cathodic protection of pipelines.  We design and produce turnkey systems that are highly customized for application, load, power and fuel source, and location requirements.  Other applications for our remote power generation systems include mobile telecommunications, security and surveillance and scientific monitoring.  Our revenues from this product include large custom systems projects ranging from $200,000 to over $2,000,000.  Quarterly results from our remote power generation business can vary significantly due to delivery timing of these custom systems to customers, among other factors.ready-to-install cable networks.

8


Patient Temperature Management Systems

Gentherm provides a full line of patient temperature management systems utilizingacross multiple modalities, including ourproduct categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute care, ambulatory, clinics and home health.  Our broad array of products for patient warming provides an improved patient experience and satisfaction. Our core brands include Blanketrol® hyper-hypothermia system, WarmAir®/FilteredFlo® convective warming system, Electri-Cool®/Micro-Temp® localized cooling/warming systems, the ASTOPAD® patient warming system that utilizes resistive warming technology which is also used in our WarmAir® convective automotive products, ASTOTHERM®/ASTOFLO® IV fluid and blood warming systems, ASTODIA® diaphanoscope for transillumination, Hemotherm® cardiovascular cooling/warming system and our FilteredFlo® recent launch of our next generation cardiovascular cooling/warming blankets, designedsystem utilized to manage patient body temperatures in operating rooms, recovery rooms, intensive care units and other areas of hospitals, our as well as for use in the home healthcare market.  Our systems offer simple programmable body temperature regulations to establish and maintain stable patient temperature. We also offer the industry-leading Hemotherm®deliver precise blood temperature management solutions that delivers reliable, effective blood temperature management control during cardiopulmonary by-pass and other related cardiovascular procedures. Revenues from the sale ofWe aspire to have innovative patient temperature management systems began in April 2016 in connectionproduct offerings coupled with the acquisitionclinical education enabling our customers to have enhanced patient outcomes and improved efficiencies of CSZ.care.

Environmental Testing Equipment and Testing Services

Gentherm provides standard and custom designed environmental test chambers that execute reliability tests by subjecting products to environmental extremes like temperature, humidity, altitude, and vibration.  Our chambers are available in a variety of sizes with capabilities ranging from basic temperature cycling to accelerated stress testing.  Gentherm designs and sells environmental test chambers for a variety of industries, which include the pharmaceutical, automotive, electronics, medical, telecommunications, aerospace and defense industries.  Revenues from the sale of environment testing equipment and testing services began in April 2016 in connection with the acquisition of CSZ.  On February 1, 2019, we completed the sale of these divisions to Weiss Technik North America, Inc. for total cash proceeds of $47,500,000.

Sponsored Research

In April 2016, the Company was selected as a subcontractor in a U.S. Air Force sponsored program award for the engineering and development of a non-invasive warming and cooling device. The device will be incorporated as medical equipment in the Air Force Expeditionary Medicine Support and Air Force Theater Hospital units supporting overseas contingency operations. Once operational testing is complete and the manufacturing processes for initial production are fully matured, the device will be submitted to the U.S. Food and Drug Administration for certification. The 30-month, $5.7 million project will be fully funded by the U.S. Air Force. As a subcontractor, Gentherm’s share of the award is approximately $2.6 million. Gentherm received $750,000, $1.2 million and $300,000 in program funding during 2018, 2017 and 2016, respectively. We expect to collect the remaining $350,000 in funding during the first quarter of 2019.

Marketing, Customers and Sales

Our Automotive segment customers include primarily light vehicle OEMs commercial vehicle OEMs, and first tier (“Tier 1”) suppliers to the automotive OEMs,1s, including automotive seat manufacturers.  We also directly supply CCS and seat heatersproducts to aftermarket seat distributors and installers.

The Company’s automotive marketing is directed primarily at automotive manufacturersthe OEMs and their Tier 1 suppliers1s and focuses on the enhanced value consumers attribute to vehicles with climate comfort products. If interested,In many cases, the manufacturersOEMs direct us to work with their suppliers, primarily their Tier 1s, to integrate our products into the vehicle’s seat or interior design. These customers will sell our product, as a component of an entire seat or seating system, to automotive OEMs.

Once the integration work is complete, prototypes are sent to the manufacturerOEMs for evaluation and testing. If a manufacturean OEM accepts our product, a program can then be launched for a particular model on a production basis, but it normally takes twoone to three years from the time a manufactureran OEM decides to include any of our products in a vehicle model to actual volume production for that vehicle. During this process, we derive funding from prototype sales but obtain no significant revenue until mass production begins. Upon commencement of mass production, our products are sold by Tier 1s to the OEMs as a component of an entire seat or seating system. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers.

The volume of products we sell is significantly affected by theglobal and regional automotive production levels of new vehicle sales and the general business conditions in the automotive industry. Our product revenues are generally based upon purchase orders issued by our customers, with updated production schedules for volume adjustments. As such, we typically do not have a backlog of firm orders at any point in time. Once we are selected to supply products for a particular platform, we typically supply those products for the platform life, which is normally five to seven years, although there is no guarantee that this will occur. In addition, when we are the incumbent supplier to a given platform, we believe we have a competitive advantage in winning the redesign or replacement platform, although there is no guarantee that this will occur.

10


For 2018,2021, our revenues from sales to our threetwo largest customers, Adient plc (“Adient”) and Lear Adient and Bosch AutomotiveCorporation (“Lear”) were $181.0 million, $166.9$156 million and $79.9$153 million, respectively, each representing 17%, 16%, and 8%15% of our totalproduct revenues respectively.that is consistent with prior years. Revenues from AdientLear and LearAdient represent sales of our climate comfort products.  Revenues from BoschOn October 28, 2021, Lear announced that it entered into an agreement to acquire the Interior Comfort Systems business unit of Kongsberg Automotive represent product sales based onASA, which is a key competitor of the Company’s climate comfort products, including CCS and seat heaters.

9


our automobile cable system technology and is used primarily in the production of automotive oxygen sensors. The loss of any one of these customers iswould likely to have a material adverse impact on our business; however,business, results of operations and cash flows. However, as noted above, our approach is to market climate comfort solutions, battery thermal management and cable technology products to thein many cases automotive OEMs who then direct their suppliers such as AdientLear and Lear,Adient to work with us.us for our climate comfort solutions, battery performance solutions and cable technology products. It is, therefore, relevant to understand how our revenues are divided among the OEMs, as shown below.

Our total product revenues including those from sales of our automotive cable systems products, for each of the past three years were divided among automotivethe OEMs as follows:

 

Manufacturer

 

2018

 

 

2017

 

 

2016

 

 

2021

 

 

2020

 

 

2019

 

General Motors

 

 

14

%

 

 

15

%

 

 

18

%

 

 

14

%

 

 

14

%

 

 

14

%

Hyundai

 

 

13

%

 

 

12

%

 

 

9

%

Volkswagen

 

 

10

%

 

 

9

%

 

 

8

%

Ford Motor Company

 

 

10

 

 

 

11

 

 

 

12

 

 

 

8

%

 

 

9

%

 

 

11

%

Volkswagen

 

 

9

 

 

 

10

 

 

 

10

 

Fiat Chrysler Automobiles

 

 

9

 

 

 

9

 

 

 

10

 

Hyundai

 

 

7

 

 

 

8

 

 

 

10

 

Stellantis(a)

 

 

8

%

 

 

9

%

 

 

10

%

BMW

 

 

6

%

 

 

6

%

 

 

6

%

Honda

 

 

6

 

 

 

6

 

 

 

6

 

 

 

5

%

 

 

6

%

 

 

7

%

Daimler

 

 

5

 

 

 

4

 

 

 

4

 

 

 

5

%

 

 

6

%

 

 

6

%

Mazda

 

 

3

%

 

 

3

%

 

 

4

%

Toyota Motor Corporation

 

 

3

%

 

 

3

%

 

 

4

%

Renault/Nissan

 

 

5

 

 

 

6

 

 

 

6

 

 

 

3

%

 

 

2

%

 

 

3

%

BMW

 

 

4

 

 

 

5

 

 

 

6

 

Toyota Motor Corporation

 

 

3

 

 

 

4

 

 

 

4

 

Jaguar/Land Rover

 

 

3

 

 

 

3

 

 

 

2

 

 

 

2

%

 

 

3

%

 

 

3

%

Other

 

 

25

 

 

 

19

 

 

 

12

 

Other (including Medical)

 

 

20

%

 

 

18

%

 

 

15

%

Total

 

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

a)

Reflective of the 2021 merger of Peugeot S.A. and Fiat Chrysler Automobiles N.V.

Non-automotive revenuesMarket Trends

We believe increased consumer demand for personalized thermal comfort in a vehicle is driving increased adoption of 9%our comfort products.  In recent years, we are seeing a trend of equipping second, and in 2018, 11%some cases, third row seats with thermal management solutions. This trend is accelerating in 2017all major markets where Gentherm is present, including North America, Europe, Japan, Korea and 8% for 2016 are included within the Other category.  China.

Our power generation systems are used by oil and gas customers for cathodic pipeline protection and other remote applications around the world.  The Gentherm product portfolio aligns well with long-term technological trends:

Increased efficiency and electric range – Our solutions, including the ClimateSense system which we continue to develop, help reduce overall energy consumption of a vehicle, resulting in improved fuel consumption for vehicles with an internal combustion engine, and increased range for electric vehicles. Our Battery Performance Solutions products help improve life and efficiency of batteries, contributing to increased adoption of powertrain electrification.

Increased demand for comfort products – We are continuously striving to bring to market products and technologies that improve the wellbeing of vehicle occupants.  From improved performance of our seat heating and cooling devices, to our introduction of the neck climate control system and heated surface products – our focus is to make vehicle comfort an integral part of vehicle occupants experience.

Growth of connected/smart devices – One of the most important objectives in achieving comfort is to create a system that is able to sense the needs of vehicle occupants and make performance adjustments based on personalized needs.  We utilize machine learning to create and optimize state of the art algorithms to make our products smarter and more advanced with each generation.

Focus on health and wellness – Consumers have an increased focus on personal health and wellness. Our technologies are at the nexus of health, wellness and comfort, where our solutions adjust to enable vehicle occupants to address their health and wellness needs.

Patient temperature management systems customers include hospitals and other health care service providers.  Customers purchase our products at prices negotiated by exclusive medical equipment distributors or, if they are a named participant, a group purchasing organization.11


Emergence of shared mobility – As the world transitions from vehicle ownership to mobility as a service model, focus on individual personalized comfort becomes even more important.  Our focus is to create microclimate solutions, when each vehicle occupant can create a personalized thermal experience tailored to their individual needs.

Our environmental testing equipment and testing services are sold to a wide variety of customer in many different industries.

Our non-automotive electronics products are sold to a variety of industrial customers, including an elevator door manufacturer and an irrigation systems company.

Outsourcing, Production and Suppliers

Our global manufacturing and distribution facilities are located close to our key customers. Our EuropeanIn Automotive, we operate two manufacturing operations aresites in Europe located at our Hungarian, Macedonianwithin North Macedonia and Ukrainian sites.Ukraine and one distribution center located in Hungary. In North America, we operate two manufacturing production sites in Acuña, Mexico, one in Celaya, Mexico, one in Cincinnati, Ohio, one in Alberta, Canada and one in Ontario, Canada.Mexico. In Asia, we operate production facilitiestwo manufacturing sites in Langfang, China and Ha Nam,one in Vietnam, and two electronics productionone distribution center in South Korea.  

For Medical, we operate one manufacturing site within Germany and one manufacturing site and distribution center within the United States.

In September 2019, we committed to a restructuring plan (the “Plan”) to improve our manufacturing productivity and rationalize our footprint. Under this Plan, we planned to relocate and consolidate certain existing automotive manufacturing facilities in Shenzhen, China.

We rely on various domestic and, foreign vendors and suppliers to supply components for our products through purchase orders, with no guaranteed supply arrangements. Components for certain products, including TEDs, are only available fromas a limitedresult, reduce the number of suppliersour manufacturing facilities by two. In March 2020, we announced the initial phase of this Plan, which included the consolidation of all North American electronics manufacturing to Celaya, Mexico. This resulted in the world. The lossclosure of any significant supplier,the Burlington, Canada facility, and the transfer of electronics manufacturing to Celaya, Mexico during 2021.  In December 2020, we announced the consolidation of our electronics manufacturing in Asia to Bantian, Shenzhen, China, which resulted in the absenceclosure of our Longgang, Shenzhen, China facility during 2021. See Note 5, "Restructuring," to the consolidated financial statements included in this Annual Report for additional information.

The automotive industry is highly reliant on semiconductors and, beginning in the fourth quarter 2020, throughout 2021 and continuing into 2022, is facing a timelysignificant supply shortage of semiconductors. See further discussion of the risks relating to the supply shortage of semiconductors and satisfactory alternative arrangement, or an inability to obtain essential components on reasonable terms or at all, could materially adversely affect our business, operationsrelated risks above in “—Impact of COVID-19, Supply Chain Disruptions and cash flows. Our businessOther Matters”, in Item 1A, “Risk Factors” and operations could also be materially adversely affected by delaysItem 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in deliveries from our suppliers.this Annual Report.

10


Proprietary Rights and Patents

The development of new or improved technologies is critical to the execution of our business strategy. PatentsCurrently owned patents and patents obtained for new or improved technologies form an important basis for the success of the Company and underpin the success of our research and development efforts. We have adopted a policy of obtaining, where practical, the exclusive rights to use technology related to our products through patents or licenses for proprietary technologies or processes. We adapt and commercialize such technologies in products for mass production. We also have developed technologies or furthered the development of acquired technologies through internal research and development efforts.

As of December 31, 2018,2021, Gentherm held 636439 issued patents, of which 273238 were U.S. patents and 363201 were non-U.S. patents.  A total of 17 patents were held jointly with other companies. Gentherm held 454309 patents directed to climate control products (including 2 patents directed to ClimateSenseTM) and thermoelectric technologies, 13941 patents directed atto heating elements and technologies, 33 patents directed to battery cell connecting and cable technologies, 26 patents directed to medical technologies, 15 patents directed to air moving devices, 12 patents directed at patient temperature management systems and 515 patents directed to environmental test chambersoccupant sensing technologies.  The Company continued to evaluate its patents during 2021 and technologies.made strategic decisions to reduce low-value patents and patents unrelated to current or planned business strategies.

Competition

TheSee further discussion of the risks relating to competition in Item 1A, “Risk Factors” in this Annual Report.

Gentherm faces competition from other automotive componentssuppliers and, systems business is highly competitive. We have several important competitors in the heated seat business andwith respect to certain vehicle manufacturers have, for some time, offered options on certain models that combine heated seats with circulation of ambient air or cooled airproducts, from the car’s air conditioning system which works similar to our heatedOEMs and ventilated seat system products.  It is possible that our competitors will be able to expandTier 1s who manufacture or modify their current products to more directly compete with our CCS products. We believe that there are other potential competitors that are working to develop systems for heating and cooling of automotive car seats.

We may experience additional competition directly from automobile manufacturers or other major suppliers, most of which have the capability to manufacture competing products. We believecertain products that our products will compete successfullyGentherm manufactures and supplies. The automotive supply industry competes on the basis of performance,technology, quality, reliability of supply and price. Design, engineering capability and competitive pricing are increasingly important factors.

Additionally, we may experience competition from non-traditional participantsThe competitive landscape for Gentherm’s climate comfort solutions and battery sub-systems includes component specialists, thermal management system suppliers, the Tier 1s and the OEMs with their own integrated solutions.  Independent suppliers that introduce newrepresent the principal competitors of Gentherm include I.G. Bauerhin GmbH and Kongsberg Automotive ASA. In October 2021,

12


Lear announced that it entered into an agreement to acquire the Interior Comfort Systems business unit of Kongsberg Automotive ASA.  The competitive landscape for patient temperature management systems includes patient thermal management medical device manufactures.  The principal manufacturers of products similar to those of Gentherm’s products include 3M Company, Stryker Corporation and Becton, Dickinson and Company.

We believe our expertise in core thermal management technologies such as advanced driver assistance technologies,and vehicle occupant thermal comfort, as well as new products or services, such as autonomous vehicles, car-our capability in applying specific component design, global footprint and ride-sharing and transportation as a service.

See “Risk Factors” for further information regardingbroad product offerings make us well positioned to compete against the significant competition in the automotive industry.

Our power generation systems compete with other technologies, such as photovoltaic solar panels and fuel cells, to deliver power to different types of oil and gas market applications.  Our products have earned a reputation for delivering highly reliable power under extreme climatic and weather conditions to locations that do not offer access to an electrical grid.  In addition to quality and performance, our ability to design and support custom solutions that integrate directly with an application’s existing infrastructure gives our products a competitive advantage over products based on other technologies.

The patient temperature management market has seven segments: convective warming, blood warming, fluid warming, surface warming, invasive warming, non-invasive cooling and invasive cooling.  Gentherm specializes in the convective warming, blood warming, surface warming and non-invasive cooling.  We compete based on the quality of our products and service to our customers and are working to develop and market the next generation of advanced temperaturetraditional thermal management systems that complies with the rulessuppliers, global Tier 1s and regulations of the U.S. Food and Drug Administration and other government regulatory bodies.

Gentherm’s environment test chamber business compete globally on the basis of performance, customization, quality and service. Our ability to modify our standard product lines to meet customer specifications helped differentiate Gentherm’s chambers from other competitive offerings. On February 1, 2019, we completed the sale of this business.

Risk Attendant to Foreign Operations

We internally manufacture the majority of our products at our production facilities in foreign countries.  Other products we sell are manufactured by third parties in foreign countries.  See “Risk Factors” for a description of risks attendant to our foreign operations.

11


See Note 9 of the consolidated financial statements for information regarding the Company’s segment revenues by geographic composition.component specialists.

Seasonality

Our principal operations are directly related to the automotive industry. Consequently, we have historically experienced seasonal fluctuations to the extent automotive vehicle production slows, such as in the summer months when many customer plants close for model year changeovers and in December when many customer plants close for the holidays. See Item 8 “Financial Statements and Supplementary Data” for selected quarterly financial data.  

Human Capital Management

Employees

At Gentherm, our mission is to “create and deliver extraordinary thermal solutions that make meaningful differences in everyday life, by improving health, wellness, comfort and energy efficiency.” Our people are the foundation for making our mission come to life every day.

Our winning culture behaviors helps shape our core Human Resource programs and our culture, the behaviors are Customer Focus, Global Mindset, Performance & Accountability and Engagement & Inclusion.

Our human capital strategy is to attract, develop and retain results-driven, high-performance talent while providing each employee with a compelling and personal employee experience. We also strive to promote a safe work environment and a culture the values fairness, diversity, equity, inclusion and belonging.  

Our global workforce creates a competitive advantage and operates in over 12 countries in 23 locations.  As of December 31, 20182021, and 2017,2020, Gentherm’s employment levels worldwide were as follows:

 

 

2021

 

 

2020

 

Mexico

 

 

3,293

 

 

 

3,938

 

Ukraine

 

 

1,906

 

 

 

1,722

 

Macedonia

 

 

1,845

 

 

 

2,131

 

China

 

 

1,456

 

 

 

1,605

 

Vietnam

 

 

858

 

 

 

916

 

United States and Canada

 

 

488

 

 

 

618

 

Hungary

 

 

285

 

 

 

253

 

Germany

 

 

264

 

 

 

263

 

Korea

 

 

45

 

 

 

36

 

Japan

 

 

21

 

 

 

20

 

Malta

 

 

9

 

 

 

12

 

United Kingdom

 

 

4

 

 

 

5

 

Total

 

 

10,474

 

 

 

11,519

 

Notable statistics as of December 31, 2021:

36% of our workforce resides in North America; 41% of our workforce resides in Europe; 23% of our workforce resides in Asia.

We have cooperative relationships in our facilities where we operate with unions and workers councils. Approximately 23% of the Company's workforce are members of industrial trade unions and are employed under the terms various labor agreements.

13


Three of nine Board members are female, and one is diverse. Four of ten executive committee members are female and two are diverse.

Over 58% of our global workforce is Female.

Within the United States, over 36% of our employees self-disclose as racially or ethnically diverse. Over the last year we increased our diversity representation at the leadership level (Directors and Vice Presidents) by three percentage points

 

Region

 

2018

 

 

2017

 

United States and Canada

 

 

1,059

 

 

 

1,155

 

Mexico

 

 

5,494

 

 

 

4,693

 

Germany

 

 

246

 

 

 

255

 

Hungary

 

 

259

 

 

 

251

 

United Kingdom

 

 

4

 

 

 

3

 

Ukraine

 

 

1,959

 

 

 

2,219

 

Malta

 

 

13

 

 

 

12

 

Macedonia

 

 

1,771

 

 

 

1,358

 

China

 

 

2,173

 

 

 

2,392

 

Korea

 

 

39

 

 

 

45

 

Japan

 

 

21

 

 

 

20

 

Vietnam

 

 

717

 

 

 

666

 

 

 

 

13,755

 

 

 

13,069

 

Racially and Ethnically Diverse (Self-reported)

 

2021

 

 

2020

 

All Employees

 

 

36

%

 

 

34

%

Leadership

 

 

23

%

 

 

20

%

Despite higher worldwide employment at December 31, 2018 as compared

Key Highlights of our Human Capital Strategy

Gentherm’s Human Capital goals have evolved to December 31, 2017,a more flexible, personal, employee value proposition since the Company’s Fit-for-Growth cost savingsonset of the pandemic to ensure we are aiding our employees in navigating through the blurred demands of work and life. We introduced a new flexible working guideline called “Locate for Your Day”.

In November 2021, we completed our first global engagement survey with a best-in-class response rate of 97%. The results of the survey in addition to several new listening tools help our managers continue to adapt and meet the needs of our workforce.

Health and Safety

At Gentherm, health and safety are an essential part of our culture and values. The “Safety Culture” of a workplace is a key issue for implementing and proceeding with the Vision Zero strategy.  This initiative realizedoutlines a 9% reductionglobal approach and mindset that strives to eliminate all work accidents and injuries by aligning the Company culture with the Seven Golden Rules:

1.

Leadership Commitment with a Top-Down Approach

2.

Identify All Hazards and Risks

3.

Set Safety and Health Targets

4.

Ensure a Safety System/ Standards

5.

Use Safe and Healthy Technology

6.

Improve Qualification

7.

Involve People

The global operating health and safety team is not only committed to the Seven Golden Rules to eliminate work accidents and injuries. These rules also are focused on identifying hazards and unsafe behaviors before they happen by “near miss reporting”.

Our teams have continued to benchmark across Gentherm sites which has fostered significant optimization and continuous improvement. By implementing consistent routine components in salaried positions during 2018.the daily work across all sites, the overall safety culture improves for all Gentherm retainsoperations.

14


Diversity, Equity and Inclusion

Our DE+I mission “Embracing Diversity Inspires Innovation” cascades from our corporate mission. We are building a culture of belonging where we value our differences to positively impact the services of outside contractors from time to time. Nonelives of our employees, customers and communities.  Our Diversity, Equity and Inclusion Council, has built strong momentum in 2021. The DE+I council conducted engagement activities and enrichment programming each month to promote awareness and celebrate various ethnic and underrepresented employees within Gentherm. We took another step forward on our DE+I journey with launching inclusion trainings to all global people leaders with the purpose of building local and global awareness of DE+I at Gentherm, ensuring all team members are educated on consistent standards, identifying feedback mechanisms to solve for conflict, and creating a culture that unites us all.

Total Rewards

Gentherm’s compensation and benefits programs are designed to attract and retain our employees in the locations where we compete for talent using a mix of elements that allow us to achieve our Company’s short and long-term goals.

We provide employee wages that are competitive and consistent with employee positions, skill levels, experience, knowledge and geographic location.

We align our executives’ and eligible employees’ annual bonus opportunity and long-term equity compensation with our shareholders’ interests by linking realizable pay with company financial and stock performance.

We are refreshing our overall compensation structure to ensure we are providing contemporary and equitable total rewards across our business.

Total Talent Development

At Gentherm, we provide foundational leadership development programs to ensure our current and future people leaders are well equipped to engage and lead in today’s complex business environment. Additionally, Gentherm’s performance management process is based on a contemporary coaching model where employees align yearly objectives with their leaders, supported with timely quarterly “check-ins” for progress updates and feedback. We have offered additional training programs to provide on-demand, flexible learning solutions for our global workforce. We introduced the Accelerator program for high potential employee development in 2021.

Environmental, Social, and Governance

In 2021, we issued our second Sustainability report and incorporated ESG into our everyday business operations and future strategies. Our sustainability efforts are based on three pillars: People, Planet, and Places.

People: At Gentherm, our leaders treat employees with respect and provide a safe working environment. We provide career opportunities, development, support and more. People create our success.

Planet: We strive to minimize our environmental impact. We believe our product lineup reduces the environmental impact of automobiles through our innovative products and technologies, and we continue to improve our operations through more efficient use of resources and reduced emissions.

Places: As a global company, we strive to be a positive force in the communities where we do business. Our teams support an array of causes, including STEM education and training, financial support for local charities and donations and support for COVID-19 efforts. Types of community involvement and support vary across our sites, based on local needs, requirements, and culture.

These actions indicate the strength of our commitment to sustainability across Gentherm.

Environmental and Regulatory Compliance

Applicable laws and regulations, and significant changes to such laws and regulations, will potentially lead to increases in costs and complexity, and failure to comply with global and specific country regulations could subject us to collective bargaining agreements.civil penalties, production

15


disruptions, or limitations on the sale of affected products. We consider our employee relationsbelieve we are materially in compliance with substantially all these requirements or expect to be satisfactory.materially in compliance by the required dates.

Executive OfficersChemical Regulation

There are numerous global laws and regulations that prohibit or restrict the selection and use of certain chemicals for product development and manufacturing and potentially impact an automobile manufacturer’s responsibility for vehicle components at the Registrant

Our current executive officers areend of a vehicle’s life. New chemical regulations continue to be introduced and passed, such as follows:

Phillip Eyler, 47, was appointed Presidentthe new European requirements that require suppliers of parts and Chief Executive Officer, andvehicles to the Company’s BoardEuropean market to disclose certain substances of Directors,concern in December 2017. Prior to joining Gentherm, Mr. Eyler served as President of the $3 billion Connected Car division at Harman, a subsidiary of Samsung since 2015. As President of the Connected Car division, Mr. Eyler oversaw an organization of more than 8,000 employees dedicated to the development of highly integrated connected car systems encompassing infotainment, telematics, connected safety and cyber security solutions, among others. Mr. Eyler joined Harman in 1997 and held various senior management positions, including Senior Vice-President and General Manager of Harman’s Global Automotive Audio business from 2011 to 2015. Mr. Eyler received a Bachelor of Science degree in mechanical engineering from Purdue University and an MBA from the Fuqua School of Business at Duke University.

Frithjof Oldorff, 52, was appointed President of the Automotive business unit in July 2013.  Prior to this appointment, Mr. Oldorff served as the Chief Operating Officer of Gentherm GmbH since 2008. He previously was a Director of Operations for Freudenberg from 2005 to 2007 and held various positions at Faurecia from 1995 to 2005. Mr. Oldorff received a master’s degree from Darmstadt Technical University (Germany) in Industrial and Mechanical Engineering.

Matteo Anversa, 47, was appointed Executive Vice President Finance, Chief Financial Officer and Treasurer in January 2019. Prior to joining Gentherm, Mr. Anversa served as Executive Vice President and Chief Financial Officer of Myers Industries since

12


December 2016. Prior to Myers Industries, Mr. Anversa worked since 2013 at Fiat Chrysler Automobiles where he held several executive management positions, including Vice President, Group FP&A Fiat Chrysler and Chief Financial Officer for Ferrari SpA where he helped prepare Ferrari for its initial public offering.  Mr. Anversa began his career with General Electric where he held various leadership roles during his 16-year tenure. Mr. Anversa holds a degree in Mechanical Engineering from the University of Parma, Italy.

Kenneth J. Phillips, 45, was appointed Senior Vice President, General Counsel and Secretary in June 2012. Prior to joining Gentherm, Mr. Phillips was a Partnerparts. Further, increases in the Detroit, Michigan officeuse of circuit boards and other electronics may require additional assessment under the law firm Honigman LLP. Mr. Phillips graduated with a J.D.directives related to certain hazardous substances and waste from Wayne State Universityelectrical and a bachelor’s degree in Accountingelectronic equipment.

Vehicle Safety

In the U.S., the National Traffic and Finance from Oakland University. Mr. Phillips is also a Certified Public Accountant.

Mark A. Potesta, 55, was appointed Senior Vice PresidentMotor Vehicle Safety Act of 1966 (the “Safety Act”) regulates motor vehicle equipment that we manufacture and Chief Technology Officer in November 2018. Prior to joining Gentherm, Mr. Potesta worked since 2017 at Panasonic Automotive Systems as Executive Vice President of Engineering and Chief Technology Officer.  Prior to 2017, Mr. Potesta worked at Delphi Corporation starting in 1999, where he held positions of increasing responsibility in engineeringsell as well as business unit leadership for electricalvehicles. The Safety Act prohibits the sale in the United States of any new vehicle or equipment that does not conform to applicable federal motor vehicle safety standards established by the National Highway Traffic Safety Administration (“NHTSA”). The Safety Act further requires that if a vehicle manufacturer or NHTSA determine a vehicle or an item of vehicle equipment does not comply with a safety standard, or that vehicle or equipment contains a defect that poses an unreasonable safety risk, the vehicle manufacturer must conduct a safety recall to remedy that condition in the affected vehicles. Should a vehicle manufacturer or NHTSA determine a safety defect or noncompliance issue exists with respect to any of our products, the cost of such recall campaigns could be substantial.  Further, many other countries have established vehicle and electronic architectures.  Mr. Potesta graduated with master’svehicle equipment safety standards and bachelor’s degrees in Electrical Engineering from Youngstown State University.regulations.  Meeting or exceeding the many safety standards is costly as global compliance and non-governmental assessment requirements continue to evolve and grow more complex, and lack harmonization globally.

Barbara J. Runyon, 48, was appointed Senior Vice President and Chief Human Resources Officer in August 2018.  Prior to joining Gentherm, Ms. Runyon worked as Vice President and Chief Human Resources Officer at La-Z-Boy Incorporated since 2015. Prior to La-Z-Boy, Ms. Runyon held roles of increasing responsibility for at PepsiCo/The Pepsi Bottling Group for over 14 years.  Ms. Runyon graduated with an MBA with emphasis in Organizational Development from Wayne State University and a BS in Human Resources from Michigan State University.

Ryan Gaul, 43, was appointed Senior Vice President of Operations in July 2018.  Mr. Gaul has spent most of his professional career with Gentherm, serving in diverse roles in Gentherm’s locations in North America, Europe and Asia. He started his career in IT, and moved into roles of increasing responsibility within the IT organization, serving as CIO from 2005 to 2009. From 2009 to 2014, he served as Managing Director of Operations for Gentherm’s Asian business. From 2014 to 2018, he served as Vice President of Strategy and Marketing.  Mr. Gaul received his bachelor’s degree from the University of Missouri.16


Yijing Brentano, 47, was appointed Senior Vice President of Investor Relations and Corporate Communications in February 2018.  Before joining Gentherm, Ms. Brentano served as the Vice President of Investor Relations and Corporate Strategy at Harman International, a Samsung company, from 2015 to 2017.  Prior to that, she spent 17 years at Sprint Corporation in multiple executive positions, including Vice President of Strategic Initiatives and Mobile Health, General Manager of International Wholesale, Vice President of Investor Relations and business unit CFO roles.  Ms. Brentano started her career at Ernst & Young and is a Certified Treasury Professional.  She holds a Bachelor of Science degree from the University of Kansas and an MBA from the University of Chicago Booth School of Business.

Paul Giberson, 38, was appointed Senior Vice President of Sales in November 2018.  Mr. Giberson has worked at Gentherm since 2006, starting as an account manager and moving to roles of ever-increasing responsibility, including Director of Sales and Marketing for North American and Vice-President of Automotive Sales.  Mr. Giberson holds a bachelor’s degree from the University of Windsor.

Officers of the Company serve at the pleasure of the Board of Directors and, to the extent applicable, in accordance with the terms of their individual Service Agreements.

ITEMITEM 1A.

RISK FACTORS

You should carefully consider each of the risks, assumptions, uncertainties and other factors described below and elsewhere in this Annual Report, as well as any amendments or updates reflected in subsequent filings or furnishings with the SEC.  We believe these risks, assumptions, uncertainties and other factors, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results and could materially and adversely affect our business operations, results of operations, financial condition and liquidity.  

13Industry and Operational Risks

The COVID-19 pandemic and measures taken to contain it have significantly adversely affected, and are likely to continue to significantly adversely affect, our business, results of operations, financial condition, cash flows, liquidity and result in stock price volatility.

The COVID-19 pandemic has caused, and continues to cause, a significant adverse effect on the level of economic activity around the world. In response to the COVID-19 pandemic, the governments of many countries, states, cities and other geographic regions have taken preventative or protective actions. The actions taken by governments, businesses and individuals in response to the pandemic have resulted in, and are expected to continue to result in, a curtailment of business activities (including changes in demand for a broad variety of goods and services), labor shortages, disruptions in supply, manufacturing and logistics, economic uncertainty and weakness, and volatility in the financial markets, both in the United States and abroad.

The COVID-19 pandemic poses the risk that Gentherm or its suppliers, customers and others may be restricted or prevented from conducting business activities for indefinite or intermittent periods of time, including as a result of employee health and safety concerns, shutdowns, shelter in place orders, travel restrictions and other actions and restrictions that may be requested or mandated by governmental authorities. At various times in the first half of 2020, substantially all of the Company’s major OEM and Tier 1 customers temporarily ceased or significantly reduced production as a result of restrictions that were requested or mandated by governmental authorities. As a result, substantially all of our manufacturing facilities either temporarily suspended production or experienced significant reductions in volumes during this period. During 2021, the Company continued to see periodic, temporary mandates by governmental authorities that impacted our employees’ ability to travel to and from our manufacturing facilities, following the resurgence of COVID-19 in certain geographic areas. Restrictions on the Company’s access to its facilities and similar limitations for the Company’s customers, OEMs, suppliers and distributors, have had a material adverse impact on the business, financial condition and results of operations and could continue to have an impact in the future.

Gentherm has implemented numerous measures attempting to manage and mitigate the effects of the virus, however, there can be no assurance that these measures will be successful now or in the future. Gentherm has modified its business practices and it may take further actions as may be required by government authorities, for the continued health and safety of the employees, or that the Company otherwise determines are in the best interests of the employees, customers, partners, and suppliers. The Company's management of the impact of COVID-19 has and will continue to require significant investment of time from its management and employees. The focus on managing and mitigating the impacts of COVID-19 on the business may cause the Company to divert or delay the application of its resources toward other or new initiatives or investments, which may cause a material adverse impact on the results of operations.

If the COVID-19 pandemic becomes more pronounced in the markets in which the Company or its customers operate, or there is a continued resurgence in the virus in markets currently recovering from the spread of COVID-19, as we experienced with the emergence of the Delta and Omicron variants during 2021 and continuing into 2022, then the Company's operations in areas impacted by such events could experience further materially adverse financial impacts.  The extent to which the COVID-19 pandemic continues to impact the Company's operations and financial condition will depend on future developments that are highly uncertain and cannot be predicted, including new government actions or restrictions, new information that may emerge concerning the severity of COVID-19, the longevity of COVID-19 and its variants and the impact of COVID-19 on economic activity. The COVID-19 pandemic has impacted the global economy creating certain macroeconomic conditions that make this a particularly challenging business environment for us and the automotive industry, including global supply chain instability, inflationary cost increases and labor shortages, as described in other risk factors in this Annual Report. To the extent the COVID-19 pandemic materially adversely affects the Company's business and financial results, it may also have the effect of significantly heightening many of the other risks associated with the Company's business, results of operations, financial condition, cash flows, liquidity and stock price, including in ways that we cannot predict.

17


Risks RelatingThe inability of our supply chain, and the supply chain of the OEMs and Tier 1s that we supply, to deliver key components, such as semiconductors, has adversely affected, and could continue to adversely affect our business, profitability and results of operations.

Our Business

Numerous general economicproducts contain a significant number of components that we source globally from suppliers who, in turn, source components from their global suppliers. If our supply chain fails to deliver products to us in sufficient quality and industry factorsquantity on a timely basis, we will be challenged to meet our production schedules, fulfilling our orders, sales and profits could decline, and our commercial reputation and customer relationships could be damaged. Similarly, OEMs and Tier 1s to whom we supply our products are dependent on an ever-greater number of global suppliers to manufacture and sell their products to consumers, which drives sales of our products. We and our customers are currently operating in a supply-constrained environment and are facing, and we do not control have significant impactsexpect to continue to face for at least the first half of 2022 and potentially longer, component shortages, manufacturing disruptions, logistics challenges and inflationary pressures, each of which is described below.  

Component shortages. The automotive industry is highly reliant on semiconductors and is facing a significant shortage of semiconductors. The semiconductor supply chain is complex, with capacity constraints occurring throughout. We, the OEMs and Tier 1s must compete among the automotive supply chain and with other industries to satisfy current and near-term requirements for semiconductors, and such allocation is not within our control even though we have attempted and will continue to attempt various mitigating actions. Certain semiconductors we utilize are sourced from a very limited number of suppliers, which further exacerbates the risks to our operations. The shortage of semiconductors and other key components (historically, such as TEDs), has disrupted our production schedule and has caused us to procure components on the open market, from time to time, at prices significantly above the contractual pricing we have with our current long-term suppliers. OEM and Tier 1 production has also been impacted by the shortage, which has resulted in reduced sales of our products. Sudden changes in the production schedules of OEMs and Tier 1s also has resulted and may continue to result in operating inefficiencies which could adversely affect our profitability and results of operations. The component shortages have had and may continue to have materially adverse effect on our business, profitability and results of operations.

Raw materials and component pricing.  In addition to the component shortages we are currently experiencing, we have experienced and we may continue to experience risks associated with pricing of components and certain other raw materials. Some of our products contain certain components, such as semiconductor chips, tellurium, a raw material used in TEDs, and other key raw materials including copper, silver and petroleum-based engineered plastics and raw materials that generally cannot be substituted. The prices for these components and raw materials fluctuate depending on market conditions. If the market prices for these components and raw materials significantly increase, as they have in the past and during the COVID-19 pandemic, our gross profit has and may continue to be adversely impacted to the extent our suppliers pass those price increases on to us.  

Labor shortages and work stoppages. Labor shortages and work stoppages, including ours and those at our suppliers or customers, and similar events could significantly disrupt our business. Because the automotive industry relies heavily on “just-in-time” delivery of components, labor shortages or work stoppages at one or more of Gentherm's production facilities or those of our suppliers could have adverse effects on the business. Similarly, if one or more of our direct customers or an OEM were to experience labor shortages or work stoppages, such as what occurred during the General Motors labor strike occurring in the Fall of 2019 or the prolonged work stoppages that occurred in the first half of 2020 as a result of the COVID-19 pandemic, our customer would likely halt or limit purchases of our products, which could result in the temporary shutdown of the related Gentherm production facilities or other restructuring initiatives.

Inflationary pressures. The automotive industry has experienced a period of sustained price increases for various material components and shipping costs. These price increases are expected to continue into the foreseeable future as supply remains constrained and demand remains elevated. Although the Company has developed and implemented strategies to mitigate the impact of higher material component costs and shipping costs, these strategies, together with commercial negotiations with Gentherm's customers and suppliers, have not historically and may not in the future fully offset our price increases which may result in adverse impacts to the Company’s profitability and results of operations.

Logistics challenges and excess supply. In order to secure components for our products, we have and may continue to strategically purchase components in advance of demand to take advantage of favorable pricing or to address concerns about future availability. If we fail to anticipate customer demand properly, a temporary oversupply could result in excess or obsolete components, which could adversely affect our business and financial performance. In addition, our ongoing efforts to optimize the efficiency of our supply chain could cause supply disruptions and be more expensive, time-consuming and

18


resource-intensive than expected. Furthermore, certain of our suppliers may decide to discontinue business with us or limit the allocation of products to us, which could result in our inability to fill our supply needs, jeopardizing our ability to fulfill our contractual obligations, which could in turn, result in a decrease in revenues and profitability, contract penalties or terminations, and damage to customer relationships.

Our supply chain has been and may in the future be adversely impacted by other events outside of our and their control, including other macroeconomic events, trade restrictions, economic recessions, political crises, labor relations issues, liquidity constraints, natural disasters and extreme weather events, which may become more frequent due to climate change.

The automotive industry, our primary market, is cyclical and resulting difficultiesa decline in the automotive industry orproduction levels of our major customers, particularly with respect to models for our key customers and suppliers would have a material and adverse effect onwhich we supply significant amounts of product, could adversely affect our business, results of operations and financial conditioncondition.

Our Automotive segment represents 91%96%, 89%95% and 92%95% of our product revenues for the years ended December 31, 2018, 20172021, 2020 and 2016,2019, respectively.  Demand for our automotive products is directly related to automotive vehicle production, which is impactedultimately dependent on consumer demand for automotive vehicles, our content per vehicle, and other factors that may limit or otherwise impact production by numerousus, our supply chain and our customers. Automotive sales and production are cyclical and have been, and we expect will continue to be, materially affected by general economic and industry factors which we do not controlconditions, labor relations issues, fuel prices, regulatory requirements, government initiatives, trade agreements, the availability and iscost of credit for us, customers and consumers and other factors.  

We operate in a highly cyclical.  In 2018,competitive industry and efforts by our product orders werecompetitors, as well as new non-traditional entrants to the industry could adversely impacted by lower than expected vehicle production in North America, Europe, and Asia, and any prolonged decrease in vehicle production may have a material adverse effect onaffect our business, results of operations and financial condition.

In particular, the automotive industry has been susceptible historically in the U.S. and globally to economic recessions, labor disputes, volatile fuel prices, complex and evolving regulatory requirements, trade agreements and government initiatives and uncertain availability and cost of credit. In addition to the continuation of these trends, future automotive vehicle production may be materially impacted by additional industry or consumer behaviors, including the development and use of autonomous and electric vehicles and increasing use of car- and ride-sharing and on-demand transportation as a service. We rely in part on market analysis, including from our customers and the IHS Markit reports on vehicle production, to make operational and strategic decisions, and increased market volatility makes it more difficult to obtain reliable data. Further, disruptions in the global economy and volatility in the financial markets may cause, among other things, lower levels of liquidity, increased borrowing rates, increased rates of default and bankruptcy, lower consumer and business spending, and lower consumer net worth, all of which may reduce demand for our products and have a material adverse effect on our business, results of operations and financial condition.  We are also limited in our ability to reduce costs to offset the results of a prolonged or severe economic downturn given certain fixed costs associated with our operations, difficulties if we overstrain our resources, and our long-term business approach that necessitates we remain in position to respond when market conditions improve.

Unfavorable economic or industry conditions could result in the financial distress of our customers and suppliers.  If our customers experience an actual decline or project a future decline in vehicle sales generally, or in sales of models for which we supply products, we may experience reductions in orders from these customers, experience difficulties in obtaining new business, incur write-offs of accounts receivable, incur impairment charges or require restructuring actions.  In addition, if any of our significant customers experiences a material work stoppage, the customer may halt or limit the purchase of our products.  This could require us to shut down or significantly reduce production at facilities relating to such products, which could have a material adverse effect on our business and harm our profitability.  

The automotive component supply industry as well as the automotive industry generally, is subject to intense competition and our current automotive products may be rendered obsolete by future technological developments

The automotive component industry, from which we derive a substantial majority of our revenues, is subject to intense competition. Business is typically awarded to the supplier offering the most favorable combination of cost, quality, timely delivery, technological innovation and service. In addition, customers often demand periodic price reductions during a vehicle’s lifeThere can be no assurance that require uswe will be able to continually assess, redefinecompete successfully with the products of our competitors. Further, our competitors’ efforts to grow market share could exert downward pressure on our product pricing and improve our operations, products and manufacturing capabilities to maintain and improve profitability.margins. Many of our competitors are substantially larger in size and have substantially greater financial, marketing and other resources than we do, and therefore may be more effective in adapting to customer requirements while being more profitable.

We must also be responsive to the entrance In addition, our customers may increase levels of non-traditional participants in the automotive industry. These non-traditional participants may seek to disrupt the historic business modelproduction insourcing for a variety of the industry through the introduction of new technologies,reasons, such as advanced driver assistance technologies,shifts in customers’ business strategies or the emergence of low-cost production opportunities in other countries, which may adversely affect our sales as well as new products or services, such asthe profit margins on our products.

If we do not respond appropriately, the evolution of the automotive industry towards electric vehicles, autonomous vehicles car- and ride-sharingmobility on demand services could adversely affect our business.

The global automotive industry is experiencing a period of significant technological change. Future automotive vehicle production may be affected by additional industry or consumer behaviors, including the development and use of autonomous and electric vehicles and increasing use of car and ridesharing and on-demand transportation as a service. Asservice, as well as related regulations. The rapidly evolving nature of the markets in which we compete has attracted, and may continue to attract, new entrants, including new entrants from outside the traditional automotive supply industry. Further, in comparison to us, our business evolves,competitors may foresee the pressurecourse of market developments more accurately, develop superior products, produce similar products at a lower cost, or adapt quicker to innovate will encompass a wider range of products and services, including products and services that may be outside of our historically core business. new technologies. If we do not accurately predict, prepare for and respond to new kinds of technological innovations, market developments and changing customer needs, our sales, profitability and long-term competitiveness may be harmed.

We manage our business based on projected future sales volume, which is highly dependent on information received from customers and general market data, and any inaccuracies or changes in such information could adversely affect our business, results of operations and financial condition.

We manage our business based upon projected future sales volumes, which are based upon many factors, including awarded business and assumptions of conversion rates thereof, customers’ forecasts and general market data. Our product revenues are generally based upon purchase orders issued by our customers, with updated production schedules for volume adjustments, and our customers generally do not guarantee sales volumes. As such, we typically do not have a backlog of firm orders at any point in time. In addition, there canawarded business may include business under arrangements that our customers have the right to terminate without penalty at any time. Further, our customers’ forecasts are subject to numerous assumptions, and such forecasts often are/may be no assurancechanged

19


rapidly with limited notice. Therefore, our actual sales volumes, and thus the ultimate amount of revenue that we will successfully differentiatederive from such sales, are not committed. We also must incur costs and make commitments well in advance of the receipt of orders and resulting revenues from customers.  If actual production orders from our productscustomers are not consistent with our projected future sales volumes, we could realize substantially less revenue and incur greater expenses over the life of vehicle programs.

The receipt of orders and resulting revenues from those of our competitors, thatcustomers is significantly affected by global automotive production levels and the marketplace will consider our current or proposed products to be superior or even comparable to those of our competitors, or that we can succeed in establishing new or maintaining existing relationships with automobile manufacturers.

14


Due to the rapid pace of technological change, as with any technology-based product, our ability to compete successfully will depend on our ability to develop and license improved technologies on a rapid and cost-efficient basis. For example,general business conditions in the automotive industry, we believe the development of new products featuring our new ClimateSenseTM technology will increase our value as an integral partindustry. Impacts of the overall vehicleCOVID-19 pandemic, including changes in demand for a broad variety of goods and services, labor shortages, inflationary pressures and a challenging and dynamic supply chain environment, has caused additional variability in customer purchase orders and caused customers to cancel their purchase orders, which has made it particularly challenging for us to project future sales volumes and manage our business in the current economic climate.

The loss or insolvency of any of our principal customers would adversely affect our future results.

For the year ended December 31, 2021, our top two customers were Adient and Lear which each comprised 15% of our product revenues. Combined, approximately 71% of product revenues to these customers was sourced directly by the Company’s OEM customers. The continued growth, viability and financial stability of our principal customers, as well as the OEMS to which our products are supplied, are critical to our success. The loss of any significant portion of our sales to any of our customers would have a material adverse effect on our results of operations and financial condition. We sometimes experience, and we expect to continue to experience, a delay in our collection of accounts receivable balances from our customers, which may be significant and would be at risk in the event of their bankruptcy or other restructuring.

On October 28, 2021, Lear announced that it entered into an agreement to acquire the Interior Comfort Systems business unit of Kongsberg Automotive ASA, which is a key competitor of our climate solution.  Our business will therefore require extensive capital expenditurescomfort products, including CCS and investmentseat heaters. The effects of this acquisition are not yet known; however, a decrease in product revenues to Lear could adversely impact our financial condition, results of operations and cash flows, and the impact of any reduced relationship with Lear on the rest of our business is uncertain.

Our inability to achieve product cost reductions which offset customer-imposed price reductions could adversely affect our financial performance.

Downward pricing pressure is customarily applied by automotive manufacturers to the automotive supply chain. Our customer contracts generally provide for annual price reductions over the production life of the vehicle, while requiring us to assume significant responsibility for the design, development manufacturing and management information systems.  Further, certainengineering of our products, as well as the costs incurred through our supply chain. Prices may also be rendered obsolete by future technologies, including from competitors in our products or widespread use of autonomous vehicles, or consumer preferences.  Our operations, financial results and competitive position would be materially and adversely affected if we were unableadjusted on an ongoing basis to anticipate such future developments and develop, or obtain access to, critical new technologies at a reasonable cost, or adapt toreflect changes in the automotive industry generally.  Anproduct content/costs and other commercial factors. Our inability to compete successfully may also hinderachieve product cost reductions that offset customer-imposed price reductions could adversely affect our ability to complete acquisitions or financings on reasonable terms or at all.

Additionally, many advanced technologies developing in the automotive industry present novel issues with which domesticfinancial condition, results of operations and foreign regulators have only limited experience and will be subject to evolving regulatory frameworks. Any current and future regulations in these areas could impact whether and how these technologies are designed and integrated into our products and may ultimately subject us to increased costs and uncertainty.cash flows.

Our inability to effectively manage the development, timing, quality and costs of new programproduct launches could adversely affect our financial performance.

Gentherm is developing and launching new products and related technologies for its battery performance solutions and electronics systems businesses and intends to launch other new products in the future. The launch of aproducts employing new programtechnologies is a complex process, the success of which depends on a wide range of factors, including the productionrobustness of our product and manufacturing process development, success in sourcing new components and commodities with suitable suppliers, readiness of our and our suppliers' manufacturing facilities and manufacturing processes, as well as factors related to tooling, equipment, employees, initial product quality and other factors. Given the complexity of new programproduct launches, we may experience difficulties managing product quality, timeliness and associated costs.

In addition, new program launches require a significant ramp up of costs; however,costs up to a few years prior to sales of such products. However, our sales related to these new programs generally are dependent upon the timing and success of our customers’ introduction of new vehicles. Our inability to effectively manage the timing, quality and costs of these new program launches could have a materially adversely effect on our operations, financial condition and operating results.

If our expansion efforts are not successfully implemented, they may adversely impact our business and results of operations

Over the past few years, we have opened or acquired new manufacturing facilities in Vietnam, Macedonia, Mexico and China, to support our customers’ global operations. Opening new, or expanding existing, manufacturing facilities entail a number of risks, including our ability to successfully manage the demands placed on our management resources and engineering and quality teams, our ability to continue production at levels, quality and within the cost and timeframe estimated, the continuing implementation of internal controls and compliance, varied local regulations, and our ability to attract and maintain a sufficient number of skilled workers at the requisite locations to meet the needs of the facilities.  Our results of operations could also be adversely impacted by start-up costs until production levels at the facilities reach planned levels, as well as any legacy issues with acquired or existing facilities.  

These newly developed or acquired facilities, as well as our other production facilities around the world, could have significant unused capacity if our product revenues do not continue to increase.  Significant unused capacity would result in overhead costs that would need to be absorbed by a smaller than expected revenue base, which could materially and adversely impact our financial results.

While there are currently no active projects to construct new manufacturing facilities, or agreements to acquire other manufacturing facilities, or plans to materially expand existing facilities, we regularly consider such opportunities and any future construction or acquisition activities, particularly in foreign countries, could entail the risks noted above.  If we experience construction or regulatory delays or increased costs, our estimates and assumptions are incorrect, or other unforeseen events occur, our business, financial conditions and results of operations could be adversely impacted.  

Our ability to market our automotive products is subject to a lengthy sales and acceptance cycle, which requires significant investment prior to significant sales revenue, and non-automotive products may be subject to similar time lags

The sales cycle for our automotive products is lengthy because an automobile manufacturer must develop a high degree of assurance that the products it buys will meet consumer needs, interface as easily as possible with the other parts of a vehicle and with the automobile manufacturer’s production and assembly process, and have minimal warranty, safety and service problems. As a result,

15


from the time that a manufacturer develops a strong interest in our products for a specified vehicle, it normally will take several years before our products are available to consumers in that vehicle.

In the automotive components industry, products typically proceed through five stages of research and development. Initial research on the product concept comes first, to assess its technical feasibility and economic costs and benefits. This stage often includes development of an internal prototype for the component supplier’s own evaluation. If the product appears feasible, the component supplier manufactures a functioning prototype to demonstrate and test the product’s features. These prototypes are then marketed and sold to automotive companies for testing and evaluation. If an automobile manufacturer shows interest in the product, it typically works with the component supplier to refine the product, then purchases second and subsequent generation engineering prototypes for further evaluation. Finally, the automobile manufacturer either decides to purchase the component for a production vehicle or terminates the program.  

The time required to progress through these five stages to commercialization varies widely. Generally, the more a component must be integrated with other vehicle systems, the longer the process takes. Further, products that are installed by the factory usually require extra time for evaluation because other vehicle systems are affected, and a decision to introduce the product into the vehicle is not easily reversed. Because our automotive products affect other vehicle systems and are factory-installed items, the process usually takes several years from conception to commercialization.

While we currently have active development programs with various seat manufacturers and automotive OEMs for our thermal management products, no assurance can be given that our products will be implemented in any particular vehicles.  During this development process, we derive minimal funding from prototype sales but generally obtain no significant revenue until mass production begins, which could have a material adverse effect on our liquidity.  If our products are not selected after a lengthy development process, ourbusiness, results of operations and financial conditioncondition.

To the extent we are not able to successfully launch new business, vehicle production at our customers could be materiallysignificantly delayed or shut down. Such operating failures could result in significant financial penalties to us or a diversion of personnel and financial resources to improving launches rather than investment in continuous process improvement or other growth initiatives, and

20


could result in our customers shifting work away from us to a competitor. Any of the foregoing matters could result in a significant loss of revenue and market shares and could have an adverse effect on our profitability and cash flows.

We use important intellectual property in our business. If we are unable to protect our intellectual property or if a third party makes assertions against us or our customers relating to intellectual property rights, our business could be adversely affected.  affected.

Non-automotive productsWe own important intellectual property, including patents, trademarks, copyrights and trade secrets. Our intellectual property plays an important role in maintaining our competitive position in many of the markets that we develop or significantly update are also likelyserve.

We cannot guarantee, however, that we will be able to secure all desired protection, nor that the steps we have a lengthy sales cycle. Because the usetaken to protect our intellectual property will be adequate, to prevent infringement of our rights or misappropriation or theft of our technology, trade secrets or know-how. For example, effective patent, trademark, copyright and trade secret protection may be unavailable or limited in some of the countries in which we operate. In addition, while we generally enter into confidentiality agreements with our employees and third parties to protect our trade secrets, know-how, business strategy and other proprietary technologyinformation, such confidentiality agreements could be breached or otherwise may not provide meaningful protection for our trade secrets and know-how related to the design, manufacture or operation of our products. If it became necessary for us to resort to litigation to protect our intellectual property rights, any proceedings could be burdensome and costly, and we may not prevail. Further, adequate remedies may not be available in the event of an unauthorized use or disclosure of our trade secrets and manufacturing expertise. Finally, for those products in our portfolio that rely on patent protection, once a patent has expired, the product is generally open to competition. Products under patent protection usually generate higher revenues and profitability than those not protected by patents. If we fail to successfully enforce our intellectual property rights, our competitive position could suffer, which could harm our business, financial condition, results of operations and cash flows.

In addition, our competitors may develop technologies that are similar or superior to our proprietary technologies or design around the patents we own or license. Further, as we expand our operations in jurisdictions where the protection of intellectual property rights is less robust, the risk of others duplicating our proprietary technologies increases, despite efforts we undertake to protect them. Foreign governments may adopt regulations, and foreign governments or courts may render decisions, requiring compulsory licensing of intellectual property rights, or foreign governments may require products to meet standards that serve to favor local companies or provide reduced protection relative to other markets is new and evolving, and because customers will likely require any new product or significantly changed product that we develop to pass certain feasibility, safety and economic viability tests before committing to purchase, it is expected that any new or significantly changed products we develop in non-automotive markets also will take several years before they are sold to customers, if at all.countries.

Our ability to market our products successfully depends on acceptance of our products by existing and potential customers and consumers, as well as the success of our customerscustomers.

We have been, and will continue to be, required to educate potential customers and demonstrate that the merits of our existing products justify the costs associated with them. Similar efforts will be required with existing and potential customers for additional products we develop using technologies we develop or license. ManufacturersCustomers will only include our products if there appears to be demand for our products from the consumers.consumer demand. For our automotive products, we rely on OEMs and applicable dealer networks to market our products to consumers, and we do not have any control over the marketing budget or messaging nor the training of employees and agents regarding our products. Further, OEMs and dealer networks may market products offered by our competitors, including products manufactured by such OEMs. If customers or consumers conclude that temperature control seats or our other automotive products are unnecessary or too expensive or that our competitors offer more favorable sales terms or better products, OEMs and other manufacturers may reduce availability or decline to include our products in their vehicles.

In addition,Security breaches and other disruptions to our information technology networks and systems, including a disruption related to cybersecurity, could interfere with our operations and could compromise the vehicle market is highly competitive among OEMs, which drives continual cost-cutting initiatives byconfidentiality of our customers.  It is possible that pricing pressures beyond our expectations could intensify as OEMs pursue restructuring and cost cutting initiatives.  If we are unable to generate sufficient production cost savings in the future to offset such price reductions, our gross margin, rate of profitability and cash flows could be materially and adversely affected.  proprietary information or personal information.

We must also satisfy the timing, performancerely on our information technology systems and quality standardsnetworks in connection with many of our business activities. Some of these networks and systems are managed by third-party service providers and are not under our direct control. Our operations routinely involve receiving, storing, processing and transmitting sensitive information pertaining to our business, customers, suppliers, employees and consumers during mass production.  Further, we are dependentother sensitive matters. We rely upon the timingcapacity, reliability and successsecurity of our customers’ continuation of existing vehiclesIT and introduction of new vehicles which include our products.  If such vehicles are not successful in the marketplace, our results of operations and financial condition could be materially and adversely affected.

16


Significant increases in the market prices and restrictions on the availability of certain raw materials may materially and adversely affect our business

Many of our products include TEDs which contain certain raw materials that generally cannot be substituted. The prices for these raw materials fluctuate depending on market conditions.  We generally have no contractual price protections with our suppliers and customers regarding raw material costs.  Substantial increases in the prices for our raw materials increase our operating costs and could reduce our profitability if we cannot recover these increases from our customers.  As an example, Tellurium is a raw material used in TEDs. If the market price for this raw material significantly increases,data security infrastructure, as it has in the past, our gross profit may be adversely impactedwell as our suppliers pass those price increases on to us. Other key raw materials include copper, silver and petroleum based engineered plastics. In addition, the availability of raw materials fluctuates from time to time due to factors outside our control, including as a result of catastrophic events, which may adversely impact our ability to meet customer commitmentsexpand and continually update this infrastructure in response to the changing needs of our business. If we experience a problem with the functioning of an important IT system or needs. Our business, resultsa security breach of operationsour IT systems, due to failure to timely upgrade systems or during system upgrades and/or new system implementations, or resulting from failures of our third-party service providers, the resulting disruptions could have an adverse effect on our business.

21


As with most companies, we have experienced cyber-attacks, attempts to breach our systems and financial conditionother similar incidents, none of which were material in 2021. Any future cyber incidents could, however, materially disrupt operational systems; result in loss of trade secrets or other proprietary or competitively sensitive information; compromise personally identifiable information regarding customers or employees; delay our ability to deliver products to customers; and jeopardize the security of our facilities. A cyber incident could be materiallycaused by malicious outsiders (including state-sponsored espionage or cyberwarfare) or insiders using sophisticated methods to circumvent firewalls, encryption and adversely affected by shortagesother security defenses. Because techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Information technology security threats, including security breaches, computer malware, “ransomware” and other cyber-attacks, are increasing in both frequency and sophistication and could create financial liability, subject us to legal or regulatory sanctions or damage our reputation with customers, dealers, suppliers and other stakeholders. Many victims of ransomware are forced to pay significant price increases of key raw materials.  

The disruption or loss of relationships with vendorsransoms to regain access to their critical business data, and suppliers for the components for our products could materiallywe may not be permitted under various regulations and adversely affect our business

Our abilitylaws to manufacture and market our products successfully is dependent on relationships with both third party vendors and suppliers. We rely on various vendors and suppliers for the componentsmake such payments.  With some of our productsemployees working from home during the COVID-19 pandemic, there may be increased opportunities for unauthorized access and procure these components through purchase orders, with no guaranteed supply arrangements. Certain components are only available fromcyber-attacks. Security breaches could also result in a limited numberviolation of suppliers. The lossU.S. and international privacy and other laws and subject the Company to various litigations, investigations and proceedings. We continuously seek to maintain a robust program of any significant supplier, ininformation security and controls, but the absenceimpact of a timely and satisfactory alternative arrangement, or an inability to obtain essential components on reasonable terms or at all, could materially and adversely affect our business, results of operations and financial condition.

Our business also could be materially and adversely affected by delays in deliveries from suppliers because we carry minimal inventory of product components.  Automobile manufacturers, in particular, demand on-time delivery of quality products, and some have required the payment of substantial financial penalties for failure to deliver components to their plants on a timely basis.  Such penalties, as well as costs to avoid them, such as overtime costs and overnight air freighting of parts that normally are shipped by other less expensive means of transportation due to our global production operations,material information technology event could have a material adverse effect on our business, results of operations and financial condition. Moreover, the inability to meet demand for our products on a timely basis would materially and adversely affect ourcompetitive position, reputation, and future commercial prospects.

In addition, financial difficulties or solvency problems with our suppliers, which may be exacerbated by the cost of remediating quality issues with these items, could lead to uncertainty in our supply chain or cause supply disruptions for us which could, in turn, disrupt our operations, including production.

Further, we engage outside contractors to perform product assembly and other production functions for certain of our products. Our reliance upon third party contractors for certain production functions reduces our control over the manufacture of our products and makes us dependent in part upon such third parties to deliver our products in a timely manner, with satisfactory quality controls and on a competitive basis.  If we are unable to meet commitments to our customers due to third party services in production, our business, results of operations, financial condition and cash flows.

Despite our implementation of security measures, our IT systems, like those of other companies, are vulnerable to damages from computer viruses, natural disasters (which may become more frequent due to climate change), unauthorized access, cyber-attack and other similar disruptions. No IT system can be fully secure and impervious to all threats or failures. Any system failure, accident or security breach could result in disruptions to our operations. A material network breach in the security of our IT systems could include the theft of our intellectual property, trade secrets, customer information, human resources information or other confidential information. To the extent that any disruptions or security breach results in a loss or damage to our data, or an inappropriate disclosure of confidential, proprietary or customer information, it could cause significant damage to our reputation, couldaffect our relationships with its customers, lead to claims against us, fines and other penalties assessed upon us by governmental authorities, and ultimately harm our business. In addition, we may be materiallyrequired to incur significant costs to remediate and adversely affected.protect against damage caused by these disruptions or security breaches in the future.

Our business is subject to risks associated with manufacturing processesprocesses.

If certain of our existing production facilities become incapable of manufacturing products or production capacity is limited for any reason, such as terror attacks, war, or other civil disturbances, natural disasters (which may be more frequent due to climate change), other catastrophic events, public health crises, labor shortages, work stoppages, or other events that cause facility closures or production disruptions, we may be unable to meet production requirements, sales and profits could decline, and our commercial reputation could be damaged. For example, we experienced extended work stoppages in the first half of 2020 as the pandemic spread and governmental authorities initiated “lock-down” orders for all non-essential activities. Without operation of certain existing production facilities, we may be limited in our ability to deliver products until we restore the manufacturing capability at the particular facility, find an alternative manufacturing facility or arrange an alternative source of supply.

We internally manufacturemaintain property damage insurance that we believe to be adequate to provide for reconstruction of facilities and equipment, as well as business interruption insurance to mitigate losses resulting from any production interruption or shutdown caused by an insured loss. However, any recovery under our insurance policies may not offset the lost sales, harm to our business reputation or increased costs that may be experienced during the disruption of operations. Further, any such proceeds may be received and accounted for in a largedifferent reporting period, which could materially and growing portion ofadversely affect our products at our fourteen production facilities.  See Item 2. below for information regarding our significant properties.  Other products we sell are manufactured by third parties.  A catastrophic loss of the use of all or a portion of our facilities due to accident, fire, explosion, labor issues, civil unrest, weather conditions, other natural disaster or otherwise, whether short or long-term, could have a material adverse effect on our business, financial condition, results of operations and cash flow generally or for a specific reporting period.

If we fail to manage our growth effectively or to integrate successfully any new or future business ventures, acquisitions, investments or strategic alliance into our business, our business could be materially adversely harmed.

We regularly consider opportunities to pursue business ventures, acquisitions, investments and strategic alliances that could leverage our products and capabilities, as well as, enhance our customer base, geographic penetration and scale, to complement our current businesses, some of which could be material. Finding and assessing a potential growth opportunity and completing a transaction involves extensive due diligence, management time and expense; however, the amount of information we can obtain about a potential growth opportunity may be limited. Further, we can give no assurance that new business ventures, acquisitions,

22


investments and strategic alliances will positively affect our financial condition.  This riskperformance or will perform as planned, including regarding anticipated synergies or other financial or operational benefits. We may not be able to successfully assimilate or integrate companies that we acquire, including personnel, financial systems, distribution, operations, internal controls and general operating procedures. Further, for significant transactions, we would expect to incur additional debt, issue equity and/or increase capital expenditures, which may increase leverage risks, result in dilution or reduce capital available for other investments in ongoing operations. If we fail to assimilate or integrate acquired companies successfully, our business, reputation and results of operations could be materially impacted. Likewise, our failure to integrate and manage acquired companies successfully may lead to future impairment of any associated goodwill and intangible asset balances. Given our limited history in the patient temperature management business, the foregoing risks may be heightened due to our lack of experience in integrating similar businesses.

Our global operations subject us to risks that may harm our operations and financial results.

In 2021, 61% of our product revenue was generated from sales to customers outside the United States. We have significant personnel, property, equipment and operations in a number of countries outside of the United States, including China, Germany, Hungary, North Macedonia, Mexico, South Korea, Ukraine and Vietnam. Our exposure to the risks described below is exacerbated bysubstantial. We also derive a significant portion of revenues from Europe and Asia and conduct certain investing and financing activities in local currencies.

In addition to the factgeneral risks relating to our operations, our international operations are subject to unique risks inherent in doing business abroad, including:

exposure to local economic, political and labor conditions;

different and complex local laws and regulations and enforcement thereof, including those relating to governance, taxes, litigation, anti-corruption, employment, employee benefits, environmental, competition, permitting, investment, product regulations, repatriation, and export/import restrictions or requirements;

increases in duties, tariffs and taxation on our products related to U.S. trade disputes; trade restrictions and potential trade wars, including limitation on imports or exports of components or assembled products, unilaterally or bilaterally;

exposure to infectious disease and epidemics, including the effects on our business operations, and those of our customers and suppliers, in geographic locations impacted by an outbreak, such as the ongoing COVID-19 pandemic;

violence and civil unrest (including acts of terrorism, drug-cartel related and other forms of violence and outbreaks of war);

expropriation, nationalization or other protectionist activities;

currency exchange rate fluctuations and currency controls; in particular, a significant portion of our revenues and expenses are denominated in currencies other than the U.S. Dollar, including the Euro, the Chinese Renminbi, the Vietnamese Dong, the Hungarian Forint, the North Macedonian Denar, the Ukrainian Hryvnia, the South Korean Won and the Mexican Peso;

local business and cultural factors that differ from our customary standards and practices, including business practices that we are prohibited from engaging in due to anti-corruption laws and regulations; and

ineffective legal protection of our intellectual property rights in certain countries.

23


Additionally, our primary manufacturing locations are in Mexico, China, Vietnam, North Macedonia and Ukraine, all countries that have historically experienced a heightened degree of political, civil and labor uncertainty.

Political conflict and related demonstrations and violence in Ukraine in recent years, for example, highlights the risks to our foreign manufacturing facilities. Although our manufacturing facility in Ukraineis located approximately 700 miles by road from Kiev, and approximately the same distance from the activities along the border of Ukraine and Russia where fighting has occurred, we

17


cannot be certain that similar demonstrations, unrest and international tensions will not affect our facility in the future, including due to electrical outages and periodic battles with separatists closer to our facility. In addition, certain of our employees in Ukraine are routinely conscripted into the military and/or sent to the Russian border to fight in the ongoing conflict. Furthermore, most of our products manufactured in Ukraine are shipped across the border from Ukraine to Hungary for further delivery to our customers. If that border crossing were to be closed or restricted for any reason, we would essentially experience a loss of the use of our Ukrainian facility, which would have a material adverse effect on our business.

Unexpected failuresDefects or quality issues associated with our automotive and medical products could adversely affect the results of our equipmentoperations.

Our design, manufacture and machinerymarketing of automotive products may subject us to warranty claims and product liability in the event that our products fail to perform as expected and, in the case of product liability, such failure of our products results or is alleged to result in bodily injury or property damage. Any large product liability claims, if made, could exceed our insurance coverage limits and insurance may not continue to be available on commercially acceptable terms, if at all, and we may incur significant costs to defend these claims. If any of our products are or are alleged to be defective, we also may resultbe required to participate in production delays, revenue lossa recall or other corrective action involving such products. Automotive manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and significant repair costs, injuries to our employees, and customer claims. Any interruption in production capability may require us to delay fulfilling orders, utilize less efficient internal facilities on a temporary basis and make large capital expenditures to remedy the situation, which could have a negative impact on our profitability and cash flows.

We maintain property damage insurance that we believe to be adequate to provide for reconstruction of facilities and equipment,product liability claims, as well as business interruptionrequiring their suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties.  OEMs historically have recalled vehicles for perceived defects in seat heaters, and we have incurred liabilities in connection with the recalls and other field actions.  In addition, governmental regulatory agencies throughout the world, such as NHTSA in the U.S., have safety standards that require manufacturers to remedy defects related to vehicle safety through safety recall campaigns, and a manufacturer is obligated to recall vehicles if it determines that the vehicles do not comply with a safety standard. A recall claim brought against us that is not insured, or a product liability claim brought against us in excess of our available insurance, to mitigate losses resulting from any production interruption or shutdown caused bycould have an insured loss.  However, any recovery underadverse impact on our insurance policies may not be offset the lost sales or increased costs that may be experienced during the disruption of operations, and such proceeds may be received and accounted for in a different reporting period, which could materially and adversely affect our business, financial condition, results of operations and cash flow generallyreputation or for a specific reporting period.

Our global operations subject us to risks that may harm our operations and financial results

In 2018, 53%market acceptance of our products.  In certain instances, allegedly defective products may be the result of components supplied by our supply chain, and we may be limited in our ability to obtain recovery from our suppliers of materials or services included within our products that are associated with product revenue was generated from salesliability and warranty claims, particularly if the affected items relate to customers outside the United States. We have significant personnel, property, equipmentglobal platforms or involve defects that are identified years after production.

The design, manufacture and operations in a numbermarketing of countries outsidemedical products involve certain inherent risks. Manufacturing or design defects, component failures, unapproved or improper use of the United States, including Canada, China, Germany, Hungary, Macedonia, Mexico, Ukraine and Vietnam.  We have also engaged third parties to produceour products, for us in China and Japan. We and these third parties maintain production facilities in lower-cost countries for cost containment reasons.  Our exposureor inadequate disclosure of risks or other information relating to the risks described below is substantial and increasing.  We also derive a significant portionuse of revenues from Europe and Asia and conduct certain investing and financing activities in local currencies.

In additionour products can lead to the general risksregulatory action, injury or other serious adverse events. These events could lead to recalls or safety alerts relating to our operations,products (either voluntary or as required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. A recall, inadequate disclosure or defect could result in significant costs and lost sales and customers, enforcement actions and/or investigations by state and federal governments or other enforcement bodies, as well as negative publicity and damage to our international operations are subject to unique risks inherent in doing business abroad, including:

exposure to local economic conditions and infrastructure;

different and complex local laws and regulations and enforcement thereof, including thosereputation that could reduce future demand for our products. Personal injuries relating to governance, taxes, litigation, anti-corruption, employment, employee benefits, environmental, competition, permitting, investment,the use of our products can also result in significant product regulations, repatriation, and export/import restrictionsliability claims being brought against us. In some circumstances, such adverse events could also cause delays in regulatory approval of new products or the imposition of post-market approval requirements, such as further clinical testing.  Such clinical testing is costly and time-consuming and could delay market approval or the recently implemented revised emissions test procedure in Europe referredmeeting of additional post-market requirements.

Legal, Regulatory and Compliance Risks

Changes to as the Worldwide Harmonized Light Vehicles Test Procedure that has limited the production of certain vehicles as OEMs have struggled to meet the new requirements;

increased uncertainty regarding social, political, immigration and trade policies in the U.S. and abroad, such as recent U.S. legislation and policies regarding NAFTA andpolicy, including tariffs and the U.K.’s pending Brexit (as defined below);

political, economic and civil instability (including acts of terrorism, civil unrest, drug-cartel related and other forms of violence and outbreaks of war);

expropriation, nationalization or other protectionist activities;

currency exchange rate fluctuations and currency controls; in particular, a significant portion of our revenues and expenses are denominated in currencies other than the U.S. Dollar, including the Euro, the Chinese Renminbi, the Vietnamese Dong, the Hungarian Forint, the Macedonian Denar, the Ukrainian Hryvnia, and the Mexican Peso;

increases in working capital requirements and greater potential for production and delivery delays due to extended logistics and geo-political developments;

local business and cultural factors that differ from our customary standards and practices, including business practices that we are prohibited from engaging in due to anti-corruption laws and regulations; and

18


global sovereign fiscal matters and creditworthiness, including potential defaults and the related impacts on economic activity, including the possible effects on credit markets, currency values, monetary unions, international treaties and fiscal policies.

See “Our business is subject to risks associated with manufacturing processes” above for a description of certain specific risks associated with our facility in Ukraine.

Modification of the North American Free Trade Agreement (“NAFTA”) or other international trade agreements, and the imposition of significant tariffs on imports into the United States,customs regulations, could have a material and adverse effect on our businessbusiness.

A significant portion of our business activities are conducted in foreign countries, including Mexico.  As a result of changes to U.S. administrative policy, there may be changes to existingExisting free trade agreements, like NAFTAlaws and its anticipated successor agreement,regulations, such as the U.S.-Mexico-CanadaUnited States-Mexico-Canada Agreement, (“USMCA”) which is stillprovide certain duties and tariffs for qualifying imports and exports, subject to approval bycompliance with the U.S., Mexicoapplicable classification and Canada, greaterother requirements. Changes in laws or policies governing the terms of foreign trade, and in particular increased trade restrictions, on free trade generally, and significant increases in tariffs on goods imported into the U.S., particularly tariffs on products manufactured in Mexico, among other possible changes.

Additionally, during 2018, the U.S. and China applied significant tariffs to certain of each other’s exports. The institution of trade tariffs, both globally and between the U.S. and China specifically, carries the risk of negatively impacting overall economic conditions, which could have negative repercussions on the Company. More directly, imposition of tariffs has caused and could cause further increases in the costs of our raw materials which we may not be able to pass on to our customers in part or in full, which would directly and negatively impact our business.  We purchase a significant amount of raw material components, including products manufactured in our China facilities, which are subject to the recently-enacted tariffs.  The imposition of tariffs has caused and could cause further increases in the costs of our raw materials, and we may not be able to mitigate the impact from these tariffs or additional future tariffs.

It remains unclear what the U.S. administration or foreign governments, including Mexico and China, will or will not do with respect to tariffs, NAFTA, USMCA or other international trade agreements and policies.  A trade war, other governmental action related to tariffs or international trade agreements, changes in U.S. social, political, regulatory and economic conditions or in laws and policies governing foreign trade, manufacturing, development and investment in the territories andtaxes on imports from countries where we currently manufacture products, such as China and sells products, and any resulting negative sentiments towards the U.S. asMexico, could have a result of such changes, likely would have anmaterial adverse effect on our business and financial condition or resultsresults. For instance, beginning in 2018, the U.S. and Chinese governments have imposed a series of operations.significant incremental retaliatory tariffs to certain imported products. Most notably with respect to the automotive industry, the U.S. imposed tariffs on imports of certain steel,

Political24


aluminum and economic uncertainty arising from the outcomeautomotive components, and China imposed retaliatory tariffs on imports of the referendum on the membership of the United Kingdom in the European Union could adversely impact our financial results

In June 2016, the United Kingdom (U.K.) voted to exit the European Union (“Brexit”) in a referendum vote. In March, 2017, the U.K. formally notified the European Union of its intention to withdraw pursuant to Article 50 of the Lisbon Treaty, which provides a two-year time period through March 2019 for the U.K.U.S. vehicles and the European Union countries to negotiate a withdrawal. The announcement of Brexitcertain automotive components. Depending upon their duration and the ongoing negotiations for the withdrawal of the U.K. from the European Union has created and may continue to create global economic uncertainty, which may continue to impact global light vehicle production, and affect the business of and/or our relationships with our customers and suppliers,implementation, as well as alter the relationship among tariffs and currencies. The long-term effects of Brexit remain uncertain, and Brexit has and may continue to contribute to volatility in stock prices of companies that have significant operations in Europe, and on currency exchange rates.  Significant currency fluctuations may negatively impact our operations; we generate certain revenues in Euro, but do not generate revenues denominated in the British Pound. In addition, Brexit could result in legal uncertainty and potentially divergent national laws and regulations as new legal relationships between the United Kingdom and the European Union are established.  The ultimate effects of Brexit on us also will depend on the terms of any agreements the U.K. and the European Union make to retain access to each other's respective markets either during a transitional period or more permanently.

Significant price volatility, or uncertainty in future pricing, or oil and natural gas may materially and adversely impact our Gentherm Global Power Technologies (GPT) business

A large portion of our GPT products are sold to companies in the oil and gas industry, in particular, pertaining to new oil and gas pipelines and wells.  Prices for oil and natural gas historically have been volatile and are expected to continue to be volatile.

19


Significant changes in the price of oil and natural gas or uncertainty as to future pricing can adversely impact the number of new oil explorations and installations, and cause the postponement or cancellation of existing projects, any of which would adversely affect our GPT business, and adversely impact our ability to sellmitigate their impact, these tariffs and other regulatory actions could materially affect our business, including in the business on favorable terms or at all.form of increased cost of goods sold, decreased margins, increased pricing for customers, and reduced sales.

Tax matters, including the changes in the corporate tax rates, disagreement with taxing authorities and imposition of new taxes could impact our results of operations and financial condition.

We are subject to income and other taxes in the U.S. and our operations, plans and results are affected by tax and other initiatives. On December 22, 2017, the Tax Cuts and Jobs Act (H.R. 1) (the “Tax Act”) was signed into law by President Trump. The Tax Act contains significant changes to corporate taxation, including reduction of the corporate tax rate from 35% to 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small business), limitation of the deduction for net operation losses (“NOLs”) to 80% of current year taxable income and elimination of NOL carrybacks, one time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), new taxes on certain foreign earnings, a new minimum tax related to payment to foreign subsidiaries and affiliates, immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits. It is uncertain if, and to what extent, various states will conform to the new tax law and foreign countries will react by adopting tax legislation or taking other actions.  

internationally. We are also subject to regular reviews, examinations, and audits by the Internal Revenue Service and other taxing authorities with respect to our taxes. Although we believe our tax estimates are reasonable, if a taxing authority disagrees with the positions we have taken, we could face additional tax liability, including interest and penalties. There can be no assurance that payment of such additional amounts upon final adjudication of any disputes will not have a material impact on our result of operations and financial position.

We also need to comply with new, evolving or revised tax laws and regulations. The enactment of or increases in tariffs, or other changes in the application or interpretation of the Tax Act,tax legislation and other initiatives, or on specific products that we sell or with which our products compete, may have an adverse effect on our business or on our results of operations.

The value of our deferred tax assets may not be realized, which could materially and adversely affect our operating results.

As of December 31, 2021, we had approximately $68 million in net deferred tax assets, inclusive of a $16 million valuation allowance. These deferred tax assets include net operating loss carryovers and tax credits that can be used to offset taxable income in future periods and reduce income taxes payable in those future periods. Each quarter, we determine the probability of the realization of deferred tax assets, using significant judgments and estimates with respect to, among other things, historical operating results and expectations of future earnings and tax planning strategies. If we determine in the future that there is not sufficient positive evidence to support the valuation of these assets, due to the risk factors described herein or other factors, we may be required to further adjust the valuation allowance to reduce our deferred tax assets. Such a reduction could result in material non-cash expenses in the period in which the valuation allowance is adjusted and could have a material adverse effect on our financial statements.

Our patient temperature management systems business is subject to extensive industry regulation and failure to comply with all applicable rules and regulation may adversely impact usus.

Our patient temperature management products are subject to extensive, complex, costly and evolving government regulation. In the United States, this is principally administered by the Food and Drug Administration (“FDA”). Various regulatory agencies in foreign countries where our medical products are sold also regulate that business. Under theseboth United States and foreign country regulations, we are subject to periodic inspection of our facilities (including third-party facilities that are performing services for us), procedures and operations and testing of our products. Following such FDA inspections, should any noncompliance with regulations or other quality issues be noted, we may receive observations, notices, citations and/or warning letters that could require us to get FDA approval of a corrective action plan and modify certain activities identified during the inspection, possibly at a significant cost. We are also required to report adverse events associated with our medical products to the FDA and other foreign regulatory authorities.authorities where our products have been approved or received market clearance. Unexpected or serious health or safety concerns could result in liability claims, recalls, market withdrawals or other regulatory actions. Changes in laws or regulations could require us to change the way we operate or to utilize resources to maintain compliance, which could increase costs or otherwise disrupt operations. In addition, failure to comply with any applicable laws or regulations could result in fines or revocation of our operating permits and licenses or, in rare circumstances, market withdrawal of the product.

The process for obtaining governmental approval to manufacture and market new medical devices is time-consuming and costly. We are dependent on receiving FDA and other governmental or third-party approvals prior to manufacturing, marketing and shipping any new medical products. We cannot be certain that any new medical products we develop will receive FDA or other necessary approvals. Also receipt of approval in one country does not guarantee approval by the FDA or any other foreign regulatory agency.

Any failure to comply with anti-corruption laws and regulations could have a material and adverse effect on our reputation, business and financial resultsresults.

Our operations outside of the United States require us to comply with various anti-bribery and anti-corruption regulations, including but not limited to the U.S. Foreign Corrupt Practices Act, the United Kingdom Bribery Act and the China Anti-Unfair

25


Competition Law. Recent years have seen a substantial increase in anti-bribery law enforcement activity, with more frequent and aggressive investigations and enforcement proceedings by both U.S. and non-U.S. regulators, and increases in criminal and civil proceedings brought against companies and individuals. We operate in many partsViolations of the world that are recognized as having governmental and commercial corruption and local customs and practices that can be inconsistent with anti-bribery laws. We have internal control

20


policies and procedures, and we have implemented training and compliance programs for our employees and agents, with respect to these regulations.  However, our policies, procedures and programs may not always protect us from negligent, reckless or criminal acts committed by our employees or agents.  We could incur significant expenses in investigating any potential violation and could incur severe criminal or civil sanctions and/or fines as a result of violations or settlements regarding such laws.  In addition, any allegations, settlements or violations could materially and adversely impact our reputation and our relationships with current and future customers, suppliers, employees and agents.  Also, some of our competitors may not be subject to, or similarly comply with, the same anti-corruption laws, which could provide them a competitive advantage.  

We are subject to significant currency risk related to our global operations

A significant portion of our global transactions is conducted in currencies other than the U.S. Dollar. While we sometimes employ financial instruments to hedge some of our transactional foreign exchange exposure, developing an effective and economical foreign currency risk strategy is complex and expensiveoften difficult to interpret and no strategy can completely insulate us from those exposures.  Hedging arrangements also may expose us to additional risks, includingapply, could result in significant criminal penalties or sanctions that a counterparty may fail to honor its obligations, and additional costs, including transaction fees and breakage costs.  Changes in the exchange rates of foreign currencies could significantlyadversely affect our reportedbusiness, financial condition, results of operations and financial condition.

In addition, concerns persist regarding the debt burden of certain European countries that have adopted the Euro currency (the "Euro Zone") and their ability to meet future financial obligations, as well as concerns regarding the overall stability of the Euro to function as a single currency among the diverse economic, social and political circumstances within the Euro Zone. For example, the announcement of the United Kingdom’s decision to exit the European Union continues to cause significant volatility in currency exchange rates, especially between the U.S. dollar and British pound sterling.  If one of the Euro Zone countries were to default on its debt or other Euro Zone countries withdraw from the Euro currency, the impact on global markets, and on our business, results of operations and financial condition, could be significant, and that impact would intensify substantially if the Euro currency were dissolved entirely. Such a development could also cause financial and capital markets across the globe to constrict, reducing liquidity and increasing borrowing costs, and could have a significant negative impact on consumer confidence and spending.

Any failure to protect our intellectual property developed or licensed could harm our business and competitive position

We believe that patents and proprietary rights have been and will continue to be very important in enabling us to compete.  If our patents are circumvented, rendered invalid or unenforceable, or narrowed in scope, the patent coverage afforded to our products would be impaired, which could significantly impede our ability to market our products, negatively affect our competitive position and materially and adversely affect our business and results of operations.

There can be no assurance that any new or pending patents will be issued, that our or our licensors’ proprietary rights will not be challenged, invalidated, circumvented or rendered unenforceable, or that our patents will provide us with meaningful competitive advantages. Furthermore, there can be no assurance that others will not independently develop similar products or will not design around any patents that have been or may be issued to our licensors or us. Also, failure to seek or obtain patents in certain foreign countries may materially and adversely affect our ability to compete effectively in those international markets.  Further, as we expand our operations in jurisdictions where the protection of intellectual property rights is less robust, such as China, the risk of others duplicating our proprietary technologies increases, despite efforts we undertake to protect them.  Foreign governments may adopt regulations—and foreign governments or courts may render decisions—requiring compulsory licensing of intellectual property rights, or foreign governments may require products to meet standards that serve to favor local companies.

Because of rapid technological developments in the automotive industry and the competitive nature of the market, the patent position of any component manufacturer is subject to uncertainties and may involve complex legal and factual issues. Consequently, although we either own or have licenses to certain patents, and are currently processing a significant number of additional patent applications, it is possible that no patents will issue from any pending applications or that claims allowed in any existing or future patents issued or licensed to us will be challenged, invalidated, circumvented, or that any rights granted under such patents will not provide us adequate protection. There is an additional risk that we may be required to participate in interference proceedings to determine the priority of inventions or may be required to commence litigation to protect our rights, which could result in substantial costs and divert the attention of management and technical and engineering personnel.  

21


In addition to patents, we rely on a combination of trademarks, copyrights, know-how, confidentiality provisions and licensing agreements to establish and protect our proprietary rights. We cannot guarantee, however, that the steps we have taken to protect our intellectual property will be adequate to prevent infringement of our rights or misappropriation thereof.

To the extent that consultants, key employees or other third parties apply technological information independently developed by them or by others to our proposed projects, disputes may arise as to the proprietary rights to such information that may not be resolved in our favor. Additionally, with respect to licensed technology, there can be no assurance that the licensor of the technology will have the resources, financial or otherwise, or desire to defend against any challenges to the rights of such licensor to its patents.

Our products may conflict with patents that have been or may be granted to competitors or others

Other persons could bring legal actions against us claiming damages and seeking to enjoin manufacturing and marketing of our products for allegedly conflicting with patents held by them. Any such litigation could result in substantial cost to us, divert the attention of management and engineering and technical personnel, and harm our reputation. If any such actions are successful, in addition to any potential liability for damages, we could be required to cease selling or using infringing products, obtain a license in order to continue to manufacture or market the affected products, or redesign the infringing products. There can be no assurance that we would prevail in any such action, that any license required under any such patent would be made available on acceptable terms, if at all, or that we could redesign such products on a timely basis and at a reasonable cost, if at all. Failure to obtain needed patents, licenses or proprietary information held by others may have a material adverse effect on our business, results of operations and financial condition. From time to time, we receive notices from third parties suggesting that our products infringe on the proprietary rights of others and historically we have had litigation regarding such matters. While we do not believe that any current claim of patent infringement is valid and material, we must spend time and resources reviewing, defending and resolving such claims.

We rely on trade secret protection through confidentiality agreements and the agreements could be breached or information may be otherwise stolen

We rely on trade secrets that we seek to protect, in part, through confidentiality and non-disclosure agreements with employees, customers and other parties. There can be no assurance that these agreements will not be breached, that we would have adequate remedies for any such breach or that our trade secrets will not otherwise become known to or independently developed by competitors.

The theft or unauthorized use or publication of our trade secrets and other confidential business information could harm our competitive position and reduce acceptance of our products, as well as the value of our investment in research and development, product development and marketing.  In addition, third parties might make claims against us related to losses of confidential or proprietary information, end-user data or system reliability. These incidents and claims could severely disrupt our business, and we could suffer losses, including the cost of product recalls and returns and reputational harm.  In addition, we may be required to incur significant costs to protect against damage caused by these disruptions or security breaches in the future.

Our most significant customers typically reserve the right unilaterally to cancel contracts or reduce prices, and the exercise of such right could reduce or eliminate any financial benefit to us anticipated from such contract

Due to their purchasing size, automotive customers typically reserve the right unilaterally to cancel contracts completely or to require price reductions during the term of the contract. Although these customers generally agree as a commercial practice to reimburse companies for actual out-of-pocket costs incurred with respect to the particular contract up to the point of cancellation, these reimbursements typically do not cover costs associated with acquiring general purpose assets, such as facilities and capital equipment, or for increases in employee count and related costs, and may be subject to negotiation and substantial delays in receiving payment on such actual out-of-pocket costs. Any unilateral cancellation of, or price reduction with respect to, any contract could reduce or eliminate any financial benefits anticipated from such contract.  If we are not able to offset pricing reductions through improved operating efficiencies and reduced expenditures, such price reduction could have a material adverse effect on our financial condition and results of operations.

22


The third parties that have agreed to reimburse portions of our research and development expenses generally also reserve the right to unilaterally terminate those contracts. There can be no assurance that we will continue to receive the third party reimbursements for any of our research and development efforts.cash flows.

A significant product liability lawsuit, warranty claim or product recall involving us or one of our major customers, or an investigation regarding vehicle safety generally, could materially and adversely affect our financial performanceperformance.

In the event that our products fail to perform as expected, whether allegedly due to our fault or that of one of our suppliers, and such failure results in, or is alleged to result in, bodily injury and/or property damage or other losses, we may be subject to product liability lawsuits and other claims, orand we have been in the past and may again be required or requested by our customers or regulators to participate in a recall or other corrective action involving such products. We also are a party to agreements with certain of our customers, whereby these customers may pursue claims against us for contribution of all or a portion of the amounts sought in connection with product liability and warranty claims. We carry insurance for certain product liability claims, butand have utilized such insurance periodically.  However, such coverage may be limited.limited for future claims. In addition, we may not be successful in recovering amounts from third parties, including suppliers, in connection with these claims. These types of claims could materially and adversely affect our financial condition, operating results and cash flows.

Over the past couple of years, there has been a significant increase in the level of scrutiny given to vehicle safety issues. Inquiries are being conducted not only by traditional regulators but also by state Attorneys General. Furthermore, the U.S. Department of Justice has commenced investigations and U.S. Congressional hearings have also been conducted in which vehicle manufacturers and in some cases suppliers are being called to testify as to particular safety risks. This increased scrutiny could materially and adversely affect the business of our customers and suppliers and subject us to fines, penalties, sanctions and/or investigations.

We are involved from time to time in various legal and regulatory proceedings and claims, which could adversely affect our financial performanceperformance.

We are involved in various legal and regulatory proceedings and claims that, from time to time, are significant. These are typically claims that arise in the normal course of business including, without limitation, commercial or contractual disputes, including disputes with our customers, suppliers or competitors, intellectual property matters, personal injury claims, environmental matters, tax matters and employment mattersmatters. Such legal and antitrust matters. No assurances can be givenregulatory proceedings could result in an adverse outcome for the Company that such proceedings and claims will notwould adversely affect our financial condition, operating results of operations and cash flows.

Our success will dependresults of operations and financial condition may be adversely impacted from a decrease in large part on retaining key personnelor cessation or clawback of government incentives related to investments, workforce or production.

We have received, and effective succession planning

Our success will depend to a large extent upon the continued contributions of key personnel. The lossmay receive economic benefits from national, state and local governments in various regions of the servicesworld in the form of oneincentives designed to encourage manufacturers to establish, maintain or moreincrease investment, workforce or production. These incentives may take various forms, including grants, loan subsidies and tax abatements or credits.  The impact of these incentives can be significant in a particular market during a reporting period.  A decrease in, expiration without renewal of, or other cessation or clawback of government incentives for any of our executive officersbusiness units, as a result of administrative decision or otherwise, could have a materialan adverse effectimpact on the successour results of our business. Effective succession planning is also important to our long-term success.  Failure to ensure effective transfer of knowledgeoperations and smooth transitions involving key employees could hinder our strategic planning and execution. Further, our success will depend, in part, uponfinancial condition, as well as our ability to retain qualified engineering and other technical and marketing personnel. There is significant competition for technologically qualified personnel in our business and we may not be successful in recruiting or retaining sufficient qualified personnel.fund new investments.

We are required to comply with environmental laws and regulations that could cause us to incur significant costscosts.

Our manufacturing facilities are subject to numerous laws and regulations designed to protect the environment, inside and outside the United States, and we expect that additional requirements with respect to environmental matters will be imposed on us in the future. We may also assume, or be deemed to assume, significant environmental liabilities in acquisitions. Environmental liability may be imposed without regard to fault, and under certain circumstances, can be joint and several, resulting in one party being held responsible for the entire obligation. Material future expenditures may be necessary if compliance standards change or material unknown conditions that require remediation are discovered. No assurance can be given that all environmental liabilities have been identified or that no prior owner or operator of our properties or former properties has created an environmental condition not known to us.  Environmental laws could also restrict our ability to expand our facilities or could require us to acquire costly equipment or to incur other significant expenses in connection with our business. Violations of these requirements could result in fines or sanctions, obligations to investigate or remediate contamination, third party property damage or personal injury claims due to the migration of contaminants off-site, or modification or revocation of our operating permits, which could materially and adversely affect our financial condition, operating results of operations and cash flows. Additionally, proposed and existing efforts to address climate change by reducing greenhouse gas emissions could directly or indirectly affect our costs of energy, materials, manufacturing, distribution, packaging and other operating costs, which could impact our business and financial results.

23


WeOur business may be negatively impacted by regulatory and customer-imposed requirements to address climate change and other sustainability issues.

As evidenced by shifting industry and consumer behaviors, including the development and use of electric vehicles, the automotive industry and consumers have a heightened focus on climate change and the environmental impact of product

26


manufacturing and end use. This increased focus on sustainability and the environmental impact of the automotive industry and manufacturing processes has caused our customers to impose additional requirements on us and our suppliers, which often exceed regulatory standards. These customer requirements include increased tracking and reporting of greenhouse gas emissions and other environmental metrics, reduced waste and wastewater from operations, increased use of sustainable materials in our products, and the use of renewable energy sources in our factory operations. We expect to incur increased operating costs and capital expenditures to procure renewable energy and additional equipment or make operational and process changes to comply with customer requirements. To the extent we are unable to realizemeet or exceed customer sustainability requirements, demand for our products and our revenues would be adversely impacted. We also expect that the expected benefits of our restructuring actions, whichincreased focus on sustainability and climate change will result in new legislation or regulations at the federal, state or local level. Such legislative developments could adversely affectimpact our profitabilitybusiness by increasing costs and could require us to make changes to our operations

In 2018, we announced significant restructuring and cost reduction actions to lower our operating costsresult in response to difficult marketsubstantial additional capital expenditures and operating conditionscosts. These additional costs, changes in various partsoperations, or loss of the world. These actions included workforce reductions, asset impairment, plant closures, and minimization or elimination of investments in non-core areas. As we continue to assess our performance throughout various regions, we may take additional restructuring actions to rationalize our operations, which may result in impairments and reduce our profitability in the periods incurred. In addition, we may not realize anticipated savings or benefits from past or future cost reduction actions in full or in part or within the time periods we expect. We are also subject to the risks of labor unrest, negative publicity and business disruption in connection with our cost reduction actions. Failure to realize anticipated savings or benefits from our cost reduction actionsrevenues could have a material adverse effect on our business, prospects, financial condition, liquidity, results of operations and cash flows.

We may not realize significant benefits from acquisitions or joint ventures because of integration difficulties and other challenges

We regularly consider acquisitions to expand the breadth of products derived from core thermal technologies as well as the markets in which they are applied.  Identifying suitable potential acquisitions, conducting due diligence, successfully negotiating and closing an acquisition and the acquisition integration process are complex, costly and time-consuming. The difficulties of completing and integrating an acquisition include, among others:

incurring additional debt and/or issuing additional securities, increasing leverage risks or dilution;

unsatisfactory returns on our investments and our inability to realize the expected benefits of such acquisitions or joint ventures;

difficulties in implementing our business plan for the combined business, including achieving anticipated synergies in amount and on time;

required significant capital expenditures to integrate our operations and pursue synergies;

unanticipated issues in integrating manufacturing, logistics, financial and other internal controls, communications and other systems;

diversion of management attention and capital from ongoing business concerns to integration matters;

challenges assimilating management and other personnel, including because of differences in culture, language and background for international acquisitions;

difficulty maintaining oversight over internal controls and preventing misconduct or other violations of applicable laws by any investment which we do not exercise control;

the size of operations acquired relative to our existing business;

unanticipated changes in applicable laws and regulations;

failure to obtain regulatory or other approvals;

failure to retain key employees, customers and suppliers of the combined business;

assumption of known and unknown liabilities, some of which may be difficult or impossible to quantify; and

non-cash impairment charges or other accounting charges relating to the acquired assets.

To the extent we complete an acquisition in a new industry, the above risks will be heightened due to our lack of familiarity with such business.

24


In the future, we may not be able to successfully identify suitable acquisition or joint venture opportunities or complete any particular acquisition, combination, joint venture or other transaction on acceptable terms. Our identification of suitable acquisition candidates and joint venture opportunities and the integration of acquired business operations involve risks inherent in assessing the values, strengths, weaknesses, risks and profitability of these opportunities, as well as significant competition for such acquisition opportunities. Our focus on acquisition opportunities may require significant financial, management and related resources that would otherwise be used for the ongoing development of our existing operations and internal expansion.

We may not generate enough liquid assets to fund our ongoing operations and investments and service our debt

Based on our current business plan, we believe our cash on hand along with cash flows from operating activities will be sufficient to meet operating and capital expenditure needs and to service our debt for the foreseeable future.  However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and materially and adversely affect our results of operations and financial condition.  In addition, we may need to complete one or more equity or debt financings if we consummate any significant acquisitions.  There can be no assurance that such capital will be available at all or on reasonable terms, which could materially and adversely affect our future operations and business strategy.


25


We may not be able to generate sufficient cash flows to meet our substantial debt service obligations, and such substantial debt service obligations could materially and adversely affect our business, results of operations and financial condition

Our ability to make payments on and to refinance our debt obligations depends on our ability to generate cash flows from operations in the future. This, to a certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. We may not be able to refinance any of our indebtedness on commercially reasonable terms, or at all.

If we cannot service our indebtedness, we may have to take actions such as selling assets, seeking additional equity or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances, any of which could impede the implementation of our business strategy or prevent us from entering into transactions that would otherwise benefit our business. Additionally, we may not be able to affect such actions, if necessary, on commercially reasonable terms, or at all.

Our debt obligations could have important consequences to our business, results of operations and financial condition. For example:

we may be more vulnerable to general adverse economic and industry conditions;

we may be required to dedicate a substantial portion of our cash flows from operations to payments on our indebtedness, thereby reducing the availability of cash flows for other purposes, including for working capital, dividends, capital expenditures, business development efforts and to finance mergers and acquisitions;

our ability to borrow additional debt for operations, working capital or to finance future mergers and acquisitions may be limited;

our ability to refinance or repay other debt obligations when they become due may be limited;

we are exposed to the risk of increased interest rates because a portion of our borrowings, including under our credit facilities, are at variable rates of interest; and

our flexibility in planning for, or reacting to, changes in our business and the industries in which we operate may be limited, thereby placing us at a competitive disadvantage compared to our competitors that have less indebtedness.

Our debt agreements contain certain restrictive covenants and customary events of default. These restrictive covenants limit our ability to take certain actions, such as, among other things: incur additional debt, make certain payments or distributions, engage in mergers or consolidations, make certain dispositions and transfers of assets, enter into transactions with affiliates and guarantee indebtedness. While not unusual for financings of the type that we have, the restrictions in our credit facilities may prevent us from taking actions that we believe would be in the best interest of our business and may make it difficult for us to execute our business plans, take advantage of business opportunities, or react to changing industry conditions.

Upon an event of default, if not waived by our lenders, our lenders may declare all amounts outstanding as due and payable, which may cause cross-defaults under our other debt obligations. If our lenders accelerate the maturity of our indebtedness, we may not have sufficient capital available at that time to pay the amounts due to all lenders on a timely basis, and there is no guarantee that we would be able to repay, refinance, or restructure the payments on such debt. Further, under our credit facilities, the lenders would have the right to foreclose on certain of our assets, which could have a material adverse effect on our business, results of operations and financial condition.

26


Our results of operations and financial condition may be adversely impacted from a decrease in or cessation or clawback of government incentives related to investments

We receive economic benefits from national, state, and local governments in various regions of the world in the form of incentives designed to encourage manufacturers to establish, maintain, or increase investment, workforce, or production. These incentives may take various forms, including grants, loan subsidies, and tax abatements or credits.  The impact of these incentives can be significant in a particular market during a reporting period. A decrease in, expiration without renewal of, or other cessation or clawback of government incentives for any of our business units, as a result of administrative decision or otherwise, could have an adverse impact on our results of operations and financial condition, as well as our ability to fund new investments.

Security breaches and other disruptions to our information technology networks and systems, including a disruption related to cybersecurity, could interfere with our operations and could compromise the confidentiality of our proprietary information

We rely upon information technology networks and systems, some of which are managed or hosted by third-parties, to process, transmit and store electronic information, and to manage or support a variety of business processes and activities, including electronic communications among our locations around the world and between Company personnel and our customers and suppliers, supply chain management, manufacturing, and invoicing and collection of payments. We use these information technology network and systems to process financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting and legal and tax requirements. Additionally, we collect and store sensitive data, including intellectual property, proprietary business information, the proprietary business information of our customers and suppliers, as well as personally identifiable information of our employees, customers and suppliers, in data centers, on information technology networks and systems, some of which are operated by third parties and third party locations. The secure operation of these data centers, information technology networks, and systems and the processing, maintenance, confidentiality, integrity and availability of this information, is critical to our business operations and strategy.

The Company maintains an information risk management program which is supervised by information technology management and reviewed by a cross-functional committee. As part of this program, reports that include analysis of emerging risks as well as the Company’s plans and strategies to address them are regularly prepared and presented to senior management and the Board of Directors. Despite security measures, such as disaster recovery and business continuity plans, including those measures related to cybersecurity, these data centers, our information technology networks and systems may be vulnerable to damage, disruptions or shutdowns due to attacks by hackers or breaches due to errors or malfeasance by employees, contractors and others who have access to our networks and systems, or other disruptions during the process of upgrading or replacing computer software or hardware, power outages, computer viruses, telecommunication or utility failures, geopolitical events, or natural disasters or other catastrophic events.

Cyber threats are constantly evolving, thereby increasing the difficulty of detecting and successfully defending against them. The occurrence of any of the aforementioned events, many of which are outside our control, could compromise our systems or networks and the information stored there, which may include confidential or proprietary information or personal information of third parties, could be accessed, publicly disclosed, compromised, corrupted, lost or stolen. Any such access, disclosure or other loss or corruption of information could result in legal claims or proceedings, liability or regulatory penalties under laws protecting the privacy of personal information, disrupt operations, cause a loss of confidence in our reputation, goodwill, products and services, reduce the competitive advantage we expect to derive from our investment in advanced technologies and adversely affect our financial condition, operating results, and cash flows. We maintain cyber risk insurance, but this insurance may not be sufficient to cover all of our losses from any future breaches of our systems.operations.

We may face particular privacy, data security and data protection risks due to the new European General Data Protection Regulationrisks.

Legislators and/or regulators in countries in which we operate are increasingly adopting or revising privacy, information security and data protection laws. In particular, the European Union’s General Data Protection Regulation (“GDPR”), which became effective on May 25, 2018, imposes additional obligations and risk upon our business and which increases substantially the penalties to which we could be subject in the event of any non-compliance. The GDPR requires companies to satisfy new requirements regarding the handling of personal data, including its use, protection and the rights of affected persons regarding their data. Failure to comply with GDPR requirements could result in penalties of up to 4% of worldwide revenue. The GDPR and other similar laws and regulations, including the new California Consumer Protection Act (“CCPA”) and other similar state laws recently or soon to be enacted, as well as any associated inquiries or investigations or any other government actions, may be costly to comply with, result in negative publicity, increase our operating costs, require significant management time and attention, and subject us to remedies that may harm our business, including findsfines or demands or orders that we modify or cease existing business practices.  The Company hasCCPA went into effect on January 1, 2020 and many of its requirements have not yet been interpreted by courts, and best practices are still being developed by the industry, all of which increase the risk of compliance failure and related adverse impacts. Furthermore, in November 2020, the California Privacy Rights Act (“CPRA”) was passed as a ballot measure. While many of the CPRA’s substantive modifications will not go into effect until 2023, they will require businesses to dedicate time and resources on compliance efforts, in some cases requiring new or modified practices and operations.

Financial Risks

Our existing indebtedness and the inability to access capital markets could restrict our business activities or our ability to execute our strategic objectives or adversely affect our financial performance.

As of December 31, 2021, our total consolidated indebtedness was $38.8 million, with $440.0 million available for additional borrowings under the Credit Agreement subject to specified conditions that Gentherm currently satisfies. We may also incur additional indebtedness in the future. If our outstanding borrowings increase, including under existing availability or if we incur additional indebtedness, the amount of our outstanding debt could have important, adverse consequences to us and our investors, including:

requiring a substantial portion of our cash flow from operations to make interest payments;

making it more difficult to satisfy other obligations;

increasing our vulnerability to general adverse economic and industry conditions;

reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our businesses;

limiting our flexibility in planning for, or reacting to, changes in our businesses and industries; and

limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise;

Our debt agreements contain certain restrictive covenants and customary events of default. These restrictive covenants limit our ability to take certain actions, such as, among other things: incur additional debt, make certain payments or distributions (including for the repurchase or redemption of our shares), engage in mergers or consolidations, make certain dispositions and transfers of assets, enter into transactions with affiliates and guarantee indebtedness. While not unusual for financings of the type that we have, the restrictions in our credit facilities may prevent us from taking actions that we believe would be in the best interest of our business and

27


taken measuresmay make it difficult for us to ensure complianceexecute our business plans, take advantage of business opportunities, or react to changing industry conditions.

To the extent that we incur additional indebtedness, the risks described above could increase. In addition, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to service our outstanding debt or to repay the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to service or refinance our debt.

If an event of default would occur under our existing debt agreements or any additional indebtedness, our lenders could declare all amounts outstanding to be immediately due and payable, which may cause cross-defaults under our other debt obligations. If our lenders accelerate the maturity of our indebtedness, we may not have sufficient capital available at that time to pay the amounts due to all lenders on a timely basis, and there is no guarantee that we would be able to repay, refinance, or restructure the payments on such debt. Further, under our existing credit facilities, the lenders would have the right to foreclose on certain of our assets, which could have a material adverse effect on our business, results of operations and financial condition.

An adverse change in the interest rates for our borrowings could adversely affect our financial condition.

The publication of the one-week and two-month USD LIBOR maturities and non-USD LIBOR maturities ceased immediately after December 31, 2021, with the GDPR. Dueremaining USD LIBOR maturities ceasing immediately after June 30, 2023. Our current outstanding variable rate indebtedness uses LIBOR as a benchmark for establishing the interest rate, and as of December 31, 2021, we had $35 million of variable rate debt tied to USD LIBOR under our First Lien Credit Agreement with maximum maturities extending past June 30, 2023. Under the lack of experience with the interpretation of this new regulation and its enforcementterms of our current measures mightCredit Agreement, the cessation of LIBOR or the announcement by the administrator of LIBOR or a governmental authority with jurisdiction over the Administrative Agent requires us to renegotiate or amend this agreement to select a replacement benchmark, which may adversely affect interest rates and result in higher borrowing costs. At this time, it is not satisfypossible to predict how markets will respond to Secured Overnight Financing Rate, or SOFR, the best practices that will be established in the coming years. As personal data is processed using information technology, the risks disclosed with respect to “Security breaches andpreferred alternative rate for LIBOR, or other disruptions” apply accordingly.

Risks Related to Our Common Stock

alternative reference rates. We have anti-takeover defenses that could make it more difficult for a third party to acquire a majority of our outstanding voting stock, which could cause the market price of our Common Stock to decline

Various provisions of our articles of incorporation and bylaws, as well as the Michigan Business Corporation Act (the “MBCA”), could havecannot predict the effect of discouraging, delayingthe potential changes to or preventing a third party from accumulating a large blockelimination of LIBOR, the use of SOFR or other alternative rates or benchmarks and the corresponding effects on our cost of capital. This could materially and adversely affect our results of operations, cash flows and liquidity. We cannot predict the effect of the potential changes to or elimination of LIBOR or the establishment and use of alternative rates or benchmarks and the corresponding effects on our cost of capital, but it may result in interest rates and/or payments that result in higher borrowing costs over time as compared to our borrowing costs if the USD LIBOR continued to be available.

We are subject to significant foreign currency risk and foreign exchange exposure related to our global operations.

A significant portion of our capital stock, engagingglobal transactions is conducted in a tender offercurrencies other than the U.S. Dollar. While we sometimes employ financial instruments to hedge some of our transactional foreign exchange exposure, developing an effective and making offerseconomical foreign currency risk strategy is complex and expensive and no strategy can completely insulate us from those exposures. Exchange rates can be volatile and could adversely affect our financial results and comparability of results from period to acquire us, andperiod.

We may be unable to realize the expected benefits of inhibiting a change in control, all ofour restructuring actions, which could adversely affect our shareholders’ abilityprofitability and operations.

We have undertaken significant restructuring activities in recent years that remain ongoing, and may take future restructuring actions to receiverealign and resize our production capacity and cost structure, lower our cost base, improve our financial performance and cash flow generation, and create a premium for their shares in connection with any such transaction. For example,simplified organization best positioned to deliver on our Articles of Incorporation authorize our Board of Directors (our “Board”)key financial and operational priorities. Charges related to issue up to 4,991,000 shares of Preferred Stock and to determine the price, rights (including conversion rights), preferences and privileges of those shares withoutthese actions or any further voterestructuring actions may have a material adverse effect on our results of operations and financial condition. We cannot ensure that any current or action byfuture restructuring will be completed as planned, on a timely basis or at all, will be on budget, or achieve the shareholders.   If we issue preferred stock in the future that has preference over our desired results.

Common Stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our Common Stock, the rights of holders of our Common Stock or the market price of our Common Stock could be adversely affected.

In addition, the anti-takeover provisions of Michigan law impose various impediments to the ability of a third party to acquire control of Gentherm, even if a change of control would be beneficial to our existing shareholders.  For example, the Company is subject to Chapter 7A of the MBCA, which prohibits us from engaging in a business combination with an interested shareholder for a period of five years after the person becomes an interested shareholder, unless certain conditions are satisfied.  

We are currently prohibited from making dividend payments on our Common Stock. Furthermore, we do not anticipate paying dividends on our Common Stock in the future

Our bank credit facilities generally prohibit payment of dividends on our Common Stock so long as such facilities are outstanding. We have never paid any cash dividends on our Common Stock and do not anticipate paying dividends in the near future.Investment Risks

The price of our Common Stock may fluctuate significantlysignificantly.

The price of our Common Stock on the Nasdaq Global Select Market has experienced substantial price volatility and may fluctuate significantlycontinue to do so in response to many factors, including:

general market and economic conditions;

actual or anticipated variations in our quarterly operating results due to such factors as acceptance of our product by automotive manufacturers and consumers, timing of our product introductions, availability and pricing of components from third parties, competition, timing of orders, foreign currency exchange rates, new product development, material acquisitions or dispositions, technological changes, resources spent on litigation activities and economic conditions generally;

changes in earnings guidance by us or earnings estimates by securities analysts with respect to us;

publication of research reports about us,the future. Additionally, the Company, the automotive industry generally or automotive component industry, and recommendations by securities or financial analysts with respect to us or other automotive suppliers;

adverse market reaction to the amount of our outstanding debt at any time, the amount of our maturing debt in the near and medium term and our ability to refinance such debt and the terms thereof or our plansstock market as a whole have experienced significant stock price and volume fluctuations that have affected stock prices in ways that may have been unrelated to incur additional debt in the future;these

the ability of our customers to pay us and meet their other obligations to us under current contract terms and our ability to hold and expand our customer base;

changes in market valuations of similar companies;

28


adverse market reaction to any securities we may register or issue or additional debt we incur in the future;

additions or departures of key management personnel;

actions by institutional shareholders;

speculation in the press or investment community;

continuing high levels ofcompanies’ operating performance.  Price volatility in the capital and credit markets; and

the realization of any of the risk factors included in, or incorporated by reference to, this Annual Report on Form 10-K.

Many of the factors listed above are beyond our control. These factorsover a given period may cause the average price at which the Company repurchases its stock to exceed the stock’s price at a given point in time. If the Company fails to meet expectations related to future growth, profitability, share repurchases or other market expectations, its stock price may decline significantly, which could have a material adverse impact on investor confidence and employee retention.

On December 11, 2020, the Board of our Common StockDirectors authorized a new stock repurchase program, pursuant to decline, regardlesswhich the Company is authorized to repurchase up to $150 million of our financial performance and condition and prospects. It is impossible to provide any assurance that the market price of our Common Stock will not fall in the future, and itcommon stock over a three-year period.  Repurchases may be difficult for holdersmade, from time to resell shares of our Common Stocktime, in amounts and at prices they find attractive, or at all. We expect that the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations.  Any Company stock repurchases under the program may result in stock price and volume fluctuations.  During the year ended December 31, 2021, the Company repurchased approximately $20 million of our Commonshares under the 2020 Stock will continue to fluctuate. In addition, the stock market in generalRepurchase Program with an average price paid per share of $83.44. The 2020 Stock Repurchase Program has experienced extreme volatility that has often been unrelated to the operating performance$130 million of a particular company. These broad market fluctuations may materially and adversely affect the market pricerepurchase authorization remaining as of our Common Stock.

Our shareholders may experience dilution if we issue additional equity securities

Subject to the limitations set forth in our Articles of Incorporation, we are not restricted from issuing additional shares of our Common Stock or preferred stock, including securities convertible or exchangeable for, or that represent the right to receive, Common Stock or preferred stock.  In most circumstances, common shareholders will not be entitled to vote on whether or not we issue additional equity securities.  Future issuances of Common Stock will reduce the percentage of our Common Stock owned by shareholders who do not participate in such issuances.  In addition, depending on the terms and pricing of additional offerings of our Common Stock and the value of our assets, our shareholders may experience dilution in the book value and fair value of their shares.  The market price of our Common Stock could decline as a result of sales of substantial amounts of additional shares of our Common Stock in the public market or in connection with future acquisitions, or the perception that such sales could occur. This could also impair our ability to raise additional capital through the sale of equity securities at a time and price favorable to us.December 31, 2021.

ITEMITEM 1B.

UNRESOLVED STAFF COMMENTS

None.


29


ITEMITEM 2.

PROPERTIES

The following table presents the Company’s significant properties asAs of December 31, 2018:

Facility

 

Location

 

Purpose

 

Segment

 

Sq.
Footage

 

 

Owned
or leased

 

Monthly Rent

 

 

Lease
Expiration

 

Gentherm Headquarters

 

Northville, MI U.S.A.

 

Corporate headquarters

 

Automotive

 

 

82,000

 

 

Owned

 

$

 

 

 

Gentherm North America

 

Farmington Hills, MI U.S.A.

 

Research and development

 

Automotive and Industrial

 

 

44,000

 

 

Owned

 

$

 

 

 

CSZ Headquarters(a)

 

Cincinnati, OH U.S.A.

 

CSZ headquarters

 

Industrial

 

 

265,300

 

 

Owned

 

$

 

 

 

Gentherm GmbH

 

Odelzhausen, Germany

 

Customer service center

 

Automotive

 

 

170,600

 

 

Owned

 

$

 

 

 

Gentherm Hungary

 

Pilisszentivan, Hungary

 

Customer service center and warehouse

 

Automotive

 

 

298,700

 

 

Owned

 

$

 

 

 

Gentherm Ukraine

 

Vinogradov, Ukraine

 

Manufacturing and warehouse

 

Automotive

 

 

209,500

 

 

Owned

 

$

 

 

 

Gentherm Macedonia

 

Prilep, Macedonia

 

Manufacturing

 

Automotive

 

 

403,539

 

 

Owned

 

$

 

 

 

Gentherm China

 

Langfang, China

 

Manufacturing

 

Automotive

 

 

279,900

 

 

Owned

 

$

 

 

 

Gentherm Asia Electronics

 

Shenzhen, China

 

Manufacturing

 

Automotive

 

 

74,400

 

 

Leased

 

$

54,800

 

 

December 31, 2019

 

Gentherm Asia Electronics

 

Shenzhen, China

 

Manufacturing

 

Automotive

 

 

49,300

 

 

Leased

 

$

24,600

 

 

November 30, 2022

 

Gentherm Vietnam

 

Ha Nam, Vietnam

 

Manufacturing

 

Automotive

 

 

245,300

 

 

Owned

 

$

 

 

 

Gentherm Mexico

 

Acuña, Mexico

 

Manufacturing

 

Automotive

 

 

101,100

 

 

Leased

 

$

27,900

 

 

June 1, 2020

 

Gentherm Mexico

 

Acuña, Mexico

 

Manufacturing

 

Automotive

 

 

101,100

 

 

Leased

 

$

44,700

 

 

July 1, 2020

 

Gentherm Mexico

 

Celaya, Mexico

 

Manufacturing

 

Automotive

 

 

143,700

 

 

Leased

 

$

65,300

 

 

October 1, 2025

 

GPT(b)

 

Calgary, Canada

 

GPT headquarters

 

Industrial

 

 

61,400

 

 

Leased

 

$

54,500

 

 

January 31, 2026

 

GPT(b)

 

Bassano, Canada

 

Manufacturing

 

Industrial

 

 

36,000

 

 

Owned

 

$

 

 

 

Etratech Canada

 

Burlington, Canada

 

Etratech manufacturing

 

Automotive

 

 

46,000

 

 

Leased

 

$

21,800

 

 

October 24, 2022

 

2021, we operate in over 23 locations across 12 countries, which are primarily for manufacturing, assembly, distribution, warehousing, engineering and testing. The majority of our Automotive facilities located outside of the U.S. are principally used in manufacturing and distribution and are located in China, Hungary, Mexico, North Macedonia, South Korea, Ukraine and Vietnam. Our global headquarters is located in Northville, Michigan, our European headquarters is located in Odelzhausen, Germany and our Asia-Pacific headquarters is located in Shanghai, China. Our Medical business is principally comprised of our headquarters and manufacturing site located in Cincinnati, Ohio and our manufacturing site in Germany. We also have sales offices, warehouses and engineering centers, strategically located throughout the world. Nearly all of our manufacturing and distribution sites in Mexico and Asia are leased, while most of our European sites are owned.

a)ITEM 3.

The CSZ headquarters facility was classified as held for sale as of December 31, 2018. On February 1, 2019, Gentherm sold the CSZ-IC business and CSZ headquarters facility. On February 1, 2019, a portion of the facility utilized by Gentherm Medical, consisting of 34,000 square feet of office space and 50,000 square feet of manufacturing space, was leased from the purchaser of the facility. Monthly rent expense for this lease is $52,000.

b)

The GPT headquarters and manufacturing facilities were classified as held for sale as of December 31, 2018.

ITEM 3.

LEGAL PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of our business, however there is no current material pending litigation to which we are a party and no material legal proceedings were terminated, settled or otherwise resolved during the fourth quarter of the fiscal year ended December 31, 2018.

2021.

ITEMITEM 4.

MINE SAFETY DISCLOSURES.

Not applicable.

 

 

 

3029


PART

PART II

 

ITEMITEM 5.

MARKET FOR THE REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our Common Stock trades on the Nasdaq Global Select Market under the symbol “THRM.” The following table sets forth the high and low sale prices for our Common Stock as reported on the Nasdaq Global Select Market for each quarterly period from January 1, 2017 through December 31, 2018.

 

  

High

 

  

Low

 

2017

  

 

 

 

  

 

 

 

1st Quarter

  

$

39.25

  

  

$

33.15

  

2nd Quarter

  

 

39.45

  

  

 

34.65

  

3rd Quarter

  

 

40.70

  

  

 

29.90

  

4th Quarter

  

 

37.55

  

  

 

31.75

  

2018

  

 

 

 

  

 

 

 

1st Quarter

  

$

34.20

  

  

$

30.65

  

2nd Quarter

  

 

39.50

  

  

 

33.75

  

3rd Quarter

  

 

49.45

  

  

 

39.55

  

4th Quarter

  

 

46.43

  

  

 

37.37

  

Holders

As of February 25, 2019,14, 2022, our Common Stock was held by 63 stockholders41 shareholders of record. A substantially greater number of holders are beneficial owners whose shares of record are held by banks, brokers and other nominees.

Dividends

We have not paid any Common Stock cash dividends since formation and we do not expect to pay any in the foreseeable future. The payment of future dividends is within the discretion of our Board of Directors and will depend upon business conditions, our earnings and financial condition and other factors.  Currently, our bank credit facilities limit payment of dividends on our Common Stock.

Stock Repurchase Program

In December 2016,2020, the Board of Directors authorized a three-year, $100 millionnew stock repurchase program. In June 2018, our Boardprogram (the “2020 Stock Repurchase Program”). pursuant to which the Company is authorized to repurchase up to $150 million of Directors authorized an increase inits issued and outstanding common stock over a three-year period, expiring December 15, 2023.

Repurchases under the stock repurchase plan to $300 million and extended the stock repurchase plan until December 2020.

Under the program, we2020 Stock Repurchase Program may repurchase,be made, from time to time, our common stock in amounts and at prices as we deemthe Company deems appropriate, taking into accountsubject to market conditions, applicable legal requirements, debt covenants and other considerations. The number of shares repurchased and the time of theAny such repurchases under the stock repurchase program will be determined by our management. Repurchases may be made on theexecuted using open market or inpurchases, privately negotiated transactions. Repurchases may also be made under aagreements or other transactions (including Rule 10b5-1 plan, which would permit shares totrading plans), and may be repurchased when we might otherwise be precludedfunded from doing so under securities laws.cash on hand, available borrowings or proceeds from potential debt or other capital markets sources. The authorization of this stock repurchase program does not require we repurchase any specific dollar value or number of shares and2020 Stock Repurchase Program may be modified, extended or terminated by our Board of Directors at any time.time without prior notice.

31


Issuer Purchases of Equity Securities During Fourth Quarter 20182021

Period

 

(a)

Total Number of Shares Purchased

 

 

(b)

Average Price

Paid Per Share

 

 

(c)

Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs

 

 

(d)

Approximate Dollar Value of Shares That May Yet Be Purchased Under the 2020 Stock Repurchase Program

 

October 1, 2021 to October 31, 2021

 

 

 

 

$

 

 

 

 

 

 

150,000,000

 

November 1, 2021 to November 30, 2021

 

 

186,809

 

 

$

83.54

 

 

 

186,809

 

 

 

134,394,481

 

December 1, 2021 to December 31, 2021

 

 

52,889

 

 

$

83.09

 

 

 

239,698

 

 

 

130,000,105

 

 

Period

  

  

(a)

Total Number of Shares Purchased (1)

 

  

(b)

Average Price Paid per Share

 

  

 

(c)

Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs

  

  

(d)

Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2)

October 1, 2018 to October 31, 2018

  

 

  

 

888,457

 

 

 

$

41.80

 

 

 

 

888,457

 

 

 

$

190,187,084

November 1, 2018 to November 30, 2018

  

 

  

 

380,967

 

 

 

$

44.48

 

 

 

 

380,967

 

 

 

$

173,242,300

December 1, 2018 to December 31, 2018

  

 

  

 

634,090

 

 

 

$

42.02

 

 

 

 

634,090

 

 

 

$

146,599,982

 

(1)ITEM 6.

All shares were purchased on the open-market in accordance with Gentherm’s Stock Repurchase Program, including, in part, pursuant to a plan adopted by the Company in accordance with Rule 10b5-1 promulgated by the U.S. Securities and Exchange Commission.

(2)

The Stock Repurchase Program, as amended, authorizes Gentherm to repurchase shares up to $300 million.RESERVED

 

ITEM 6.

SELECTED FINANCIAL DATA

The following table sets forth selected financial data and should be read in conjunction with the consolidated financial statements and the notes thereto, as well as Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this Report.

 

 

 

Year Ended December 31,

 

 

 

(In thousands except per share data)

 

 

 

2018

 

 

2017

 

 

2016

 

 

2015

 

 

2014

 

Product revenues

 

$

1,038,259

 

 

$

985,683

 

 

$

917,600

 

 

$

856,445

 

 

$

811,300

 

Operating income

 

 

72,788

 

 

 

97,098

 

 

 

106,119

 

 

 

121,319

 

 

 

98,434

 

Net income

 

 

41,899

 

 

 

35,227

 

 

 

76,598

 

 

 

95,393

 

 

 

70,119

 

Basic earnings per share

 

 

1.17

 

 

 

0.96

 

 

 

2.10

 

 

 

2.65

 

 

 

1.98

 

Diluted earnings per share

 

 

1.16

 

 

 

0.96

 

 

 

2.09

 

 

 

2.62

 

 

 

1.95

 

 

 

As of December 31,

 

 

 

(In thousands)

 

 

 

2018

 

 

2017

 

 

2016

 

 

2015

 

 

2014

 

Working capital(a)(b)

 

$

267,679

 

 

$

289,754

 

 

$

295,130

 

 

$

270,320

 

 

$

187,432

 

Total assets(b)

 

 

803,047

 

 

 

883,405

 

 

 

843,030

 

 

 

648,343

 

 

 

555,911

 

Long term obligations

 

 

147,952

 

 

 

158,216

 

 

 

189,002

 

 

 

118,596

 

 

 

112,465

 

Accumulated earnings

 

 

363,965

 

 

 

293,645

 

 

 

256,922

 

 

 

180,324

 

 

 

84,931

 

a)

Represents current assets less current liabilities.

b)

Total assets for all prior periods presented have been adjusted to conform with the current year presentation. Working capital and total assets for the years ended December 31, 2018, 2017, 2016 and 2015 reflect the noncurrent presentation of deferred tax liabilities and assets, as well as related valuation allowance. For the year ended December 31, 2014, working capital and total assets include $6,247 in current deferred tax assets and $0 in current deferred tax liabilities.


3230


 

ITEMITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements (and notes related thereto) and other more detailed financial information appearing elsewhere in this Annual Report. Further, you should read the following discussion and analysis of our financial condition and results of operations together with the “Risk Factors” included elsewhere in this Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. See also “Forward-Looking Statements” in Item 1Part I of this Annual Report.

Overview

Gentherm Incorporated is a global technologydeveloper, manufacturer and industry leader in the design, development, and manufacturingmarketer of innovative thermal management technologies.  Ourtechnologies for a broad range of heating and cooling and temperature control applications in the automotive and medical industries. Within the automotive industry, our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management remote power generation,and cell connecting systems. Within the medical industry our products provide patient temperature management and other consumer and industrial temperature control needs.solutions. Our automotive products can be found on the vehicles ofmanufactured by nearly all the major automotive manufacturersOEMs operating in North America and Europe, and several major OEMs in Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the developmentcapabilities. The Company is also developing a number of new technologies and new applications fromproducts that are expected to enable improvements to existing technologiesproducts and to create new product applications for existing and market opportunities for a wide array of thermal management solutions.  new markets.

Our sales are driven by the number of vehicles produced by the OEMs, which is ultimately dependent on consumer demand for automotive vehicles, our product content per vehicle, and other factors that may limit or otherwise impact production by us, our supply chain and our customers.  Historically, new vehicle demand and product content (i.e. vehicle features) have been driven by macro-economic and other factors, such as interest rates, automotive manufacturer and dealer sales incentives, fuel prices, consumer confidence, employment levels, income growth trends and government and tax incentives. Vehicle content has also been driven by trends in consumer preferences, such as preferences for smart devices and features, personalized user experience, and comfort, health and wellness. Economic volatility or weakness, as well as geopolitical factors, in North America, Europe or Asia, have had and could result in a significant reduction in automotive sales and production by our customers, which would have an adverse effect on our business, results of operations and financial condition.  In 2020 and 2021, and continuing into 2022, the automotive industry has experienced fluctuating demand and production disruptions related to supply chain challenges, facility closures, labor shortages, work stoppages and inflationary pressures, as a result of the COVID-19 pandemic and associated macroeconomic conditions, as described below. We believe our diversified OEM customer base and geographic revenue base, along with our flexible cost structure, have well positioned us to withstand the impact of industry downturns, including the ongoing impact of the COVID-19 pandemic and associated economic conditions, and benefit from industry upturns in the ordinary course.  However, shifts in the mix of global automotive production to higher cost regions or to vehicles with less of our product content as well as continuing production challenges and inflationary pressures could adversely impact our profitability.  In addition, we may be adversely impacted by volatility, weakness or accelerated growth in markets for hybrid or electric vehicles specifically. We believe our products offer certain advantages for hybrid and electric vehicles, including improved energy efficiency, and position us well to withstand changes in the volume mix between vehicles driven by internal combustion engines and hybrid and other electric vehicles. We also believe that products we are solddeveloping, such as ClimateSense®, position us well to automobileaddress trends in consumer preferences such as personalized user experience, comfort, health and wellness.

Recent Trends

General Economic Condition

The COVID-19 pandemic that began around December 2019 introduced significant volatility to the global economy, disrupted supply chains and had a widespread adverse effect on the global automotive industry in the first half of 2020, with various direct and indirect adverse impacts continuing throughout 2021 and into 2022.

Beginning in February 2020 and continuing into June 2020, substantially all of the Company’s major OEM and Tier 1 customers temporarily ceased or significantly reduced production as a result of restrictions that were requested or mandated by governmental authorities. As a result, substantially all of our manufacturing facilities either temporarily suspended production or experienced significant reductions in volumes during this period. By the end of the second quarter of 2020, the Company had reopened all of its manufacturing facilities, in line with industry demand, and in accordance with local government requirements.

31


Although global automotive industry production has improved relative to the first half of 2020, production remains below recent historic levels.

The lingering impacts of COVID-19 into 2021 have impeded global supply chains, resulted in longer lead times and delays in procuring component parts and raw materials, and resulted in inflationary cost increases in certain raw materials, labor and transportation. These broad-based inflationary impacts have negatively impacted the Company’s financial condition, results of operations and cash flows throughout 2021. We expect these inflationary impacts to continue for the foreseeable future.

Supply shortages of semiconductor chips and other components have resulted in decreases in global automotive vehicle production and significant volatility in customer vehicle production schedules. The Company's semiconductor suppliers, along with most automotive component supply companies that use semiconductors, including Gentherm, have been unable to fully meet the vehicle production demands of the OEMs due to events which are outside the Company's control, including but not limited to, the COVID-19 pandemic, the global semiconductor shortage, fires at suppliers’ facilities, significant weather events impacting semiconductor supplier facilities in the southern United States, and other extraordinary events. The Company was able to mitigate the impacts of supply chain disruptions in order to satisfy customer orders during the first three quarters of 2021, however, during the fourth quarter of 2021 and continuing into 2022 we have experienced and may continue to experience direct impacts of ongoing shortages of semiconductors. Our ability to meet customer orders without significant delay and/or expense for 2022 and beyond remains subject to significant uncertainty.

In response to the global supply chain instability and inflationary cost increases the Company has taken several actions to minimize any potential and actual adverse impacts by working closely with its suppliers and customers to closely monitor the availability of semiconductor microchips and other component parts and raw materials, customer vehicle production schedules and any other supply chain inefficiencies that may arise. We expect global supply chain instability will continue to have an adverse impact on our business and financial performance for the foreseeable future, and such adverse impact may be material. The consequences of the pandemic, global supply chain instability and inflationary cost increases and their adverse impact to the global economy continue to evolve. Accordingly, the significance of the future adverse impact on our business and financial statements remains subject to significant uncertainty as of the date of this filing.

Light Vehicle Production Volumes

Our sales are driven by the number of vehicles produced by the automotive manufacturers, which is ultimately dependent on consumer demand for automotive vehicles, and our content per vehicle, and other factors that may limit or otherwise impact production by us, our supply chain and our customers. According to the forecasting firm IHS Markit (February 2022 release), global light truck OEMsvehicle production in 2021 in the Company’s key markets of North America, Europe, China, Japan and Korea, as compared to 2020, are shown below (in millions of units):

 

 

2021

 

 

2020

 

 

% Change

 

North America

 

 

13.0

 

 

 

13.0

 

 

 

0.0

%

Europe

 

 

15.9

 

 

 

16.6

 

 

 

(4.2

)%

Greater China

 

 

24.8

 

 

 

23.6

 

 

 

5.1

%

Japan / South Korea

 

 

10.9

 

 

 

11.2

 

 

 

(2.7

)%

Total light vehicle production volume in key markets

 

 

64.6

 

 

 

64.4

 

 

 

0.3

%

The IHS Markit (February 2022 release) forecasted light vehicle production volume in the Company’s key markets for full year 2022 to increase to 70.8 million units, an 9.6% increase from full year 2021 light vehicle production volumes. Forecasted light vehicle production volumes are a component of the data we use in forecasting future business. However, these forecasts generally are updated monthly, and future forecasts may be significantly different from period to period due to changes in macroeconomic conditions or their tier one suppliers. Inherentmatters specific to the automotive supplierindustry, such as the fluctuations that occurred since 2020 and remain ongoing due to the COVID-19 pandemic.  Further, due to differences in regional product mix at our manufacturing facilities, as well as material production schedules from our customers for our products on specific vehicle programs, our future forecasted results do not directly correlate with the global and/or regional light vehicle production forecasts of IHS Markit or other third-party sources.

New Business Awards

We believe that innovation is an important element to gaining market acceptance of our products and strengthening our market position. During 2021, we secured an estimated $1,613 million of automotive new business awards, which is at the high end of the

32


range of new business awards in recent years. Automotive new business awards represent the aggregate projected lifetime revenue of new awards provided by our customers to Gentherm in the applicable period, with the value based on the price and volume projections received from each customer as of the award date. Although automotive new business awards are not firm customer orders, we believe that new business awards are an indicator of future revenue. New business awards are not projections of revenue or future business as of December 31, 2021, the date of this Annual Report or any other date. Customer projections regularly change over time and we do not update our calculation of any new business award after the date initially communicated. Automotive new business awards in 2021 also do not reflect, in particular, the impact of the COVID-19 pandemic and related macroeconomic challenges on future business. Revenues resulting from automotive new business awards also are subject to additional risks and uncertainties as described in Item 1 under “Forward-Looking Statements” of this Annual Report.

Restructuring

Manufacturing Footprint Rationalization

In September 2019, the Company committed to a restructuring plan (“Plan”) to improve the Company’s manufacturing productivity and rationalize its footprint. Under this Plan, the Company is relocating and consolidating certain automotive electronics manufacturing plants in North America and China.

During 2021, the Company completed the closures and relocation of its automotive electronics manufacturing operations from Burlington, Canada to Celaya, Mexico and from Longgang, Shenzhen, China to Bantian, Shenzhen, China. As of December 31, 2021, the electronics manufacturing in Acuña, Mexico continues to transition to Celaya, Mexico.

During the year ended December 31, 2021, the Company recognized restructuring expense of $1.3 million for employee separation costs and commitments that$1.7 million for other costs, primarily related to equipment move and set up costs. During the year ended December 31, 2020, the Company recognized restructuring expense of $(0.8) million primarily related to a reduction in the estimates of previously recognized employee separation costs and $1.0 million for other costs, primarily related to accelerated depreciation and equipment move and set up costs. During the year ended December 31, 2019, the Company recognized restructuring expense of $4.9 million for employee separation costs, and $2.1 million of other costs, primarily related to accelerated depreciation and fixed asset impairment.

The Company has recorded approximately $10.1 million of restructuring expenses since the inception of this program and as of December 31, 2021, $0.9 remains accrued. Actions under the Plan are incurred well in advanceexpected to be substantially completed by the first half of 2022 and future expenses are expected to be less than $1 million.           

Other Restructuring Activities

As part of the receiptCompany’s continued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the years ended December 31, 2021, 2020 and 2019, the Company recognized $0.9 million, $5.4 million and $3.2 million of ordersemployee separation costs, respectively, and resulting revenues$0.0 million, $0.2 million and $2.8 million of other related costs, respectively. These restructuring expenses were primarily associated with restructuring actions focused on the rotation of our manufacturing footprint to best cost locations and the reduction of global overhead costs.

See Note 5, “Restructuring,” to the consolidated financial statements included in this Annual Report for information about our restructuring activities.

Divestitures

Divestiture of GPT

On October 1, 2019, the Company completed the sale of its remote power generation systems business, Gentherm Global Power Technologies (“GPT”) for a nominal amount and recognized a $5.9 million loss on sale for the year ended December 31, 2019, which is classified as Net loss on divestitures within the consolidated statements of income. During 2019, the Company also recognized impairment losses of $21.2 million for its GPT assets held for sale. These impairment charges are classified as Impairment loss within the consolidated statements of income.

33


Divestiture of CSZ-IC

On February 1, 2019, the Company completed the sale of its environmental test equipment business, Cincinnati Sub Zero industrial chamber business (“CSZ-IC”) and former Cincinnati Sub-Zero headquarters facility for total cash proceeds of $47.5 million. The Company recognized a $4.3 million pre-tax gain on the sale of CSZ-IC for the year ended December 31, 2019 which is classified as Net loss on divestitures within the consolidated statements of income.

Acquisitions

Acquisition of Beckmann & Egle Industrieelektronik GmbH

On July 1, 2021, the Company acquired the medical business unit of Beckmann & Egle Industrieelektronik GmbH (“B&E”), a developer and manufacturer of electronic control units, for a purchase price of $2.8 million. The acquisition was accounted for as a business combination with the purchase price assigned to inventory, property and equipment and other intangible assets based on their estimated fair values as of the acquisition date. The pro-forma effect of the B&E acquisition does not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented. The results of operations of B&E are reported within the Company’s Medical segment from customers.the date of acquisition.

Acquisition of Stihler Electronic GmbH

On April 1, 2019, the Company acquired Stihler Electronic GmbH (“Stihler”), a leading developer and manufacturer of patient and blood temperature management systems, for a purchase price of $15.5 million, net of cash acquired and including $0.7 million of contingent consideration that was paid upon achievement of a milestone during the year ended December 31, 2020. The results of operations of Stihler are reported within the Company’s Medical segment from the date of acquisition.

Investments in non-consolidated affiliates

During 2021, the Company’s Automotive segment invested $5.2 million for an ownership interest in Carrar Ltd. (“Carrar”), an Israel-based technology developer of advanced thermal management systems for the electric mobility market. The Company determined that Carrar is a VIE; however, the Company does not have a controlling financial interest or have the power to direct the activities that most significantly affect the economic performance of the investment. Therefore, the Company has concluded that it is not the primary beneficiary. Gentherm’s investment in Carrar is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

During 2021, the Company’s Automotive segment invested $2.4 million for an ownership interest in Forciot Oy (“Forciot”), a Finland-based technology developer of sensors for touch, motion and force measurement. Gentherm’s investment in Forciot is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

In December 2021, the Company committed to make a $5 million investment in Autotech Fund III, L.P., pursuant to a limited partnership agreement. As a limited partner, the Company will periodically make capital contributions toward this total commitment amount over the expected ten-year life of the fund. The Company has not made any contributions to the Autotech Fund III, LP as of December 31, 2021. This is due in part tofund focuses broadly on the automotive manufacturers requiringindustry and compliments the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.Company’s innovation strategy.

Reportable Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial.  See Note 9 to the consolidated financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income.Medical.  The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

New Strategic Plan

On June 25, 2018, Gentherm announced a new strategic plan intended to improve business performance and position the company to deliver above-market growth and improved profitability to its shareholders. An important elementThe Automotive reporting segment is comprised of the strategyresults from our global automotive businesses, including the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems.

The Medical reporting segment is comprised of the Fit-for-Growth initiative that focuses on purchasing excellence, rationalization of research and development activities and expenses, reducing selling, general and administrative expense, minimization or elimination of investments in non-core areas and developing a manufacturing footprint commensurate withresults from the new plan. Non-core areas of investment under the Fit-for-Growth initiative are concentratedpatient temperature management business in the following areas of Gentherm’s industrial segment: Gentherm Global Power Technologies (“GPT”), Cincinnati Sub Zero’s Industrial Chamber business (“CSZ-IC”) and our battery management systems division in Irvine, California. We also completed the site consolidation plan for our advanced research and development operations and vacated two lease facilities in Azusa, California. On February 1, 2019, we completed the sale of CSZ-IC to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million.

The strategy also identified several product categories the Company has now exited, including furniture, aviation, battery management electronics, industrial battery packs, automotive thermoelectric generators and other non-core electronics.medical industry.

See Note 1 to our consolidated financial statements for information about our Fit-for-Growth initiative, related cost savings and related restructuring costs.

33


Etratech

On November 1, 2017, we acquired substantially all of the assets and assumed substantially all of the operating liabilities of Etratech Inc., an Ontario corporation and all of the outstanding shares of Etratech Hong Kong, an entity organized under the laws of Hong Kong, in an all-cash transaction.  Etratech manufactures advanced electronic controls and control systems for the automotive, RV and marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are located in Burlington, Canada. See Note 1719, “Segment Reporting,” to the consolidated financial statements included in this Annual Report for additional information regarding the acquisition of Etratech.  

North American Reorganization

On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business (the “Windsor Operations”).  As parta description of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities.  As a result of the Reorganization, some of the business activities previously performed by the Windsor Operations are now being performed by other subsidiaries.

Relatedreportable segments as well as their proportional contribution to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7.6 million during 2016.  Additionally, the Company incurred income tax expense of $2.5 million related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.  

In addition to the $7.6 million of withholding tax and $2.5 million of income taxes, the Reorganization required the Company to make a one-time income tax payment of approximately $32.6 million.  The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2.5 million and $32.6 million were paid during the first quarter of 2017.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities,product revenues and expenses, and related disclosures at the date of our financial statements. Actual results may differ from these estimates under different assumptions or conditions. These estimates and assumptions include, but are not limited to:

Product revenues;

Impairments of goodwill and other intangible assets

Accrued warranty costs;

Litigation reserves;

Allowances for doubtful accounts;

Inventory reserves;

Income taxes;

Stock compensation; and

Pension plans

Product Revenues

Revenue is recognized from agreements containing enforceable rights and obligations when promised goods are delivered or services are completed, the price is fixed or determinable, and payment has been received or is collectable. The amount of revenueoperating income.  

34


recognized is net of the Company’s obligation for returns, rebates, discounts, taxes, if any, collected from customers, and consideration that is paid to a customer, unless such payment is in exchange for a distinct good or service. The amount of revenue recognized from a contract with a customer reflects the amount of consideration expected to be received in exchange for the transfer of good or services.

Automotive Revenues

The Company sells automotive seat comfort systems, specialized automotive cable systems and automotive thermal convenience products under long-term supply agreements (“LTAs”) and, for arrangements that are less than one year in length, purchase orders. LTAs are multiple-year business awards to provide custom designed parts for a particular automotive vehicle program in quantities and at intervals of the customer’s choosing.  LTAs are often multiple-element agreements. The main element in LTAs are production parts; distinct promises from which the customer can benefit separately from other promises or elements in the contract. A second element in LTAs are production part purchase options that provide customers the ability to purchase additional parts at set prices in the future. Judgement is used to determine whether a production part purchase option represents a material right to the customer and should be accounted for as a separate performance obligation.  LTAs that provide customers with a purchase option discount incrementally higher than the range discounts typically given to automotive customers contain a material right. The magnitude of change in the year-over-year option prices and the total number of units expected to be ordered are important factors in the calculation of the option’s fair value and the allocation of transaction price.

The price for parts is set at the point in time the customer exercises its option to purchase additional parts from the Company. A firm order, stating the number of each production part to be delivered, is an independent contract with a discrete transaction price. Revenues are allocated to production parts based on the relative standalone selling prices observed on the LTAs. As a practical alternative to estimating the standalone selling price of an option that provides a customer with a material right, the Company allocates transaction price to options by reference to the production part volumes expected to be ordered and the consideration expected to be received. The Company satisfies its obligation to provide product parts to the customer upon shipment.

When an option to purchase additional production parts in the future represents a material right, the customer effectively is paying Gentherm in advance for production parts each time it exercises the option by placing a firm order commitment. Revenue from options containing a material right are recognized on the basis of direct measurement of the value of production parts transferred to date relative to the total number of production parts expected to be delivered over the life of the vehicle program. Judgement is required to determine the pattern and timing with which an option containing a material right is satisfied and the production part is transferred to a customer.

Industrial Revenues

Our industrial business unit generates revenue from the sale of products and services by our wholly-owned subsidiaries CSZ and GPT. Industrial business unit revenues and medical business unit revenues discussed below are reported within the Company’s industrial reportable segment (see Note 9). Industrial business unit customers commonly enter into multiple-element agreements for the purchase of products and services.  Installation services, for example, are separate and distinct performance obligations that are often included in contracts to purchase customized environmental test chambers. Depending on the application, delivery of an environmental test chamber or remote power generation system to the customer’s place of business can range from two weeks to nine months from commencement of the contract. Installation services, while reliant on the specifications and timing from the customer, rarely remain incomplete more than two months after delivery.

Revenues allocated to environmental test chambers or remote power systems are based on the stand alone selling price of products themselves. Judgement is used to determine the degree to which early pay discounts and other credits are utilized in the calculation of standalone selling price, and only included to the extent it is probable that a significant reversal of any incremental revenue will not occur. Revenues are recognized at the point in time the chamber or power system is shipped to the customer. For contracts that also include a promise for installation, the portion of total transaction price allocated to the installation is recognized as revenue at the point in time the installation is complete.  

Revenues from our medical business unit are generated from the sale of products and equipment. Our medical products and equipment focus on body and blood temperature management. The Company sells medical products and equipment primarily through distributor and group purchasing organization agreements. These agreements allow member participants to the distributor or group

35


purchasing organization to make purchases at discounted prices negotiated by the distributor or group purchasing organization.  A rebate is incurred at the point in time a member participant purchases product covered under these types of agreements. Rebates are accounted for as variable consideration, using an expected value, probability weighted approach, based on the level of sales to the distributor and the time lag between the initial sale and the rebate claim in determining the transaction price of a contract.  Revenue is recognized at the point in time the medical products or equipment is transferred to the customer.

Impairments of Goodwill and Other Intangible Assets

Whenever events or changes in circumstances indicate that it is more likely than not that a reporting unit’s fair value is less than its carrying amount, the Company then compares the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized. The fair value of a reporting unit is estimated by analyzing internal inputs (level 3) to calculate forward values and discounting those values to the present value.

Accrued Warranty Costs

The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions.  While we believe our warranty reserve is adequate and that the judgment applied is appropriate, such estimates could differ materially from what will actually transpire in the future. The warranty policy is reviewed by management annually. Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims.

Litigation Reserves

We record estimated future costs related to new or ongoing litigation based on input from legal counsel and our best estimate of probable loss. These estimates include costs associated with attorney fees and potential claims and assessments less any amounts we anticipate are recoverable under insurance policies. Final resolution of the litigation contingencies could result in amounts different from current accruals and, therefore, have an impact on our consolidated financial results in future reporting periods.

Allowance for Doubtful Accounts

We record an allowance for doubtful accounts once exposure to collection risk of an accounts receivable is specifically identified. We analyze the length of time an account receivable is outstanding, as well as a customer’s payment history to determine the need for and amount of an allowance for doubtful accounts.

Inventory Reserves

We recognize a reserve for obsolete and slow moving inventories based on estimates of future sales and an inventory item’s capacity to be repurposed for a different use. We consider the number of months supply on hand based on current planned requirements, uncommitted future projections and historical usage in estimating the inventory reserve.  Additional provisions are made for supplier claims for obsolete materials, prototype inventory, spare or customer service inventory and, for all periods other than at year-end, estimates for physical inventory adjustments.

Income Taxes

We record income tax expense using the liability method which specifies that deferred tax assets and liabilities be measured each year based on the difference between the financial statement and tax bases of assets and liabilities at the applicable enacted tax rates. A valuation allowance is provided for deferred tax assets when management considers it more likely than not that the asset will not be realized.   At December 31, 2018 and 2017, a valuation allowance has been provided for certain deferred tax assets which we have concluded are more likely than not to not be realized.  If future annual taxable income were to be significantly less than current and projected levels, there is a risk that certain of our deferred tax assets not already provided for by the valuation allowance would expire prior to utilization.

We recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. We recognize interest and penalties related to income tax matters in income tax expense.

36


Stock Based Compensation

We account for grants of employee stock options, time-based restricted stock units and restricted stock as compensation expense based upon the fair value on the date of grant and such expense is recognized over the vesting condition, either based on a period of service of based on the performance of a specific achievement. For awards measured at fair value, the fair value is determined using the Black-Scholes option pricing model. The Black-Scholes option pricing model incorporates certain assumptions, such as expected volatility, expected life of options, risk-free interest rate and expected dividend yield, in order to arrive at a fair value estimate. Expected volatilities are based on the average of the historical volatility of the Company’s Common Stock and that of an index of companies in our industry group. To evaluate our assumptions for the expected lives of options, we consider the average holding period of previously exercised options and the remaining terms of outstanding options. The risk-free interest rate is based upon quoted market yields for United States Treasury debt securities. The expected dividend yield is based upon the Company’s history of having never issued a dividend, the limitations to issue a dividend under the Amended Credit Agreement and management’s current expectation regarding future dividends. We believe that the assumptions selected by management are reasonable; however, significant changes could materially impact the results of the calculation of fair value.  We also have granted restricted stock units measured based on either a target return on invested capital ratio (“ROIC”), as defined in the award agreement, for a specified fiscal year, or the Company’s common stock market price returning a target total shareholder return (“TSR”), as defined, during a specific three-year measurement period. Upon achievement of the performance measurement, performance based restricted stock units vest over a three-year period.

Stock appreciation rights (“SARs”) are also an award type granted under out management incentive program and they are accounted for using the liability method since they are settled in cash, which requires mark-to-market adjustments based on the current trading price of Gentherm Common Stock to be recognized in statement of income.

Pension Plans

The Company’s obligations and expenses for its pension plans are substantially dependent on the Company’s selection of discount rate and, for the Gentherm GmbH Plan, expected long-term rate of return on plan assets assumptions used by actuaries to calculate these amounts.  Actual results that differ from assumptions used are accumulated and amortized over future periods and generally affect recognized expense in future periods. As such, assumptions used to calculate benefit obligations as of the annual measurement date directly impact the expense to be recognized in future periods.

Results of Operations Year Ended December 31, 20182021 Compared to Year Ended December 31, 20172020

Product revenues. This section discusses our consolidated results of operations for the year ended December 31, 2021 compared to the year ended December 31, 2020. For a detailed discussion of our consolidated results of operations for the years ended December 31, 2020 compared to the year ended December 31, 2019, see Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operation” under “Results of Operations Year Ended December 31, 2020 Compared to Year Ended December 31, 2019” in our annual report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 1, 2021.

The results of operations for the years ended December 31, 2021 and 2020, in thousands, were as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Product revenues

 

$

1,046,150

 

 

$

913,098

 

 

$

133,052

 

Cost of sales

 

 

742,519

 

 

 

644,994

 

 

 

(97,525

)

Gross margin

 

 

303,631

 

 

 

268,104

 

 

 

35,527

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

 

91,807

 

 

 

81,968

 

 

 

(9,839

)

Reimbursed research and development expenses

 

 

(16,593

)

 

 

(13,928

)

 

 

2,665

 

Net research and development expenses

 

 

75,214

 

 

 

68,040

 

 

 

(7,174

)

Selling, general and administrative expenses

 

 

109,554

 

 

 

105,044

 

 

 

(4,510

)

Restructuring expenses

 

 

3,857

 

 

 

5,803

 

 

 

1,946

 

Total operating expenses

 

 

188,625

 

 

 

178,887

 

 

 

(9,738

)

Operating income

 

 

115,006

 

 

 

89,217

 

 

 

25,789

 

Interest expense, net

 

 

(2,758

)

 

 

(4,559

)

 

 

1,801

 

Foreign currency gain (loss)

 

 

1,487

 

 

 

(5,439

)

 

 

6,926

 

Other income

 

 

117

 

 

 

2,337

 

 

 

(2,220

)

Earnings before income tax

 

 

113,852

 

 

 

81,556

 

 

 

32,296

 

Income tax expense

 

 

20,418

 

 

 

21,866

 

 

 

1,448

 

Net income

 

$

93,434

 

 

$

59,690

 

 

$

33,744

 

Product revenues by product category, in thousands, for the years ended December 31, 20182021 and 2017 are2020 were as follows:

 

 

 

Year Ended December 31,

 

 

 

 

2018

 

 

 

2017

 

 

%

Change

Climate Control Seats (CCS)

 

$

374,816

 

 

$

387,961

 

 

(3.4

)

%

Seat Heaters

 

 

305,337

 

 

 

307,309

 

 

(0.6

)

%

Steering Wheel Heaters

 

 

69,845

 

 

 

62,125

 

 

12.4

 

%

Automotive Cables

 

 

98,931

 

 

 

92,093

 

 

7.4

 

%

Battery Thermal Management (BTM)(a)

 

 

28,472

 

 

 

10,043

 

 

183.5

 

%

Etratech

 

 

54,267

 

 

 

8,398

 

 

(1.3

)

%(b)

Other Automotive

 

 

16,924

 

 

 

11,528

(c)

 

46.8

 

%

Subtotal Automotive

 

$

948,592

 

 

$

879,457

 

 

7.9

 

%

Remote Power Generation (GPT)

 

 

19,222

 

 

 

31,891

 

 

(39.7

)

%

Cincinnati Sub-Zero Products (CSZ)

 

 

70,445

 

 

 

74,335

 

 

(5.2

)

%

Subtotal Industrial

 

$

89,667

 

 

$

106,226

 

 

(15.6

)

%

Total Company

 

$

1,038,259

 

 

$

985,683

 

 

5.3

 

%

 

 

Year Ended December 31

 

 

 

2021

 

 

2020

 

 

% Change

 

Climate Control Seat

 

$

393,816

 

 

$

342,550

 

 

 

15.0

%

Seat Heaters

 

 

270,054

 

 

 

249,665

 

 

 

8.2

%

Steering Wheel Heaters

 

 

102,496

 

 

 

76,272

 

 

 

34.4

%

Automotive Cables

 

 

84,114

 

 

 

73,997

 

 

 

13.7

%

Battery Performance Solutions

 

 

69,594

 

 

 

50,901

 

 

 

36.7

%

Electronics

 

 

51,648

 

 

 

53,238

 

 

 

(3.0

)%

Other Automotive

 

 

32,911

 

 

 

23,375

 

 

 

40.8

%

Subtotal Automotive segment

 

 

1,004,633

 

 

 

869,998

 

 

 

15.5

%

Medical Segment

 

 

41,517

 

 

 

43,100

 

 

 

(3.7

)%

Total Company

 

$

1,046,150

 

 

$

913,098

 

 

 

14.6

%

`

Product Revenues

Below is a summary of our Product revenues, in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

Variance Due To:

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

 

 

Automotive Volume

 

 

FX

 

 

Pricing/Other

 

 

Total

 

Product revenues

 

$

1,046,150

 

 

$

913,098

 

 

$

133,052

 

 

 

$

127,044

 

 

$

21,846

 

 

$

(15,838

)

 

$

133,052

 

 

35


Product revenues for the year ended December 31, 2021 increased 14.6% as compared to the year ended December 31, 2020. Revenue increased in all product categories except Electronics. The increase in product revenues is due to favorable volumes in our Automotive segment and favorable foreign currency impacts, primarily related to the Euro, Chinese Renminbi and Korean Won. The decrease in product revenues included in Variance Due To Pricing/Other above is primarily attributable to decreases in automotive customer pricing and product revenue in our Medical segment.

Cost of Sales

Below is a summary of our Cost of sales and Gross margin, in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

Variance Due To:

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

 

 

Automotive Volume

 

 

Operational

Performance

 

 

FX

 

 

Other

 

 

Total

 

Cost of sales

 

$

742,519

 

 

$

644,994

 

 

$

(97,525

)

 

 

$

(76,750

)

 

$

3,877

 

 

$

(14,294

)

 

$

(10,358

)

 

$

(97,525

)

Gross margin

 

 

303,631

 

 

 

268,104

 

 

 

35,527

 

 

 

$

50,294

 

 

$

3,877

 

 

$

7,552

 

 

$

(26,196

)

 

$

35,527

 

Gross margin - Percentage of product revenues

 

 

29.0

%

 

 

29.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales for the year ended December 31, 2021 increased by 15.1% as compared to the year ended December 31, 2020. The increase in cost of sales is primarily related to increased volumes in our Automotive segment and unfavorable foreign currency impacts primarily attributable to the Euro and Chinese Renminbi.  The offsetting Variance Due To Operational Performance is primarily attributable to an increase in manufacturing productivity, partially offset by higher material and freight costs. The increase in cost of sales is also due to the following items included in Variance Due To Other above:

 

a)

Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system which began during the fourth quarter of 2017.

37


b)

Amount represents the pro-forma growth for Etratech by comparing the amount of revenue during 2018$3.7 million increase due to Etratech’s revenue during 2017 which totaled $54,987, and which was not all included in Gentherm’s revenue since the acquisition did not occur until November 1, 2017.higher factory costs

 

c)

Includes $2.0$3.5 million rebateincrease due to customer during 2017.wage inflation

$1.2 million increase due to the absence of COVID-19 government subsidy programs

$1.1 million increase due to pre-production costs

$0.9 million increase due to exercises and mark-to-market adjustments in cash settled stock appreciation rights

$0.8 million increase due to higher incentive compensation expense

$0.9 million decrease due to lower volumes in Medical segment

Product revenues for 2018 were $1,038.3 million compared with product revenuesNet Research and Development Expenses

Below is a summary of $985.7 million for 2017, an increase of $52.6 million, or 5.3%.  The increase included higher product revenues in the automotive segment, which increased $69.1 million, or 7.9%, to $948.6 million, partially offset by lower industrial segment product revenues which decreased $16.6 million, or 15.6%, to $89.7 million. Automotive product revenues for 2018 included $54.3 million from Etratech compared to only $8.4 million in 2017.  Gentherm acquired Etratech on November 1, 2017 and recognized product revenues from Etratech during last two months of 2017.  

Our automotive segment revenues outperformed automotive vehicle product volumes during 2018.  Global automotive production decreased 1% during 2018 as compared to 2017. On a combined basis and weighted for the Company’s revenue in each region, automotive vehicle production declined by 1.3% in the Company’s key regions. These lower rates were partially attributable to the negative impact of the new Worldwide Harmonized Light Vehicle Test Procedure (“WLTP”) regulations in Europe. Authorities have been taking longer than expected to certify OEM vehicles under the new WLTP emissions tests, causing production delays.

Adjusting for the impact from currency translation and the Etratech acquisition, automotive segment revenues increased 1% in 2018 as compared to 2017. Gentherm achieved higher revenues in our BTM, steering wheel heaters and automotive cable product categories which were partially offset by lower revenues in our CCS and seat heater product categories. BTM revenues contributed the largest increase totaling $18.4 million, or 183.5%, due to the 2018 launches of the actively cooled version on the Mercedes S-Class and the Jeep Wrangler. Other products that experienced significant growth in revenue during 2018 included automotive steering wheel heaters which increased by $7.7 million, or 12.4%, and automotive cables which increased by $6.8 million, or 7.4%.  The growth in steering wheel heater product revenues is due to new program awards, which included the Nissan Pathfinder, Nissan Murano, and the Audi A6 and Audi A8 vehicle programs. The growth in automotive cables product revenues is attributable to an increase in Oxygen Sensor business with Bosch, totaling $5.1 million. CCS revenues decreased by $13.1 million, or 3.4%, to $374.8 million due to an unfavorable mix between the higher priced active cooling technology and the lower priced heated and ventilated version. The decrease of $2.0 million, or 1%, in seat heater revenues was concentrated in Europe and Asia due to lower production volumes in those regions in 2018 as compared to 2017.

Lower revenues in the industrial segment in 2018 were attributable to decreased revenue of GPT and the CSZ industrial chamber business of $12.7 million, or 39.7%, and $3.7 million, or 8.4%, respectively. During 2018, GPT earned significantly lower revenue due to a decrease in the shipment of custom projects. Lower CSZ industrial chamber business revenues were mainly due to lower product revenues on custom climate testing chambers in 2018.  In June 2018, Gentherm announced that GPT and the CSZ industrial chamber business (“CSZ-IC”) would be sold.  Both businesses were classified as held for sale on December 31, 2018.  See Note 1 to our consolidated financial statements for additional information about Gentherm’s new strategic growth plan and, specifically, the February 2019 sale of CSZ-IC and the planned sale of GPT.  

Cost of sales. Cost of sales increased to $743.6 million during 2018 from $674.8 million during 2017, an increase of $68.8 million, or 10.2%.  Higher cost of sales were primarily due to changes in product mix favoring low margin products, including BTM and Etratech products, and lower quantities of higher margin products, including CCS and automotive seat heaters. The low margin realized on BTM product revenues during 2018 was partially due to higher than expected launch phase costs for the new actively cooled technology programs and higher fixed overhead costs, including depreciation expense, that were incurred in anticipation of higher, post-launch phase volumes.  Freight costs were $4.2 million higher in 2018 compared to 2017 and were attributable to the ramp-up of production at our Celaya Mexico facility. During 2018, labor costs grew $7.2 million compared to 2017 primarily due to higher sales, higher incurred overtime and higher wage rates at our production facilities in Mexico and Ukraine. Lastly, global tariffs, which became effective during the second half of 2018, contributed $1.3 million in additional costs of sales as compared to 2017.  

Net research and development expenses. Net research and development expenses, were $79.9 million during 2018in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Research and development expenses

 

$

91,807

 

 

$

81,968

 

 

$

(9,839

)

Reimbursed research and development expenses

 

 

(16,593

)

 

 

(13,928

)

 

 

2,665

 

Net research and development expenses

 

$

75,214

 

 

$

68,040

 

 

$

(7,174

)

Percentage of product revenues

 

 

7.2

%

 

 

7.5

%

 

 

 

 

Net research and development expenses for the year ended December 31, 2021 increased 10.5% as compared to $82.5 million in 2017, a decrease of $2.6 million, or 3.1%.the year ended December 31, 2020. The decreaseincrease in net research and development expenses wasis primarily drivenrelated to increased project-related spending, including increased investments in ClimateSense and battery performance solutions and higher incentive compensation expense, partially offset by the impact of the Fit-for-Growth cost reduction initiatives and higher-than-normal development and tooling costhigher reimbursements for new production applications. Researchcosts to design, develop and development reimbursement totaled $18.8 million during 2018 and $12.0 million during 2017, an increase of $6.8 million, or 57%. We classify development and prototype costs and relatedpurchase tooling pursuant to customer contracts.

3836


reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Research and development expenses increased $4.1 million, or 4%, to 98.7 million in 2018 due to higher costs for additional resources, including personnel, that are focused on the development of new products, including a program to develop the next generation of seat comfort products, and application engineering for production programs of existing products. The increase also included $1.4 million in foreign currency transaction and research and development expenses of Etratech, which totaled $2.2 million.

Selling, General and Administrative Expenses. Expenses

Below is a summary of our Selling, general and administrative expenses, decreased $3.4 million, or 2.6%,in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Selling, general and administrative expenses

 

$

109,554

 

 

$

105,044

 

 

$

(4,510

)

Percentage of product revenues

 

 

10.5

%

 

 

11.5

%

 

 

 

 

Selling, general and administrative expenses for the year ended December 31, 2021 increased 4.3% as compared to $127.2 million during 2018 from $130.5 million during 2017.the year ended December 31, 2020. The decrease was due to CEO transition expenses of $6.7 million during 2017 and savings associated with cost reduction activities of the Company’s Fit-for-Growth initiative of $3.3 million. This decrease was partially offset byincrease in selling, general and administrative expenses associated with Etratech totaling $4.9is primarily related to higher incentive compensation expense, as well as the absence of COVID-19 cost reduction initiatives that were taken by the Company in the second quarter of 2020 to manage its liquidity position in light of the significant economic uncertainty and the financial impact of the COVID-19 pandemic, partially offset by higher stock compensation expense in 2020 due to the exercises and mark-to-market adjustments of cash settled stock appreciation rights.

Restructuring Expenses

Below is a summary of our Restructuring expenses, in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Restructuring expenses

 

$

3,857

 

 

$

5,803

 

 

$

1,946

 

Restructuring expenses primarily relate to the Manufacturing Footprint Rationalization restructuring program and other discrete restructuring activities focused on optimizing our manufacturing and engineering footprint and the reduction of global overhead expenses. During the year ended December 31, 2021, the Company recognized expenses of $2.2 million higher mark-to-market adjustmentfor employee separation costs charges and $1.7 million of other costs, primarily related to equipment move and set up costs. During the year ended December 31, 2020, the Company recognized expenses of $4.6 million for employee separation costs and $1.2 million of other related costs.

See Note 5, "Restructuring," in notes to the consolidated financial statements included in this Annual Report for additional information.

Interest Expense

Below is a summary of our Interest expense, in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Interest expense, net

 

$

(2,758

)

 

$

(4,559

)

 

$

1,801

 

The decrease in interest expense during the year ended December 31, 2021 compared to 2020 reflects the $169.5 million increased borrowings under the Credit Facility in the first quarter of 2020, primarily to provide additional liquidity and financial flexibility in response to the initial impacts from the onset of the COVID-19 pandemic. A portion of these increased borrowings were repaid by the end of December 31, 2020, and the remainder was repaid in the first quarter of 2021. No amounts were drawn on cash-settled stock optionsthe

37


Credit Facility during the year ended December 31, 2021.  Amounts outstanding on the Revolving Credit Facility as of $2.9the year ended December 31, 2021 and 2020 were $35.0 million and higher expenses related$186.2 million, respectively.

See Note 9, "Debt," to the consolidated financial statements included in this Annual Report for additional information.

Foreign Currency Gain (Loss)

Below is a summary of our Foreign currency translation of $800 thousand.gain (loss), in thousands, for the years ended December 31, 2021 and 2020:

Restructuring expenses. The Company recognized $14.8 million in restructuring expense during 2018 as a result of completed actions associated with the Fit-for-Growth cost savings initiative as more fully described above. The completed Fit-for-Growth actions are expected to deliver annualized saving of approximately $37.0 million.  In 2018, $65.0 million in savings opportunities were identified and we expect to achieve our $75.0 million overall savings target by 2021. No restructuring charges were incurred during 2017.

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Foreign currency gain (loss)

 

$

1,487

 

 

$

(5,439

)

 

$

6,926

 

Foreign currency gain (loss). During 2018, we incurred afor the year ended December 31, 2021, included net realized foreign currency loss of $1.6 million and unrealized net foreign currency gain of $622 thousand which$3.1 million.

Foreign currency loss for the year ended December 31, 2020, included a net realized foreign currency gain of $33 thousand$2.2 million and a net unrealized gain of $589 thousand. During 2017, we incurred a net foreign currency loss of $23.1 million which included an unrealized loss$7.6 million.

Other Income

Below is a summary of $21.8 million, our Other income, in thousands, for the years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Other income

 

$

117

 

 

$

2,337

 

 

$

(2,220

)

The unrealized gaindecrease in 2018 and the unrealized loss in 2017 wasother income is primarily the result of holding significant amount of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to the 2020 non-recurring gain on sale of certain intercompany relationships between these European subsidiariespatents from a non-core business.  See Note 7, “Goodwill and our U.S. based companies. The USD strengthened relativeOther Intangibles,” to the EUR in 2018 but had significantly weakened during 2017. If the USD continues to strengthen, we will likely have unrealized gains, but if the USD weaken, we will likely have unrealized losses.

Impairment loss. During 2018, the Company recorded an impairment loss totaling $11.5 million associated with the Company’s plans to divest GPT and CSZ-IC, both of which areconsolidated financial statements included in this Annual Report for additional information.

Income Tax Expense

Below is a summary of our Income tax expense, in thousands, for the industrial segment.  The loss is not expected to be fully deductible for income tax purposes. No impairment loss was recorded in 2017.years ended December 31, 2021 and 2020:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

Favorable /

(Unfavorable)

 

Income tax expense

 

$

20,418

 

 

$

21,866

 

 

$

1,448

 

Income tax expense. We recorded anexpense was $20.4 million for the year ended December 31, 2021, on earnings before income tax expense of $16.2$113.9 million, during 2018 representing an effective tax rate of 28%17.9%. The effective tax rate differed from the U.S. Federal statutory rate of 21% primarily due to certain favorable tax effects on equity vesting, intercompany transactions during the year and the impact of income taxes on foreign earnings taxed at rates varying from the U.S. statutory rate, offset by the unfavorable impact of the global intangible low-tax income (“GILTI”), withholding taxes, other non-deductible expenses and uncertain tax positions.

Income tax expense was $21.9 million for the year ended December 31, 2020, on earnings before income tax of $58.1 million.$81.6 million, representing an effective tax rate of 26.8%. The pre-tax earningstax amount included the non-deductible impairment losseffect of $11.5the settlement and closure of multi-year international tax audits of $3.4 million. AdjustingAdjusted for the impairment loss,audit impacts, the effective tax rate was 23% for 2018.22.6%.  The effective tax rate differed from the U.S. Federal statutory rate of 21% primarily due to the international provisions of the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017, partly offset by certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions.  We recorded an income tax expense of $34.0 million during 2017 which included the one-time transition tax of $20.2 million relating to the 2017 Tax Cut and Jobs Act (the “Tax Act”). Excluding this one-time expense, our income tax expense would have been $13.8 million representing an effective tax rate of 20% on earnings before income tax of $69.3 million. GILTI.

Industrial segment operating loss. The industrial segment, which includes GPT, CSZ and our advanced research and development activities, reported an operating loss totaling $22.5 million and $14.8 million during 2018 and 2017, respectively. We incurred these losses for several reasons.  First, the advanced research and development activities, the total cost for which were $15.6 million and $13.9 million during 2018 and 2017, respectively, are focused on products and technologies that are currently not generating product revenues. Second, in conjunction with the Fit-for-Growth initiative, a number of advanced research activities have been curtailed or ceased and we have executed site consolidations at our Irvine, California and Azusa, California facilities.  These changes are expected to lead to lower spending rates in future periods. We expect advanced research activities focused on our core technologies to continue and to generate profitable revenue in future periods, a significant portion of which we expected will be recognized in the Automotive segment. Lastly, CSZ incurred $5.2 million in expenses in 2018 associated with a new direct sale force for the medical business unit that has yet to be fully offset by a corresponding increase in the amount of revenue and related operating income. We continue to believe the direct sales force will lead to higher medical product revenues in future periods that will generate operating profits in excess of the costs for the direct sales team.


3938


Results of Operations Year Ended December 31, 2017 Compared to Year Ended December 31, 2016

Product revenues. Product revenues by product category, in thousands, for the years ended December 31, 2017 and 2016 are as follows:

 

 

Year Ended December 31,

 

 

 

 

2017

 

 

 

2016

 

 

%

Change

Climate Control Seats (CCS)

 

$

387,961

 

 

$

405,795

 

 

(4.4

)

%

Seat Heaters

 

 

307,309

 

 

 

288,939

 

 

6.4

 

%

Steering Wheel Heaters

 

 

62,125

 

 

 

49,516

 

 

25.5

 

%

Automotive Cables

 

 

92,093

 

 

 

85,283

 

 

8.0

 

%

Battery Thermal Management (BTM)(a)

 

 

10,043

 

 

 

6,546

 

 

53.4

 

%

Etratech

 

 

8,398

 

 

 

 

 

 

 

Other Automotive

 

 

11,528

(b)

 

 

11,349

 

 

1.6

 

%

Subtotal Automotive

 

$

879,457

 

 

$

847,428

 

 

3.8

 

%

Remote Power Generation (GPT)

 

 

31,891

 

 

 

18,628

 

 

71.2

 

%

Cincinnati Sub-Zero Products (CSZ)

 

 

74,335

 

 

 

51,544

 

 

44.2

 

%

Subtotal Industrial

 

$

106,226

 

 

$

70,172

 

 

51.4

 

%

Total Company

 

$

985,683

 

 

$

917,600

 

 

7.4

 

%

a)

Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system which began during the fourth quarter of 2017.

b)

Includes $2.0 million rebate to customer during 2017.

Product revenues for 2017 were $985.7 million compared with product revenues of $917.6 million for 2016, an increase of $68.1 million, or 7.4%.  This increase included the full year effect of the 2016 acquisition of CSZ, which operated as a part of Gentherm for a full year in 2017 but only for nine months during 2016, $8.4 million in additional revenue attributable to the 2017 acquisition of Etratech after it was acquired on November 1, 2017, and a $5 million favorable impact of foreign currency translation.  Adjusting for these effects, our pro-forma product revenue growth was 4.6% and included a 2.7% increase in Automotive segment product revenues to $879.5 million and a 23.4% increase in Industrial segment product revenue to $106.2 million.

The increase in the Automotive segment occurred despite lower global automotive production volumes and a special rebate of $2.0 million recorded during 2017.  The increases included higher revenue volume for heated seat products, totaling $18.4 million, or 6.4%, heated steering wheels of $12.6 million, or 25.5%, automotive cable systems of $6.8 million, or 8.0%, and battery thermal management products of $3.5 million, or 53.4%.  These higher amounts were attributable to new program awards, higher vehicle application rates and higher component content.  Higher component content in heat seat products, for example, included a greater number of programs for which Gentherm provides the electronic controlling device along with the heating element.  These increases were partially offset by lower CCS product revenues which decreased by $17.8 million, or 4.4%.  CCS product revenue was disproportionately impacted by the lower global production volumes which were more unfavorable in our primary CCS market, North America, which was down by 4%, compared to an increase of 2% for the global automotive industry.  CCS revenues were also reduced as a result of certain vehicle programs changing technologies from the higher priced active cooling seat application to the lower priced heated and ventilated seat technology. 

Product revenues from GPT totaled $31.9 million which represented an increase of $13.3 million, or 71%.  Continuing market weakness in North America was more than offset by higher sales to other markets.  Product sales in this business unit are typically large custom remote power systems having long lead times and, during 2017, there were more shipments than in the prior year.  During 2016, demand for GPT’s products sold in North America was unfavorably impacted by lower oil prices.  While we do not generally sell our products for oil exploration, production or transportation activities, the impact of lower oil prices reduced capital investments for the natural gas industry being made by GPT’s principal customers.  As a result, those customers curtailed orders during that year.

40


CSZ product revenue increased by $22.8 million which included both an acquisition related increase of $15.9 million and organic growth of $6.9 million, or 10%.   This increase included higher revenue of environmental chamber products totaling $8.1 million or 22% partially offset by lower revenue of patient temperature management products of $1.2 million or 3.9%.  The higher revenue for environmental chambers included several large custom orders as well as stronger demand for standard chambers.  Patient temperature management product revenue equally benefited 2017 and 2016 from a temporary surge in demand for the Hemotherm product, a blood heater cooler used in hospital operating rooms during open heart surgery, but did not yet show improvements associated with a transition to a direct sales force that occurred throughout 2017.

Cost of sales. Cost of sales increased to $674.8 million in 2017 from $622.6 million in 2016. The increase of $52.2 million, or 8%, was due to increased sales volume, unfavorable inventory adjustments, other increased expenses and changes in product mix partially offset by a one-time $4.0 million expense from the purchase accounting effect of inventory for the CSZ acquisition which occurred in 2016.  The gross margin rate was 31.6% during 2017 representing a decrease of 60 basis points as compared with the 2016 gross margin rate of 32.2%.  This decrease was due to the special rebate and the inventory adjustments and the higher expenses.  The unfavorable inventory adjustments totaled $2.3 million and were mainly comprised of a reserve recorded for inventory held for the heated and cooled mattress product line based upon a reduced sales outlook.  Increased expenses totaling approximately $7.0 million included higher fixed costs associated with our new manufacturing facilities in Mexico and Macedonia, labor expense inflation at our Ukraine factory, and factory launch expenses for the new advanced battery thermal management product and electronics.

Net research and development expenses. Net research and development expenses were $82.5 million during 2017 compared to $72.9 million in 2016, an increase of $9.6 million, or 13%. This increase was primarily driven by higher costs for additional resources, including personnel focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. 

Increases in research and development were partially offset by research and development reimbursement totaling $12.0 million during 2017 and $6.7 million during 2016. 

Acquisition transaction expenses. During 2017, we incurred $789 thousand in fees and expenses associated with the acquisition of Etratech which was completed on November 1, 2017.  During 2016, we incurred $743 thousand in fees and expenses associated with the acquisition of CSZ which was completed on April 1, 2016.

Selling, general and administrative expenses. Selling, general and administrative expenses were $130.5 million , which included $1.1 million in selling, general and administrative expenses for Etratech and $6.1 million in higher expenses for CSZ due to the additional three months of operations during 2017 as compared to 2016, the year CSZ was acquired.   Excluding the Etratech expenses and additional CSZ expenses, selling, general and administrative expenses increased by $8.1 million, or 7%, from $115.3 million in the prior year. This increase was partly due to expenses associated with the transition to a new CEO, higher selling costs for CSZ’s medical products business, and increased management incentive compensation costs partially offset by a one-time expense associated with a management reorganization totaling $2.0 million incurred in 2016 but not 2017.  During 2017 our former CEO, Daniel R. Coker, retired and as a result, we recorded expenses totaling $6.7 million which included accelerated stock compensation amortization and accrued cash bonus.  The amount also included a signing bonus and a make whole bonus for Mr. Coker’s successor and fees associated with the recruitment process.  CSZ’s selling expenses include an increase of $3.9 million associated with a direct sales force for its medical division started during 2017.  Lastly, expenses for our management incentive program were $968 thousand higher during 2017 as compared to 2016.

Foreign currency gain (loss).  During 2017 we incurred a net foreign currency loss of $23.1 million which included a net realized loss of $1.3 million and a net unrealized loss of $21.8 million.  During 2016, we incurred a net foreign currency gain of $7.8 million which included a net realized gain of $1.7 million and a net unrealized gain of $6.1 million. The unrealized loss in 2017 and the unrealized gain in 2016 was primarily the result of holding significant amounts of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies.  During 2017, the USD significantly weakened relative to the EUR but strengthened during 2016. 

41


Income tax expense. We recorded an income tax expense of $34.0 million during 2017 which included the one-time transition tax of $20.1 million relating to the Tax Act.  Excluding this one-time expense, our income tax expense would have been $13.9 million representing an effective tax rate of 20% on earnings before income tax of $69.3 million.  We recorded an income tax expense of $34.0 million during 2016 which included the one-time withholding tax expense of $7.6 million and income tax expense of $2.5 million related to the Reorganization.  Excluding these one-time expenses, our income tax expense would have been $23.9 million representing an effective tax rate of 22% on earnings before income tax of $110.6 million.

The Tax Act was enacted on December 22, 2017.  The Tax Act reduces the U.S. federal corporate tax rate from 35% to 21%, requires companies to pay a one-time transition tax on all offshore earnings that were previously tax deferred and creates new taxes on certain foreign sourced earnings.  As of December 31, 2017, in accordance with guidance provided by Staff Accounting Bulletin No. 118 (SAB 118), we have not completed our accounting for the tax effects of the Tax Act; however, in certain cases, as described below, we have made a provisional estimate of the effects on our existing deferred tax balances and the one-time transition tax.  In the year ended December 31, 2017, the provision for income taxes includes a provisional income tax expense of $20.2 million related to items for which we were able to determine a reasonable estimate.  In all cases, we will continue to make and refine our calculations as additional analysis is completed.  In addition, our estimates may be affected as additional regulatory guidance is issued with respect to the Tax Act.  Any adjustments to the provisional amounts will be recognized as a component of the provision for income taxes in the period in which such adjustments are determined, but in any event, no later than the fourth quarter of 2018, in accordance with SAB 118.  

Deferred tax assets and liabilities.  We remeasured our U.S. deferred tax assets and liabilities at 21%.  However, we were still analyzing certain aspects of the Tax Act and refining our calculations, which could have potentially affected the measurement of these balances or potentially give rise to new deferred tax amounts.  In the year ended December 31, 2017, the provision for income taxes includes provisional income tax expense of $5.8 million related to the remeasurement of deferred tax balances.

Transition tax on deferred foreign earnings.  The one-time transition tax is based on our post-1986 earnings and profits (“E&P”) that were previously deferred from U.S. income taxes.  In the year ended December 31, 2017, the provision for income taxes includes provisional income tax expense of $23.9 million related to the one-time transition tax liability of our foreign subsidiaries.  We have not completed our calculation of the total post-1986 E&P for these foreign subsidiaries.  Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets.  This amount may change when we finalize the calculation of post-1986 E&P previously deferred from U.S. income taxes and the amounts held in cash or other specified assets.  A benefit of $9.6 million was included in the provision for income taxes to offset the one-time transition tax related to the previous deferred tax liability that existed for the undistributed foreign earnings that were not permanently reinvested.  However, we continue to recognize a deferred tax liability related to foreign withholding tax that will be incurred for undistributed foreign earnings that are not permanently reinvested. See Note 2 to our consolidated financial statements for additional information about the one-time transition tax.

Industrial segment operating loss.  The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $14.8 million and $16.7 million during 2017 and 2016, respectively.  The loss during 2016 included the one-time purchase accounting adjustment related to the CSZ acquisition.  After adjusting for this one-time expense, the 2017 loss was $2.0 million, or 16%, higher than the loss in the Industrial segment, as adjusted, in 2016.  We incurred these losses for three reasons.  First, the advanced research and development activities, the total cost for which were $13.9 million and $12.1 million, during 2017 and 2016, respectively, are focused on products and technologies that are currently not generating product revenues.  Second, CSZ incurred approximately $2.0 million in cost overruns on several large customer environmental test chambers during 2017.  These cost overruns are not expected to recur in future periods.  Finally, CSZ’s $3.9 million in higher expenses in 2017 associated with the new direct sales force was not yet offset by a corresponding increase in the amount of revenue and related operating income. 

Liquidity and Capital Resources

CashOverview

Our primary sources of liquidity and Cash Flows

The Company has funded its financial needs primarily throughcapital resources are cash flows from operations and borrowings available under our Credit Agreement. Our cash requirements consist principally of working capital, capital expenditures, research and development, operating activitieslease payments, income tax payments and equity and debt financings.  Our new strategic plan sets forth a capital allocation strategy that includes a targeted debt-to-earnings leverage ratio and allows for some ofgeneral corporate purposes. We generally reinvest available cash flows from operations into our cash flow to be paid back to investors through Common Stock repurchases.  On June 25, 2018,business, while opportunistically utilizing our Board of Directors increased the Company’sauthorized stock repurchase authorization to $300 million, of which $146.6 million of availability remainedprogram. Further, we continuously evaluate acquisition and investment opportunities that will enhance our business strategies.

42


asAs of December 31, 2018.  This authorization expires on December 16, 2020. Based on its current operating plan, management believes2021, the Company had $190.6 million of cash and cash equivalents, at$440 million of availability under our Credit Agreement and $26.5 million of availability under our North America receivables factoring arrangement. We also continue to maintain access to the capital markets and may issue debt or equity securities, which may provide an additional source of liquidity.

We continue to expect to be able to move funds between different countries to manage our global liquidity needs without material adverse tax implications, subject to current monetary policies and the terms of the Credit Agreement. We utilize a combination of strategies, including dividends, cash pooling arrangements, intercompany loan repayments and other distributions and advances to provide the funds necessary to meet our global liquidity needs. There are no significant restrictions on the ability of our subsidiaries to pay dividends or make other distributions to Gentherm Incorporated. As of December 31, 2018, together with2021, the Company’s cash flowsand cash equivalents held by our non-U.S. subsidiaries totaled approximately $161.5 million. If additional non-U.S. cash was needed for our U.S. operations, we may be required to accrue and pay withholding if we were to distribute such funds from operating activities, and borrowing available undernon-U.S. subsidiaries to the U.S.; however, based on our credit agreement, are sufficient to meet operating and capital expenditurecurrent liquidity needs and to service debt, for at least the next 12 months. However, if cash flows from operations decline,strategies, we maydo not anticipate a need to obtain alternative sources of capitalaccrue and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition.  In addition, it is likelypay such additional amounts.

We currently believe that we will need to complete one or more equity or debt financings if we consummate any significant acquisition or several smaller acquisitions.  There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.  

The following table represents our cash and cash equivalents and short-term investments:borrowings available under our Credit Agreement and the North America receivables factoring arrangement will be adequate to meet anticipated cash requirements for at least the next twelve months and the foreseeable future.

Cash and Cash Flows

The table below summarizes our cash activity for each of the last two fiscal years (in thousands):

 

 

  

December 31,
2018

 

  

December 31,
2017

 

 

  

(in Thousands)

 

Cash and cash equivalents at beginning of period

 

$

103,172

 

 

$

177,187

 

Cash from operating activities

 

 

118,434

 

 

 

49,880

 

Cash used in investing activities

 

 

(40,757

)

 

 

(117,688

)

Cash from financing activities

 

 

(139,266

)

 

 

(31,564

)

Foreign currency effect on cash and cash equivalents

 

 

(1,963

)

 

 

25,357

 

Cash and cash equivalents at end of period

 

$

39,620

 

 

$

103,172

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Cash, cash equivalents and restricted cash at beginning of period

 

$

268,345

 

 

$

52,948

 

Net cash provided by operating activities

 

 

143,076

 

 

 

110,695

 

Net cash used in investing activities

 

 

(48,830

)

 

 

(18,220

)

Net cash (used in) provided by financing activities

 

 

(169,141

)

 

 

115,480

 

Foreign currency effect on cash and cash equivalents

 

 

(2,844

)

 

 

7,442

 

Cash, cash equivalents and restricted cash at end of period

 

$

190,606

 

 

$

268,345

 

Cash Flows From Operating Activities

We manage our cash, cash equivalents and short-term investments to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities earned during 2018 with those earned in 2017:

 

 

Year Ended December 31,

 

 

 

2018

 

 

2017

 

 

Change

 

Operating Activities:

 

(in Thousands)

 

Net income

 

$

41,899

 

 

$

35,227

 

 

$

6,672

 

Non-cash adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

50,638

 

 

 

44,972

 

 

 

5,666

 

Deferred income taxes

 

 

6,699

 

 

 

5,135

 

 

 

1,564

 

Stock compensation

 

 

9,047

 

 

 

12,507

 

 

 

(3,460

)

Defined benefit pension plan expense

 

 

82

 

 

 

(23

)

 

 

105

 

Provision for doubtful accounts

 

 

(1

)

 

 

(469

)

 

 

468

 

Loss on sale of property and equipment

 

 

2,602

 

 

 

1,042

 

 

 

1,560

 

Impairment loss

 

 

11,476

 

 

 

 

 

 

11,476

 

Net income before non-cash adjustments

 

 

122,442

 

 

 

98,391

 

 

 

24,051

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

3,024

 

 

 

6,033

 

 

 

(3,009

)

Inventory

 

 

(7,689

)

 

 

(4,348

)

 

 

(3,341

)

Prepaid expenses and other assets

 

 

(4,428

)

 

 

(12,334

)

 

 

7,906

 

Accounts payable

 

 

12,380

 

 

 

(7,691

)

 

 

20,071

 

Accrued liabilities

 

 

(7,295

)

 

 

(30,171

)

 

 

22,876

 

Net cash provided by operating activities

 

 

118,434

 

 

 

49,880

 

 

 

68,554

 

43


Cash provided by operating activities during 2018 was $118.4 million representing an increase of $68.6 million from cash provided by operating activities during 2017, which was $49.9 million. The following table highlights significant differences between the operating cash flows for the periods ending December 31, 2018 and 2017, respectively:

(in Thousands)

Net cash provided by operating activities during 2017

$

49,880

 

Higher net income before changes in operating assets and liabilities

 

24,051

 

Changes in working capital, net

 

46,843

 

Changes in other assets and liabilities

 

(2,340

)

Net cash provided by operating activities during 2018

$

118,434

 

Net cash provided by operating activities beforetotaled $143.1 million and $110.7 million for the years ended December 31, 2021 and 2020, respectively. Cash flow provided by operating activities for the year ended December 31, 2021 consisted primarily of net income of $93.4 million, increased by $54.3 million for non-cash charges for depreciation, amortization, non-cash stock based compensation, and loss on disposition of property and equipment, partially offset by non-cash charges of $0.5 million for deferred income taxes and other, and $4.2 million related to changes in assets and liabilities. Cash flows provided by operating activities for the year ended December 31, 2020 consisted primarily of net income of $59.7 million, increased by $51.5 million for non-cash charges for depreciation, amortization, non-cash stock based compensation, deferred income taxes and loss on disposition of property and equipment, and $2.3 million related to changes in operating assets and liabilities, increased during 2018 due to higher revenues partially offset by higher cash based operating expenses and impairment losses recognized$2.7 million net gain on goodwill, other intangible asset and assets held for sale of $6.2 million, $3.1property and equipment and other.

39


Cash Flows From Investing Activities

Net cash used in investing activities totaled $48.8 million and $2.2$18.2 million for the years ended December 31, 2021 and 2020, respectively. Additionally, workingThe increase in usage is primarily attributable to increased capital net provided favorable cash flows related to accounts receivable and accrued liabilities and unfavorable amounts related to inventory, prepaid expenses and other assets and accounts payable.

Working Capital

The following table illustrates changes in working capital during 2018:

(in Thousands)

Working capital at December 31, 2017

$

289,754

 

Decrease in cash

 

(61,768

)

Decrease in accounts receivable

 

(13,932

)

Decrease in inventory

 

(6,552

)

Increase in tax receivables, net

 

14,801

 

Increase in prepaid expenses and other assets

 

(722

)

Increase in accounts payable

 

(5,494

)

Decrease in accrued liabilities

 

1,743

 

Current assets classified as held for sale, net

 

10,717

 

Non-current assets classified as held for sale

 

46,833

 

Foreign currency effect on working capital

 

(7,701

)

Working capital at December 31, 2018

$

267,679

 

The following table highlights significant transactions that contributed to the decrease in cash experiencedexpenditures of $21.2 million during the year ended December 31, 2018:

(in Thousands)

Net cash provided by operating activities

$

118,434

 

Purchases of property and equipment

 

(41,541

)

Repayments of Debt

 

(99,460

)

Borrowings from U.S. Revolving Note

 

94,679

 

Stock repurchases

 

(148,074

)

Proceeds from the exercise of Common Stock options

 

14,777

 

Other items

 

(583

)

Decrease in cash

$

(61,768

)

In addition2021 as compared to these transactions, working capital was impacted by decreases in accounts receivable, inventory, prepaid expenses and other assets, and accrued liabilities and increases in accounts payable.  The changes in current assets and liabilities reflects the classification of GPT and CSZ-IC (disposal group) as held for sale during 2018.  All assets and liabilities of the disposal group are classified as held for sale within current assets and current liabilities, respectively, on the Company’s consolidated balance sheet for the year ended December 31, 2018.  See Note 15 to our consolidated financial statement2020. Additionally, during the year ended December 31, 2021, usage included $10.4 million paid for additional information aboutbusiness acquisitions and technology investments. During the year ended December 31, 2020, usage included $3.1 million paid for acquisition of intangible assets, and liabilities classified as heldpartially offset by $2.1 million proceeds for sale. Lastly, Gentherm recognized an increase in current tax receivable relating to timingthe sale of required payment to tax authorities.

44


Cash Flows From Investing Activities

Cash used in investing activities was $40.8 million during 2018, reflecting purchases ofpatents, property and equipment related to the expansion of production capacity, including at our newest facilities in Mexico, Vietnam, Macedonia and our Etratech facility in Canada.equipment.

Cash Flows From Financing Activities

CashNet cash used in financing activities was $139.3totaled $169.1 million for the year ended December 31, 2021 and net cash provided by financing activities totaled $115.5 million for the year ended December 31, 2020. Cash flows used in financing activities for the year ended December 31, 2021 primarily included $153.2 million of debt repayments, $20.0 million paid to repurchase common stock and $4.1 million paid for employee taxes related to the net settlement of restricted stock units that vested during 2018, reflecting payments of principal on the U.S. Revolving Note, the DEG China Loan and the DEG Vietnam Loan totaling $99.5 million in aggregate,year, partially offset by additional borrowings on$8.3 million of proceeds from the U.S. Revolving Note totaling $94.7 million. Asexercise of common stock options. Cash flows provided by financing activities for the year ended December 31, 2018,2020 primarily included proceeds of $201.1 million received from the total availabilityincreased borrowings under our Credit Agreement, $16.6 million of proceeds from the U.S. Revolving Note was $221.9 million. Cash was alsoexercise of common stock options, partially offset by $91.4 million of debt repayments, $9.1 million paid to repurchase Common Stock totaling $148.1common stock and $1.1 million andpaid for cancellationsemployee taxes related to the net settlement of restricted stock awards totaling $1.2 million.units that vested during the year.

Debt

The Company,following table summarizes the Company’s debt at December 31, 2021 and 2020 (dollars in thousands).

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

 

Interest

Rate

 

 

Principal

Balance

 

 

Interest

Rate

 

 

Principal

Balance

 

Amended Credit Agreement:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar denominations)

 

 

1.35

%

 

$

35,000

 

 

 

1.65

%

 

$

171,500

 

U.S. Revolving Note (Euro denominations)

 

 

 

 

 

 

 

 

1.50

%

 

 

14,684

 

DEG Vietnam Loan

 

 

5.21

%

 

 

3,750

 

 

 

5.21

%

 

 

6,250

 

Total debt

 

 

 

 

 

 

38,750

 

 

 

 

 

 

 

192,434

 

Current maturities

 

 

 

 

 

 

(2,500

)

 

 

 

 

 

 

(2,500

)

Long-term debt, less current maturities

 

 

 

 

 

$

36,250

 

 

 

 

 

 

$

189,934

 

Credit Agreement

Gentherm, together with certain directof its subsidiaries, maintain a revolving credit note (“U.S. Revolving Note”) under its Amended and indirect subsidiaries, has an outstanding credit agreementRestated Credit Agreement (the “Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides the Company a revolving credit note (“U.S. Revolving Note”) withhas a maximum borrowing capacity of $350 million.

All subsidiary borrowers$475 million and guarantors participating in the Credit Agreement have entered into a related pledge and security agreement. The security agreement grants a security interest to the lenders in substantially all of the personal property of subsidiaries designated as borrowers to secure their respective obligations under the Credit Agreement, including the stock and membership interest of specified subsidiaries (limited to 66% of the stock in case of certain non-US subsidiaries).matures on June 27, 2024. The Credit Agreement restrictscontains covenants, that, among other things, (i) prohibit or limit the amountability of dividend payments the Company canborrowers and any material subsidiary to incur additional indebtedness, create liens, pay dividends, make to shareholders.  

The Credit Agreement requirescertain types of investments (including acquisitions), enter into certain types of transactions with affiliates, prepay other indebtedness, sell assets, merge with other companies or enter into certain other transactions outside the Company toordinary course of business, and (ii) require that Gentherm maintain a minimum Consolidated Interest Coverage Ratio and a Consolidated Leverage Ratio.  DefinitionsRatio (based on consolidated EBITDA for these financial ratios are providedthe applicable trailing 12-month period as defined in the  Credit Agreement.

Under the Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The base rate is equal to the highestAgreement) as of the Federal Funds Rate (2.40% at December 31, 2018) plus 0.50%, Bankend of America’s prime rate (5.50% at December 31, 2018), or a one month Eurocurrency rate (0.00% at December 31, 2018) plus 1.00%. The Eurocurrency rate for loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (2.50% at December 31, 2018). In April 2018, the Credit Agreement was amended to establish a means for determining an alternative for LIBOR if it is determined that ascertaining LIBOR is no longer possible. All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.any fiscal quarter.

The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company.  As long as the Company is not in default of the terms and conditions of the Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%, respectively, for Base Rate Loans.  DEG Vietnam Loan

The Company also has twoa fixed interest rate loansloan with the German Investment Corporation (“DEG”), a subsidiary of KfW banking group,Banking Group, a GermanGermany government-owned development bank.  The first, a loan we used to fund capital investments in China (the “DEG China Loan”), is subject to semi-annual principal payments that began March, 2015 and will end September, 2019.  Under the terms of the DEG China Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Ltd.

The Company’s second fixed interest rate senior loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments that began November, 2017 and will end May, 2023.  

40


See Note 9, “Debt,” to the consolidated financial statements included in this Annual Report for additional information.

Other Sources of Liquidity

In June, 2021, we entered into a receivable factoring agreement with HSBC Bank USA, National Association. Under the termsreceivable factoring agreement, we can sell receivables for certain of our North America account debtors up to $41.3 million, on a revolving basis, subject to outstanding balances and concentration limits. As of December 31, 2021, there were no outstanding receivables transferred under the DEG Vietnam Loan,receivable factoring agreement and our availability under the Company must maintain a minimum Currency Ratio, Equity Ratio and Enhanced Equity Ratio, each as defined by the DEG Vietnam Loanreceivables factoring agreement based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.  was $26.5 million.

45Material Cash Requirements


The following table summarizes the Company’s debt at December 31, 2018 (dollars in thousands).

 

 

  

Interest
Rate

 

 

Principal
Balance

 

Credit Agreement:

 

 

 

 

 

 

 

 

     U.S. Revolving Note (U.S. Dollar Denominations)

 

 

4.02

%

 

$

122,000

 

     U.S. Revolving Note (Euro Denominations)

 

 

1.50

%

 

 

5,727

 

DEG China Loan

 

 

4.25

%

 

 

913

 

DEG Vietnam Loan

 

 

5.21

%

 

 

11,250

 

Total debt

 

 

 

 

 

 

139,890

 

Current portion

 

 

 

 

 

 

(3,413

)

Long-term debt, less current maturities

 

 

 

 

 

$

136,477

 

As of December 31, 2018, we were in compliance with all terms as outlined in the Credit Agreement, DEG China Loancurrent and DEG Vietnam Loan. Undrawn borrowing capacity under the U.S. Revolving Note was $221.9 millionlong-term material cash requirements as of December 31, 2018.

Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Revenue from Contracts2021, which we expect to fund primarily with Customers

In May 2014, the FASB issued Accounting Standard Update (“ASU”) 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue andoperating cash flows arising from contracts with customers. The update’s core principal is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those good or services. Issuers are to use a five-step contract review model to ensure revenue is measured, recognized, and disclosed in accordance with this principle. The FASB issued several amendments to the update, including a one-year deferral of the original effective date, and new methods for identifying performance obligations that are intended to reduce the cost and complexity of compliance.

We adopted ASU 2014-09 and related amendments effective January 1, 2018 using the cumulative catch-up transition method, which required us to disclose the cumulative effect of initially applying the update recognized at the date of initial application. We elected to apply the guidance in ASU 2014-09 to contracts that were not completed at January 1, 2018.

The most significant impact from adoption of ASU 2014-09 occurred within our Automotive segment and relates to our accounting for production part purchase options that grant customers a material right to purchase additional parts under long-term supply agreements in the future. Due to the complexity of certain of our automotive supply contracts, the actual revenue recognition treatment for customer purchase options will depend on contract-specific terms and could vary from other contracts that are similar in nature. Revenue recognition related to goods and services reported in the Industrial segment remains substantially unchanged.

46


The amount by which each financial statement line item was affected by application of ASU 2014-09 and related amendments during the period ended December 31, 2018, in thousands, is as follows:flows.

 

 

  

Revenue Based on Previously Effective Guidance

 

  

New Revenue Standard Adjustment

 

  

Revenue Based on New Revenue Standard

 

Twelve Months Ended December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,035,773

 

 

$

2,486

 

 

$

1,038,259

 

Income tax expense (benefit)

 

 

16,727

 

 

 

507

 

 

 

16,220

 

Net income

 

 

39,920

 

 

 

1,979

 

 

 

41,899

 

Basic earnings per share

 

 

1.11

 

 

 

0.06

 

 

 

1.17

 

Diluted earnings per share

 

 

1.10

 

 

 

0.06

 

 

 

1.16

 

 

  

Revenue Based on Previously Effective Guidance

 

  

New Revenue Standard Adjustment

 

  

Revenue Based on New Revenue Standard

 

Balance Sheet December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net of allowance for doubtful accounts

 

$

166,858

 

 

$

 

 

$

166,858

 

Accrued liabilities(a)

 

$

64,211

 

 

$

1,597

 

 

$

65,808

 

Unearned revenue(a)

 

$

 

 

$

1,597

 

 

$

1,597

 

Deferred income taxes, net

 

$

62,522

 

 

$

325

 

 

$

62,847

 

Accumulated earnings

 

$

365,237

 

 

$

(1,272

)

 

$

363,965

 

 

 

Payments Due by Period

 

Material Cash Requirements (in thousands)

 

Total

 

 

Less than 1 year

 

 

1 to 3 years

 

 

3 to 5 years

 

 

More than 5 years

 

Long-term debt obligations (1)

 

$

38,750

 

 

$

2,500

 

 

$

36,250

 

 

$

 

 

$

 

Operating lease obligations (2)

 

 

29,671

 

 

 

6,541

 

 

 

8,864

 

 

 

6,728

 

 

 

7,538

 

Purchase obligations (3)

 

 

24,457

 

 

 

19,832

 

 

 

4,625

 

 

 

 

 

 

 

Capital commitments (4)

 

 

5,388

 

 

 

5,388

 

 

 

 

 

 

 

 

 

 

Other

 

 

250

 

 

 

50

 

 

 

100

 

 

 

100

 

 

 

 

Total

 

$

98,516

 

 

$

34,311

 

 

$

49,839

 

 

$

6,828

 

 

$

7,538

 

 

 

a)(1)

During 2018, unearned revenues associated with GPT and CSZ-IC were classified as liabilities heldLong-term debt obligations do not include an amount payable for sale.  As of December 31, 2018, 5,351interest. See Note 9, “Debt,” to the consolidated financial statements included in unearned revenues associated with GPT and CSZ-IC were classified as liabilities heldthis Annual Report for sale.

Adoption of ASU 2014-09 and related amendments had no impact to cash from or used in operating, investing or financing activities on our consolidated statements of cash flows.

Statement of Cash Flows

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.”  ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company focused its evaluation on the following transactions to determine the effect ASU 2016-15 will have on the Company’s Consolidated Statements of Cash Flows:

1)

Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities.  Previously, Gentherm classified debt extinguishment payments within operating activities.  additional information.

 

2)(2)

Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities upSee Note 8, “Leases,” to the amount of the liability recognized at the acquisition date.  Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflowsconsolidated financial statements included in this Annual Report for operating activities.additional information.

 

3)(3)

Cash receipts fromPurchase obligations are comprised of commitments to secure the settlementsupply of insurance claims, excluding thosecertain semiconductor chips. We have entered into agreements with various suppliers to reserve the rights to certain semiconductor chips over the next 12 to 24 months, with volume commitments determined based on our anticipated production requirements. Such agreements provide the Company with priority access to semiconductor chips as they become available, however, these agreements do not guarantee that our suppliers will meet the timing and quantities requested by Gentherm. We have not included amounts for other material and component purchase obligations related to corporate-owned life insurance policies shall be classified on the basisstandard recurring purchases of the related insurance coverage.  For example, proceeds receivedmaterials for use in our manufacturing operations as these amounts are generally consistent from year to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities.year, closely reflect our levels of production, and are not long-term in nature.

 

4)(4)

Cash receipts from the settlementCapital commitments is comprised of corporate-owned life insurance policies shall be classified as cash inflows from investing activities.commitments for capital expenditures. Such commitments are typically less than one year.  

We have adopted ASU 2016-15 and related amendments effective January 1, 2018. None of the cash receipt and cash payment transactions addressed by the update occurred during any of the periods presented in this report. Adoption of this update and related amendments did not have a material impact on the cash flows of the Company.

47


Income TaxesOther Commitments

In October 2016,December 2021, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” ASU 2016-16 modifies the current prohibitionCompany committed to recognize deferred income taxes from differences between the tax basis of assetsmake a $5 million investment in the buyer’s tax jurisdiction and their cost resulting from an intra-entity transfer from one tax-paying componentAutotech Fund III, L.P., pursuant to another tax-paying component of the same consolidated group.  Under current GAAP, deferred income taxes for intra-entity asset transfers are not recognized until the asset is sold to an outside party.  ASU 2016-16 allows entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs.

We adopted ASU 2016-16 and related amendments effective January 1, 2018 on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of such adoption date.limited partnership agreement. As a result oflimited partner, the amendments in ASU 2016-16, a favorable adjustment of $31,645 was recorded directly to retained earnings. The new deferred tax assetsCompany will be recognized ratablyperiodically make capital contributions toward this total commitment amount over the usefulexpected ten year life of the fund. The Company has not made any contributions to the Autotech Fund III, LP as of December 31, 2021. Timing of the capital contributions is unknown and therefore amounts have been excluded from the Material Cash Requirements table above.

Capital Expenditures

We anticipate capital expenditures in fiscal year 2022 of approximately $50 million to $60 million. We will continue support organic growth through capacity expansion in our facilities and make capital improvements as necessary. We believe cash on hand, cash generated from operations, and the borrowing capacity available under our Credit Agreement will be sufficient to support our capital expenditures.

41


Stock Repurchase Program

On December 11, 2020, the Board of Directors authorized the 2020 Stock Repurchase Program, pursuant to which the Company is authorized to repurchase up to $150 million of its issued and outstanding common stock over a three-year period, expiring December 15, 2023. During the year ended December 31, 2021, the Company repurchased approximately $20 million of shares under the 2020 Stock Repurchase Program with an average price paid per share of $83.44.  The 2020 Stock Repurchase Program has $130 million of repurchase authorization remaining as of December 31, 2021.

Repurchases may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable assets.legal requirements, debt covenants and other considerations. Any such repurchases may be executed using open market purchases, privately negotiated agreements or other transactions. Repurchases may be funded from cash on hand, available borrowings or proceeds from potential debt or other capital markets sources.

Accumulated Other Comprehensive IncomeFor further information related to our stock repurchase program, see Note 15, "Equity" in notes to the consolidated financial statements included in this Annual Report.

Effects of Inflation

The automotive component supply industry has historically been subject to inflationary pressures with respect to materials and labor. In February 2018,2021 and continuing in 2022, macroeconomic effects of the FASB issued ASU 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” ASU 2018-02 provides a remedyCOVID-19 pandemic have resulted in inflationary cost increases in certain materials, labor and transportation. These inflationary cost increases are expected to a narrow-scope financial reporting issue created bycontinue into the Tax Act.  The Tax Act required entitiesforeseeable future as demand remains elevated and supply remains constrained. Although the Company has developed and implemented strategies to adjust deferred tax assets and liabilities to reflectmitigate the impact from newly enacted lower corporate income tax rates,of higher material component costs and recognizetransportation costs, these strategies, together with commercial negotiations with Gentherm's customers and suppliers may not fully offset our future cost increases. Such inflationary cost increase may increase the effect in income from continuing operations.  This requirement appliedcash required to all deferred tax assets and liabilities, even those which arose from transactions originally recognized in other comprehensive income.  The amendments in ASU 2018-02 allow adjustments to deferred tax assets and liabilities due to newly enacted lower corporate income tax rates to be recognized in retained earnings, if those deferred tax balances arose from transactions originally recognized in other comprehensive income.  fund our operations by a material amount.

Income tax effects are released from accumulated other comprehensive income and recorded against the deferred tax balance in theCritical Accounting Estimates

Our consolidated balance sheet when the underlying activity is realized.  

ASU 2018-02 is effective for annual and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update is permitted, including adoption in any interim period for which financial statements have not yet been issued. The amendmentsprepared in ASU 2018-02 must be appliedaccordance with accounting principles generally accepted in the periodUnited States of adoption or retrospectivelyAmerica (“GAAP”). In preparing these consolidated financial statements, management was required to each periodmake estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. Because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material to our financial statements.

We have identified the following estimates as our most critical accounting estimates, which are those that are most important to aid in fully understanding and evaluating the effectCompany’s financial condition and results of operations, and that require management’s most subjective and complex judgments. Information regarding our other significant accounting estimates and policies are disclosed in Note 2, Summary of Significant Accounting Policies, of the changenotes to the consolidated financial statements.

Impairments of Goodwill

Critical estimates: Goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in U.S. federal corporate income tax rate incircumstances indicate that the Tax Actcarrying value may not be recoverable. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is recognized. We electedmore likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to early adopt ASU 2018-02 and related amendments effective January 1, 2018. An adjustmentperform a qualitative assessment of $40 was recognized against retained earnings for effecta reporting unit, we then compare the fair value of the change in the federal corporate income tax rate on deferred tax amounts. There are no related adjustmentsreporting unit to the Company’s valuation allowance and no other income tax effects fromrelated net book value. If the Tax Act on balances that remain in accumulated other comprehensive income were reclassified.  

Tax Act

In January 2018, the FASB released guidance on the accounting for tax on the global intangible low-taxed income (“GILTI”) provisions of the Tax Act. The GILTI provisions impose a tax on foreign income in excess of deemed return on tangible assets of foreign corporations. During 2018, the Company elected to treat any potential GILTI inclusions as a period cost.

Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 modified the concept of impairment of goodwill to be a condition that exists when the carryingnet book value of a reporting unit that includes goodwill exceeds its fair value. An entity should recognizevalue, an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limitedloss is measured and recognized.

42


The Company utilizes an income approach to the total amount of goodwill allocated to that reporting unit. Entities no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigningestimate the fair value of a reporting unit and a market valuation approach to allfurther support this analysis. The income approach is based on projected debt-free cash flow that is discounted to the present value using discount factors that consider the timing and risk of itscash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in our industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect a risk factor, if necessary. Other significant assumptions include terminal value growth rates and terminal value margin rates. To further support the fair value estimate determined by the income approach, the Company utilizes a market valuation approach to estimate the fair value of a reporting unit. The market approach considers historical and/or anticipated financial metrics of a reporting unit and applies valuation multiples based on recent observed transactions involving companies similar enough to the reporting units from which to draw meaningful conclusions.

Judgments and uncertainties: These fair value calculations contain uncertainties as they require management to make assumptions about future cash flows and appropriate discount rates to reflect the risk inherent in the future cash flows and to derive a reasonable enterprise value and related premium. Our ability to realize the future cash flows used in our fair value calculations is affected by factors such as the success of strategic initiatives, changes in economic conditions, changes in our operating performance and changes in our business strategies. The estimated future cash flows reflect management's latest assumptions of the financial projections based on current and anticipated competitive landscape, including estimates of revenue based on production volumes over the foreseeable future and long-term growth rates, and operating margins based on historical trends and future cost containment activities.

Also, the market valuation approach is highly subjective as it requires the selection of comparable companies and valuation multiples.

Impact if actual results differ from assumptions: As of December 31, 2021, our goodwill balance included $37.3 million related to our Automotive segment and $28.7 million related to our Medical segment. These balances could be fully or partially impaired if management does not achieve the expected cash flows assumed in the fair value estimates or if assumptions and cash flow estimates change in future periods.

Income Taxes

Critical estimates: The Company is subject to income taxes in the United States and numerous international jurisdictions. In calculating our effective income tax rate, we make judgments regarding certain tax positions, including the timing and amount of deductions and allocations of income among various tax jurisdictions. When determining whether we will be able to realize deferred tax assets, judgment is used to evaluate the positive and negative evidence, including forecasting taxable income using historical and future operating results. The provision for income taxes includes current income taxes as well as deferred income taxes. Deferred tax assets and liabilities as if the reporting unit had been acquired in a business combination.

48


ASU 2017-04 is effective for annual and any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-04 must be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company has adopted the accounting principles in ASU 2017-04 and applied them to our test for goodwill impairment. See Note 12 for information about the goodwill impairment loss recognized in 2018.

Recently Issued Accounting Pronouncements Not Yet Adopted

Derivatives and Hedging

In October 2018, the FASB issued ASU 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes.” ASU 2018-16 adds the OIS Rate based on SOFR to the list of eligible benchmark interest rates that can be used for hedge accounting purposes under Topic 815.  SOFR is a volume-weighted median interest rate that is calculated daily based on overnight transactions from the prior day’s trading activity in specified segments of the U.S. Treasury repo market. The designation of the OIS rate based on SOFR as a benchmark interest rate for hedge accounting purposes is in response to ongoing concerns about the sustainability of LIBOR and the Federal Reserve’s intent to have a suitable alternative to USD LIBOR that is more firmly based on actual transactions in a robust market. Prior to this update, the only eligible benchmark interest rates were the interest rates on direct Treasury obligations of the U.S. government (UST), the LIBOR swap rate, the OIS Rateare measured based on the Fed Funds Effective Ratedifference between the financial statement and tax base of assets and liabilities at the applicable enacted tax rates.

Judgments and uncertainties: We have various tax filing positions with regard to the timing and amount of deductions and credits and the Securities Industryallocation of income among various tax jurisdictions, based on our interpretation of local tax laws, supported by external advisor review for material positions.

Valuation allowances are established when necessary on a jurisdictional basis to reduce deferred tax assets to the amounts expected to be realized when management considers it more likely than not that some portion or all of a deferred tax asset will not be realized. The determination as to whether a deferred tax asset will be realized is based on the evaluation of positive and Financial Markets Association (SIFMA) Municipal Swap Rate.

ASU 2018-16 is effective for annual and interim periods beginning after December 15, 2018.  Early adoptionnegative evidence, which includes historical profitability, future market growth, future taxable income, the expected timing of the amendments in this update is permitted.reversals of existing temporary differences and tax planning strategies. The amendments in this update should be adoptedCompany assesses deferred taxes and the adequacy or need for a valuation allowance on a prospective basisquarterly basis.

43


The Company is subject to ongoing tax examinations and assessments in various jurisdictions. At any time, multiple tax years are subject to audit by the various tax authorities and a number of years may elapse before a particular matter, for qualifying newwhich a liability has been established, is audited and fully resolved or redesigned hedging relationships entered into on or afterclarified. In evaluating the date of adoption.  Whileexposures associated with various tax filing positions, the Company has not executed any U.S. benchmark interest rate transactions in order to apply hedge accounting under Topic 815, we are currentlymay record liabilities for such exposures. The Company generally adjusts its liabilities for unrecognized tax benefits and related indemnification obligations through earnings in the processperiod in which an uncertain tax position is effectively settled, the statute of determininglimitations expires for the relevant taxing authority to examine the tax position, or when more information becomes available. Although management believes that the judgments and estimates discussed herein are reasonable, actual results could differ, and may materially increase or decrease the effective tax rate, as well as impact implementationthe Company’s operating results.

Impact if actual results differ from assumptions: Some or all of ASU 2018-16 willmanagement’s judgments are subject to review by the taxing authorities. If one or more of the taxing authorities were to successfully challenge our right to realize some or all of the tax benefit we have recorded, and we were unable to realize this benefit, it could have a material adverse effect on our strategy approachfinancial results and cash flows. Further, if the Company is unable to generate sufficient future taxable income, there is a material change in the actual effective tax rates, a change to the management of interest rate risk.time period within which the underlying temporary differences become taxable or deductible, or if the tax laws change unfavorably, then the Company could be required to increase the valuation allowance against deferred tax assets, resulting in an increase in income tax expense and the effective tax rate.

Cloud Computing Arrangements That Are Service Contracts

In August 2018,For the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 provides guidance on when costs incurred to implement a hosting arrangement that is a service contract are and are not capitalized, aligning with the guidance for capitalizing implementation costs incurred to develop or obtain internal-use software. Entities must first determine the project stageyear ended December 31, 2021, each change of the implementation activity; depending on their nature, costs for implementation activities in the application development stage are capitalized and costs incurred during the preliminary project and post-implementation stages are expensed as the activities are performed. Capitalized implementation costs should be amortized over the termeffective tax rate by one percentage point would impact income tax expense by $1.1 million.

Recent Accounting Pronouncements

For a complete description of the hosting arrangement on a straight-line basis and presented in the same line items in the consolidated statement of income as the expense for fees for the associated hosting arrangements.  Similarly, capitalized implementation costs should be presented in same line item in the balance sheet as prepaid fees for the associated hosting arrangement and cash flows from capitalized implementation costs should be classified in the same manner as cash flows for the fees for the associated hosting arrangement.

ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of the amendments in this update is permitted, including adoption in any interim period forrecent accounting standards which financial statementswe have not yet been issued. ASU 2018-15 permits two methods of adoption: prospectively to costs for activities performed on or after the date the entity first applies the content from the update, or retrospectively to all periods presented. We are currently in the process of determining the impact implementation of ASU 2018-15 will have on the Company’s financial statement note disclosures.

Retirement Benefits

In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” The amendments in ASU 2018-14 were developed using the concepts incorporated in the FASB’s Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018.  The amendments in this update remove the following disclosure requirements, among others, from Subtopic 715-20:

49


1)

The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year.

2)

The amount and timing of plan assets expected to be returned to the employer.

The following disclosure requirements were added to Subtopic 715-20:

1)

The weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates.

2)

An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period.

ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update are permitted. Entities should apply the amendments in this update on a retrospective basis to all periods presented.  We are currently in the process of determining the impact implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.”  The amendments in ASU 2018-13 were developed using the concepts incorporated in the FASBs Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018.  The amendments in this update remove the following disclosure requirements from Topic 820:

1)

The amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy.

2)

The policy for timing of transfer between levels.

3)

The valuation processes for Level 3 fair value measurements.

The following disclosure requirements were added to Topic 820:

1)

The changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period.

2)

The range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements.

ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of disclosures that are removed is permitted, but adoption is delayed for the new additional disclosures until their effective date. The amendments in ASU 2018-13 that provide for new additional disclosure should be applied on a prospective basis, while all other amendments should be applied retrospectively to all periods presented upon their effective date. We are currently in the process of determining the impact implementation of ASU 2018-13 will have on the Company’s financial statement note disclosures.

Leases

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).”  ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease.  While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases will be recognized on the balance sheet.  

ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted. The FASB has issued several amendments to ASU 2016-02, including ASU 2018-11, “Leases (Topic 842): Targeted Improvements” that introduced an additional transition method permitting an entity to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption.  We expect to elect this transition method.  

50


ASU 2016-02 includes optional practical expedients intended to reduce the cost and complexityrequired to implement which may be applicable to our operations, as well as significant accounting standards that have been adopted during the new lease standard, such as an option to maintain the current lease classification for all existing lease arrangements and the option to use hindsight in evaluating lessee options to extend or terminate a lease. We expect to elect these practical expedients. The Company expects to add right-of-use assets and the corresponding liabilitiesyear ended December 31, 2021, see Note 3, “New Accounting Pronouncements,” to the consolidated balance sheet equal to approximately 1.5% to 2.5% of total assets as of the implementation date.  Any differences between the total carrying value of right-of-use assets and lease liabilities will be recognized as a reduction to the 2019 opening balancefinancial statements included in retained earnings.this Annual Report.

Off-Balance Sheet Arrangements

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and CSZ.  The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract.  Extensions are normally made if performance obligations continue beyond the expected completion date.  At December 31, 2018, we had outstanding letters of credit of $455 thousand.

Tabular Disclosure of Contractual Obligations

As of December 31, 2018, the following amounts, aggregated by type of contract obligation, are known to come due in the periods stated:

Contractual Obligations (In thousands)

  

Total

 

  

Less than
1 Yr

 

  

1-3 Yrs

 

  

3-5 Yrs

  

  

More than
5 Yrs

Long-Term Debt Obligations (1)

  

$

139,890

  

  

$

3,413

  

  

$

132,727

 

  

$

3,750

 

 

$

Operating Lease Obligations

  

$

18,718

  

  

$

4,686

  

  

$

6,327

 

  

$

3,684

 

 

$

4,021

Purchase Obligations

  

$

4,001

  

  

$

2,844

  

  

$

1,157

 

  

$

 

 

$

Totals

  

$

162,609

  

  

$

10,943

  

  

$

140,211

 

  

$

7,434

 

 

$

4,021

 

(1)ITEM 7A.

Long-Term Debt Obligations do not include an amount payable for interest.

The Company does not have any outstanding capital lease agreements.

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK  

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U. S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, North Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge ourthe Company hedges its exposure to foreign currency exchange risks and price fluctuations in material commodities is one year.fifteen months. We had foreign currency derivative contracts with a notional value of $33.3$14.0 million and $29.3$13.3 million outstanding at December 31, 20182021 and 2017, respectively.

51


The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years.  We had2020 and copper commodity swap contracts with a notional value of $0.3 million and $0 and $404 thousandmillion outstanding atas of December 31, 20182021 and 2017,2020, respectively. The potential loss in fair value for foreign currency derivative contracts from a hypothetical 10% adverse change in quoted currency exchange rates would be approximately $1.3 million and $1.3 million as of December 31, 2021 and 2020, respectively. The potential gain in fair value from a hypothetical 10% change in quoted currency exchange rates would be approximately $1.6 million and $1.6 million as of December 31, 2021 and 2020, respectively. The impact of a 10% change in rates on fair value differs from a 10% change in the net fair value asset due to the existence of hedges. The model assumes a parallel shift in currency exchange rates; however, currency exchange rates rarely move in the same direction. The assumption that currency exchange rates change in a parallel fashion may overstate the impact of changing currency exchange rates on assets and liabilities denominated in currencies other than the U.S. dollar.

44


The potential loss in fair value for copper commodity swap contracts from a hypothetical 10% adverse change in quoted copper commodity prices would be $0.1 million and $0 million as of December 31, 2021 and 2020, respectively. The potential gain in fair value from a hypothetical 10% positive change in quoted copper commodity prices would be $0.1 million and $0 million as of December 31, 2021 and 2020, respectively.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulatedAccumulated other comprehensive loss in the consolidated balance sheet.  When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated statementstatements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.  We record the ineffective portion of foreign currency and copper commodity hedging instruments, if any, to foreign currency gain (loss)cost of sales in the consolidated statements of income. See Note 14 to our consolidated financial statements for the amount of unrealized loss associated with copper commodity derivatives reported in accumulated other comprehensive income as of December 31, 2017 that was reclassified into earnings during 2018. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the fair values of derivative instruments in our consolidated balance sheet as of December 31, 2018 is as follows (in thousands):

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

 

  

 

92

 

  

Current liabilities

 

$

 

 

$

92

 

Information related to the fair values of derivative instruments in our consolidated balance sheet as of December 31, 2017 is as follows (in thousands):

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

 

  

141

 

  

Current liabilities

 

$

(1,050

)

 

$

(909

)

Commodity derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

  

  

$

72

  

  

 

 

 

 

 

 

$

72

 

Information related to the effect of derivative instruments on our consolidated income statement and statement of comprehensive income is as follows (in thousands):

 

 

Location

  

Year
Ended
December 31,
2018

 

 

Year
Ended
December 31,
2017

 

Foreign currency derivatives

 

Product revenues

 

 

 

 

 

(3

)

 

 

Cost of sales

 

 

(444

)

 

 

2,209

 

 

 

Selling, general and administrative

 

 

75

 

 

 

(216

)

 

 

Other comprehensive income

 

 

1,096

 

 

 

302

 

 

 

Foreign currency gain

 

 

50

 

 

 

(112

)

Total foreign currency derivatives

 

 

 

$

777

 

 

$

2,180

 

Commodity derivatives

 

Cost of sales

 

$

145

 

 

$

202

 

 

 

Other comprehensive (loss) income

 

 

(218

)

 

 

54

 

Total commodity derivatives

 

 

 

$

(73

)

 

$

256

 

52


Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or European Euros (€EUR), asthe currency indicated in parentheses.

 

 

Expected Maturity Date

 

 

 

2022

 

 

2023

 

 

2024

 

 

Total

 

 

Fair Value

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-Term Debt:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Variable rate ($USD)

 

$

 

 

$

 

 

$

35,000

 

 

$

35,000

 

 

$

35,000

 

Variable interest rate as of December 31, 2021

 

 

 

 

 

 

 

 

 

 

1.35

%

 

 

1.35

%

 

 

 

 

Fixed rate ($USD)

 

$

2,500

 

 

$

1,250

 

 

$

 

 

$

3,750

 

 

$

3,778

 

Fixed interest rate

 

 

5.21

%

 

 

5.21

%

 

 

 

 

 

 

5.21

%

 

 

 

 

Based on the amounts outstanding as of December 31, 2018

 

 

Expected Maturity Date

 

 

 

2019

 

 

2020

 

 

2021

 

 

2022

 

 

2023

 

 

Thereafter 

 

 

Total

 

 

Fair
Value

 

 

 

(In thousands except rate information)

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long Term Debt:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed Rate (€EUR)

 

$

913

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

913

 

 

$

929

 

Average Interest Rate

 

 

4.25

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.25

%

 

 

 

 

Variable Rate (€EUR)

 

$

 

 

$

 

 

$

5,727

 

 

$

 

 

$

 

 

$

 

 

$

5,727

 

 

$

5,727

 

Average Interest Rate

 

 

 

 

 

 

 

 

 

 

1.50

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.50

%

 

 

 

 

Variable Rate ($USD)

 

$

 

 

$

 

 

$

122,000

 

 

$

 

 

$

 

 

$

 

 

$

122,000

 

 

$

122,000

 

Average Interest Rate

 

 

 

 

 

 

 

 

 

 

4.02

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.02

%

 

 

 

 

Fixed Rate ($USD)

 

$

2,500

 

 

$

2,500

 

 

$

2,500

 

 

$

2,500

 

 

$

1,250

 

 

$

 

 

$

11,250

 

 

$

11,092

 

Average Interest Rate

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

 

 

2021, a hypothetical 100 basis point change (increase or decrease) in interest rates would impact annual interest expense by $0.4 million.

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates.  The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

December 31, 2018

 

 

Expected Maturity or Transaction Date

 

Anticipated Transactions and Related Derivatives

 

2019

 

 

2020

 

 

2021

 

 

2022

 

 

2023

 

 

Thereafter

 

 

Total

 

 

Fair
Value

 

 

 

(In thousands except rate information)

 

$US functional currency

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward Exchange Agreements:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Receive MXN/Pay USD$)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Contract Amount ($)

 

$

33,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

33,250

 

 

$

92

 

Average Contract Rate

 

 

20.30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20.30

 

 

 

 

 

 

 

Expected Maturity or Transaction Date

 

 

Anticipated Transactions and Related Derivatives

 

2022

 

 

Total

 

 

Fair Value

 

 

USD Functional Currency

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward Exchange Agreements:

 

 

 

 

 

 

 

 

 

 

 

 

 

(Receive $MXN / Pay $USD)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total contract amount

 

$

13,974

 

 

$

13,974

 

 

$

294

 

 

Average contract rate

 

 

21.47

 

 

 

21.47

 

 

 

 

 

 

 

 

53

45


ITEMITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Supplementary Financial Information – Selected Quarterly Financial Data

Unaudited Quarterly Financial Data

For the Years Ended December 31, 2018 and 2017

(In thousands, except per share data)

 

  

For the three months ended,

 

 

  

March 31,
2018

 

 

June 30,
2018

 

 

September 30,
2018

 

 

December 31,
2018

 

Product revenues

  

$

261,889

  

 

$

263,779

  

 

$

258,939

  

 

$

253,652

  

Gross margin

  

 

78,545

  

 

 

74,471

  

 

 

73,139

  

 

 

68,457

  

Operating income

  

 

20,649

  

 

 

15,593

  

 

 

15,713

  

 

 

20,833

  

Net income (loss)

  

 

12,966

  

 

 

16,659

  

 

 

(355

)

 

 

12,629

 

Basic earnings (loss) per share

  

$

0.35

  

 

$

0.46

  

 

$

(0.01

)

 

$

0.37

 

Diluted earnings (loss) per share

  

$

0.35

  

 

$

0.45

  

 

$

(0.01

)

 

$

0.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

For the three months ended,

 

 

  

March 31,
2017

 

 

June 30,
2017

 

 

September 30,
2017

 

 

December 31,
2017

 

Product revenues

  

$

249,267

  

 

$

243,378

  

 

$

235,853

  

 

$

257,185

  

Gross margin

  

 

85,151

  

 

 

78,318

  

 

 

70,186

  

 

 

77,232

  

Operating income

  

 

34,840

  

 

 

25,136

  

 

 

16,134

  

 

 

20,988

  

Net income (loss)

  

 

25,402

 

 

 

8,513

  

 

 

6,554

  

 

 

(5,242

)

Basic earnings (loss) per share

  

$

0.69

 

 

$

0.23

 

 

$

0.18

 

 

$

(0.14

)

Diluted earnings (loss) per share

  

$

0.69

 

 

$

0.23

 

 

$

0.18

 

 

$

(0.14

)

The sum of the quarterly amounts shown above may not be the same as the annual totals shown in our consolidated financial statements or elsewhere in this report due to rounding. The audited consolidated financial statements and related financial information required to be filed hereunder are indexed on page F-1 of this reportAnnual Report and are incorporated herein by reference.

 

ITEMITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEMITEM 9A.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

DisclosureManagement of the Company, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of December 31, 2021. As defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (as amended, the “Exchange Act”), disclosure controls and procedures are controls and procedures designed to ensureprovide reasonable assurance that information required to be disclosed by us in the reports that we filefiled or submitsubmitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securitieson a timely basis, and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executivethe Chief Executive Officer and principal financial officers,Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

In designing Based upon this evaluation, the Chief Executive Officer and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.  Because of the inherent limitations of all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.  These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can

54


occur because of a simple error or mistake.  The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Our management has evaluated, with the participation of our principal executive and principal financial officers, the effectiveness of our disclosure controls and procedures as of December 31, 2018.  Based on their evaluation, our principal executive and principal financial officersChief Financial Officer have concluded that ourthe Company’s disclosure controls and procedures were not effective as of December 31, 2018 due to a material weakness in internal control over financial reporting described below.2021.

Management’s Report Onon Internal Control Over Financial Reporting

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f), for the Company. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, including the possibility of collusion or improper management override of controls, misstatements due to error or fraud, internal control over financial reporting may not prevent or detect misstatements on a timely basis or not at all. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision of and with the participation of ourthe Chief Executive Officer and Chief Financial Officer, management we assessedconducted an evaluation of the effectiveness of ourthe Company’s internal control over financial reporting as of December 31,2018 using31, 2021 based on the criteriaframework set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated“Internal Control-Integrated Framework (2013). Based on this assessment, it was identified that our Information Technology General Controls (“ITGC”) related to a stand-alone system at our wholly owned subsidiary, Cincinnati Sub-Zero Products, LLC., did not operate in a way to appropriately restrict elevated access and address segregation of duty conflicts at both the information technology and end user levels. This impaired our ability to rely on the completeness and accuracy of the system generated data used in the execution and testing of our financial controls for this subsidiary.

Due to the pervasiveness of the ITGC weakness noted above and the way in which the financial controls rely on the effectiveness of these controls and system generated data, weevaluation, management has concluded that this represented a material weakness. The Company did not maintain a control environment that was designed and operating in a way to prevent or detect a material misstatement in the Company’s consolidated financial statements.  

Despite the above noted material weakness, management believes that our consolidated financial statements included in this Annual Report on Form 10-K have been prepared in accordance with generally accepted accounting principles. Our principal executive officer and principal financial officer have certified that, based on each such officer’s knowledge, the financial statements, and other financial information included in this Annual Report on Form 10-K, fairly present in all material respects our financial condition, results of operations, and cash flows as of, and for, the periods presented in this Annual Report on Form 10-K. There was no adjustment required as a result of this material weakness. In addition, we have developed a remediation plan for this material weakness, which is described below.

Based on the assessment described above, management of the Company believes that, as of December 31, 2018, the Company’s internal control over financial reporting was not effective.  Oureffective as of December 31, 2021.

The attestation report of the Company’s independent registered public accounting firm, Grant Thornton LLP, independently assessedregarding the effectiveness of ourthe Company’s internal control over financial reporting, as statedis set forth in its reportItem 15, "Exhibits and Financial Statement Schedules," included herein, which report expressed an adverse opinion onunder the effectivenesscaption "Report of our internal control over financial reporting as of December 31, 2018.Independent Registered Public Accounting Firm".

Remediation

Management plans to remediate the material weakness noted at the Cincinnati Sub-Zero Products, LLC by enhancing financial statement review controls and decommissioning the stand-alone system and integrating the location into the Company’s global

55


information technology environment. Although we believe that these corrective steps, when taken, will enable management to conclude that the internal control over financial reporting are effective, we cannot provide assurance that these steps will be sufficient or the timing thereof.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting, that occurred during the quarter ended December 31, 2021, that have materially affected, or are reasonably likely to materially affect, Gentherm’sthe Company’s internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting expect as otherwise describedwill prevent or detect all errors and all fraud. A control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in Item 9a.all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

 

ITEMITEM 9B.

OTHER INFORMATION

NoneNone.

 

 

5646


PART

ITEM 9C.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

47


PART III

 

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this item is set forth under the following captions in our proxy statement to be filed with respect to the 20192022 annual meeting of shareholders (the “Proxy Statement”), all of which is incorporated herein by reference: “Proposal No. 1 – Election of Directors”, “Board Matters – The Board of Directors”, “Board Matters – Significant Refreshment of Standing Committees of the Board”, “Board Matters – Corporate Governance”,  “Executive Officers”, “Additional  Information – Delinquent Section 16(a) Beneficial Ownership Reporting Compliance”Reports” and “Additional Information – Requirements for Submission of Shareholder Proposals and Nominations for 20202023 Annual Meeting.”

 

ITEM 11.

EXECUTIVE COMPENSATION.

The information required by this item set forth under the following captions in our Proxy Statement, all of which is incorporated herein by reference: “Compensation Discussion and Analysis”, “Named Executive Officer Compensation Tables”, “Board Matters – Director Compensation”, “Compensation Committee Interlocks and Insider Participation” and “Compensation Committee Report.”

 

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

The information required by this item is set forth under the following captions in our Proxy Statement, all of which is incorporated herein by reference: “Additional Information – Equity Compensation Plans” and “Security Ownership of Certain Beneficial Owners and Management.”

 

ITEM 13.

The information required by this item is set forth under the following captions in our Proxy Statement, all of which is incorporated herein by reference: “Related Person Transactions” and “Proposal No. 1 – ElectionA Board Substantially Consisting of Directors – Director Independence.Independent Directors.

 

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES.

The information required by this item is set forth under the following captions in our Proxy Statement, all of which is incorporated by reference herein by reference: “Audit Committee Matters.”

 

 

 

5748


PART

PART IV

 

ITEMITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

The following documents are filed as part of this Annual Report:

 

1.

Financial Statements.

The following financial statements of the Company and reports of independent accountants are included in Item 15 of this Annual Report:

 

 

  

Page

Reports of Ernst & Young LLP, Independent Registered Public Accounting Firm (PCAOB ID: 42).

 

FF-2

2

Consolidated Balance SheetsReport of Grant Thornton LLP, Independent Registered Public Accounting Firm (PCAOB ID: 248)

 

FF-5

5

Consolidated Statements of IncomeBalance Sheets

 

FF-6

6

Consolidated Statements of Income

F-7

Consolidated Statements of Comprehensive Income

  

FF-8

7

Consolidated Statements of Changes in Shareholders’ Equity

  

FF-9

8

Consolidated Statements of Cash Flows

  

FF-10

9

Notes to the Consolidated Financial Statements

  

FF-11

10

 

2.

Financial Statement Schedule.

The following Schedule to Financial Statements is included herein:

Schedule II — Valuation and Qualifying Accounts.

5849


 

3.

Exhibits.

The exhibits to this Annual Report are as follows:

 

 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

  2.1**

  

Membership Interest Purchase Agreement dated April 1, 2016 by and among the Company, Cincinnati Sub-Zero Products, LLC, CSZ Holdings, Inc., The Leonard Berke Q-Tip Trust, The Leonard Berke Exempt Q-Tip Trust, The Leonard Berke Credit Shelter Trust, Cincinnati Sub-Zero Trust F/B/O Steven Berke DTD 5/20/1999 and Steven J. Berke

 

 

 

8-K

 

 

 

2.1

 

4/4/16

  2.2**

 

Real Estate Purchase Agreement

 

 

 

8-K

 

 

 

2.2

 

4/4/16

  2.3**

 

Share and Asset Purchase Agreement, dated as of November 1, 2017, by and among Gentherm Incorporated, certain of its subsidiaries, Etratech Inc., Etratech Enterprises Inc., and certain subsidiaries and all of the shareholders of Etratech Enterprises Inc.

 

 

 

8-K

 

 

 

2.1

 

11/1/17

  3.1

  

Second Amended and Restated Articles of Incorporation of Gentherm Incorporated (the “Company”)

 

 

 

8-K

 

 

 

3.1

 

5/28/15

  3.2

  

Amended and Restated Bylaws of the Company

 

 

 

8-K

 

 

 

3.2

 

3/5/18

10.1*

  

Summary of Non-Employee Director Compensation

 

X

 

 

 

 

 

 

 

 

10.2*

 

Amended and Restated Gentherm Incorporated Senior Level Performance Bonus Plan

 

X

 

 

 

 

 

 

 

 

10.3.1*

  

2006 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

4/24/06

10.3.2*

  

First Amendment to 2006 Equity Incentive Plan

 

 

 

10-K

 

12/31/06

 

10.3.2

 

2/20/07

10.3.3*

  

Second Amendment to 2006 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

3/20/07

10.3.4*

  

Third Amendment to 2006 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

B

 

4/20/09

10.3.5*

  

Fourth Amendment to 2006 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.8

 

3/31/11

10.3.6*

  

Fifth Amendment to 2006 Equity Incentive Plan

 

 

 

10-K

 

12/31/11

 

10.3.6

 

3/15/12

10.3.7*

 

Sixth Amendment to 2006 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

5/20/13

10.4.1*

  

2011 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

5/20/11

10.4.2*

  

First Amendment to 2011 Equity Incentive Plan

 

 

 

10-K

 

12/31/11

 

10.3.8

 

3/15/12

10.4.3*

  

Second Amendment to 2011 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

5/11/12

10.4.4*

  

Third Amendment to 2011 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

5/20/13

10.5.1*

 

2013 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

4/22/13

10.5.2*

 

Amendment to the Gentherm Incorporated 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

5/19/17

10.5.3*

 

Form of Stock Option Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

6/27/13

10.5.4*

 

Form of Stock Appreciation Right Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

6/27/13

10.5.5*

 

Form of Restricted Stock Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

6/27/13

10.5.6*

 

Form of Restricted Stock Award Agreement (Retention Award) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

10/4/17

 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

  3.1

  

Second Amended and Restated Articles of Incorporation of Gentherm Incorporated

 

 

 

8-K

 

 

 

3.2

 

3/5/18

  3.2

  

Amended and Restated Bylaws of Gentherm Incorporated

 

 

 

8-K

 

 

 

3.1

 

5/26/16

  4

  

Description of Securities

 

 

 

10-K

 

12/31/19

 

4

 

2/20/20

10.1**

  

Summary of Non-Employee Director Compensation (effective starting with the 2021 annual meeting of shareholders)

 

 

 

10-Q 

 

6/30/21 

 

10.3 

 

7/30/21 

10.2**

 

Second Amended and Restated Gentherm Incorporated Senior Level Performance Bonus Plan

 

 

 

8-K 

 

 

 

10.1 

 

3/15/21 

10.3**

 

Gentherm Incorporated Second Half 2020 Senior Level Performance Bonus Plan

 

 

 

8-K

 

 

 

10.1

 

10/6/20

10.4.1**

 

2013 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

4/22/13

10.4.2**

 

Amendment to the Gentherm Incorporated 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

5/19/17

10.4.3**

 

Second Amendment to the Gentherm Incorporated 2013 Equity Incentive Plan, effective as of May 21, 2020

 

 

 

8-K

 

 

 

10.1

 

5/26/20

10.4.4**

 

Form of Stock Option Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

6/27/13

10.4.5**

 

Form of Stock Appreciation Right Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

6/27/13

10.4.6**

 

Form of Restricted Stock Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

6/27/13

10.4.7**

 

Form of Restricted Stock Award Agreement (Retention Award) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

10/4/17

10.4.8**

 

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

6/13/18

10.4.9**

 

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

6/13/18

10.4.10**

 

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan – Anversa

 

 

 

8-K

 

 

 

10.2

 

12/12/18

10.4.11**

 

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan – Anversa

 

 

 

8-K

 

 

 

10.3

 

12/12/18

10.4.12**

 

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan (effective as of 2020 grants)

 

 

 

10-Q

 

3/31/20

 

10.1

 

5/7/20

10.4.13**

 

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan (effective as of 2020 grants)

 

 

 

10-Q

 

3/31/20

 

10.2

 

5/7/20

10.4.14**

 

Form of Restricted Stock Award Agreement (Director) under the Gentherm Incorporated 2013 Equity Incentive Plan  

 

 

 

10-Q 

 

 6/30/20

 

10.7 

 

8/4/20

10.4.15**

 

Form of Restricted Stock Award Agreement (Director) (effective as of 2021 grants)

 

 

 

10-Q

 

6/30/21

 

10.2

 

7/30/21

10.4.16**

 

Form of Restricted Stock Unit Award Agreement under the 2013 Equity Incentive Plan (effective as of 2021 grants)

 

 

 

8-K

 

 

 

10.2

 

3/15/21

5950


 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

10.5.7*

 

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

6/13/18

10.5.8*

 

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

6/13/18

10.5.9*

 

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan – Anversa

 

 

 

8-K

 

 

 

10.2

 

12/12/18

10.5.10*

 

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan – Anversa

 

 

 

8-K

 

 

 

10.3

 

12/12/18

10.6.1*

  

The Executive Nonqualified Defined Benefit Plan of Gentherm Incorporated effective as of April 1, 2008

 

 

 

10-Q

 

6/30/08

 

10.18

 

8/11/08

10.6.2*

 

Amendment To The Executive Nonqualified Benefit Plan Adoption Agreement

 

 

 

8-K

 

 

 

10.1

 

5/19/17

10.7.1

  

Credit Agreement, dated as of August 7, 2014, by and among the Company, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Canada Ltd., Global Thermoelectric Inc., the lenders party thereto and Bank of America, N.A., as administrative agent

 

 

 

8-K

 

 

 

10.1

 

8/7/14

10.7.2

  

First Amendment to Credit Agreement, dated as of April 15, 2015, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Canada Ltd., Global Thermoelectric Inc., Gentherm Properties II, LLC, the lenders party thereto, and Bank of America, N.A., as administrative agent.

 

 

 

8-K

 

 

 

10.1

 

4/16/15

10.7.3

 

Second Amendment to Credit Agreement, dated March 17, 2016, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm GmbH, Gentherm Global Power Technologies Inc., Gentherm Canada ULC, Gentherm Licensing, LP, Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Enterprises, Gentherm Properties III, LLC,  the lenders party thereto, and Bank of America, N.A., as administrative agent.

 

 

 

8-K

 

 

 

10.1

 

3/18/16

10.7.4

 

Designated Borrower Request and Assumption Agreement

 

 

 

8-K

 

 

 

10.1

 

4/4/16

10.7.5

 

Third Amendment to Credit Agreement, dated December 15, 2016, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Licensing, LP, Gentherm GmbH, Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Global Power Technologies, Inc., Gentherm Canada ULC,  the lenders party thereto, and Bank of America, N.A., as administrative agent.

 

 

 

8-K

 

 

 

10.1

 

12/16/16

10.7.6

  

Pledge and Security Agreement, dated as of August 7, 2014, by and among the Company, Gentherm (Texas), Inc., Westridge Haggerty LLC and Bank of America, N.A.

 

 

 

8-K

 

 

 

10.2

 

8/7/14

10.7.7

  

Fourth Amendment to Credit Agreement, dated April 24, 2018, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Licensing, LP, Gentherm GmbH, Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Global Power Technologies, Inc., Gentherm Canada ULC, the lenders party thereto, and Bank of America, N.A., as administrative agent

 

 

 

8-K

 

 

 

10.1

 

4/24/18

10.8*

 

Amended and Restated Gentherm Incorporated Performance Bonus Plan dated as of February 12, 2018

 

 

 

8-K

 

 

 

10.1

 

2/14/18

10.9.1*

  

Executive Relocation and Employment Agreement, dated August 1, 2015, by and between Gentherm Incorporated and Frithjof Oldorff

 

 

 

8-K

 

 

 

10.1

 

8/3/15

 

 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

10.4.17**

 

Form of Performance Stock Unit Award Agreement under the 2013 Equity Incentive Plan (effective as of 2021 grants)

 

 

 

8-K

 

 

 

10.3

 

3/15/21

10.5.1

 

Amended and Restated Credit Agreement, dated as of June 27, 2019, by and among Gentherm Incorporated, Gentherm (Texas), Inc., Gentherm Licensing, Limited Partnership, Gentherm Medical, LLC, Gentherm GmbH, Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Global Power Technologies Inc. and Gentherm Canada ULC, the lenders party thereto, and Bank of America, N.A., as administrative agent, swing line lender and L/C issuer.

 

 

 

8-K

 

 

 

10.1

 

6/28/19

10.5.2

 

Amended and Restated Pledge and Security Agreement, dated as of June 27, 2019, by and among Gentherm Incorporated, Gentherm Licensing, Limited Partnership, Gentherm (Texas), Inc., Gentherm Medical, LLC, Gentherm Properties I, LLC, Gentherm Properties II, LLC and Bank of America, N.A.

 

 

 

8-K

 

 

 

10.2

 

6/28/19

10.5.3

 

First Amendment to Amended and Restated Credit Agreement, dated as of October 7, 2019 and effective as of October 1, 2019, by and among Gentherm Incorporated, Gentherm Licensing, Limited Partnership, Gentherm (Texas), Inc., Gentherm Medical, LLC, Gentherm Properties I, LLC, Gentherm Properties II, LLC and Bank of America, N.A.

 

 

 

10-K 

 

12/31/19 

 

10.6.3 

 

2/20/20 

10.6.1**

 

Employment Contract between Gentherm Incorporated and Phillip Eyler, dated as of September 18, 2017

 

 

 

8-K

 

 

 

10.1

 

10/3/17

10.6.2**

 

Amendment to Employment Terms between Gentherm Incorporated and Phillip Eyler, dated as of December 7, 2018

 

 

 

8-K

 

 

 

10.1

 

12/7/18

10.6.3**

 

Second Amendment to Employment Terms between Gentherm Incorporated and Phillip Eyler dated as of April 21, 2020

 

 

 

10-Q 

 

6/30/20

 

10.4

 

8/4/20

10.7.1**

 

Offer Letter between Gentherm Incorporated and Matteo Anversa, dated as of October 22, 2018

 

 

 

8-K

 

 

 

10.1

 

12/12/18

10.7.2**

 

First Amendment to Offer Letter Agreement between Gentherm Incorporated and Matteo Anversa dated as of April 21, 2020

 

 

 

10-Q 

 

6/30/20

 

10.5

 

8/4/20

10.7.3**

 

Second Amendment to Offer Letter Agreement between Gentherm Incorporated and Matteo Anversa, dated as of March 12, 2021

 

 

 

8-K

 

 

 

10.5

 

3/15/21

10.8.1**

 

Employment Contract between Gentherm GmbH and Thomas Stocker, effective September 1, 2019

 

 

 

10-Q

 

9/30/19 

 

10.1

 

10/29/19

10.8.2**

 

First Amendment to the Employment Agreement between Gentherm Enterprises GmbH and Thomas Stocker, effective June 28, 2021

 

 

 

10-Q

 

6/30/21

 

10.1

 

7/30/21

10.9**

 

Offer Letter between Gentherm Incorporated and Hui (Helen) Xu, effective November 4, 2019

 

 

 

10-K 

 

12/31/19 

 

10.11 

 

2/20/20

10.10**

 

Offer Letter between Gentherm Incorporated and Yijing Brentano, effective February 23, 2018

 

 

 

10-K 

 

12/31/19 

 

10.12 

 

2/20/20

10.11**

 

Offer Letter between Gentherm Incorporated and Matt Fisch dated January 29, 2020

 

X

 

 

 

 

 

 

 

 

10.12.1**

 

Executive Relocation and Employment Agreement between Gentherm Incorporated and Paul Giberson dated June 6, 2019

 

 

 

10-Q 

 

6/30/20

 

10.2

 

8/4/20

6051


Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed/Furnished Herewith

Form

Period Ending

Exhibit / Appendix Number

Filing Date

10.9.2*

Extension of Executive Relocation and Employment Agreement dated as of October 3, 2017

10-Q

9/30/17

10.2.2

10/30/17

10.10*

Retirement Agreement between Gentherm Incorporated and Daniel R. Coker, dated as of June 28, 2017

8-K

10.1

6/28/17

10.11.1*

Employment Contract between Gentherm Incorporated and Phillip Eyler, dated as of September 18, 2017

8-K

10.1

10/3/17

10.11.2*

Amendment to Employment Terms between Gentherm Incorporated and Phillip Eyler, dated as of December 7, 2018

8-K

10.1

12/7/18

10.12*

Separation Agreement and Release between Gentherm Incorporated and Darren Schumacher, dated as of May 29, 2018.

8-K

10.3

6/13/18

10.13*

Offer Letter between Gentherm Incorporated and Matteo Anversa, dated as of October 22, 2018

8-K

10.1

12/12/18

10.14*

Separation Agreement between Gentherm Incorporated and Barry G. Steele, dated as of December 11, 2018

8-K

10.4

12/12/18

21

List of Subsidiaries (Direct and Indirect) of the Company

X

23.1

Consent of Grant Thornton LLP

X

24

Power of Attorney

X

31.1

Section 302 Certification - CEO

X

31.2

Section 302 Certification – CFO

X

32.1

Section 906 Certification – CEO

X

32.2

Section 906 Certification - CFO

X

101.INS

XBRL Instance Document.

X

101.SCH

XBRL Taxonomy Extension Schema Document.

X

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

X

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

X

101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

X

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

X

 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

10.12.2**

 

First Amendment to Executive Relocation and Employment Agreement between Gentherm Incorporated and Paul Giberson dated as of April 21, 2020

 

 

 

10-Q 

 

6/30/20

 

10.3

 

8/4/20

10.12.3**

 

Second Amendment to Executive Relocation and Employment Agreement between Gentherm Incorporated and Paul Giberson, dated as of March 12, 2021

 

 

 

8-K

 

 

 

10.6

 

3/15/21

10.12.4**

 

Letter Agreement with Paul Giberson, dated as of September 22, 2021

 

 

 

10-Q

 

9/30/21

 

10.1

 

10/29/21

10.13**

 

Severance Pay Plan for Eligible Employees of Gentherm Incorporated

 

 

 

8-K

 

 

 

10.4

 

3/15/21

10.14**

 

Form of First Amendment to Executive Offer Letter

 

 

 

8-K

 

 

 

10.7

 

3/15/21

10.15.1**

 

Amended and Restated Gentherm Incorporated Deferred Compensation Plan, dated May 20, 2019 (and effective January 1, 2019)

 

 

 

10-Q

 

6/30/19

 

10.4

 

7/26/19

10.15.2**

 

Deferred Compensation Agreement, between Gentherm Incorporated and Phillip Eyler, dated as of December 31, 2018.

 

 

 

8-K

 

 

 

10.2

 

1/4/19

16.1

 

Letter from Grant Thornton LLP

 

 

 

8-K

 

 

 

16

 

1/31/20

16.2

 

Letter from Grant Thornton LLP

 

 

 

8-K/A

 

 

 

16

 

2/26/20

21

  

List of Subsidiaries (Direct and Indirect) of the Company

 

X

 

 

 

 

 

 

 

 

23.1

  

Consent of Ernst & Young LLP

 

X

 

 

 

 

 

 

 

 

23.2

 

Consent of Grant Thornton LLP

 

X

 

 

 

 

 

 

 

 

24

 

Power of Attorney

 

X

 

 

 

 

 

 

 

 

31.1

  

Section 302 Certification - CEO

 

X

 

 

 

 

 

 

 

 

31.2

  

Section 302 Certification – CFO

 

X

 

 

 

 

 

 

 

 

32.1

  

Section 906 Certification – CEO

 

X

 

 

 

 

 

 

 

 

32.2

  

Section 906 Certification - CFO

 

X

 

 

 

 

 

 

 

 

101.INS

  

Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

X

 

 

 

 

 

 

 

 

101.SCH

  

Inline XBRL Taxonomy Extension Schema Document.

 

X

 

 

 

 

 

 

 

 

101.CAL

  

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

 

X

 

 

 

 

 

 

 

 

101.DEF

  

Inline XBRL Taxonomy Extension Definition Linkbase Document.

 

X

 

 

 

 

 

 

 

 

101.LAB

  

Inline XBRL Taxonomy Extension Label Linkbase Document.

 

X

 

 

 

 

 

 

 

 

101.PRE

  

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

 

X

 

 

 

 

 

 

 

 

104

 

Cover Page Interactive Date File – the cover page XBRL tags are embedded within the Inline XBRL document

 

X

 

 

 

 

 

 

 

 

 

*

Indicates management contract or compensatory plan or arrangement.

**

Gentherm Incorporated agrees to furnish any omitted schedules or exhibits upon the request of the Securities and Exchange Commission.

**

Indicates management contract or compensatory plan or arrangement.

ITEM 16.

Form 10-K Summary

None.

 

 

6152


INDEX TO FINANCIAL STATEMENTS

 

 

  

Page

Reports of Ernst & Young LLP, Independent Registered Public Accounting Firm(PCAOB ID: 42)

  

FF-2

2

Report of Grant Thornton LLP, Independent Registered Public Accounting Firm (PCAOB ID: 248)

F-5

Consolidated Balance Sheets as of December 31, 20182021 and 20172020

  

FF-6

5

Consolidated Statements of Income for the years ended December 31, 2018, 20172021, 2020 and 20162019

  

FF-7

6

Consolidated Statements of Comprehensive Income for the years ended December 31, 2018, 20172021, 2020 and 20162019

  

FF-8

7

Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2018, 20172021, 2020 and 20162019

  

FF-9

8

Consolidated Statements of Cash Flows for the years ended December 31, 2018, 20172021, 2020 and 20162019

  

FF-10

9

Notes to the Consolidated Financial Statements

  

FF-11

10

 

 

 

F-1


 

Report of Independent Registered Public Accounting Firm

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors and Shareholders

of Gentherm Incorporated

Opinion on the financial statementsFinancial Statements

We have audited the accompanying consolidated balance sheets of Gentherm Incorporated (a Michigan corporation) and subsidiaries (the “Company”)Company) as of December 31, 20182021 and 2017,2020, the related consolidated statements of income, comprehensive income, changes in shareholders’shareholders' equity and cash flows for each of the threetwo years in the period ended December 31, 2018,2021, and the related notes and financial statement schedule included underlisted in the Index at Item 15(a)15 (collectively referred to as the “financial“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as ofat December 31, 20182021 and 2017,2020, and the results of its operations and its cash flows for each of the threetwo years in the period ended December 31, 2018,2021, in conformity with accounting principlesU.S. generally accepted in the United States of America.accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the Company’sCompany's internal control over financial reporting as of December 31, 2018,2021, based on criteria established in the 2013 Internal Control—IntegratedControl-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”),(2013 framework) and our report dated February 26, 201917, 2022 expressed an adverse opinion.unqualified opinion thereon.

Basis for opinionOpinion

These financial statements are the responsibility of the Company’sCompany's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supportingregarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical audit matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.

Valuation of Goodwill – Medical

Description of the Matter

As of December 31, 2021, the Company’s goodwill related to the medical reporting unit (segment) was $28.7 million. As discussed in Note 2 to the consolidated financial statements, goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that it is more likely than not that a reporting unit’s fair value is less than it’s carrying amount.

Auditing management’s annual goodwill impairment assessment for the medical reporting unit was complex and highly judgmental due to the significant estimation required to determine the fair value of the reporting unit. In particular, the fair value estimates used in the valuation of the medical reporting unit were sensitive to significant assumptions, such as changes in the discount rate, revenue growth rates, including the terminal growth rate and operating margins, which are affected by expectations about future market or economic conditions.

How We Addressed the Matter in our Audit

We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s annual goodwill assessment, and annual forecasting process whereby the Company develops significant assumptions that are used in its analyses.  This included controls over management's review of the valuation model and the significant assumptions used in the fair value measurements discussed above.  

To test the estimated fair value of the Company’s medical reporting unit, we performed audit procedures that included, among others, assessing the methodologies used and directly testing the significant assumptions and the underlying data used by the Company in its analysis, including assessing the completeness and accuracy of such underlying data. We utilized internal valuation specialists to assist in the evaluation of the assumptions and other relevant information that are most significant to the fair value estimate of the reporting unit, such as assessing the fair value methodologies applied and evaluating the reasonableness of the discount rate selected by management. We compared the significant assumptions used by management to current industry and economic trends, historical performance, guideline public companies in the same industry and strategic plans. We performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the assumptions. Furthermore, we assessed the appropriateness of the disclosures in the consolidated financial statements.

F-2


/s/ GRANT THORNTONERNST & YOUNG LLP

We have served as the Company’s auditor since 2007.2020.

Southfield,Detroit, Michigan

February 26, 201917, 2022

 

F-2

F-3


 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors and Shareholders

of Gentherm Incorporated

Opinion on internal control over financial reportingInternal Control Over Financial Reporting

We have audited theGentherm Incorporated’s internal control over financial reporting of Gentherm Incorporated (a Michigan corporation) and subsidiaries (the “Company”) as of December 31, 2018,2021, based on criteria established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”)(2013 framework) (the COSO criteria). In our opinion, because of the effect of theGentherm Incorporated (the Company) maintained, in all material weakness described in the following paragraphs on the achievement of the objectives of the control criteria, the Company has not maintainedrespects, effective internal control over financial reporting as of December 31, 2018,2021, based on criteria established in the 2013 Internal Control—Integrated Framework issued by COSO.

A material weakness is a deficiency, or combination of control deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management’s assessment.

The Company’s internal controls over the general information technology (“IT”) environment and IT general controls (“ITGC”) at a wholly owned subsidiary did not operate in a way to appropriately restrict elevated access and address segregation of duty conflicts at both the information technology and end user levels. This impairs the Company’s ability to rely on the completeness and accuracy of the system generated data used in the execution and testing of financial controls for this entity. Due to the pervasiveness of the ITGC weakness noted and the way in which the financial controls rely on the effectiveness of these controls and system generated data, it is concluded that this represented a material weakness.COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the consolidated financial statementsbalance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for each of the yeartwo years in the period ended December 31, 2018. The material weakness identified above was considered2021, and the related notes and financial statement schedule listed in determining the nature, timing, Index at Item 15and extent of audit tests applied in our audit of the 2018 consolidated financial statements, and this report does not affect our report dated February 26, 2019 which17, 2022 expressed an unqualified opinion on those financial statements.thereon.

Basis for opinionOpinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report Onon Internal Control overOver Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and limitationsLimitations of internal control over financial reportingInternal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial

F-3


statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Other Information/s/ ERNST & YOUNG LLP

Detroit, Michigan

February 17, 2022

F-4


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders

Gentherm Incorporated

Opinion on the financial statements

We do nothave audited the consolidated balance sheet of Gentherm Incorporated (a Michigan corporation) and subsidiaries (the “Company”) as of December 31, 2019 (not presented herein), and the related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for the year then ended, and the related notes and financial statement schedule included under Item 15 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Companyas of December 31, 2019, and the results of itsoperations and itscash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

Basis for opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion or any other form of assurance on the Company’s remediationfinancial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan disclosedand perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as partwell as evaluating the overall presentation of Management’s Report on Internal Control.

the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ GRANT THORNTON LLP

We served as the Company’s auditor from 2007 to 2020.

Southfield, Michigan

February 26, 201920, 2020 (except for the section of Note 2 entitled Revision of Prior Period Financial Statements in the previously filed 2020 financial statements, which is not presented herein, and Note 18 and Note 19 as to which the date is March 1, 2021)

 

F-4

F-5


 

GENTHERM INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

  

December 31,

 

 

December 31,

 

  

2018

 

 

2017

 

 

2021

 

 

2020

 

ASSETS

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

  

$

39,620

  

 

$

103,172

  

 

$

190,606

 

 

$

268,345

 

Accounts receivable, less allowance of $851 and $973, respectively

  

 

166,858

  

 

 

185,058

  

Accounts receivable, net

 

 

182,987

 

 

 

211,672

 

Inventory, net

  

 

112,535

  

 

 

121,409

  

 

 

159,477

 

 

 

122,401

 

Derivative financial instruments

  

 

92

  

 

 

213

  

Prepaid expenses and other assets

  

 

54,271

  

 

 

51,217

  

Assets held for sale

  

 

69,699

 

 

 

 

Other current assets

 

 

32,775

 

 

 

41,188

 

Total current assets

  

 

443,075

  

 

 

461,069

  

 

 

565,845

 

 

 

643,606

 

Property and equipment, net of accumulated depreciation of $98,705 and $83,404, respectively

  

 

171,380

  

 

 

200,294

  

Property and equipment, net

 

 

155,270

 

 

 

152,581

 

Goodwill

  

 

55,311

  

 

 

69,685

  

 

 

66,033

 

 

 

68,024

 

Other intangible assets, net of accumulated amortization of $81,198 and $77,622, respectively

  

 

56,385

 

 

 

83,286

  

Deferred financing costs

  

 

647

  

 

 

936

  

Other intangible assets, net

 

 

37,554

 

 

 

46,421

 

Operating lease right-of-use assets

 

 

24,387

 

 

 

30,642

 

Deferred income tax assets

  

 

64,024

  

 

 

30,152

  

 

 

69,630

 

 

 

73,912

 

Other non-current assets

  

 

12,225

  

 

 

37,983

  

 

 

16,624

 

 

 

7,653

 

Total assets

  

$

803,047

  

 

$

883,405

 

 

$

935,343

 

 

$

1,022,839

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

  

$

93,113

  

 

$

89,596

  

 

$

122,727

 

 

$

116,043

 

Accrued liabilities

  

 

65,808

  

 

 

77,209

  

Current lease liabilities

 

 

5,669

 

 

 

6,032

 

Current maturities of long-term debt

  

 

3,413

  

 

 

3,460

  

 

 

2,500

 

 

 

2,500

 

Derivative financial instruments

  

 

 

 

 

1,050

  

Liabilities held for sale

  

 

13,062

  

 

 

 

Other current liabilities

 

 

82,193

 

 

 

81,409

 

Total current liabilities

  

 

175,396

  

 

 

171,315

  

 

 

213,089

 

 

 

205,984

 

Pension benefit obligations

  

 

7,211

  

 

 

7,913

  

Other Liabilities

  

 

3,087

  

 

 

2,747

  

Long-term debt, less current maturities

  

 

136,477

  

 

 

141,209

  

 

 

36,250

 

 

 

189,934

 

Deferred tax liabilities

  

 

1,177

 

 

 

6,347

  

Non-current lease liabilities

 

 

19,789

 

 

 

24,233

 

Pension benefit obligation

 

 

6,832

 

 

 

8,163

 

Other non-current liabilities

 

 

5,577

 

 

 

8,194

 

Total liabilities

  

 

323,348

  

 

 

329,531

  

 

$

281,537

 

 

$

436,508

 

Shareholders’ equity:

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock:

  

 

 

 

 

 

 

 

 

 

 

 

 

 

No par value; 55,000,000 shares authorized, 33,856,629 and 36,761,362 issued and outstanding at December 31, 2018 and 2017, respectively

  

 

140,300

  

 

 

265,048

  

No par value; 55,000,000 shares authorized 33,008,185 and 32,921,341 issued and outstanding at December 31, 2021 and December 31, 2020, respectively

 

 

118,646

 

 

 

121,073

 

Paid-in capital

  

 

14,934

 

 

 

15,625

 

 

 

5,866

 

 

 

7,458

 

Accumulated other comprehensive loss

  

 

(39,500

)

 

 

(20,444

)

 

 

(36,922

)

 

 

(14,982

)

Accumulated earnings

  

 

363,965

 

 

 

293,645

 

 

 

566,216

 

 

 

472,782

 

Total shareholders’ equity

  

 

479,699

  

 

 

553,874

  

 

 

653,806

 

 

 

586,331

 

Total liabilities and shareholders’ equity

  

$

803,047

  

 

$

883,405

  

 

$

935,343

 

 

$

1,022,839

 

The accompanying notes are an integral part of these consolidated financial statements

 

 

F-5F-6


 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

 

  

Year Ended December 31,

 

 

Year Ended December 31,

 

  

2018

 

 

2017

 

 

2016

 

 

2021

 

 

2020

 

 

2019

 

Product revenues

  

$

1,038,259

  

 

$

985,683

  

 

$

917,600

  

 

$

1,046,150

 

 

$

913,098

 

 

$

971,684

 

Cost of sales

  

 

743,647

  

 

 

674,796

  

 

 

622,563

  

 

 

742,519

 

 

 

644,994

 

 

 

683,349

 

Gross margin

  

 

294,612

  

 

 

310,887

  

 

 

295,037

  

 

 

303,631

 

 

 

268,104

 

 

 

288,335

 

Operating costs and expenses:

  

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

  

 

98,663

  

 

 

94,515

  

 

 

79,583

  

 

 

91,807

 

 

 

81,968

 

 

 

91,033

 

Reimbursed research and development expenses

  

 

(18,763

 

 

(12,037

 

 

(6,660

 

 

(16,593

)

 

 

(13,928

)

 

 

(18,557

)

Net research and development expenses

  

 

79,900

  

 

 

82,478

  

 

 

72,923

  

 

 

75,214

 

 

 

68,040

 

 

 

72,476

 

Acquisition transaction expenses

  

 

  

 

 

789

  

 

 

743

  

Selling, general and administrative expenses

  

 

127,152

  

 

 

130,522

  

 

 

115,252

  

 

 

109,554

 

 

 

105,044

 

 

 

118,680

 

Restructuring expenses

  

 

14,772

  

 

 

 

 

 

 

 

 

3,857

 

 

 

5,803

 

 

 

12,919

 

Total operating costs and expenses

  

 

221,824

  

 

 

213,789

  

 

 

188,918

  

Total operating expenses

 

 

188,625

 

 

 

178,887

 

 

 

204,075

 

Operating income

  

 

72,788

  

 

 

97,098

  

 

 

106,119

  

 

 

115,006

 

 

 

89,217

 

 

 

84,260

 

Interest expense

  

 

(4,942

)

 

 

(4,885

)

 

 

(3,257

Interest expense, net

 

 

(2,758

)

 

 

(4,559

)

 

 

(4,763

)

Foreign currency gain (loss)

  

 

622

 

 

 

(23,108

)

 

 

7,810

 

 

 

1,487

 

 

 

(5,439

)

 

 

2,326

 

Impairment loss

  

 

(11,476

)

 

 

  

 

 

 

 

 

 

 

 

 

 

 

(21,206

)

Other income (loss)

  

 

1,127

 

 

 

150

 

 

 

(109

)

Net loss on divestitures

 

 

 

 

 

 

 

 

(1,587

)

Other income

 

 

117

 

 

 

2,337

 

 

 

121

 

Earnings before income tax

  

 

58,119

  

 

 

69,255

  

 

 

110,563

  

 

 

113,852

 

 

 

81,556

 

 

 

59,151

 

Income tax expense

  

 

16,220

  

 

 

34,028

  

 

 

33,965

  

 

 

20,418

 

 

 

21,866

 

 

 

10,285

 

Net income

  

$

41,899

  

 

$

35,227

  

 

$

76,598

  

 

$

93,434

 

 

$

59,690

 

 

$

48,866

 

Basic earnings per share

  

$

1.17

  

 

$

0.96

  

 

$

2.10

  

 

$

2.82

 

 

$

1.83

 

 

$

1.48

 

Diluted earnings per share

  

$

1.16

  

 

$

0.96

  

 

$

2.09

  

 

$

2.79

 

 

$

1.81

 

 

$

1.47

 

Weighted average number of shares—basic

  

 

35,921

  

 

 

36,721

  

 

 

36,448

  

Weighted average number of shares—diluted

  

 

36,177

  

 

 

36,814

  

 

 

36,601

  

Weighted average number of shares – basic

 

 

33,086

 

 

 

32,666

 

 

 

33,120

 

Weighted average number of shares – diluted

 

 

33,510

 

 

 

33,028

 

 

 

33,298

 

The accompanying notes are an integral part of these consolidated financial statements

 

 

F-6

F-7


 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

 

 

 

Year Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Net Income

 

$

41,899

 

 

$

35,227

 

 

$

76,598

 

Other comprehensive gain (loss), gross of tax:

 

 

 

 

 

 

 

 

 

 

 

 

Net gain (loss) on pension benefit obligations

 

 

91

 

 

 

244

 

 

 

(675

)

Foreign currency translation adjustments

 

 

(19,212

)

 

 

48,059

 

 

 

(16,678

)

Unrealized gain (loss) on foreign currency derivative securities

 

 

1,096

 

 

 

301

 

 

 

(1,395

)

Unrealized gain (loss) on commodity derivative securities

 

 

(218

)

 

 

55

 

 

 

743

 

Other comprehensive gain (loss), gross of tax

 

$

(18,243

)

 

$

48,659

 

 

$

(18,005

)

Other comprehensive gain (loss), related tax effects:

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative effect of accounting change due to ASU 2018-02

 

 

(40

)

 

 

 

 

 

 

Net gain (loss) on pension benefit obligations

 

 

(15

)

 

 

(60

)

 

 

185

 

Foreign currency translation adjustments

 

 

(390

)

 

 

148

 

 

 

297

 

Unrealized gain (loss) on foreign currency derivative securities

 

 

(300

)

 

 

(81

)

 

 

375

 

Unrealized gain (loss) on commodity derivative securities

 

 

(68

)

 

 

(19

)

 

 

(273

)

Other comprehensive gain (loss), related tax effect

 

$

(813

)

 

$

(12

)

 

$

584

 

Other comprehensive loss, net of tax:

 

$

(19,056

)

 

$

48,647

 

 

$

(17,421

)

Comprehensive income:

 

 

22,843

 

 

 

83,874

 

 

 

59,177

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net income

 

$

93,434

 

 

$

59,690

 

 

$

48,866

 

Other comprehensive (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

Pension benefit obligations

 

 

558

 

 

 

(80

)

 

 

(1,032

)

Foreign currency translation adjustments

 

 

(21,551

)

 

 

27,242

 

 

 

(2,722

)

Unrealized (loss) gain on foreign currency derivative securities, net of tax

 

 

(952

)

 

 

211

 

 

 

899

 

Unrealized gain on commodity derivative securities, net of tax

 

 

5

 

 

 

 

 

 

 

Other comprehensive (loss) income, net of tax

 

 

(21,940

)

 

 

27,373

 

 

 

(2,855

)

Comprehensive income

 

$

71,494

 

 

$

87,063

 

 

$

46,011

 

The accompanying notes are an integral part of these financial statements

F-7


GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

 

 

Common

 

 

 

 

 

Loss on
Pension

 

 

Currency

 

 

Foreign
Currency

 

 

Commodity

 

 

 

 

 

 

 

 

 

Stock

 

 

Paid-in

 

 

Benefit

 

 

Translation

 

 

Hedge

 

 

Hedge

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Obligation

 

 

Adjustment

 

 

Adjustment

 

 

Adjustment

 

 

Earnings

 

 

Total

 

Balance at December 31, 2015

 

 

36,322

 

 

$

256,919

 

 

$

(1,282

)

 

$

(2,060

)

 

$

(49,381

)

 

$

 

 

$

(229

)

 

$

180,324

 

 

$

384,291

 

Exercise of Common Stock options for cash

 

 

113

 

 

 

1,939

 

 

 

(501

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,438

 

Tax benefit from Exercises of Common Stock options

 

 

 

 

 

 

 

 

7,509

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,509

 

Common Stock issued to Board of Directors and employees

 

 

137

 

 

 

4,589

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,589

 

Stock option compensation

 

 

 

 

 

 

 

 

4,597

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,597

 

Cancelation of restricted stock

 

 

(38

)

 

 

(1,196

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,196

)

Net loss on pension benefit obligation, net

 

 

 

 

 

 

 

 

 

 

 

(490

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(490

)

Currency translation, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16,381

)

 

 

 

 

 

 

 

 

 

 

 

(16,381

)

Foreign currency hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,020

)

 

 

 

 

 

 

 

 

(1,020

)

Commodity hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

470

 

 

 

 

 

 

470

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

76,598

 

 

 

76,598

 

Balance at December 31, 2016

 

 

36,534

 

 

$

262,251

 

 

$

10,323

 

 

$

(2,550

)

 

$

(65,762

)

 

$

(1,020

)

 

$

241

 

 

$

256,922

 

 

$

460,405

 

Exercise of Common Stock options for cash

 

 

202

 

 

 

3,662

 

 

 

(907

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,755

 

Cumulative effect of accounting change due to adoption of ASU 2016-09

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,496

 

 

 

1,496

 

Common Stock issued to Board of Directors and employees

 

 

242

 

 

 

6,298

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,298

 

Stock repurchases

 

 

(164

)

 

 

(5,326

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,326

)

Stock option compensation

 

 

 

 

 

 

 

 

 

6,209

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,209

 

Cancelation of restricted stock

 

 

(53

)

 

 

(1,837

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,837

)

Net gain on pension benefit obligation, net

 

 

 

 

 

 

 

 

 

 

 

184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

184

 

Currency translation, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

48,207

 

 

 

 

 

 

 

 

 

 

 

 

48,207

 

Foreign currency hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

220

 

 

 

 

 

 

 

 

 

220

 

Commodity hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

36

 

 

 

 

 

 

36

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

35,227

 

 

 

35,227

 

Balance at December 31, 2017

 

 

36,761

 

 

$

265,048

 

 

$

15,625

 

 

$

(2,366

)

 

$

(17,555

)

 

$

(800

)

 

$

277

 

 

$

293,645

 

 

$

553,874

 

Exercise of Common Stock options for cash

 

 

615

 

 

 

18,755

 

 

 

(3,979

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,776

 

Cumulative effect of accounting change due to adoption of ASU 2014-09

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,264

)

 

 

(3,264

)

Cumulative effect of accounting change due to adoption of ASU 2016-16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31,645

 

 

 

31,645

 

Cumulative effect of accounting change due to adoption of ASU 2018-02

 

 

 

 

 

 

 

 

 

 

 

(49

)

 

 

 

 

 

 

 

 

9

 

 

 

40

 

 

 

 

Common Stock issued to Board of Directors and employees

 

 

22

 

 

 

5,759

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,759

 

Stock repurchases

 

 

(3,470

)

 

 

(148,074

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(148,074

)

Stock option compensation

 

 

 

 

 

 

 

 

3,288

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,288

 

Cancelation of restricted stock

 

 

(71

)

 

 

(1,188

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,188

)

Net gain on pension benefit obligation, net

 

 

 

 

 

 

 

 

 

 

 

76

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

76

 

Currency translation, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(19,602

)

 

 

 

 

 

 

 

 

 

 

 

(19,602

)

Foreign currency hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

796

 

 

 

 

 

 

 

 

 

796

 

Commodity hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(286

)

 

 

 

 

 

(286

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

41,899

 

 

 

41,899

 

Balance at December 31, 2018

 

 

33,857

 

 

$

140,300

 

 

$

14,934

 

 

$

(2,339

)

 

$

(37,157

)

 

$

(4

)

 

$

 

 

$

363,965

 

 

$

479,699

 

The accompanying notes are an integral part of theseconsolidated financial statements

 

 

F-8


 

 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Earnings

 

 

Total

 

Balance at December 31, 2018

 

 

33,857

 

 

$

140,300

 

 

$

14,934

 

 

$

(39,500

)

 

$

363,965

 

 

$

479,699

 

Cumulative effect of accounting change due to adoption of ASU 2016-02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

261

 

 

 

261

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

48,866

 

 

 

48,866

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(2,855

)

 

 

 

 

 

(2,855

)

Stock compensation, net

 

 

412

 

 

 

25,490

 

 

 

(4,082

)

 

 

 

 

 

 

 

 

21,408

 

Stock repurchase

 

 

(1,595

)

 

 

(63,283

)

 

 

 

 

 

 

 

 

 

 

 

(63,283

)

Balance at December 31, 2019

 

 

32,674

 

 

$

102,507

 

 

$

10,852

 

 

$

(42,355

)

 

$

413,092

 

 

$

484,096

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

59,690

 

 

 

59,690

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

27,373

 

 

 

 

 

 

27,373

 

Stock compensation, net

 

 

493

 

 

 

27,658

 

 

 

(3,394

)

 

 

 

 

 

 

 

 

24,264

 

Stock repurchase

 

 

(246

)

 

 

(9,092

)

 

 

 

 

 

 

 

 

 

 

 

(9,092

)

Balance at December 31, 2020

 

 

32,921

 

 

$

121,073

 

 

$

7,458

 

 

$

(14,982

)

 

$

472,782

 

 

$

586,331

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

93,434

 

 

 

93,434

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(21,940

)

 

 

 

 

 

(21,940

)

Stock compensation, net

 

 

327

 

 

 

17,573

 

 

 

(1,592

)

 

 

 

 

 

 

 

 

15,981

 

Stock repurchase

 

 

(240

)

 

 

(20,000

)

 

 

 

 

 

 

 

 

 

 

 

(20,000

)

Balance at December 31, 2021

 

 

33,008

 

 

$

118,646

 

 

$

5,866

 

 

$

(36,922

)

 

$

566,216

 

 

$

653,806

 

The accompanying notes are an integral part of these consolidated financial statements


F-9


GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

  

Year Ended December 31,

 

 

  

2018

 

 

2017

 

 

2016

 

Operating Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Net income

  

$

41,899

 

 

$

35,227

 

 

$

76,598

 

Adjustments to reconcile net income to cash provided by operating activities:

  

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

  

 

50,638

 

 

 

44,972

 

 

 

37,764

 

Deferred income taxes

  

 

6,699

 

 

 

5,135

 

 

 

(8,843

)

Stock compensation

  

 

9,047

 

 

 

12,507

 

 

 

9,186

 

Defined benefit pension plan (income) expense

  

 

82

 

 

 

(23

)

 

 

184

 

Provision for doubtful accounts

  

 

(1

)

 

 

(469

)

 

 

108

 

Loss on sale of property and equipment

  

 

2,602

 

 

 

1,042

 

 

 

468

 

Impairment loss

  

 

11,476

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

  

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

  

 

3,024

 

 

 

6,033

 

 

 

(17,971

)

Inventory

  

 

(7,689

)

 

 

(4,348

)

 

 

(5,933

)

Prepaid expenses and other assets

  

 

(4,428

)

 

 

(12,334

)

 

 

9,106

 

Accounts payable

  

 

12,380

 

 

 

(7,691

)

 

 

4,419

 

Accrued liabilities

  

 

(7,295

)

 

 

(30,171

)

 

 

3,314

 

Net cash provided by operating activities

  

 

118,434

 

 

 

49,880

 

 

 

108,400

 

Investing Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Investment in subsidiary, net of cash acquired

  

 

(15

)

 

 

(66,994

)

 

 

(73,593

)

Investment in development-stage entity

  

 

 

 

 

 

 

 

(4,486

)

Purchases of property and equipment

  

 

(41,541

)

 

 

(50,785

)

 

 

(66,316

)

Proceeds from the sale of property and equipment

  

 

799

 

 

 

91

 

 

 

57

 

Net cash used in investing activities

  

 

(40,757

)

 

 

(117,688

)

 

 

(144,338

)

Financing Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Cash paid for financing costs

  

 

 

 

 

 

 

 

(649

)

Borrowing of Debt

  

 

94,679

 

 

 

 

 

 

115,000

 

Repayments of Debt

  

 

(99,460

)

 

 

(27,156

)

 

 

(42,244

)

Cash paid for the cancellation of restricted stock

  

 

(1,188

)

 

 

(1,837

)

 

 

(1,196

)

Cash paid for the repurchase of common stock

 

 

(148,074

)

 

 

(5,326

)

 

 

 

Excess tax benefit from equity awards

  

 

 

 

 

 

 

 

7,509

 

Proceeds from the exercise of Common Stock options

  

 

14,777

 

 

 

2,755

 

 

 

1,438

 

Net cash (used in) provided by financing activities

  

 

(139,266

)

 

 

(31,564

)

 

 

79,858

 

Foreign currency effect on cash and cash equivalents

  

 

(1,963

)

 

 

25,357

 

 

 

(11,212

)

Net (decrease) increase in cash and cash equivalents

  

 

(63,552

)

 

 

(74,015

)

 

 

32,708

 

Cash and cash equivalents at beginning of period

  

 

103,172

 

 

 

177,187

 

 

 

144,479

 

Cash and cash equivalents at end of period

  

$

39,620

 

 

$

103,172

 

 

$

177,187

 

Supplemental disclosure of cash flow information:

  

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

  

$

5,027

 

 

$

4,540

 

 

$

3,029

 

Cash paid for taxes

  

$

23,159

 

 

$

76,741

 

 

$

21,608

 

Supplemental disclosure of non-cash transactions:

  

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued to directors and employees

  

$

5,759

 

 

$

6,298

 

 

$

4,589

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Operating Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

93,434

 

 

$

59,690

 

 

$

48,866

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

38,780

 

 

 

41,114

 

 

 

44,246

 

Deferred income taxes

 

 

(150

)

 

 

849

 

 

 

(7,743

)

Non-cash stock based compensation

 

 

14,530

 

 

 

8,829

 

 

 

6,253

 

Loss on disposition of property and equipment

 

 

973

 

 

 

683

 

 

 

462

 

Gain on sale of patents

 

 

 

 

 

(1,978

)

 

 

 

Impairment loss

 

 

 

 

 

 

 

 

21,206

 

Net loss on divestitures

 

 

 

 

 

 

 

 

1,587

 

Other

 

 

(271

)

 

 

(748

)

 

 

1,042

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

25,099

 

 

 

(46,742

)

 

 

7,154

 

Inventory

 

 

(39,873

)

 

 

(814

)

 

 

(3,859

)

Other assets

 

 

10,307

 

��

 

(11,997

)

 

 

13,363

 

Accounts payable

 

 

8,166

 

 

 

29,960

 

 

 

(10,253

)

Other liabilities

 

 

(7,919

)

 

 

31,849

 

 

 

(3,521

)

Net cash provided by operating activities

 

 

143,076

 

 

 

110,695

 

 

 

118,803

 

Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(38,468

)

 

 

(17,219

)

 

 

(23,729

)

Cost of technology investments

 

 

(7,557

)

 

 

 

 

 

 

Proceeds from the sale of patents and property and equipment

 

 

22

 

 

 

2,140

 

 

 

219

 

Acquisition of business

 

 

(2,827

)

 

 

 

 

 

(14,823

)

Acquisition of intangible assets

 

 

 

 

 

(3,141

)

 

 

 

Proceeds from divestiture of businesses, net

 

 

 

 

 

 

 

 

 

44,173

 

Net cash (used in) provided by investing activities

 

 

(48,830

)

 

 

(18,220

)

 

 

5,840

 

Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

Borrowing of debt

 

 

 

 

 

201,194

 

 

 

37,812

 

Repayments of debt

 

 

(153,243

)

 

 

(91,439

)

 

 

(96,999

)

Cash paid for the repurchase of Common Stock

 

 

(20,000

)

 

 

(9,092

)

 

 

(63,283

)

Proceeds from the exercise of Common Stock options

 

 

8,279

 

 

 

16,552

 

 

 

16,557

 

Cash paid for the cancellation of restricted stock

 

 

(4,108

)

 

 

(1,117

)

 

 

(1,402

)

Acquisition contingent consideration payment

 

 

(69

)

 

 

(618

)

 

 

 

Cash paid for financing costs

 

 

 

 

 

 

 

 

(1,278

)

Net cash (used in) provided by financing activities

 

 

(169,141

)

 

 

115,480

 

 

 

(108,593

)

Foreign currency effect

 

 

(2,844

)

 

 

7,442

 

 

 

(2,722

)

Net (decrease) increase in cash, cash equivalents and restricted cash

 

 

(77,739

)

 

 

215,397

 

 

 

13,328

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

268,345

 

 

 

52,948

 

 

 

39,620

 

Cash, cash equivalents and restricted cash at end of period

 

$

190,606

 

 

$

268,345

 

 

$

52,948

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for taxes

 

$

14,857

 

 

$

5,013

 

 

$

11,008

 

Cash paid for interest

 

$

2,378

 

 

$

4,204

 

 

$

4,462

 

The accompanying notes are an integral part of these consolidated financial statements

 

 

F-9F-10


 

GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 1 — The CompanyOverview

Gentherm Incorporated, a Michigan corporation, and its consolidated subsidiaries (“Gentherm”, “we”, “us”, “our” or the “Company”) is a global technologydeveloper, manufacturer and industry leader in the design, development, and manufacturingmarketer of innovative thermal management technologies. Unlesstechnologies for a broad range of heating, cooling and temperature control applications, primarily in the context otherwise requires,automotive and medical industries. Within the terms “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Ourautomotive industry, our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management remote power generation,and cell connecting systems. Within the medical industry our products provide patient temperature management environmental product testing and other consumer and industrial temperature control needs.solutions. Our automotive products can be found on the vehicles ofmanufactured by nearly all the major automotive original equipment manufacturers (“OEMs”) operating in North America and Europe, and several major OEMs in Asia. We operate in locations aligned with our major customers’ product strategies to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets.   We concentrate our research on the developmentcapabilities. The Company is also developing a number of new technologies and new applications fromproducts that are expected to enable improvements to existing technologiesproducts and to create new product applications for existing and market opportunities fornew markets.

Impact of COVID-19, Supply Chain Disruptions and Other Matters

  The COVID-19 pandemic that began around December 2019 introduced significant volatility to the global economy, disrupted supply chains and had a wide arraywidespread adverse effect on the global automotive industry in the first half of thermal management solutions.  2020, with various direct and indirect adverse impacts continuing throughout 2021.

New Strategic Plan

OnBeginning in February 2020 and continuing into June 25, 2018, Gentherm announced2020, substantially all of the Company’s major OEM and Tier 1 customers temporarily ceased or significantly reduced production as a new strategic plan intended to improve business performance and positionresult of restrictions that were requested or mandated by governmental authorities. As a result, substantially all of our manufacturing facilities either temporarily suspended production or experienced significant reductions in volumes during this period. By the end of the second quarter of 2020, the Company had reopened all of its manufacturing facilities, in line with industry demand, and in accordance with local government requirements. Although global automotive industry production has improved relative to deliver above-market growththe first half of 2020, production remains below recent historic levels.

The lingering impacts of COVID-19 into 2021 has impeded global supply chains, resulted in longer lead times and improved profitabilitydelays in procuring component parts and raw materials, and resulted in inflationary cost increases in certain raw materials, labor and transportation. These broad-based inflationary impacts have negatively impacted the Company’s financial condition, results of operations and cash flows for the fiscal year ended December 31, 2021.

Supply shortages of semiconductor chips and other components have resulted in decreases in global automotive vehicle production and significant volatility in customer vehicle production schedules. The Company's semiconductor suppliers, along with most automotive component supply companies that use semiconductors, including Gentherm, have been unable to its shareholders. An important elementfully meet the vehicle production demands of the strategy isOEMs due to events which are outside the Fit-for-Growth initiative that focuses on purchasing excellence, rationalization of research and development activities, reducing selling, general and administrative expense, minimization or elimination of investments in non-core areas and developing a manufacturing footprint commensurate withCompany's control, including but not limited to, the new plan. Non-core areas of investment underCOVID-19 pandemic, the Fit-for-Growth initiative are concentratedglobal semiconductor shortage, fires at suppliers’ facilities, significant weather events impacting semiconductor supplier facilities in the following areas of Gentherm’s industrial segment: Non-core areas of investment undersouthern United States, and other extraordinary events.

In response to the Fit-for-Growth initiative are concentrated in the following areas of Gentherm’s industrial segment: Gentherm Global Power Technologies (“GPT”), Cincinnati Sub Zero’s Industrial Chamber business (“CSZ-IC”)global supply chain instability and our battery management systems division in Irvine, California. We also completed the site consolidation plan for our advanced research and development operations and vacated two lease facilities in Azusa, California. On February 1, 2019, we completed the sale of CSZ-IC to Weiss Technik North America, Inc. for total cash proceeds of $47.5 million.

The strategy also identified several product categoriesinflationary cost increases the Company has now exited, including furniture, aviation, battery management electronics, industrial battery packs, automotive thermoelectric generatorstaken several actions to minimize any potential and actual adverse impacts by working with its suppliers and customers to closely monitor the availability of semiconductor microchips and other non-core electronics.component parts and raw materials, customer vehicle production schedules and any other supply chain inefficiencies that may arise. The consequences of the pandemic and adverse impact to the global economy continue to evolve. Accordingly, the future adverse impact on our business and financial statements remains subject to significant uncertainty as of the date of this filing.

Fit-for-Growth

The Fit-for-Growth cost savings initiative began in January 2018. Consultant costs associated with the initiative were reported in restructuring expenses.  The total amount of consultant costs incurred during 2018 was $2,852. We expect to incur an additional $600 thousand in consultant costs in the first quarter of 2019 from implementing Fit-for-Growth.  

Gentherm also recognized $6,598 in one-time employee termination costs in restructuring expenses pertaining to Fit-for-Growth. Gentherm recognized $17 in contract termination costs in restructuring expenses pertaining to Fit-for-Growth.

Advanced Research and Development Rationalization and Site Consolidation

In June 2018, Gentherm completed a sale of its battery management systems division located in Irvine, California.  A loss on the sale of $1,107 was recognized in restructuring expenses.  

F-10F-11


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

On February 1, 2019, the Company completed the divestiture of its environmental test equipment business, Cincinnati Sub Zero industrial chamber business (“CSZ-IC”) and on October 1, 2019, the Company completed the divestiture of its remote power generation systems business, Gentherm Global Power Technologies (“GPT”). The Company’s consolidated financial statements herein include the results of CSZ-IC and GPT through their respective dates of divestiture, and are included in the Medical segment. CSZ-IC and GPT are not subject to discontinued operations classification.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries and those entities in which it has a controlling financial interest. The Company evaluates its relationship with other entities for consolidation and to identify whether such entities are variable interest entities (“VIE”) and to assess whether the Company is the primary beneficiary of such entities. Investments in affiliates in which Gentherm does not have control but does have the ability to exercise significant influence over operating and financial policies are accounted for under the equity method. When Gentherm does not have the ability to exercise significant influence (generally when ownership interest is less than 20%), investments in affiliates are measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer.

Intercompany transactions and balances between consolidated businesses have been eliminated.

Use of Estimates

In preparing these consolidated financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances that would require us to update such estimates and assumptions or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.

Segment Reporting

The Company has 2 reportable segments: Automotive and Medical.

The Automotive reporting segment is comprised of the results from our global automotive businesses, including the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems.

The Medical reporting segment is comprised of the results from the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute care, ambulatory, clinics and home health.

Revenue Recognition

Revenue is recognized from agreements containing enforceable rights and obligations, when promised goods are delivered or services are completed. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-

F-12


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

producing transaction, that are collected by the Company from a customer, are excluded from Product revenues. Shipping and handling fees billed to customers are included in Product revenues, while costs of shipping and handling are included in Cost of sales.

Automotive Revenues

The Company provides production parts to its customers under long-term supply agreements (“LTAs”). The duration of an LTA is generally consistent with the life cycle of a vehicle; however, an LTA does not reach the level of a performance obligation until Gentherm receives either a purchase order and/or a materials release from its customer for a specific number of production parts at a specified price, at which point an enforceable contract exists. Revenue is recognized when control of the production parts has completedtransferred to the customer according to the terms of the contract, which typically occurs when the parts are shipped or delivered to the customer’s premises. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring production parts.

Certain LTAs provide for annual price reductions over the production life of the vehicle. Agreements that are determined to provide customers with purchase option discounts that would not be received without entering into the contract are considered to contain a material right (for example, a discount given to a customer that is incremental to the range of discounts typically given to that class of customer). The material right represents a purchase option that provides the customer with the ability to purchase additional production parts at a set price in the future and is accounted for as a separate performance obligation. Under these circumstances, each transfer of production parts under the LTA requires allocation of the purchase price to the production part and the purchase option. As a practical alternative to estimating the standalone selling price of an option, the Company allocates transaction price to the purchase option by reference to the production part volumes expected to be ordered and the consideration expected to be received over the life of the vehicle program.

The production part’s relative standalone selling price observed under the LTA is subtracted from the total amount of consideration expected to be received in exchange for transferring of parts under the current contract and the difference is allocated to the purchase option. Revenue from options containing a material right is recognized when the amounts billed to the customer for production parts transferred, under the LTA, is less than the standalone selling price of those production parts.

Medical Revenues

Revenues from our patient temperature management business unit are generated from the sale of products and equipment. Our medical products and equipment focus on body and blood temperature management. The Company sells medical products and equipment primarily through distributor and group purchasing organization agreements. These agreements allow member participants to the distributor or group purchasing organization to make purchases at discounted prices negotiated by the distributor or group purchasing organization. A rebate is incurred at the point in time a member participant purchases product covered under these types of agreements. Rebates are accounted for as variable consideration, using an expected value, probability weighted approach, based on the level of sales to the distributor and the time lag between the initial sale and the rebate claim in determining the transaction price of a contract. Revenue is recognized at the point in time the medical products or equipment is transferred to the customer.

Assets Recognized from the Costs to Obtain a Contract with a Customer

The Company has no material contract assets or contract liabilities as of December 31, 2021.

The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be realized for a period greater than one year. Total capitalized costs to obtain a contract were $1,946 and $1,805 as of December 31, 2021 and 2020, respectively. These amounts are recorded in Other non-current assets and are being amortized into Product revenues over the expected production life of the applicable program. During the year ended December 31, 2021 and 2020, $174 and $263, respectively, was amortized into Product revenues.

F-13


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Cash and Cash Equivalents and Restricted Cash

The Company considers all highly liquid investments purchased with original maturities of less than 90 days to be cash equivalents. Cash balances in individual banks may exceed the federally insured limit by the Federal Deposit Insurance Corporation.  The Company had Cash and cash equivalents of $161,496 and $106,598 held in foreign jurisdictions as of December 31, 2021 and 2020, respectively. Restricted cash includes cash that is legally restricted as to use or withdrawal.

Disclosures About Fair Value of Financial Instruments

The carrying amounts of financial instruments comprising cash and cash equivalents, short-term investments, accounts receivable, notes receivable and accounts payable approximate fair value because of the short maturities of these instruments. The carrying amount of the Company’s revolving credit note under the June 27, 2019 amended and restated credit agreement (“Credit Agreement”) approximates its site consolidation planfair value because interest charged on the loan balance is variable.  See Note 14, “Fair Value Measurement,” for information about the techniques used to assess the fair value of advancedfinancial assets and liabilities, including our fixed rate debt instruments.

Concentration of Credit Risk

Financial assets, which subject the Company to concentration of credit risk, consist primarily of cash equivalents, short-term investments, accounts receivable and notes receivable. Cash equivalents consist primarily of money market funds managed by major financial services companies. The credit risk for these cash equivalents is considered low. The Company does not require collateral from its customers. As of December 31, 2021, the Company’s Automotive customers, Adient and Lear both individually represented 22% and 18%, respectively, of the Company’s accounts receivable balance.  As of December 31, 2020, Adient and Lear both individually represented 18% of the Company’s accounts receivable balance.  

Accounts Receivable

Accounts receivable are stated at the invoiced amount, less allowance for doubtful accounts for estimated amounts not expected to be collected, and do not bear interest. The Company determines the allowances based on historical write-off experience by industry and regional economic data, current expectations of future credit losses and historical cash discounts. The Company’s accounts receivables are continually assessed for collectability and any allowance is recorded based upon the age of outstanding receivables, historical payment experience and customer creditworthiness. We write-off accounts receivable when they become uncollectible. The allowance for doubtful accounts was $1,399 and $1,161 as of December 31, 2021 and 2020, respectively.  

Primarily in the Asia-Pacific region, the Company receives bank notes from certain customers to settle trade receivables. The collection of such bank notes is included in operating cash flows based on the substance of the underlying transactions, which are operating in nature. Bank notes held by the Company are classified as notes receivable within other current assets. The Company may hold such bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash.

Inventory

The Company’s inventory is measured at the lower of cost or net realizable value. Raw materials, components and consumables are measured using the weighted average cost method. Work-in-process and finished goods are measured using the first-in first-out method. If the net realizable value expected on the reporting date is below cost, a write-down is recorded to adjust inventory to its net realizable value. We recognize a reserve for obsolete and slow-moving inventories based on estimates of future sales and an inventory item’s capacity to be repurposed for a different use. We consider the number of months supply on hand based on current planned requirements, uncommitted future projections and historical usage in estimating the inventory reserve.

F-14


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Property and Equipment

Property and equipment, including additions and improvements, are recorded at cost less accumulated depreciation. Expenditures for general repairs and maintenance are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded as Operating income or expense.

Depreciation is computed using the straight-line method. The estimated useful lives of the Company’s Property and equipment are as follows:

Asset Category

Useful Life

Buildings and improvements

1 to 30 years

Plant and equipment

10 years

Production tooling

2 to 10 years

Leasehold improvements

Term of lease

Information technology

1 to 5 years

The Company recognized depreciation expense of $29,622, $31,037 and $33,639 for the years ended December 31, 2021, 2020 and 2019, respectively.

Tooling

The Company incurs costs related to tooling used in the manufacture of products sold to its customers. In some cases, the Company enters into contracts with its customers whereby the Company incurs the costs to design, develop and purchase tooling and is then reimbursed by the customer under a reimbursement contract. Tooling costs that will be reimbursed by customers are included in Other current assets in the accompanying consolidated balance sheets at the lower of accumulated cost or the customer reimbursable amount. As of December 31, 2021 and 2020, the Company had $3,778 and $4,831, respectively, of reimbursable tooling costs capitalized. Company-owned tooling is included in Property and equipment and depreciated over its expected useful life, generally two to ten years. Management periodically evaluates the recoverability of tooling costs, based on estimated future cash flows, and makes provisions, where appropriate, for tooling costs that will not be recovered.

Goodwill and Other Intangible Assets

Goodwill and other intangible assets recorded in conjunction with business combinations are based on the Company’s estimate of fair value, as of the date of acquisition.

Amortization of other intangible assets is computed using the straight-line method. The fair value and corresponding useful lives for acquired intangible assets are listed below as follows:

Asset Category

Useful Life

Customer relationships

8 to 15 years

Technology

5 to 10 years

Product development costs

5 to 10 years

Trade names

Indefinite

Our business strategy largely centers on designing products based upon internally developed and purchased technology, and we protect certain technology with patents that have value to our business strategy. Our policy is to expense all costs associated with the

F-15


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

development and issuance of new patents as incurred. Such costs are classified as research and development operationsexpenses in the accompanying consolidated statements of income.

Impairments of Other Intangible Assets and vacatedGoodwill

Goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that the two leased facilities in Azusa, California. Gentherm recognized $643 in contract termination costs in restructuring expenses from implementingcarrying value may not be recoverable. In conducting our site consolidation plan.

Gentherm recognized $1,094 in one-time employee termination costs in restructuring expenses pertainingannual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the site consolidation planrelated net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized.

The Company utilizes an income approach to estimate the fair value of a reporting unit and a market valuation approach to further support this analysis (level 3). The income approach is based on projected debt-free cash flow that is discounted to the present value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in our industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect a risk factor, if necessary. Other significant assumptions include terminal value growth rates and terminal value margin rates. While there are inherent uncertainties related to the assumptions used and to management’s application of these assumptions to this analysis, we believe that the income approach provides a reasonable estimate of the fair value of a reporting unit.

The Company performs its indefinite-lived intangible asset impairment assessment annually as of December 31, and between annual assessments if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.

Investments in non-consolidated affiliates

During 2021, the Company’s Automotive segment invested $5,200 for an ownership interest in Carrar Ltd. (“Carrar”), an Israel-based technology developer of advanced thermal management systems for the electric mobility market. The Company determined that Carrar is a VIE; however, the Company does not have a controlling financial interest or have the power to direct the activities that most significantly affect the economic performance of the investment. Therefore, the Company has concluded that it is not the primary beneficiary. Gentherm’s investment in Carrar is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

During 2021, the Company’s Automotive segment invested $2,357 for an ownership interest in Forciot Oy (“Forciot”), a technology developer of sensors for touch, motion and force measurement. Gentherm’s investment in Forciot is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

In December 2021, the Company committed to make a $5,000 investment in Autotech Fund III, L.P., pursuant to a limited partnership agreement. As a limited partner, the Company will periodically make capital contributions toward this total commitment amount over the expected ten year life of the fund. The Company has not made any contributions to the Autotech Fund III, LP as of December 31, 2021. This fund focuses broadly on the automotive industry and compliments the Company’s innovation strategy.

Research and Development Expenses

Research and development activities are expensed as incurred. The Company groups development and prototype costs and related reimbursements in research and development.  

F-16


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Leases

The Company has operating leases for office, manufacturing and research and development operations.facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. We also have operating leases for office equipment and automobiles. Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 10 years and may include options to extend the lease.  Land leases have remaining lease terms that range from 39 to 41 years and some which specify that the end of the lease term is at the discretion of the lessee. We do not have lease arrangements with related parties.

Lastly,The Company determines whether a contractual arrangement is or contains a lease at inception. Leases that are operating in nature are recognized in Operating lease right-of-use assets, Current lease liabilities and Non-current lease liabilities in the accompanying consolidated balance sheets. Gentherm is not currently party to any leases that qualify as financing leases.

Lease liabilities are measured initially at the present value of the sum of the future minimum rental payments at the commencement date of the lease. Lease payments that will vary in the future due to changes in facts and circumstances are excluded from the calculation of rental payments, unless those variable payments are based on an index or rate. Rental payments are discounted using an incremental borrowing rate, unless there is a rate implicit in the lease agreement. The incremental borrowing rate is based on the Company’s credit rating, determined on a fully collateralized loan basis from information available at commencement date, and the duration of the lease term (the “reference rate”). Judgement is used to assess the importance of risk factor inputs during the computation of the Company’s credit rating. For leases at foreign subsidiaries denominated in U.S. Dollars, a risk premium associated with the borrower subsidiary’s country is added to the reference rate. For significant leases at foreign subsidiaries denominated in a foreign currency, the U.S. Dollar risk free rate with a duration similar to that of the lease term is subtracted from the reference rate and a corresponding foreign currency risk free rate with a duration similar to that of the lease term is added to the reference rate.

Operating lease right-of-use assets are measured at the amount of the lease liability, adjusted for prepaid or accrued lease payments, lease incentive received, and initial direct costs incurred, as applicable. Periods covered by an option to extend the lease are initially included in the measurement of an operating lease right-of-use asset and lease liability only when it is reasonably certain we will exercise the option. Gentherm’s lease agreements do not contain residual value guarantees or impose restrictions or covenants on the Company.  

For all classes of underlying assets, the Company accounts for leases that contain separate lease and non-lease components as containing a single lease component. The Company does not recognize lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less and, instead, recognizes rent payments on a straight-line basis over the lease term in the consolidated statements of income.

Income Taxes

The Company records income tax expense using the liability method which specifies that deferred tax assets and liabilities be measured each year based on the difference between the financial statement and tax base of assets and liabilities at the applicable enacted tax rates. A valuation allowance is provided for deferred tax assets when management considers it more likely than not that the asset will not be realized. At December 31, 2021 and 2020, a valuation allowance has been provided for certain deferred tax assets which the Company has concluded are more likely than not to not be realized.  If future annual taxable income were to be significantly less than current and projected levels, there is a risk that certain of our deferred tax assets not already provided for by the valuation allowance would expire prior to utilization.

F-17


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized $1,400 in restructuring expensesthe financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in Income tax expense.

Derivative Financial Instruments – Hedge Accounting

The Company accounts for its derivative financial instruments as cash flow hedges. For derivative contracts which are designated as a cash flow hedge, the disposaleffective portion of long-lived assets controlledthe change in the fair value of the derivative contract is recorded to Accumulated other comprehensive loss (“AOCI”) in the accompanying consolidated balance sheets.  When the underlying hedge transaction is realized, the gain or loss included in AOCI is recorded into earnings in the accompanying consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.  Any ineffective portion of the gain or loss is recognized in the accompanying consolidated statements of income under Foreign currency gain (loss) for foreign currency derivatives, and cost of goods sold for commodity derivatives. These hedging transactions and the respective correlations meet the requirements for hedge accounting.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the respective period. The Company’s diluted earnings per share give effect to all potential shares of common stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the number of diluted shares outstanding, the treasury stock method is used in Azusa, California.order to arrive at a net number of shares created upon the conversion of common stock equivalents.

GPTStock Based Compensation

Share based payments that involve the issuance of common stock to employees, including grants of employee stock options, restricted stock, and CSZ-ICtime-based and performance-based restricted stock units, are recognized in the consolidated financial statements as compensation expense based upon the fair value on the date of grant.  

Share based payments that are satisfied only by the payment of cash, such as stock appreciation rights, are accounted for as liabilities. The liability is reported at market value of the vested portion of the underlying units. During 2018, Gentherm launchedeach period, the change in the liability is recorded as compensation expense.

Note 3 — New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes". This ASU simplifies the accounting for income taxes by removing certain exceptions previously included in the guidance. In addition, the ASU amends existing guidance to improve consistent application. The Company adopted ASU 2019-12 as of January 1, 2021 and there was no significant impact on its financial statements and related disclosures as a programresult.

F-18


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting”. ASU 2020-04 provides practical expedients and exceptions for applying GAAP to actively market GPTcontracts, hedging relationships, and CSZ-ICother transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to potential buyerscontracts, hedging relationships, and initiated all other actions requiredtransactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to completebe discontinued as a result of reference rate reform. These amendments are not applicable to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. In January 2021, the divestiture plan. Gentherm incurred $304FASB subsequently issued ASU 2021-01, “Reference Rate Reform (Topic 848): Scope” to clarify that certain optional expedients and exceptions in consultant costs in restructuring expensesTopic 848 for contract modifications and hedge accounting apply to launchderivatives that are affected by the sales plandiscounting transition. ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2022 and may be applied retrospectively to contract modifications and hedging relationships from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. Upon adoption of this standard, the Company does not expect it to incur additional consultanthave a material impact to the Company’s financial statements.

Note 4 – Acquisitions and Divestitures

Acquisition of Beckmann & Egle Industrieelektronik GmbH

On July 1, 2021, the Company acquired the medical business unit of Beckmann & Egle Industrieelektronik GmbH (“B&E”), a developer and manufacturer of electronic control units, for a purchase price of $2,827. The acquisition was accounted for as a business combination with the purchase price assigned to inventory, property and equipment and other intangible assets based on their estimated fair values as of the acquisition date. The pro forma effect of the B&E acquisition does not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented. The results of operations of B&E are reported within the Company’s Medical segment from the date of acquisition.

Divestiture of GPT

On October 1, 2019, the Company completed the sale of GPT for a nominal amount and recognized a $5,885 loss on sale for the year ended December 31, 2019, which is classified as Net loss on divestitures within the consolidated statements of income. During 2019, the Company also recognized impairment losses of $21,206 for its GPT assets held for sale. These impairment charges are classified as Impairment loss within the consolidated statements of income.

Acquisition of Stihler Electronic GmbH

On April 1, 2019, the Company acquired Stihler Electronic GmbH (“Stihler”), a leading developer and manufacturer of patient and blood temperature management systems, for a purchase price of $15,476, net of cash acquired and including $653 of contingent consideration that was paid upon achievement of a milestone during the year ended December 31, 2020. The results of operations of Stihler are reported within the Company’s Medical segment from the date of acquisition.

Divestiture of CSZ-IC

On February 1, 2019, the Company completed the sale of its environmental test equipment business, CSZ-IC and former Cincinnati Sub-Zero headquarters facility for total cash proceeds of $47,500. The Company recognized a $4,298 pre-tax gain on the sale of CSZ-IC for the year ended December 31, 2019 which is classified as Net loss on divestitures within the consolidated statements of income.

F-19


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 5 Restructuring

Manufacturing Footprint Rationalization

In September 2019, the Company committed to a restructuring plan (“Plan”) to improve the Company’s manufacturing productivity and rationalize its footprint. Under this Plan, the Company is relocating and consolidating certain automotive electronics manufacturing plants in North America and China.

During 2021, the Company completed the closures and relocation of its automotive electronics manufacturing operations from Burlington, Canada to Celaya, Mexico and from Longgang, Shenzhen, China to Bantian, Shenzhen, China. As of December 31, 2021, the electronics manufacturing in Acuña, Mexico continues to transition to Celaya, Mexico.

During the year ended December 31, 2021, the Company recognized restructuring expense of $1,303 for employee separation costs and $1,665 for other costs, primarily related to equipment move and set up costs.  

During the year ended December 31, 2020, the Company recognized restructuring expense of $(832) for employee separation costs and $1,019 for other costs, primarily related to accelerated depreciation and equipment move and set up costs. The net activity for the year ended December 31, 2020 was primarily related to a reduction in the estimates of previously recognized employee separation costs.      

During the year ended December 31, 2019, the Company recognized restructuring expense of $4,863 for employee separation costs, and $2,087 of other costs, primarily related to accelerated depreciation and fixed asset impairment.

The Company has recorded approximately $10,105 of restructuring expenses since the inception of this program and as of December 31, 2021, $943 remains accrued. Actions under the Plan are expected to be substantially completed by the first half of 2022 and future expenses are expected to be less than $1,000.           

Other Restructuring Activities

As part of the Company’s continued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the years ended December 31, 2021, 2020 and 2019, the Company recognized $889, $5,382 and $3,193 of employee separation costs, respectively, and $0, $234 and $2,776 of other related costs, respectively. These restructuring expenses were primarily associated with restructuring actions focused on the plan inrotation of our manufacturing footprint to best cost locations and the future. Lastly, Gentherm recognized $757 in one-time employee termination costs in restructuring expenses related toreduction of global overhead costs.

Restructuring Expenses By Reporting Segment

Restructuring expense by reporting segment for the divestiture process. See Note 15 to our consolidated financial statements for additional information regarding the assetsyears ended December 31, 2021, 2020 and liabilities classified2019 was as held for sale.follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Automotive

 

$

2,793

 

 

$

5,075

 

 

$

9,353

 

Medical

 

 

 

 

 

112

 

 

 

1,838

 

Corporate

 

 

1,064

 

 

 

616

 

 

 

1,728

 

Total

 

$

3,857

 

 

$

5,803

 

 

$

12,919

 

F-20


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Restructuring LiabilityUse of Estimates

A reconciliation of the beginning and ending restructuring liability is as follows:

 

 

One-Time

Employee

Termination

Benefit Costs

 

 

Contract

Termination

Costs

 

 

Consulting

Costs

 

 

Asset

Disposal Costs

 

 

Total

 

Year Ended December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Additions, charged to costs

 

 

8,449

 

 

 

660

 

 

 

3,156

 

 

 

2,507

 

 

 

14,772

 

Payments

 

 

(6,370

)

 

 

(271

)

 

 

(3,077

)

 

 

(2,507

)

 

 

(12,225

)

Balance, end of period

 

$

2,079

 

 

$

389

 

 

$

79

 

 

$

 

 

$

2,547

 

The cumulative amount of restructuring expenses incurred and recognized in the automotive reporting segment during 2018 was $9,164.  The cumulative amount of restructuring expenses incurred and recognized in the industrial reporting segment during the year ended December 31, 2018 was $5,608. See Note 9 to ourIn preparing these consolidated financial statements, for a descriptionmanagement was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances that would require us to update such estimates and assumptions or revise the carrying value of our reportable segmentsassets or liabilities. Our estimates may change, however, as well as their proportional contribution to the Company’s reported product revenuesnew events occur and operating income.

Etratech

On November 1, 2017, we acquired substantially all of the assets and assumed substantially all of the operating liabilities of Etratech Inc., an Ontario corporation and all of the outstanding shares of Etratech Hong Kong, an entity organized under the laws of Hong Kong, in an all-cash transaction.  Etratech manufactures advanced electronic controls and control systems for the automotive, recreational vehicle, marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are located in Burlington, Canada. See Note 17 to the consolidated financial statements for additional information regarding the acquisition of Etratech.  


F-11


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 1 — The Company – (Continued)

North American Reorganization

On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business (the “Windsor Operations”).  As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities.is obtained. As a result, of the Reorganization, some of the business activities previously performed by the Windsor Operations are now being performed by other subsidiaries.actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.

Related to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7,600 during 2016.  Additionally, the Company incurred income tax expense of $2,500 related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.  

In addition to the $7,600 of withholding tax and $2,500 of income taxes, the Reorganization required the Company to make a one-time income tax payment of approximately $32,600.  The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2,500 and $32,600 were paid during the first quarter of 2017. No payments related to the Reorganization were made in 2018.

Reportable SegmentsSegment Reporting

The Company has two2 reportable segments for financial reporting purposes: segments: Automotive and Industrial.

AutomotiveMedical.

The Automotive reporting segment is comprised of the results from our global automotive businesses. Operating results from ourbusinesses, including the design, development, manufacturing and sales of automotive climate comfort systems, specialized automotive cable systems, battery thermal management,performance solutions, and automotive electronic and software systems are all reported in the Automotive segment because of their complementary focus on automotive content, passenger thermal comfort and convenience.  Etratech’s operating results are included within Gentherm’s Automotive segment due to the concentration of product applications within the automotive, RV and marine industries.

Climate comfort system solutions include seat heaters, variable temperature Climate Control Seats (“CCS”) designed to provide individualized thermal comfort to automobile passengers, and integrated electronic components, such as blowers and electronic control units and that utilize our proprietary electronics technology and software.  Other climate comfort system solutions include steering wheel heaters, neck climate control systems and surface climate control system products for doors, armrests, cupholders and storage bins.

Industrialsystems.

The IndustrialMedical reporting segment representsis comprised of the combined results from our remote power generation systems business, ourthe patient temperature management systems business our environmental testing equipment business and our advanced research and product development division.  Our remote power generation systems business is managed by our subsidiary Gentherm Global Power Technologies (“GPT”) and our patientin the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and environment test equipment businessesadditional warming/cooling therapies utilized in acute care, ambulatory, clinics and home health.

Revenue Recognition

Revenue is recognized from agreements containing enforceable rights and obligations, when promised goods are manageddelivered or services are completed. Taxes assessed by our subsidiary Cincinnati Sub-Zero (“CSZ”). The advanced researcha governmental authority that are both imposed on and product development division is engaged in projects to improve the efficiency and functionality of thermal management technologies and to develop, market, and distribute products based on these new technologies.  The operating results from these businesses and division are presented together as one reporting segment because of their joint concentration on identifying new markets and product applications based on thermal management technologies.concurrent with a specific revenue-

F-12


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 1 —producing transaction, that are collected by the Company from a customer, are excluded from Product revenues. Shipping and handling fees billed to customers are included in Product revenues, while costs of shipping and handling are included in Cost of sales.

Automotive Revenues

The Company provides production parts to its customers under long-term supply agreements (“LTAs”). The duration of an LTA is generally consistent with the life cycle of a vehicle; however, an LTA does not reach the level of a performance obligation until Gentherm receives either a purchase order and/or a materials release from its customer for a specific number of production parts at a specified price, at which point an enforceable contract exists. Revenue is recognized when control of the production parts has transferred to the customer according to the terms of the contract, which typically occurs when the parts are shipped or delivered to the customer’s premises. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring production parts.

Certain LTAs provide for annual price reductions over the production life of the vehicle. Agreements that are determined to provide customers with purchase option discounts that would not be received without entering into the contract are considered to contain a material right (for example, a discount given to a customer that is incremental to the range of discounts typically given to that class of customer). The material right represents a purchase option that provides the customer with the ability to purchase additional production parts at a set price in the future and is accounted for as a separate performance obligation. Under these circumstances, each transfer of production parts under the LTA requires allocation of the purchase price to the production part and the purchase option. As a practical alternative to estimating the standalone selling price of an option, the Company allocates transaction price to the purchase option by reference to the production part volumes expected to be ordered and the consideration expected to be received over the life of the vehicle program.

The production part’s relative standalone selling price observed under the LTA is subtracted from the total amount of consideration expected to be received in exchange for transferring of parts under the current contract and the difference is allocated to the purchase option. Revenue from options containing a material right is recognized when the amounts billed to the customer for production parts transferred, under the LTA, is less than the standalone selling price of those production parts.

Medical Revenues

Revenues from our patient temperature management business unit are generated from the sale of products and equipment. Our medical products and equipment focus on body and blood temperature management. The Company sells medical products and equipment primarily through distributor and group purchasing organization agreements. These agreements allow member participants to the distributor or group purchasing organization to make purchases at discounted prices negotiated by the distributor or group purchasing organization. A rebate is incurred at the point in time a member participant purchases product covered under these types of agreements. Rebates are accounted for as variable consideration, using an expected value, probability weighted approach, based on the level of sales to the distributor and the time lag between the initial sale and the rebate claim in determining the transaction price of a contract. Revenue is recognized at the point in time the medical products or equipment is transferred to the customer.

Assets Recognized from the Costs to Obtain a Contract with a Customer

The Company has no material contract assets or contract liabilities as of December 31, 2021.

The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be realized for a period greater than one year. Total capitalized costs to obtain a contract were $1,946 and $1,805 as of December 31, 2021 and 2020, respectively. These amounts are recorded in Other non-current assets and are being amortized into Product revenues over the expected production life of the applicable program. During the year ended December 31, 2021 and 2020, $174 and $263, respectively, was amortized into Product revenues.

F-13


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Cash and Cash Equivalents and Restricted Cash

The Company considers all highly liquid investments purchased with original maturities of less than 90 days to be cash equivalents. Cash balances in individual banks may exceed the federally insured limit by the Federal Deposit Insurance Corporation.  The Company had Cash and cash equivalents of $161,496 and $106,598 held in foreign jurisdictions as of December 31, 2021 and 2020, respectively. Restricted cash includes cash that is legally restricted as to use or withdrawal.

Disclosures About Fair Value of Financial Instruments

The carrying amounts of financial instruments comprising cash and cash equivalents, short-term investments, accounts receivable, notes receivable and accounts payable approximate fair value because of the short maturities of these instruments. The carrying amount of the Company’s revolving credit note under the June 27, 2019 amended and restated credit agreement (“Credit Agreement”) approximates its fair value because interest charged on the loan balance is variable.  See Note 914, “Fair Value Measurement,” for information about the techniques used to assess the fair value of financial assets and liabilities, including our fixed rate debt instruments.

Concentration of Credit Risk

Financial assets, which subject the Company to concentration of credit risk, consist primarily of cash equivalents, short-term investments, accounts receivable and notes receivable. Cash equivalents consist primarily of money market funds managed by major financial services companies. The credit risk for these cash equivalents is considered low. The Company does not require collateral from its customers. As of December 31, 2021, the Company’s Automotive customers, Adient and Lear both individually represented 22% and 18%, respectively, of the consolidated financial statements for information regardingCompany’s accounts receivable balance.  As of December 31, 2020, Adient and Lear both individually represented 18% of the Company’s segment revenuesaccounts receivable balance.  

Accounts Receivable

Accounts receivable are stated at the invoiced amount, less allowance for doubtful accounts for estimated amounts not expected to be collected, and do not bear interest. The Company determines the allowances based on historical write-off experience by industry and regional economic data, current expectations of future credit losses and historical cash discounts. The Company’s accounts receivables are continually assessed for collectability and any allowance is recorded based upon the age of outstanding receivables, historical payment experience and customer creditworthiness. We write-off accounts receivable when they become uncollectible. The allowance for doubtful accounts was $1,399 and $1,161 as of December 31, 2021 and 2020, respectively.  

Primarily in the Asia-Pacific region, the Company receives bank notes from externalcertain customers including geographic composition,to settle trade receivables. The collection of such bank notes is included in operating income, depreciation and amortization, and goodwill.cash flows based on the substance of the underlying transactions, which are operating in nature. Bank notes held by the Company are classified as notes receivable within other current assets. The Company may hold such bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash.

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation

ConsolidationInventory

The consolidated financial statementsCompany’s inventory is measured at the lower of cost or net realizable value. Raw materials, components and consumables are measured using the weighted average cost method. Work-in-process and finished goods are measured using the first-in first-out method. If the net realizable value expected on the reporting date is below cost, a write-down is recorded to adjust inventory to its net realizable value. We recognize a reserve for obsolete and slow-moving inventories based on estimates of future sales and an inventory item’s capacity to be repurposed for a different use. We consider the number of months supply on hand based on current planned requirements, uncommitted future projections and historical usage in estimating the inventory reserve.

F-14


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Property and Equipment

Property and equipment, including additions and improvements, are recorded at cost less accumulated depreciation. Expenditures for general repairs and maintenance are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded as Operating income or expense.

Depreciation is computed using the straight-line method. The estimated useful lives of the Company’s Property and equipment are as follows:

Asset Category

Useful Life

Buildings and improvements

1 to 30 years

Plant and equipment

10 years

Production tooling

2 to 10 years

Leasehold improvements

Term of lease

Information technology

1 to 5 years

The Company recognized depreciation expense of $29,622, $31,037 and $33,639 for the years ended December 31, 2018, 20172021, 2020 and 2016,2019, respectively.

Tooling

The Company incurs costs related to tooling used in the manufacture of products sold to its customers. In some cases, the Company enters into contracts with its customers whereby the Company incurs the costs to design, develop and purchase tooling and is then reimbursed by the customer under a reimbursement contract. Tooling costs that will be reimbursed by customers are included in Other current assets in the accompanying consolidated balance sheets at the lower of accumulated cost or the customer reimbursable amount. As of December 31, 2021 and 2020, the Company had $3,778 and $4,831, respectively, of reimbursable tooling costs capitalized. Company-owned tooling is included in Property and equipment and depreciated over its expected useful life, generally two to ten years. Management periodically evaluates the recoverability of tooling costs, based on estimated future cash flows, and makes provisions, where appropriate, for tooling costs that will not be recovered.

Goodwill and Other Intangible Assets

Goodwill and other intangible assets recorded in conjunction with business combinations are based on the Company’s estimate of fair value, as of the date of acquisition.

Amortization of other intangible assets is computed using the straight-line method. The fair value and corresponding useful lives for acquired intangible assets are listed below as follows:

Asset Category

Useful Life

Customer relationships

8 to 15 years

Technology

5 to 10 years

Product development costs

5 to 10 years

Trade names

Indefinite

Our business strategy largely centers on designing products based upon internally developed and purchased technology, and we protect certain technology with patents that have value to our business strategy. Our policy is to expense all costs associated with the

F-15


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

development and issuance of new patents as incurred. Such costs are classified as research and development expenses in the accompanying consolidated statements of income.

Impairments of Other Intangible Assets and Goodwill

Goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized.

The Company utilizes an income approach to estimate the fair value of a reporting unit and a market valuation approach to further support this analysis (level 3). The income approach is based on projected debt-free cash flow that is discounted to the present value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in our industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect a risk factor, if necessary. Other significant assumptions include terminal value growth rates and terminal value margin rates. While there are inherent uncertainties related to the assumptions used and to management’s application of these assumptions to this analysis, we believe that the income approach provides a reasonable estimate of the fair value of a reporting unit.

The Company performs its indefinite-lived intangible asset impairment assessment annually as of December 31, and between annual assessments if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.

Investments in non-consolidated affiliates

During 2021, the Company’s Automotive segment invested $5,200 for an ownership interest in Carrar Ltd. (“Carrar”), an Israel-based technology developer of advanced thermal management systems for the electric mobility market. The Company determined that Carrar is a VIE; however, the Company does not have a controlling financial interest or have the power to direct the activities that most significantly affect the economic performance of the investment. Therefore, the Company has concluded that it is not the primary beneficiary. Gentherm’s investment in Carrar is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

During 2021, the Company’s Automotive segment invested $2,357 for an ownership interest in Forciot Oy (“Forciot”), a technology developer of sensors for touch, motion and force measurement. Gentherm’s investment in Forciot is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

In December 2021, the Company committed to make a $5,000 investment in Autotech Fund III, L.P., pursuant to a limited partnership agreement. As a limited partner, the Company will periodically make capital contributions toward this total commitment amount over the expected ten year life of the fund. The Company has not made any contributions to the Autotech Fund III, LP as of December 31, 2021. This fund focuses broadly on the automotive industry and compliments the Company’s innovation strategy.

Research and Development Expenses

Research and development activities are expensed as incurred. The Company groups development and prototype costs and related reimbursements in research and development.  

F-16


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Leases

The Company has operating leases for office, manufacturing and research and development facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. We also have operating leases for office equipment and automobiles. Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 10 years and may include options to extend the lease.  Land leases have remaining lease terms that range from 39 to 41 years and some which specify that the end of the lease term is at the discretion of the lessee. We do not have lease arrangements with related parties.

The Company determines whether a contractual arrangement is or contains a lease at inception. Leases that are operating in nature are recognized in Operating lease right-of-use assets, Current lease liabilities and Non-current lease liabilities in the accompanying consolidated balance sheets. Gentherm is not currently party to any leases that qualify as financing leases.

Lease liabilities are measured initially at the present value of the sum of the future minimum rental payments at the commencement date of the lease. Lease payments that will vary in the future due to changes in facts and circumstances are excluded from the calculation of rental payments, unless those variable payments are based on an index or rate. Rental payments are discounted using an incremental borrowing rate, unless there is a rate implicit in the lease agreement. The incremental borrowing rate is based on the Company’s credit rating, determined on a fully collateralized loan basis from information available at commencement date, and the duration of the lease term (the “reference rate”). Judgement is used to assess the importance of risk factor inputs during the computation of the Company’s credit rating. For leases at foreign subsidiaries denominated in U.S. Dollars, a risk premium associated with the borrower subsidiary’s country is added to the reference rate. For significant leases at foreign subsidiaries denominated in a foreign currency, the U.S. Dollar risk free rate with a duration similar to that of the lease term is subtracted from the reference rate and a corresponding foreign currency risk free rate with a duration similar to that of the lease term is added to the reference rate.

Operating lease right-of-use assets are measured at the amount of the lease liability, adjusted for prepaid or accrued lease payments, lease incentive received, and initial direct costs incurred, as applicable. Periods covered by an option to extend the lease are initially included in the measurement of an operating lease right-of-use asset and lease liability only when it is reasonably certain we will exercise the option. Gentherm’s lease agreements do not contain residual value guarantees or impose restrictions or covenants on the Company.  

For all classes of underlying assets, the Company accounts for leases that contain separate lease and non-lease components as containing a single lease component. The Company does not recognize lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less and, instead, recognizes rent payments on a straight-line basis over the lease term in the consolidated statements of income.

Income Taxes

The Company records income tax expense using the liability method which specifies that deferred tax assets and liabilities be measured each year based on the difference between the financial statement and tax base of assets and liabilities at the applicable enacted tax rates. A valuation allowance is provided for deferred tax assets when management considers it more likely than not that the asset will not be realized. At December 31, 2021 and 2020, a valuation allowance has been provided for certain deferred tax assets which the Company has concluded are more likely than not to not be realized.  If future annual taxable income were to be significantly less than current and projected levels, there is a risk that certain of our deferred tax assets not already provided for by the valuation allowance would expire prior to utilization.

F-17


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in Income tax expense.

Derivative Financial Instruments – Hedge Accounting

The Company accounts for its derivative financial instruments as cash flow hedges. For derivative contracts which are designated as a cash flow hedge, the effective portion of the change in the fair value of the derivative contract is recorded to Accumulated other comprehensive loss (“AOCI”) in the accompanying consolidated balance sheets.  When the underlying hedge transaction is realized, the gain or loss included in AOCI is recorded into earnings in the accompanying consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.  Any ineffective portion of the gain or loss is recognized in the accompanying consolidated statements of income under Foreign currency gain (loss) for foreign currency derivatives, and cost of goods sold for commodity derivatives. These hedging transactions and the respective correlations meet the requirements for hedge accounting.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the respective period. The Company’s diluted earnings per share give effect to all potential shares of common stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the number of diluted shares outstanding, the treasury stock method is used in order to arrive at a net number of shares created upon the conversion of common stock equivalents.

Stock Based Compensation

Share based payments that involve the issuance of common stock to employees, including grants of employee stock options, restricted stock, and time-based and performance-based restricted stock units, are recognized in the consolidated financial position and consolidated operating resultsstatements as compensation expense based upon the fair value on the date of grant.  

Share based payments that are satisfied only by the Company.  Investments in affiliates in which Gentherm does not have control but does have the ability to exercise significant influence over operating and financial policies,payment of cash, such as stock appreciation rights, are accounted for as liabilities. The liability is reported at market value of the vested portion of the underlying units. During each period, the change in the liability is recorded as compensation expense.

Note 3 — New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes". This ASU simplifies the accounting for income taxes by removing certain exceptions previously included in the guidance. In addition, the ASU amends existing guidance to improve consistent application. The Company adopted ASU 2019-12 as of January 1, 2021 and there was no significant impact on its financial statements and related disclosures as a result.

F-18


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting”. ASU 2020-04 provides practical expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued as a result of reference rate reform. These amendments are not applicable to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. In January 2021, the FASB subsequently issued ASU 2021-01, “Reference Rate Reform (Topic 848): Scope” to clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2022 and may be applied retrospectively to contract modifications and hedging relationships from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. Upon adoption of this standard, the Company does not expect it to have a material impact to the Company’s financial statements.

Note 4 – Acquisitions and Divestitures

Acquisition of Beckmann & Egle Industrieelektronik GmbH

On July 1, 2021, the Company acquired the medical business unit of Beckmann & Egle Industrieelektronik GmbH (“B&E”), a developer and manufacturer of electronic control units, for a purchase price of $2,827. The acquisition was accounted for as a business combination with the purchase price assigned to inventory, property and equipment and other intangible assets based on their estimated fair values as of the acquisition date. The pro forma effect of the B&E acquisition does not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented. The results of operations of B&E are reported within the Company’s Medical segment from the date of acquisition.

Divestiture of GPT

On October 1, 2019, the Company completed the sale of GPT for a nominal amount and recognized a $5,885 loss on sale for the year ended December 31, 2019, which is classified as Net loss on divestitures within the consolidated statements of income. During 2019, the Company also recognized impairment losses of $21,206 for its GPT assets held for sale. These impairment charges are classified as Impairment loss within the consolidated statements of income.

Acquisition of Stihler Electronic GmbH

On April 1, 2019, the Company acquired Stihler Electronic GmbH (“Stihler”), a leading developer and manufacturer of patient and blood temperature management systems, for a purchase price of $15,476, net of cash acquired and including $653 of contingent consideration that was paid upon achievement of a milestone during the year ended December 31, 2020. The results of operations of Stihler are reported within the Company’s Medical segment from the date of acquisition.

Divestiture of CSZ-IC

On February 1, 2019, the Company completed the sale of its environmental test equipment business, CSZ-IC and former Cincinnati Sub-Zero headquarters facility for total cash proceeds of $47,500. The Company recognized a $4,298 pre-tax gain on the sale of CSZ-IC for the year ended December 31, 2019 which is classified as Net loss on divestitures within the consolidated statements of income.

F-19


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 5 Restructuring

Manufacturing Footprint Rationalization

In September 2019, the Company committed to a restructuring plan (“Plan”) to improve the Company’s manufacturing productivity and rationalize its footprint. Under this Plan, the Company is relocating and consolidating certain automotive electronics manufacturing plants in North America and China.

During 2021, the Company completed the closures and relocation of its automotive electronics manufacturing operations from Burlington, Canada to Celaya, Mexico and from Longgang, Shenzhen, China to Bantian, Shenzhen, China. As of December 31, 2021, the electronics manufacturing in Acuña, Mexico continues to transition to Celaya, Mexico.

During the year ended December 31, 2021, the Company recognized restructuring expense of $1,303 for employee separation costs and $1,665 for other costs, primarily related to equipment move and set up costs.  

During the year ended December 31, 2020, the Company recognized restructuring expense of $(832) for employee separation costs and $1,019 for other costs, primarily related to accelerated depreciation and equipment move and set up costs. The net activity for the year ended December 31, 2020 was primarily related to a reduction in the estimates of previously recognized employee separation costs.      

During the year ended December 31, 2019, the Company recognized restructuring expense of $4,863 for employee separation costs, and $2,087 of other costs, primarily related to accelerated depreciation and fixed asset impairment.

The Company has recorded approximately $10,105 of restructuring expenses since the inception of this program and as of December 31, 2021, $943 remains accrued. Actions under the equity method. Intercompany accounts have been eliminated in consolidation. Certain reclassificationsPlan are expected to be substantially completed by the first half of prior year’s amounts have been made2022 and future expenses are expected to conformbe less than $1,000.           

Other Restructuring Activities

As part of the Company’s continued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the years ended December 31, 2021, 2020 and 2019, the Company recognized $889, $5,382 and $3,193 of employee separation costs, respectively, and $0, $234 and $2,776 of other related costs, respectively. These restructuring expenses were primarily associated with restructuring actions focused on the current year’s presentation. Notably, results from asset disposals during 2017 were reclassified from other incomerotation of our manufacturing footprint to best cost locations and the reduction of sales.global overhead costs.

Restructuring Expenses By Reporting Segment

Restructuring expense by reporting segment for the years ended December 31, 2021, 2020 and 2019 was as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Automotive

 

$

2,793

 

 

$

5,075

 

 

$

9,353

 

Medical

 

 

 

 

 

112

 

 

 

1,838

 

Corporate

 

 

1,064

 

 

 

616

 

 

 

1,728

 

Total

 

$

3,857

 

 

$

5,803

 

 

$

12,919

 

F-20


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Use of Estimates

The presentation ofIn preparing these consolidated financial statements, in conformity with generally accepted accounting principles in the United States of America requires management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and liabilities atexpenses. These estimates and assumptions are based on our historical experience, the dateterms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances that would require us to update such estimates and assumptions or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.

Segment Reporting

The Company has 2 reportable segments: Automotive and Medical.

The Automotive reporting segment is comprised of the financial statementsresults from our global automotive businesses, including the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems.

The Medical reporting segment is comprised of the reported amountsresults from the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of revenueshyper-hypothermia therapy in intensive care, normothermia in surgical procedures and expenses during the reporting period. Actual results could differ from those estimates.additional warming/cooling therapies utilized in acute care, ambulatory, clinics and home health.

Revenue Recognition

Revenue is recognized from agreements containing enforceable rights and obligations, when promised goods are delivered or services are completed, the price is fixed or determinable,completed. Taxes assessed by a governmental authority that are both imposed on and payment has been received or is collectable. The amount of revenue recognized is net of the Company’s obligation for returns, rebates, discounts, taxes, if any, collected from customers, and consideration that is paid to a customer, unless such payment is in exchange for a distinct good or service. The amount of revenue recognized from a contractconcurrent with a customer reflects the amount of consideration expected to be received in exchange for the transfer of goods or services.specific revenue-

Automotive Revenues

The Company sells automotive climate comfort solution, specialized automotive cable systems and automotive thermal convenience products under long-term supply agreements (“LTAs”) and, for arrangements that are less than one year in length, purchase orders. LTAs are multiple-year business awards to provide custom designed parts for a particular automotive vehicle program in quantities and at intervals of the customer’s choosing.  LTAs are often multiple-element agreements. The main element in LTAs are production parts; distinct promises from which the customer can benefit separately from other promises or elements in the contract. A second element in LTAs are production part purchase options that provide customers the ability to purchase additional parts at set prices in the future. Judgement is used to determine whether a production part purchase option represents a material right to the customer and should be accounted for as a separate performance obligation.  LTAs that provide customers with a purchase option discount incrementally higher than the range discounts typically given to automotive customers contain a material right. The magnitude of change in the year-over-year option prices and the total number of units expected to be ordered are important factors in the calculation of the option’s fair value and the allocation of transaction price.


F-13F-12


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 2 – Summaryproducing transaction, that are collected by the Company from a customer, are excluded from Product revenues. Shipping and handling fees billed to customers are included in Product revenues, while costs of Significant Accounting Policiesshipping and Basishandling are included in Cost of Presentation – (Continued)sales.

Automotive Revenues

The Company provides production parts to its customers under long-term supply agreements (“LTAs”). The duration of an LTA is generally consistent with the life cycle of a vehicle; however, an LTA does not reach the level of a performance obligation until Gentherm receives either a purchase order and/or a materials release from its customer for a specific number of production parts at a specified price, forat which point an enforceable contract exists. Revenue is recognized when control of the production parts is set at the point in timehas transferred to the customer exercises itsaccording to the terms of the contract, which typically occurs when the parts are shipped or delivered to the customer’s premises. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring production parts.

Certain LTAs provide for annual price reductions over the production life of the vehicle. Agreements that are determined to provide customers with purchase option discounts that would not be received without entering into the contract are considered to contain a material right (for example, a discount given to a customer that is incremental to the range of discounts typically given to that class of customer). The material right represents a purchase option that provides the customer with the ability to purchase additional production parts fromat a set price in the Company. A firm order, statingfuture and is accounted for as a separate performance obligation. Under these circumstances, each transfer of production parts under the numberLTA requires allocation of eachthe purchase price to the production part to be delivered, is an independent contract with a discrete transaction price. Revenues are allocated to production parts based onand the relative standalone selling prices observed on the LTAs. purchase option. As a practical alternative to estimating the standalone selling price of an option, that provides a customer with a material right, the Company allocates transaction price to optionsthe purchase option by reference to the production part volumes expected to be ordered and the consideration expected to be received. received over the life of the vehicle program.

The Company satisfies its obligationproduction part’s relative standalone selling price observed under the LTA is subtracted from the total amount of consideration expected to provide productbe received in exchange for transferring of parts under the current contract and the difference is allocated to the customer upon shipment.

When an option to purchase additional production parts in the future represents a material right, the customer effectively is paying Gentherm in advance for production parts each time it exercises the option by placing a firm order commitment. option. Revenue from options containing a material right areis recognized onwhen the basis of direct measurement ofamounts billed to the value ofcustomer for production parts transferred, to date relative tounder the total number of production parts expected to be delivered overLTA, is less than the life of the vehicle program. Judgement is required to determine the pattern and timing with which an option containing a material right is satisfied and the production part is transferred to a customer.

Industrial Revenues

Our industrial business unit generates revenue from the sale of products and services by our wholly-owned subsidiaries CSZ and GPT. Industrial business unit revenues and medical business unit revenues discussed below are reported within the Company’s industrial reportable segment (see Note 9). Industrial business unit customers commonly enter into multiple-element agreements for the purchase of products and services.  Installation services, for example, are separate and distinct performance obligations that are often included in contracts to purchase customized environmental test chambers. Depending on the application, delivery of an environmental test chamber or remote power generation system to the customer’s place of business can range from two weeks to nine months from commencement of the contract. Installation services, while reliant on the specifications and timing from the customer, rarely remain incomplete more than two months after delivery.

Revenues allocated to environmental test chambers or remote power systems are based on the stand alonestandalone selling price of products themselves. Judgement is used to determine the degree to which early pay discounts and other credits are utilized in the calculation of standalone selling price, and only included to the extent it is probable that a significant reversal of any incremental revenue will not occur.those production parts.

Medical Revenues are recognized at the point in time the chamber or power system is shipped to the customer. For contracts that also include a promise for installation, the portion of total transaction price allocated to the installation is recognized as revenue at the point in time the installation is complete.  

Revenues from our medicalpatient temperature management business unit are generated from the sale of products and equipment. Our medical products and equipment focus on body and blood temperature management. The Company sells medical products and equipment primarily through distributor and group purchasing organization agreements. These agreements allow member participants to the distributor or group purchasing organization to make purchases at discounted prices negotiated by the distributor or group purchasing organization. A rebate is incurred at the point in time a member participant purchases product covered under these types of agreements. Rebates are accounted for as variable consideration, using an expected value, probability weighted approach, based on the level of sales to the distributor and the time lag between the initial sale and the rebate claim in determining the transaction price of a contract. Revenue is recognized at the point in time the medical products or equipment is transferred to the customer.

Contract Balances

We record a receivable when revenue is recognized at the time of invoicing and unearned revenue when revenue is recognized subsequent to invoicing. For contracts where control of the goods or service is transferred to the customer over time, or whose terms require the customer to make milestone payments throughout the fulfillment period, the timing of revenue recognition is likely to differ from the timing of invoicing to customers.

F-14


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

The opening balance of our accounts receivable, net of allowance for doubtful accounts, was $185,058 as of January 1, 2018.

Most of Gentherm’s unearned revenue pertains to LTAs containing a material right. In the early periods of an LTA containing a material right, when payments collected from the customer are greater than the standalone selling price of the production parts, revenue associated with the material right is deferred. In future periods, when amounts collected from customers as payment is less than the standalone selling price of the production parts delivered, the deferred revenue is reversed into revenue. For LTAs containing a material right and, thus, the timing of revenue recognition is likely to differ from the timing of invoicing to customer, the aggregate amount of transaction price allocated to material rights that remained unsatisfied under LTAs as of December 31, 2018 was $1,597. We expect to recognize into revenue, 64% of this balance in 2019, and the remaining 19%, 10%, 4%, 3% in 2020, 2021, 2022 and 2023, respectively.

Gentherm often requires milestone payments for contracts to provide environmental test chambers or remote power systems to customers. Milestone payments do not provide the Company with a right to payment for the work completed to date and do not represent the satisfaction of a performance obligation. Milestone payments are deferred and reported within unearned revenue until construction is complete and the unit has been delivered or is installed. If the environmental test chamber contract includes a separate promise to provide installation services, any installation-related payments received from the customer are deferred until the point in time the installation is complete.

The total amount of unearned revenue associated with environmental chamber and remote power system contracts, including environmental chamber contracts that include a separate obligation to provide installation, that existed as of December 31, 2018 was $5,296.  Unearned revenue associated with environmental chamber and remote power system contracts is classified within Liabilities held for sale on the consolidated balance sheet at December 31, 2018 and within Accrued liabilities. See Note 15 to our consolidated financial statement for information about the assets and liabilities classified as held for sale. This entire balance is expected to be recognized into revenue during the next 12 months.

See Note 16 for information regarding the unearned revenue associated with these arrangements, including unearned revenue by segment and amounts recognized into revenue during the year ended December 31, 2018.

Payment terms for contracts with customers generally range from 30 to 120 days from the date of shipment of goods or completion of service or, if applicable, the scheduled milestone payment due date, and do not include components designed to provide customers with financing. For 2018, our revenues from sales to our three largest customers, Lear, Adient and Bosch Automotive were $181,000, $166,900 and $79,900, respectively, representing 17%, 16% and 8% of our total revenues, respectively.

Assets Recognized from the Costs to Obtain a Contract with a Customer

We recognizeThe Company has no material contract assets or contract liabilities as of December 31, 2021.

The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be realized for a period greater than one year. Total capitalized costs to obtain a contract were immaterial during 2018$1,946 and $1,805 as of December 31, 2021 and 2020, respectively. These amounts are recorded in Other non-current assets and are included in prepaid expensesbeing amortized into Product revenues over the expected production life of the applicable program. During the year ended December 31, 2021 and other assets2020, $174 and other non-current assets.$263, respectively, was amortized into Product revenues.

F-13


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Cash and Cash Equivalents and Restricted Cash

The Company considers all highly liquid investments purchased with original maturities of less than 90 days to be cash equivalents. Cash balances in individual banks may exceed the federally insured limit by the Federal Deposit Insurance Corporation.  The Company had cashCash and cash equivalents of $33,955$161,496 and $88,440$106,598 held in foreign jurisdictions as of December 31, 20182021 and 2017,2020, respectively. Restricted cash includes cash that is legally restricted as to use or withdrawal.

F-15


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 – Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

Disclosures About Fair Value of Financial Instruments

The carrying amounts of financial instruments comprising cash and cash equivalents, short-term investments, accounts receivable, notes receivable and accounts receivablepayable approximate fair value because of the short maturities of these instruments. The carrying amount of the Company’s U.S. Revolving Noterevolving credit note under the June 27, 2019 amended and restated credit agreement (“Credit Agreement”) approximates its fair value because interest charged on the loan balance is variable.  See Note 1114, “Fair Value Measurement,” for information about the techniques used to assess the fair value of financial assets and liabilities, including our fixed rate debt instruments.

Concentration of Credit Risk

Financial assets, which subject the Company to concentration of credit risk, consist primarily of cash equivalents, short-term investments, accounts receivable and accountsnotes receivable. Cash equivalents consist primarily of money market funds managed by major financial services companies. The credit risk for these cash equivalents is considered low. The Company does not require collateral from its customers. As of December 31, 2018, Lear,2021, the Company’s Automotive customers, Adient and Faurecia comprised 21%, 18%Lear both individually represented 22% and 9%18%, respectively, of the Company’s accounts receivable balance.  As of December 31, 2017, Lear,2020, Adient and Magna comprised 24%, 20% and 7% respectively,Lear both individually represented 18% of the Company’s accounts receivable balance.  These accounts

Accounts Receivable

Accounts receivable are currently in good standing.

Allowance for Doubtful Accounts

We record anstated at the invoiced amount, less allowance for doubtful accounts once exposurefor estimated amounts not expected to collection riskbe collected, and do not bear interest. The Company determines the allowances based on historical write-off experience by industry and regional economic data, current expectations of an accountfuture credit losses and historical cash discounts. The Company’s accounts receivables are continually assessed for collectability and any allowance is recorded based upon the age of outstanding receivables, historical payment experience and customer creditworthiness. We write-off accounts receivable is specifically identified. We analyze the length of time an account receivable is outstanding, as well as a customer’s payment history and ability to pay to determine the need to record an allowance for doubtful accounts.

Activity in thewhen they become uncollectible. The allowance for doubtful accounts was $1,399 and $1,161 as follows:of December 31, 2021 and 2020, respectively.  

 

  

December 31,

 

 

  

2018

 

 

2017

 

Balance at beginning of year

  

$

973

  

 

$

1,391

  

Additions charged to costs

  

 

1,005

  

 

 

1,239

  

Recoveries recognized in costs

  

 

(1,006

 

 

(1,708

Reclassified to assets held for sale

 

 

(96

)

 

 

 

Adjustment due to currency translation

  

 

(25

)

 

 

51

 

Balance at end of year

  

$

851

  

 

$

973

  

Primarily in the Asia-Pacific region, the Company receives bank notes from certain customers to settle trade receivables. The collection of such bank notes is included in operating cash flows based on the substance of the underlying transactions, which are operating in nature. Bank notes held by the Company are classified as notes receivable within other current assets. The Company may hold such bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash.

Inventory

The Company’s inventory is measured at the lower of cost or market, with cost being determinednet realizable value. Raw materials, components and consumables are measured using the first-in first-out basis. Raw materials, consumables and commodities are measured atweighted average cost of purchase and unfinishedmethod. Work-in-process and finished goods are measured at cost of production, using the weighted averagefirst-in first-out method. If the net realizable value expected on the reporting date is below cost, a write-down is recorded to adjust inventory to its net realizable value. We recognize a reserve for obsolete and slow movingslow-moving inventories based on estimates of future sales and an inventory item’s capacity to be repurposed for a different use. We consider the number of months supply on hand based on current planned requirements, uncommitted future projections and historical usage in estimating the inventory reserve.  Additional provisions are made for supplier claims for obsolete materials, prototype inventory, spare or customer service inventory and, for all periods other than at year-end, estimates for physical inventory adjustments.


F-16F-14


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

The following is a reconciliation of the changes in the inventory reserve:

 

  

December 31,

 

 

  

2018

 

 

2017

 

Balance at beginning of year

  

$

7,887

  

 

$

4,790

  

Expense

  

 

2,712

  

 

 

3,521

  

Inventory write off

  

 

(3,282

 

 

(726

Reclassified to assets held for sale

 

 

(899

)

 

 

 

Adjustment due to currency translation

  

 

(148

)

 

 

302

 

Balance at end of year

  

$

6,270

  

 

$

7,887

  

Property and Equipment

Property and equipment, including additions and improvements, are recorded at cost less accumulated depreciation. Expenditures for general repairs and maintenance are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded as operatingOperating income or expense.

Depreciation and amortization areis computed using the straight-line method. The estimated useful lives of the Company’s propertyProperty and equipment are as follows:

 

Asset Category

 

Useful Life

Buildings and building improvements

2 to 50 years

Plant and Equipment

 

1 to 2030 years

Plant and equipment

10 years

Production tooling

 

2 to 710 years

Leasehold improvements

 

Term of lease

Computer equipment and softwareInformation technology

 

1 to 105 years

Capital Leases

 

Term of lease

The Company recognized depreciation expense of $36,270, $32,224$29,622, $31,037 and $24,873$33,639 for the years ended December 31, 2018, 20172021, 2020 and 2016,2019, respectively.

Goodwill and Other Intangible Assets

Goodwill and other intangible assets recorded in conjunction with business combinations are based on the Company’s estimate of fair value, as of the date of acquisition.

The fair value and corresponding useful lives for acquired intangible assets are listed below as follows:

Asset Category

Useful Life

Customer relationships

8-15 years

Technology

2-10 years

Production Development Costs

5-10 years

Our business strategy largely centers on designing products based upon internally developed and purchased technology. When possible, we protect these technologies with patents. Our policy is to expense all costs associated with the development and issuance of new patents as incurred. Such costs are classified as research and development expenses in our consolidation statements of income.

F-17


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

Patents purchased as part of a business combination are capitalized based on their fair values.  Periodically, we review the recoverability and remaining lives of our capitalized patents, and if necessary, make adjustments to reported amounts, based upon unfavorable impacts from market conditions, the emergence of competitive technologies and changes in our projected business plans.

A total of $14,043, $12,425 and $12,675 in other intangible assets, including capitalized patent costs, were amortized in 2018, 2017 and 2016, respectively.

An estimate of intangible asset amortization by year, is as follows:

2019

  

$

10,464

  

2020

  

 

8,710

  

2021

  

 

7,887

  

2022

  

 

7,853

  

2023

  

 

7,853

  

Thereafter

  

 

13,619

  

Impairments of Long-Lived Assets, Other Intangible Assets and Goodwill

Whenever events or changes in circumstances indicate that it is more likely than not that a long-lived asset’s fair value, other intangible asset’s fair value or a reporting unit’s fair value is less than it’s carrying amount, the Company then compares the fair value of the long-lived asset, other intangible asset or reporting unit to the related net book value. If the net book value of a long-lived asset, other intangible asset or reporting unit exceeds its fair value, an impairment loss is recognized for the amount by which the carrying amount of the asset exceeds its fair value. The fair value of a long-lived asset, other intangible asset or reporting unit is estimated by analyzing internal inputs (level 3) to calculate forward values and discounting those values to the present value.

During 2018, Gentherm determined GPT and CSZ-IC met the held for sale criteria, described below, and recorded an impairment loss on assets held for sale, goodwill and other intangible assets of $2,190, $6,151 and $3,135, respectively. An impairment of long-lived assets, goodwill or other intangible assets did not occur during the periods ending December 31, 2017 and 2016, respectively.  

A roll forward of goodwill from December 31, 2016 to December 31, 2018 is as follows:

December 31, 2016

  

$

51,735

  

Goodwill arising from the acquisition of Etratech

 

 

14,881

 

Exchange rate impact

  

 

3,069

 

December 31, 2017

  

$

69,685

  

Reclassification to assets held for sale

 

 

(6,844

)

Impairment of goodwill

 

 

(6,151

)

Exchange rate impact

  

 

(1,379

)

December 31, 2018

  

$

55,311

 

Accrued Warranty Costs

The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions.  Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims.

F-18


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

The following is a reconciliation of the changes in accrued warranty costs for the reporting period:

 

 

December 31,

 

 

 

2018

 

 

2017

 

Balance at beginning of year

 

$

5,382

 

 

$

5,443

 

Warranty claims paid

 

 

(905

)

 

 

(979

)

Warranty expense for products shipped during the current period

 

 

2,678

 

 

 

3,162

 

Adjustments to warranty estimates from prior periods

 

 

(608

)

 

 

(2,655

)

Reclassification to liabilities held for sale

 

 

(1,884

)

 

 

 

Adjustment due to currency translation

 

 

(149

)

 

 

411

 

Balance at end of year

 

$

4,514

 

 

$

5,382

 

Tooling

The Company incurs costs related to tooling used in the manufacture of products sold to its customers. In some cases, the Company enters into contracts with its customers whereby the Company incurs the costs to design, develop and purchase tooling and is then reimbursed by the customer under a reimbursement contract. Tooling costs that will be reimbursed by customers are included in prepaid expenses and otherOther current assets in the accompanying consolidated balance sheets at the lower of accumulated cost or the customer reimbursable amount. Approximately $6,628As of December 31, 2021 and $6,9942020, the Company had $3,778 and $4,831, respectively, of reimbursable tooling was capitalized within prepaid expenses and other current assets as of December 31, 2018 and 2017, respectively.costs capitalized. Company-owned tooling is included in propertyProperty and equipment and depreciated over its expected useful life, generally two to seventen years. Management periodically evaluates the recoverability of tooling costs, based on estimated future cash flows, and makes provisions, where appropriate, for tooling costs that will not be recovered.

Goodwill and Other Intangible Assets

Goodwill and other intangible assets recorded in conjunction with business combinations are based on the Company’s estimate of fair value, as of the date of acquisition.

Amortization of other intangible assets is computed using the straight-line method. The fair value and corresponding useful lives for acquired intangible assets are listed below as follows:

Asset Category

Useful Life

Customer relationships

8 to 15 years

Technology

5 to 10 years

Product development costs

5 to 10 years

Trade names

Indefinite

Our business strategy largely centers on designing products based upon internally developed and purchased technology, and we protect certain technology with patents that have value to our business strategy. Our policy is to expense all costs associated with the

F-15


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

development and issuance of new patents as incurred. Such costs are classified as research and development expenses in the accompanying consolidated statements of income.

Impairments of Other Intangible Assets and Goodwill

Goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized.

The Company utilizes an income approach to estimate the fair value of a reporting unit and a market valuation approach to further support this analysis (level 3). The income approach is based on projected debt-free cash flow that is discounted to the present value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in our industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect a risk factor, if necessary. Other significant assumptions include terminal value growth rates and terminal value margin rates. While there are inherent uncertainties related to the assumptions used and to management’s application of these assumptions to this analysis, we believe that the income approach provides a reasonable estimate of the fair value of a reporting unit.

The Company performs its indefinite-lived intangible asset impairment assessment annually as of December 31, and between annual assessments if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.

Investments in non-consolidated affiliates

During 2021, the Company’s Automotive segment invested $5,200 for an ownership interest in Carrar Ltd. (“Carrar”), an Israel-based technology developer of advanced thermal management systems for the electric mobility market. The Company determined that Carrar is a VIE; however, the Company does not have a controlling financial interest or have the power to direct the activities that most significantly affect the economic performance of the investment. Therefore, the Company has concluded that it is not the primary beneficiary. Gentherm’s investment in Carrar is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

During 2021, the Company’s Automotive segment invested $2,357 for an ownership interest in Forciot Oy (“Forciot”), a technology developer of sensors for touch, motion and force measurement. Gentherm’s investment in Forciot is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

In December 2021, the Company committed to make a $5,000 investment in Autotech Fund III, L.P., pursuant to a limited partnership agreement. As a limited partner, the Company will periodically make capital contributions toward this total commitment amount over the expected ten year life of the fund. The Company has not made any contributions to the Autotech Fund III, LP as of December 31, 2021. This fund focuses broadly on the automotive industry and compliments the Company’s innovation strategy.

Research and Development Expenses

Research and development activities are expensed as incurred. The Company groups development and prototype costs and related reimbursements in research and development.  

F-16


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Leases

The Company has operating leases for office, manufacturing and research and development facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. We also have operating leases for office equipment and automobiles. Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 10 years and may include options to extend the lease.  Land leases have remaining lease terms that range from 39 to 41 years and some which specify that the end of the lease term is at the discretion of the lessee. We do not have lease arrangements with related parties.

The Company determines whether a contractual arrangement is or contains a lease at inception. Leases that are operating in nature are recognized in Operating lease right-of-use assets, Current lease liabilities and Non-current lease liabilities in the accompanying consolidated balance sheets. Gentherm is not currently party to any leases that qualify as financing leases.

Lease liabilities are measured initially at the present value of the sum of the future minimum rental payments at the commencement date of the lease. Lease payments that will vary in the future due to changes in facts and circumstances are excluded from the calculation of rental payments, unless those variable payments are based on an index or rate. Rental payments are discounted using an incremental borrowing rate, unless there is a rate implicit in the lease agreement. The incremental borrowing rate is based on the Company’s credit rating, determined on a fully collateralized loan basis from information available at commencement date, and the duration of the lease term (the “reference rate”). Judgement is used to assess the importance of risk factor inputs during the computation of the Company’s credit rating. For leases at foreign subsidiaries denominated in U.S. Dollars, a risk premium associated with the borrower subsidiary’s country is added to the reference rate. For significant leases at foreign subsidiaries denominated in a foreign currency, the U.S. Dollar risk free rate with a duration similar to that of the lease term is subtracted from the reference rate and a corresponding foreign currency risk free rate with a duration similar to that of the lease term is added to the reference rate.

Operating lease right-of-use assets are measured at the amount of the lease liability, adjusted for prepaid or accrued lease payments, lease incentive received, and initial direct costs incurred, as applicable. Periods covered by an option to extend the lease are initially included in the measurement of an operating lease right-of-use asset and lease liability only when it is reasonably certain we will exercise the option. Gentherm’s lease agreements do not contain residual value guarantees or impose restrictions or covenants on the Company.  

For all classes of underlying assets, the Company accounts for leases that contain separate lease and non-lease components as containing a single lease component. The Company does not recognize lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less and, instead, recognizes amounts due as reimbursements for expenses as these expenses are incurred.  rent payments on a straight-line basis over the lease term in the consolidated statements of income.

Income Taxes

The Company records income tax expense using the liability method which specifies that deferred tax assets and liabilities be measured each year based on the difference between the financial statement and tax base of assets and liabilities at the applicable enacted tax rates. A valuation allowance is provided for deferred tax assets when management considers it more likely than not that the asset will not be realized. At December 31, 20182021 and 2017,2020, a valuation allowance has been provided for certain deferred tax assets which the Company has concluded are more likely than not to not be realized.  If future annual taxable income were to be significantly less than current and projected levels, there is a risk that certain of our deferred tax assets not already provided for by the valuation allowance would expire prior to utilization.

F-17


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The Company recognizerecognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in incomeIncome tax expense.

F-19


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

Derivative Financial Instruments – Hedge Accounting

The Company accounts for some of its derivative financial instruments as cash flow hedges as defined in Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 815.hedges. For derivative contracts which can be classifiedare designated as a cash flow hedge, the effective potionportion of the change in the fair value of the derivative contract is recorded to accumulatedAccumulated other comprehensive incomeloss (“AOCI”) in the accompanying consolidated balance sheet.sheets.  When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive incomeAOCI is recorded ininto earnings in the accompanying consolidated statementstatements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.  Any ineffective portion of the gain or loss is recognized in the accompanying consolidated statements of income statement under Foreign currency gain (loss) for foreign currency (loss) gain or revaluationderivatives, and cost of derivatives gain (loss).goods sold for commodity derivatives. These hedging transactions and the respective correlations meet the requirements for hedge accounting.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted average number of shares of Common Stockcommon stock outstanding during the respective period. The Company’s diluted earnings per common share give effect to all potential shares of Common Stockcommon stock outstanding during a period that aredo not anti-dilutive.have an anti-dilutive impact to the calculation. In computing the number of diluted shares outstanding, the treasury stock method is used in order to arrive at a net number of shares created upon the conversion of Common Stockcommon stock equivalents.

Stock Based Compensation

Share based payments that involve the issuance of Common Stockcommon stock to employees, including grants of employee stock options, restricted stock, and time-based and performance-based restricted stock units, are recognized in the consolidated financial statements as compensation expense based upon the fair value on the date of grant.  Performance-based restricted stock unit awards are measured based on either a target return on invested capital ratio (“ROIC”), as defined in the award agreement, for a specified fiscal year, or the Company’s common stock market price returning a target total shareholder return (“TSR”), as defined, during a specific three-year measurement period. Upon achievement of the performance measurement, performance based restricted stock units vest over a three-year period.

Share based payments that are satisfied only by the payment of cash, such as stock appreciation rights, are accounted for as liabilities. The liability is reported at market value of the vested portion of the underlying units. During each period, the change in the liability is recorded as compensation expense during periods whenexpense.

Note 3 — New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the liability increases orFASB issued ASU No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes". This ASU simplifies the accounting for income during periodstaxes by removing certain exceptions previously included in which the liability decreases.

guidance. In addition, the ASU amends existing guidance to improve consistent application. The Company’s stock-based compensation expenseCompany adopted ASU 2019-12 as of January 1, 2021 and there was no significant impact on its financial statements and related deferred tax benefit were $12,177disclosures as a result.

F-18


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and $2,434, respectively,per share data)

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting”. ASU 2020-04 provides practical expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued as a result of reference rate reform. These amendments are not applicable to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. In January 2021, the FASB subsequently issued ASU 2021-01, “Reference Rate Reform (Topic 848): Scope” to clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2022 and may be applied retrospectively to contract modifications and hedging relationships from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. Upon adoption of this standard, the Company does not expect it to have a material impact to the Company’s financial statements.

Note 4 – Acquisitions and Divestitures

Acquisition of Beckmann & Egle Industrieelektronik GmbH

On July 1, 2021, the Company acquired the medical business unit of Beckmann & Egle Industrieelektronik GmbH (“B&E”), a developer and manufacturer of electronic control units, for a purchase price of $2,827. The acquisition was accounted for as a business combination with the purchase price assigned to inventory, property and equipment and other intangible assets based on their estimated fair values as of the acquisition date. The pro forma effect of the B&E acquisition does not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented. The results of operations of B&E are reported within the Company’s Medical segment from the date of acquisition.

Divestiture of GPT

On October 1, 2019, the Company completed the sale of GPT for a nominal amount and recognized a $5,885 loss on sale for the year ended December 31, 2018, $12,7272019, which is classified as Net loss on divestitures within the consolidated statements of income. During 2019, the Company also recognized impairment losses of $21,206 for its GPT assets held for sale. These impairment charges are classified as Impairment loss within the consolidated statements of income.

Acquisition of Stihler Electronic GmbH

On April 1, 2019, the Company acquired Stihler Electronic GmbH (“Stihler”), a leading developer and $4,339, respectively,manufacturer of patient and blood temperature management systems, for a purchase price of $15,476, net of cash acquired and including $653 of contingent consideration that was paid upon achievement of a milestone during the year ended December 31, 2020. The results of operations of Stihler are reported within the Company’s Medical segment from the date of acquisition.

Divestiture of CSZ-IC

On February 1, 2019, the Company completed the sale of its environmental test equipment business, CSZ-IC and former Cincinnati Sub-Zero headquarters facility for total cash proceeds of $47,500. The Company recognized a $4,298 pre-tax gain on the sale of CSZ-IC for the year ended December 31, 2017,2019 which is classified as Net loss on divestitures within the consolidated statements of income.

F-19


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and $8,147per share data)

Note 5 Restructuring

Manufacturing Footprint Rationalization

In September 2019, the Company committed to a restructuring plan (“Plan”) to improve the Company’s manufacturing productivity and $2,891, respectively,rationalize its footprint. Under this Plan, the Company is relocating and consolidating certain automotive electronics manufacturing plants in North America and China.

During 2021, the Company completed the closures and relocation of its automotive electronics manufacturing operations from Burlington, Canada to Celaya, Mexico and from Longgang, Shenzhen, China to Bantian, Shenzhen, China. As of December 31, 2021, the electronics manufacturing in Acuña, Mexico continues to transition to Celaya, Mexico.

During the year ended December 31, 2021, the Company recognized restructuring expense of $1,303 for employee separation costs and $1,665 for other costs, primarily related to equipment move and set up costs.  

During the year ended December 31, 2020, the Company recognized restructuring expense of $(832) for employee separation costs and $1,019 for other costs, primarily related to accelerated depreciation and equipment move and set up costs. The net activity for the year ended December 31, 2016.2020 was primarily related to a reduction in the estimates of previously recognized employee separation costs.      

Pension PlansDuring the year ended December 31, 2019, the Company recognized restructuring expense of $4,863 for employee separation costs, and $2,087 of other costs, primarily related to accelerated depreciation and fixed asset impairment.

The Company has recorded approximately $10,105 of restructuring expenses since the inception of this program and as of December 31, 2021, $943 remains accrued. Actions under the Plan are expected to be substantially completed by the first half of 2022 and future expenses are expected to be less than $1,000.           

Other Restructuring Activities

As part of the Company’s obligationscontinued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the years ended December 31, 2021, 2020 and 2019, the Company recognized $889, $5,382 and $3,193 of employee separation costs, respectively, and $0, $234 and $2,776 of other related costs, respectively. These restructuring expenses for its pension plans are dependentwere primarily associated with restructuring actions focused on the Company’s selectionrotation of discount rate, expected long-term rateour manufacturing footprint to best cost locations and the reduction of return on plan assetsglobal overhead costs.

Restructuring Expenses By Reporting Segment

Restructuring expense by reporting segment for the years ended December 31, 2021, 2020 and other assumptions used by actuaries to calculate these amounts.2019 was as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Automotive

 

$

2,793

 

 

$

5,075

 

 

$

9,353

 

Medical

 

 

 

 

 

112

 

 

 

1,838

 

Corporate

 

 

1,064

 

 

 

616

 

 

 

1,728

 

Total

 

$

3,857

 

 

$

5,803

 

 

$

12,919

 


F-20


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation – (Continued)

Assets and Liabilities Held for SaleRestructuring Liability

The Company classifies assetsfollowing table summarizes restructuring activity for all restructuring initiatives for the years ended December 31, 2021 and liabilities (disposal groups) to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the disposal group; the disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such disposal groups; an active program to locate a buyer and other actions required to complete the plan to sell the disposal group have been initiated; the sale of the disposal group is probable, and transfer of the disposal group is expected to qualify as a completed sale within one year, except if events or circumstances beyond the Company’s control extend the period of time required to sell the disposal group beyond one year; the disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.2020:

 

 

Employee Separation Costs

 

 

Other Related Costs

 

 

Total

 

 

 

Balance at December 31, 2019

 

$

5,994

 

 

$

71

 

 

$

6,065

 

 

 

Additions, charged to restructuring expenses

 

 

6,932

 

 

 

1,271

 

 

 

8,203

 

 

 

Change in estimate

 

 

(2,382

)

 

 

(18

)

 

 

(2,400

)

 

 

Cash payments

 

 

(5,052

)

 

 

(757

)

 

 

(5,809

)

 

 

Non-cash utilization

 

 

 

 

 

(687

)

 

 

(687

)

 

 

Currency translation and other

 

 

135

 

 

 

120

 

 

 

255

 

 

 

Balance at December 31, 2020

 

$

5,627

 

 

$

 

 

$

5,627

 

 

 

Additions, charged to restructuring expenses

 

 

2,406

 

 

 

1,927

 

 

 

4,333

 

 

 

Change in estimate

 

 

(214

)

 

 

(262

)

 

 

(476

)

 

 

Cash payments

 

 

(6,129

)

 

 

(1,709

)

 

 

(7,838

)

 

 

Non-cash utilization

 

 

 

 

 

(218

)

 

 

(218

)

 

 

Currency translation and other

 

 

(196

)

 

 

262

 

 

 

66

 

 

 

Balance at December 31, 2021

 

$

1,494

 

 

$

 

 

$

1,494

 

 

 

The Company initially measures a disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Gains are not recognized on the sale of a disposal group until the date of sale. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent losses as an adjustment to the carrying value of the disposal group.

The Company reports assets and liabilities of the disposal group in the line items assets held for sale and liabilities held for sale in the Consolidated Balance Sheet in the period the disposal group meets the criteria to be classified as held for sale. See Note 15 to our consolidated financial statement for information about the assets and liabilities classified as held for sale.

Subsequent Events

We have evaluated subsequent events through the date that our consolidated financial statements are issued. On February 1, 2019, we completed the sale of CSZ-IC and the CSZ headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47,500.

F-21


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 36 — Details of Certain Financial Statement Components

 

  

December 31,

 

 

  

2018

 

 

2017

 

Inventory:

  

 

 

 

 

 

 

 

Raw materials, net of reserve

  

$

61,679

  

 

$

64,175

  

Work in process, net of reserve

  

 

5,939

  

 

 

16,139

  

Finished goods, net of reserve

  

 

44,917

  

 

 

41,095

  

 

  

$

112,535

  

 

$

121,409

  

Property and equipment:

  

 

 

 

 

 

 

 

Buildings, plant and equipment

  

$

213,257

  

 

$

213,329

  

Automobiles

  

 

1,180

  

 

 

1,281

  

Production tooling

  

 

15,526

  

 

 

16,540

  

Leasehold improvements

  

 

10,320

  

 

 

15,263

  

Computer equipment and software

  

 

26,381

  

 

 

27,880

  

Construction in progress

  

 

3,421

  

 

 

9,405

  

 

  

 

270,085

  

 

 

283,698

  

Less: Accumulated depreciation

  

 

(98,705

)

 

 

(83,404

)

 

  

$

171,380

  

 

$

200,294

  

Other intangible assets:

  

 

 

 

 

 

 

 

Customer relationships

  

$

87,316

  

 

$

101,213

  

Technology

  

 

39,167

  

 

 

47,641

  

Product development costs

  

 

11,100

  

 

 

12,054

  

 

  

$

137,583

  

 

$

160,908

  

Less: Accumulated amortization

  

 

(81,198

)

 

 

(77,622

)

 

  

$

56,385

 ��

 

$

83,286

  

Accrued liabilities:

  

 

 

 

 

 

 

 

Tax accruals

  

$

6,468

  

 

$

16,169

  

Accrued warranty

  

 

4,514

  

 

 

5,382

  

Accrued employee liabilities

  

 

25,449

  

 

 

25,503

  

Liabilities from discounts and rebates

  

 

16,907

  

 

 

16,057

  

Other accrued liabilities

  

 

12,470

  

 

 

14,098

  

 

  

$

65,808

  

 

$

77,209

  

 

 

December 31,

 

 

 

2021

 

 

2020

 

Inventory:

 

 

 

 

 

 

 

 

Raw materials, net of reserve

 

$

96,426

 

 

$

68,362

 

Work in process, net of reserve

 

 

9,495

 

 

 

8,247

 

Finished goods, net of reserve

 

 

53,556

 

 

 

45,792

 

Total inventory, net

 

$

159,477

 

 

$

122,401

 

Other current assets:

 

 

 

 

 

 

 

 

Notes receivable

 

$

13,033

 

 

$

19,200

 

Income tax and other tax receivable

 

 

10,681

 

 

 

10,514

 

Billable tooling

 

 

3,778

 

 

 

4,831

 

Prepaid expenses

 

 

3,407

 

 

 

3,930

 

Other

 

 

1,876

 

 

 

2,713

 

Total other current assets

 

$

32,775

 

 

$

41,188

 

Property and equipment:

 

 

 

 

 

 

 

 

Machinery and equipment

 

$

155,463

 

 

$

142,833

 

Buildings and improvements

 

 

100,788

 

 

 

99,011

 

Information technology

 

 

33,060

 

 

 

30,338

 

Production tooling

 

 

25,180

 

 

 

22,783

 

Leasehold improvements

 

 

11,445

 

 

 

11,762

 

Construction in progress

 

 

14,506

 

 

 

8,968

 

Total property and equipment

 

 

340,442

 

 

 

315,695

 

Less: accumulated depreciation

 

 

(185,172

)

 

 

(163,114

)

Total property and equipment, net

 

$

155,270

 

 

$

152,581

 

Other current liabilities:

 

 

 

 

 

 

 

 

Accrued employee liabilities

 

$

28,818

 

 

$

26,612

 

Liabilities from discounts and rebates

 

 

27,343

 

 

 

22,910

 

Income tax and other taxes payable

 

 

17,068

 

 

 

14,714

 

Restructuring

 

 

1,494

 

 

 

5,627

 

Accrued warranty

 

 

1,916

 

 

 

2,391

 

Other

 

 

5,554

 

 

 

9,155

 

Total other current liabilities

 

$

82,193

 

 

$

81,409

 

 

Note 4 7 Income TaxesGoodwill and Other Intangibles

U.S. Tax ReformGoodwill

AsChanges in the carrying amount of goodwill, by reportable segment, for the years ended December 31, 2017, the Company had not completed its accounting for the tax effects of the Tax Cuts2021 and Jobs Act (Tax Act); however, in accordance with guidance provided by Staff Accounting Bulletin No. 118 (SAB 118), the Company made a provisional estimate of $20,153 for the effects on our existing deferred tax balances, the one-time transition tax and our indefinite reinvestment assertion regarding foreign subsidiary earnings.  The measurement period begins in the reporting period that includes the Tax Act’s enactment date, which was December 22, 2017, and ends when the additional information is obtained, prepared, or analyzed to complete the accounting requirements under ASC Topic 740.  The measurement periods should not extend beyond one year from the enactment date.2020 were as follows:

 

 

Automotive

 

 

Medical

 

 

Total

 

December 31, 2019

 

$

36,938

 

 

$

27,634

 

 

$

64,572

 

Exchange rate impact

 

 

2,557

 

 

 

895

 

 

 

3,452

 

Balance as of December 31, 2020

 

$

39,495

 

 

$

28,529

 

 

$

68,024

 

Acquisition of B&E

 

 

 

 

 

976

 

 

 

976

 

Exchange rate impact

 

 

(2,166

)

 

 

(801

)

 

 

(2,967

)

Balance as of December 31, 2021

 

$

37,329

 

 

$

28,704

 

 

$

66,033

 

 

F-22


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 4 Income Taxes – (Continued)

As of December 31, 2018, the Company evaluated the provisional amounts initially recorded for the year ended December 31, 2017Other Intangible Assets

Other intangible assets and recorded adjustments based on updates to the Company’s assumptions and the application of additional interpretative guidance as issued during 2018.  The adjustments are primarily a result of refining the net deferred tax asset position with the completion of our 2017 U.S. income tax return and changing tax accounting methods that affected the timing of certain US tax deductions.  These adjustments resulted in (i) a decrease in our existing deferred tax assetaccumulated amortization balances which resulted in an income tax expense of $4,950 and (ii) a net increase to the one-time transition tax which resulted in an income tax expense of $24,625.  No adjustment was required to the $9,578 tax benefit included in the provision for income taxes as of December 31, 2017 to offset2021 and 2020 were as follows:

 

 

Gross

Carrying Value

 

 

Accumulated

Amortization

 

 

Net Carrying

Value

 

Definite-lived:

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

90,448

 

 

$

(64,105

)

 

$

26,343

 

Technology

 

 

29,464

 

 

 

(24,487

)

 

 

4,977

 

Product development costs

 

 

20,329

 

 

 

(19,772

)

 

 

557

 

Software development

 

 

1,007

 

 

 

 

 

 

1,007

 

Indefinite-lived:

 

 

 

 

 

 

 

 

 

 

 

 

Tradenames

 

 

4,670

 

 

 

 

 

 

4,670

 

Balance as of December 31, 2021

 

$

145,918

 

 

$

(108,364

)

 

$

37,554

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

Carrying Value

 

 

Accumulated

Amortization

 

 

Net Carrying

Value

 

Definite-lived:

 

 

 

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

97,815

 

 

$

(63,432

)

 

$

34,383

 

Technology

 

 

30,615

 

 

 

(24,075

)

 

 

6,540

 

Product development costs

 

 

22,164

 

 

 

(21,336

)

 

 

828

 

Indefinite-lived:

 

 

 

 

 

 

 

 

 

 

 

 

Tradenames

 

 

4,670

 

 

 

 

 

 

4,670

 

Balance as of December 31, 2020

 

$

155,264

 

 

$

(108,843

)

 

$

46,421

 

In connection with the one-time transition tax related toacquisition of B&E, the previous deferred tax liability that existedCompany recorded technology of $976. These definite-lived assets are being amortized using the straight-line method over their estimated useful lives of approximately seven years.

On February 28, 2020, Gentherm acquired the automotive patents and technology of a development-stage technology company for $3,141. The investment was accounted for as an asset acquisition of defensive intangible assets and will be amortized over six years.

On June 19, 2020, Gentherm sold patents from a non-core business for $2,055.  The gain on sale of $1,978 was recorded in Other income in the undistributed foreign earnings thatconsolidated statements of income.

A total of $8,821, $9,226 and $10,068 in other intangible assets were not permanently reinvested. As of December 31, 2018, the total income tax expense was $19,997 for the year ended December 31, 2017, as compared to the provisionalamortized in 2021, 2020 and 2019, respectively.

An estimate of $20,153. In accordance with the Security and Exchange Commission’s Staff Accounting Bulletin No. 118 (SAB 118), at December 31, 2018, the Company had completed its accounting for the tax effects of the Tax Act.other intangible asset amortization by year, is as follows:

The deferred tax assets and deferred tax liabilities and related valuation allowance were comprised of the following:

2022

 

$

7,929

 

2023

 

$

4,752

 

2024

 

$

3,692

 

2025

 

$

3,678

 

2026

 

$

3,261

 

   

 

  

December 31,

 

 

  

2018

 

 

2017

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

 

7,666

 

 

 

12,731

 

Intangible assets

 

 

42,853

 

 

 

 

Research and development credits

 

 

8,211

 

 

 

27,257

 

Depreciation

 

 

6,321

 

 

 

5,571

 

Valuation reserves and accrued liabilities

 

 

4,849

 

 

 

6,020

 

Foreign tax credit

 

 

376

 

 

 

 

Stock compensation

 

 

4,128

 

 

 

3,955

 

Inventory

 

 

1,069

 

 

 

2,062

 

Patents

 

 

150

 

 

 

163

 

Defined benefit obligation

 

 

1,796

 

 

 

1,977

 

Other credits

 

 

1,291

 

 

 

589

 

Unrealized foreign currency exchange loss

 

 

 

 

 

2,556

 

Other

 

 

2,499

 

 

 

36

 

 

 

 

81,209

 

 

 

62,917

 

Valuation allowance

 

 

(9,977

)

 

 

(27,578

)

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Intangible assets

 

 

 

 

 

(2,925

)

Unrealized foreign currency exchange gains

 

 

(554

)

 

 

 

Undistributed profits of subsidiary

 

 

(4,352

)

 

 

(6,450

)

Property and equipment

 

 

(2,896

)

 

 

(1,611

)

Other

 

 

(583

)

 

 

(548

)

 

 

 

(8,385

)

 

 

(11,534

)

Net deferred tax asset

 

$

62,847

 

 

$

23,805

 

F-23


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 4 8 Income Taxes – (Continued)Leases

Reconciliations between the statutory Federal income tax rateComponents of 21% and 34% and the effective rate of income taxlease expense for each of the three years in the period ended December 31, 2018 are2021, 2020 and 2019 were as follows:

 

  

Year Ended December 31,

 

 

  

2018

 

 

2017

 

 

2016

 

Statutory Federal income tax rate

  

 

21.0

%

 

 

34.0

%

 

 

34.0

%

Increase (Decrease) resulting from:

  

 

 

 

 

 

 

 

 

 

 

 

U.S. Taxes on foreign income, net of taxes paid credit

  

 

 

 

 

 

 

 

1.3

%

Change in valuation allowance

  

 

(6.6

%)

 

 

10.6

%

 

 

5.3

%

Foreign, state and local tax, net of Federal benefit

  

 

1.8

%

 

 

0.8

%

 

 

1.1

%

Nondeductible expenses

  

 

3.4

%

 

 

2.4

%

 

 

2.4

%

Stock option compensation

  

 

 

 

 

(2.2

%)

 

 

 

Research and development credits

  

 

(2.5

%)

 

 

(4.6

%)

 

 

(0.7

%)

Effect of different tax rates of foreign jurisdictions

  

 

(6.6

%)

 

 

(20.8

%)

 

 

(15.0

%)

Undistributed profits of subsidiaries

  

 

1.2

%

 

 

5.8

%

 

 

7.9

%

Tax reform items

  

 

10.8

%

 

 

29.1

%

 

 

 

Other tax exempt income

  

 

 

 

 

 

 

 

 

Tax effects of intercompany transfers

  

 

0.8

%

 

 

(5.0

%)

 

 

(5.3

%)

Other

  

 

4.6

%

 

 

(1.0

%)

 

 

(0.3

%)

Effective rate

  

 

27.9

%

 

 

49.1

%

 

 

30.7

%

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Lease cost:

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease cost

 

$

8,227

 

 

$

6,773

 

 

$

5,899

 

Short-term lease cost

 

 

1,941

 

 

 

1,834

 

 

 

3,444

 

Sublease income

 

 

(163

)

 

 

(158

)

 

 

(128

)

Total lease cost

 

$

10,005

 

 

$

8,449

 

 

$

9,215

 

 

The Company has Net Operating Loss (“NOL”) carryforwardsOther information related to leases is as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

 

 

Operating cash flows for operating leases

 

$

7,685

 

 

$

6,817

 

Right-of-use lease assets obtained in exchange for lease obligations:

 

 

 

 

 

 

 

 

Operating leases

 

$

2,379

 

 

$

25,161

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

December 31, 2020

 

Weighted average remaining lease term:

 

 

 

 

 

 

 

 

Operating leases

 

6.9 years

 

 

5.4 years

 

Weighted average discount rate:

 

 

 

 

 

 

 

 

Operating leases

 

 

4.53

%

 

 

4.65

%

 

Jurisdiction

  

Amount as of
December 31, 2018

 

  

Years of Expiration

 

U.S. Federal and state income tax

  

$

80,337

 

 

 

2019- 2037

  

Foreign

 

$

15,912

 

 

 

2019- 2038

 

Foreign

  

$

5,776

 

 

 

Indefinite

  

A portionsummary of the U.S. Federal NOLs was incurred prior to the June 8, 1999 Preferred Financing, which qualified as a change in ownership under Section 382 of the Internal Revenue Code (“IRC”). Due to this change in ownership, the NOL accumulated prior to the change in control can only be utilized against current earnings up to a maximum annual limitation of approximately $591. As a result of the annual limitation, approximately $2,191 remaining of these carryforwards are expected to expire before ultimately becoming available to reduce future tax liabilities in addition to $17,158 in NOLs generated prior to the change in control which have already expired without being utilized.

We have incurred NOLs in various states associated with the benefits of the state dividends received reduction along with the foreign royalty exclusion.  The state net operating loss carryforwards expire at various dates from 2019 to 2037. Management has concluded that it is more likely than not that a majority of these NOLs will not be utilized, and thus has not recognized the benefit of these NOLs.

At December 31, 2018, certain non-U.S. subsidiaries have net operating loss carryforwards totaling $21,688. This amount includes $15,912 in NOLs that expire at various dates from 2019 through 2038 and the remaining $5,776 have no expiration date. The Company has a valuation allowance recorded against $5,746 of the total non-U.S. subsidiaries’ net operating loss carryforwardsleases as of December 31, 2018. In 2014 through 2018, we incurred NOLs in Vietnam associated2021, under all non-cancellable operating leases with the startup activities of new production facilities. The remaining NOLs are expected to be utilized in 2019 through 2020terms exceeding one year is as the locations maintain profitability. We also incur NOLs in Luxembourg associated with our foreign holding company legal structure. Management has concluded that it is more likely than not these NOLs will not be utilized, and thus has not recognized the benefit of these NOLs.follows:

.

2022

 

$

6,541

 

2023

 

 

4,664

 

2024

 

 

4,200

 

2025

 

 

3,783

 

2026

 

 

2,945

 

2027 or later

 

 

7,538

 

Total future minimum lease payments

 

 

29,671

 

Less imputed interest

 

 

(4,213

)

Total

 

$

25,458

 

F-24


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 4 9 Income Taxes – (Continued)

On January 1, 2017, the Company adopted Accounting Standards Update (“ASU”) 2016-09, “Improvements to Employee Share-Based Payment Accounting.”  Under the new standard, income tax benefits and deficiencies are recognized as an income tax expense or benefit in the income statement and the tax effects of exercised or vested awards should be treated as discrete items in the period they occur.  The update also requires the Company to recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period. The standard also required a modified retrospective adoption for previously unrecognized excess tax benefits.  Accordingly, the Company recognized a deferred tax asset and a corresponding credit to retained earnings equal to $1,496 in conjunction with the adoption.  The effects of adopting the other provisions of ASU 2016-09 resulted in approximately 2% reduction of the effective tax rate during 2017. Debt  

The earnings before income taxes and our tax provision are comprised offollowing table summarizes the following:

 

  

Year Ended December 31,

 

 

  

2018

 

  

2017

 

  

2016

 

Income before income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

10,092

 

 

$

1,258

 

 

$

12,981

 

Foreign

 

 

48,027

 

 

 

67,997

 

 

 

97,582

 

Total income before income taxes

 

$

58,119

 

 

$

69,255

 

 

$

110,563

 

 

  

Year Ended December 31,

 

 

  

2018

 

 

2017

 

 

2016

 

Current income tax expense (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

340

 

 

$

4,140

 

 

$

9,215

 

State and local

 

 

(71

)

 

 

150

 

 

 

749

 

Foreign

 

 

9,224

 

 

 

24,672

 

 

 

32,844

 

Total current income tax expense

 

$

9,493

 

 

$

28,962

 

 

$

42,808

 

Deferred income tax expense (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(1,422

)

 

$

15,207

 

 

$

(10,597

)

State and local

 

 

20

 

 

 

2,308

 

 

 

(742

)

Foreign

 

 

8,129

 

 

 

(12,449

)

 

 

2,496

 

Total deferred income tax expense

 

$

6,727

 

 

$

5,066

 

 

$

(8,843

)

Total tax expense

 

$

16,220

 

 

$

34,028

 

 

$

33,965

 

AsCompany’s debt as of December 31, 2018 the previously recognized deferred taxes related to earnings from foreign subsidiaries has been reversed since all of these earnings are subject to the one-time transition tax2021 and are not taxable upon repatriation to the United States.  However, the Company continues to provide a deferred tax liability for foreign withholding tax that will be incurred with respect to the undistributed foreign earnings that are not permanently reinvested.

The Company is subject to taxation in the United States and various state and foreign jurisdictions. As of December 31, 2018, the Company is no longer subject to U.S. Federal examinations by tax authorities for tax years before 2014 and is no longer subject to foreign examinations by tax authorities for tax years before 2012.

During 2015, to entice the Company to construct a new facility in Macedonia, the government of Macedonia granted the Company a tax holiday that released the Company from the obligation to pay corporate income taxes for a ten year period, subject to certain limitations.  The amount of corporate income tax savings realized by the Company as a result of this tax holiday during 2018 and 2017, respectively, was zero as a result of operating losses generated during each period. The aggregate dollar effect and per share effect of the corporate income tax holiday during 2018 and 2017 was, therefore, immaterial.

F-25


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 4 Income Taxes – (Continued)

At December 31, 2018, 2017 and 2016, the Company had total unrecognized tax benefits of $2,854, $4,522 and $4,486, respectively, all of which, if recognized, would affect the effective income tax rates. The reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

2020:

 

  

Year Ended December 31, 

 

 

  

2018

 

  

2017

 

2016

 

Balance at beginning of year

 

$

4,522

 

 

$

4,486

 

$

4,443

 

Additions based on tax position related to current year

 

 

221

 

 

 

1,758

 

 

80

 

Additions based on tax positions related to prior year

 

 

458

 

 

 

4

 

 

366

 

Reductions from settlements and statute of limitation expiration

 

 

(2,179

)

 

 

(2,247

)

 

(299

)

Effect of foreign currency translation

 

 

(168

)

 

 

529

 

 

(104

)

Balance at end of year

 

$

2,854

 

 

$

4,522

 

$

4,486

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

 

Interest

Rate

 

 

Principal

Balance

 

 

Interest

Rate

 

 

Principal

Balance

 

Amended Credit Agreement:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar denominations)

 

 

1.35

%

 

$

35,000

 

 

 

1.65

%

 

$

171,500

 

U.S. Revolving Note (Euro denominations)

 

 

 

 

 

 

 

 

1.50

%

 

 

14,684

 

DEG Vietnam Loan

 

 

5.21

%

 

 

3,750

 

 

 

5.21

%

 

 

6,250

 

Total debt

 

 

 

 

 

 

38,750

 

 

 

 

 

 

 

192,434

 

Current maturities

 

 

 

 

 

 

(2,500

)

 

 

 

 

 

 

(2,500

)

Long-term debt, less current maturities

 

 

 

 

 

$

36,250

 

 

 

 

 

 

$

189,934

 

The Company classifies income tax-related penalties and net interest as income tax expense.  In the years ended December 31, 2018, 2017 and 2016 income tax related interest and penalties were insignificant. The Company believes that it is reasonably possible that there may be a decrease to its unrecognized tax benefits in the next 12 months due to audit settlements and statute expirations, but the amount expected to reverse is insignificant in relation to the consolidated financial statements.

Note 5  Debt  

Credit Agreement

The On June 27, 2019, the Company together with certain directentered into an Amended and indirect subsidiaries, have an outstanding credit agreementRestated Credit Agreement (the “Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent. The Credit Agreement provides the Companyagent, which includes a revolving credit note (“U.S. Revolving Note”) with a. The Credit Agreement has maximum borrowing capacity of $350,000.$475,000 and matures on June 27, 2024. The Credit Agreement also provides $15,000 availability for the issuance of letters of credit and a maximum of $40,000 for swing line borrowing. Any amount of the facility utilized for letters of credit or swing line loans outstanding will reduce the amount available under the Credit Agreement. The Company had 0 outstanding letters of credit issued under the Credit Agreement as of December 31, 2021 and December 31, 2020.

All subsidiary       The U.S. borrowers and guarantors participating in the Credit Agreement havealso entered into a related amended and restated pledge and security agreement.  The amended and restated pledge and security agreement grants a security interest to the lenders in substantially all of the personal property of the Company and its U.S. subsidiaries designated as borrowers to secure their respective obligations under the Credit Agreement, including the stock and membership interestinterests of specified subsidiaries (limited to 66% of the stock in the case of certain non-U.S. subsidiaries). In addition to the security obligations, all obligations under the Credit Agreement are unconditionally guaranteed by certain of the Company’s subsidiaries. The Credit Agreement restricts, among other things, the amount of dividend payments the Company can make to shareholders.

The Credit Agreement requirescontains covenants, that, among other things, (i) prohibit or limit the Companyability of the borrowers and any material subsidiary to incur additional indebtedness, create liens, pay dividends, make certain types of investments (including acquisitions), enter into certain types of transactions with affiliates, prepay other indebtedness, sell assets, merge with other companies or enter into certain other transactions outside the ordinary course of business, and (ii) require that Gentherm maintain a minimum Consolidated Interest Coverage Ratio and a Consolidated Leverage Ratio. DefinitionsRatio (based on consolidated EBITDA for these financial ratios are providedthe applicable trailing 12-month period as defined in the Credit Agreement) as of the end of any fiscal quarter. The Credit Agreement also contains customary events of default. As of December 31, 2021, the Company was in compliance with the terms of the Credit Agreement.

Under the Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The base rate for Base Rate Loans is equal to the highest of the Federal Funds Rate (2.40%(0.07% at December 31, 2018)2021) plus 0.50%, Bank of America’s prime rate (5.50%(3.25% at December 31, 2018)2021), or a one monththe Eurocurrency rate (0.00% at December 31, 2018) plus 1.00%. The Eurocurrency rate for loansEurocurrency Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (2.50%(0.10% at December 31, 2018)2021). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.

The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Amended Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%2.25%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%1.25%, respectively, for Base Rate Loans.

The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW banking group, a German government-owned development bank.

F-26F-25


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 5 — Debt – (Continued)

DEG China Loan

In March 2020, the Company increased its borrowings under the Credit Agreement by $169,546 as a safeguard to increase its cash position and provide additional financial flexibility due to the COVID-19 pandemic. The proceeds were used for working capital and for other general corporate purposes permitted by the Credit Agreement. As of the end of the first a loan we used to fund capital investments in China (the “DEG China Loan”),quarter of 2021, the Company repaid the full drawdown of $169,546 from March 2020 under the Credit Agreement. As of December 31, 2021, $35,000 was outstanding under the Credit Agreement. Borrowing availability is subject to, semi-annual principal payments that began March, 2015among other things, the Company’s compliance with the minimum Consolidated Interest Coverage Ratio and end September, 2019.  Under the termsConsolidated Leverage Ratio as of the DEG China Loan,end of any fiscal quarter. Based upon consolidated EBITDA for the Company must maintain a minimum Debt-to-Equitytrailing twelve months calculated for purposes of the Consolidated Leverage Ratio, Current Ratio and Debt Service Coverage Ratio,$440,000 remained available as defined byof December 31, 2021 for additional borrowings under the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary,Credit Agreement subject to specified conditions that Gentherm Automotive Systems (China) Ltd.currently satisfies.    

DEG Vietnam Loan

The Company’s secondCompany also has a fixed interest rate loan with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank.  The fixed interest rate senior loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”).  The DEG Vietnam Loan is subject to semi-annual principal payments that began November, 2017 and will end May, 2023.  Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Currency Ratio, Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.

As of December 31, 2018, we were2021, the Company was in compliance with all terms as outlined in the Credit Agreement, DEG China Loan and DEG Vietnam Loan. Undrawn borrowing capacity under the U.S. Revolving Note was $221,871

The scheduled principal maturities of our debt as of December 31, 2018. 2021 were as follows:

 

 

DEG

Vietnam

Note

 

 

U.S.

Revolving

Note

 

 

Total

 

2022

 

$

2,500

 

 

$

 

 

$

2,500

 

2023

 

 

1,250

 

 

 

 

 

 

1,250

 

2024

 

 

 

 

 

35,000

 

 

 

35,000

 

Total

 

$

3,750

 

 

$

35,000

 

 

$

38,750

 

Note 10 Pension and Other Post Retirement Benefit Plans

The following table summarizesCompany maintains a U.S. defined benefit pension plan covering its former Chief Executive Officer (“U.S. Plan”) and a German defined benefit pension plan covering certain retired executive employees of the Company’s debt atwholly owned subsidiary, Gentherm GmbH (“German Plan”).

The components of net periodic benefit cost for the Company’s defined benefit plans for the years ended December 31, 2018.2021, 2020 and 2019 were as follows:

 

 

U.S. Plan

 

 

German Plan

 

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

2021

 

 

2020

 

 

2019

 

Net periodic benefit cost:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service cost

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Interest cost

 

 

42

 

 

 

85

 

 

 

127

 

 

 

91

 

 

 

88

 

 

 

147

 

Expected return on plan assets

 

 

 

 

 

 

 

 

 

 

 

(120

)

 

 

(121

)

 

 

(126

)

Amortization of prior service cost and actuarial loss

 

 

26

 

 

 

7

 

 

 

 

 

 

133

 

 

 

124

 

 

 

72

 

Net periodic benefit cost

 

$

68

 

 

$

92

 

 

$

127

 

 

$

104

 

 

$

91

 

 

$

93

 

Assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

 

1.20

%

 

 

2.40

%

 

 

3.65

%

 

 

1.08

%

 

 

1.06

%

 

 

1.06

%

Long-term return on assets

 

N/A

 

 

N/A

 

 

N/A

 

 

 

2.90

%

 

 

3.10

%

 

 

3.10

%

F-26


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Interest
Rate

 

 

Principal
Balance

 

Credit Agreement:

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar Denominations)

 

4.02

%

 

$

122,000

 

U.S. Revolving Note (Euro Denominations)

 

1.50

%

 

$

5,727

 

DEG China Loan

 

4.25

%

 

 

913

 

DEG Vietnam Loan

 

5.21

%

 

 

11,250

 

Total debt

 

 

 

 

$

139,890

 

Current portion

 

 

 

 

 

(3,413

)

Long-term debt, less current maturities

 

 

 

 

$

136,477

 

The following table summarizes

A reconciliation of the Company’s debt atchange in benefit obligation and the change in plan assets for the years ended December 31, 2017.2021 and 2020 is as follows:

 

 

U.S. Plan

 

 

German Plan

 

 

 

As of December 31,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Change in projected benefit obligation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at beginning of year

 

$

3,847

 

 

$

3,871

 

 

$

8,934

 

 

$

8,353

 

Interest cost

 

 

42

 

 

 

85

 

 

 

91

 

 

 

88

 

Paid pension distributions

 

 

(342

)

 

 

(342

)

 

 

(310

)

 

 

(294

)

Actuarial (gain) loss

 

 

(101

)

 

 

233

 

 

 

9

 

 

 

40

 

Exchange rate impact

 

 

 

 

 

 

 

 

(622

)

 

 

747

 

Balance at end of year

 

$

3,446

 

 

$

3,847

 

 

$

8,102

 

 

$

8,934

 

Change in plan assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at beginning of year

 

 

 

 

 

 

 

 

4,276

 

 

 

3,825

 

Actual return on plan assets

 

 

 

 

 

 

 

 

98

 

 

 

96

 

Contributions

 

 

 

 

 

 

 

 

310

 

 

 

294

 

Paid pension distributions

 

 

 

 

 

 

 

 

(310

)

 

 

(294

)

Exchange rate impact

 

 

 

 

 

 

 

 

(305

)

 

 

355

 

Balance at end of year

 

$

 

 

$

 

 

$

4,069

 

 

$

4,276

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underfunded Status

 

$

(3,446

)

 

$

(3,847

)

 

$

(4,033

)

 

$

(4,658

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance sheet classification:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities

 

$

(342

)

 

$

(342

)

 

$

(306

)

 

$

 

Pension benefit obligation

 

 

(3,104

)

 

 

(3,505

)

 

 

(3,727

)

 

 

(4,658

)

Accumulated other comprehensive loss (pre-tax):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Actuarial losses

 

 

575

 

 

 

701

 

 

 

3,288

 

 

 

3,644

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

 

1.80

%

 

 

1.20

%

 

 

1.25

%

 

 

1.08

%

Pre-tax amounts included in AOCI that are expected to be recognized in net periodic benefit cost during the year ended December 31, 2022 are as follows:

 

 

U.S Plan

 

 

German Plan

 

Actuarial losses

 

$

21

 

 

$

124

 

The accumulated benefit obligations were as follows:

 

 

U.S. Plan

 

 

German Plan

 

 

 

As of December 31,

 

 

As of December 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Accumulated benefit obligation

 

$

3,446

 

 

$

3,847

 

 

$

8,102

 

 

$

8,934

 

Interest costs are recognized in Selling, general and administrative expenses in the consolidated statements of income and actuarial gains and losses are included the consolidated balance sheet as part of Accumulated other comprehensive loss within shareholders’ equity. Actuarial gains or losses are amortized to Selling, general and administrative expense in the consolidated statements of income based on the average future life of the Plan using the corridor method. Prior service cost is included in Selling, general and administrative expenses in the consolidated statements of income.

 

 

Interest
Rate

 

 

Principal
Balance

 

Credit Agreements:

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar Denominations)

 

3.07

%

 

 

129,000

 

DEG China Loan

 

4.25

%

 

 

1,919

 

DEG Vietnam Loan

 

5.21

%

 

 

13,750

 

Total debt

 

 

 

 

$

144,669

 

Current portion

 

 

 

 

 

(3,460

)

Long-term debt, less current maturities

 

 

 

 

$

141,209

 

F-27


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 5 — Debt

Plan assets(Continued)German Plan

Plan assets are comprised of Gentherm GmbH’s pension insurance policies and are pledged to the beneficiaries of the German Plan. A market valuation technique, based on observable underlying insurance charges, is used to determine the fair value of the pension plan assets (Level 2).

The scheduled principal maturitiesexpected return on plan assets assumption used to calculate Gentherm GmbH’s pension benefit obligation was determined using actual returns realized on plan assets in the prior year.

Contributions

We do 0t expect contributions to be paid to the U.S. Plan or the German Plan during the next fiscal year.

The schedule of future expected pension payments is as follows:

 

 

Projected Pension

Benefit Payments

 

Year

 

U.S Plan

 

 

German Plan

 

2022

 

$

342

 

 

$

306

 

2023

 

 

342

 

 

 

316

 

2024

 

 

342

 

 

 

309

 

2025

 

 

342

 

 

 

301

 

2026

 

 

342

 

 

 

292

 

2027-2031

 

 

1,710

 

 

 

2,988

 

Total

 

$

3,420

 

 

$

4,512

 

Defined contribution plans

The Company also sponsors defined contribution plans for eligible employees. On a discretionary basis, the Company matches a portion of the employee contributions and or makes additional discretionary contributions. Gentherm recognized costs of $1,724, $1,275 and $1,384 related to contributions to its defined contribution plans during the years ended December 31, 2021, 2020 and 2019, respectively.  

Note 11 Commitments and Contingencies  

Legal and other contingencies

The Company may be subject to various legal actions and claims in the ordinary course of its business, including those arising out of breach of contracts, intellectual property rights, environmental matters, regulatory matters and employment-related matters.  The Company establishes accruals for matters which it believes that losses are probable and can be reasonably estimated. Although it is not possible to predict with certainty the outcome of these matters, the Company is of the opinion that the ultimate resolution of these matters will not have a material adverse effect on its consolidated results of operations or financial position. Product liability and warranty reserves are recorded separately from legal reserves.

Product Liability and Warranty Matters

In the event that the Company’s products fail to perform as expected or result in alleged bodily injury or property damage, our products may subject us to warranty claims and product liability. If any of our debtproducts are or are alleged to be defective, we may be required to participate in a recall or other corrective action involving such products. The Company maintains liability insurance coverage at levels based on commercial norms and historical claims experience. The Company can provide no assurances that it will not experience material claims in the future or that it will not incur significant costs to defend such claims.

F-28


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions. Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims.  

The following is a reconciliation of the changes in accrued warranty costs:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Balance at beginning of year

 

$

2,391

 

 

$

4,596

 

Warranty claims paid

 

 

(2,164

)

 

 

(2,598

)

Warranty expense for products shipped during the current period

 

 

1,813

 

 

 

1,223

 

Adjustments to warranty estimates from prior periods

 

 

(73

)

 

 

(893

)

Adjustments due to currency translation

 

 

(51

)

 

 

63

 

Balance at end of year

 

$

1,916

 

 

$

2,391

 

Other matters

Purchase commitments for materials, supplies, services and capital expenditures, as part of the normal course of business, are generally consistent from year to year. Commitments for capital expenditures as of December 31, 20182021 were $5,388. During the year ended December 31, 2021, the Company entered into agreements with various suppliers to reserve the right to purchase certain semiconductor chips over the next 24 months, with volume commitments determined based on our anticipated production requirements. As of December 31, 2021, the Company’s total commitments for these semiconductor chip agreements was $24,457. Such agreements provide the Company with priority access to semiconductor chips as they become available, however, these agreements do not guarantee that our suppliers will meet the timing and quantities requested by Gentherm. All other purchase commitments as of December 31, 2021 were immaterial.

Employees

Approximately 23% of the Company’s workforce are members of industrial trade unions and are employed under the terms of various labor agreements.None of these agreements expire in 2022.

Note 12 Earnings Per Share

The following table illustrates earnings per share and the weighted average shares outstanding used in calculating basic and diluted earnings per share:  

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Net income

 

$

93,434

 

 

$

59,690

 

 

$

48,866

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares of Common Stock outstanding

 

 

33,085,732

 

 

 

32,666,025

 

 

 

33,120,076

 

Dilutive effect of stock options, restricted stock awards and restricted stock units

 

 

423,988

 

 

 

362,079

 

 

 

177,513

 

Diluted weighted average shares of Common Stock outstanding

 

 

33,509,720

 

 

 

33,028,104

 

 

 

33,297,589

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

2.82

 

 

$

1.83

 

 

$

1.48

 

Diluted earnings per share

 

$

2.79

 

 

$

1.81

 

 

$

1.47

 

F-29


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The following table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Anti-dilutive securities share impact

 

 

 

 

 

12,000

 

 

 

214,000

 

See Note 17 for information about the Company’s different equity incentive plans.

Note 13 —Financial Instruments

Derivative Financial Instruments

The Company is exposed to various market risks including, but not limited to, changes in foreign currency exchange rates, changes in interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to its debt obligations under the Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, North Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which the Company hedges its exposure to foreign currency exchange risks and price fluctuations in material commodities is fifteen months. The Company had foreign currency derivative contracts with a notional value of $13,974 and $13,299 and copper commodity swap contracts with a notional value of $309 and $0 outstanding as of December 31, 2021 and 2020, respectively. The principal currency hedged by the Company was the Mexican Peso.

The Company does not enter into derivative financial instruments for speculative or trading purposes. The Company’s hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to AOCI in the consolidated balance sheets. When the underlying hedge transaction is realized, the gain or loss included in Accumulated other comprehensive loss is recorded in earnings in the consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The Company records the ineffective portion of foreign currency and copper commodity hedging instruments, if any, to cost of sales, in the consolidated statements of income. Cash flows associated with derivatives are reported in net cash provided by operating activities in the Company’s Consolidated Statements of Cash Flows.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounting such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative financial instruments in the consolidated balance sheet as of December 31, 2021 is as follows:

 

Year

 

U.S.
Revolving
Note

 

 

DEG China Loan

 

 

DEG Vietnam Loan

 

 

Total

  

2019

 

$

 

 

$

913

 

 

$

2,500

 

 

$

3,413

 

2020

 

 

 

 

 

 

 

 

2,500

 

 

 

2,500

 

2021

 

 

127,727

 

 

 

 

 

 

2,500

 

 

 

130,227

 

2022

 

 

 

 

 

 

 

 

2,500

 

 

 

2,500

 

2023

 

 

 

 

 

 

 

 

1,250

 

 

 

1,250

 

Total

 

$

127,727

 

 

$

913

 

 

$

11,250

 

 

$

139,890

 

 

 

 

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

 

 

 

 

 

Hedge

Designation

 

Fair Value

Hierarchy

 

Balance Sheet

Location

 

Fair

Value

 

 

Balance Sheet

Location

 

Fair

Value

 

 

Net Asset/

(Liabilities)

 

Foreign currency derivatives

 

Cash flow hedge

 

Level 2

 

Other current assets

 

$

294

 

 

Other current liabilities

 

$

 

 

$

294

 

Commodity hedges

 

Cash flow hedge

 

Level 2

 

Other current assets

 

$

6

 

 

Other current liabilities

 

$

 

 

$

6

 

F-30


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Information related to the recurring fair value measurement of derivative financial instruments in the consolidated balance sheet as of December 31, 2020 is as follows:  

 

 

 

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

 

 

 

 

 

Hedge

Designation

 

Fair Value

Hierarchy

 

Balance Sheet

Location

 

Fair

Value

 

 

Balance Sheet

Location

 

Fair

Value

 

 

Net Asset/

(Liabilities)

 

Foreign currency derivatives

 

Cash flow hedge

 

Level 2

 

Other current assets

 

$

1,513

 

 

Other current liabilities

 

$

 

 

$

1,513

 

Commodity hedges

 

Cash flow hedge

 

Level 2

 

Other current assets

 

$

 

 

Other current liabilities

 

$

 

 

$

 

Information related to the effect of derivative instruments in the consolidated statements of income is as follows:  

 

 

 

 

Year Ended December 31,

 

 

 

Location

 

2021

 

 

2020

 

 

2019

 

Foreign currency derivatives

 

Cost of sales

 

$

1,609

 

 

$

(1,629

)

 

$

1,976

 

 

 

Other comprehensive (loss) income

 

 

(1,217

)

 

 

272

 

 

 

1,151

 

 

 

Foreign currency loss

 

 

 

 

 

(118

)

 

 

(46

)

Total foreign currency derivatives

 

 

 

$

392

 

 

$

(1,475

)

 

$

3,081

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commodity derivatives

 

Cost of sales

 

$

14

 

 

$

 

 

$

 

 

 

Other comprehensive (loss) income

 

 

6

 

 

 

 

 

 

 

Total commodity derivatives

 

 

 

$

20

 

 

$

 

 

$

 

The Company did 0t incur any hedge ineffectiveness during the years ended December 31, 2021 and 2020.  

Accounts Receivable Factoring

In June 2021, the Company entered into a receivable factoring arrangement that provides for aggregate purchases of up to $41,300 of specified customer accounts in North America. The receivable factoring arrangement results in true sales of the transferred receivables, which are excluded from amounts reported in the consolidated condensed balance sheets when the receivables are transferred in accordance with ASC 860, "Transfers and Servicing”.  As of December 31, 2021, there were 0 outstanding receivables transferred under the receivable factoring agreement.

F-31


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

Note 6 14 Fair Value Measurement

Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  Fair value measurements are based on one or more of the following three valuation techniques:

Market: This approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

Income: This approach uses valuation techniques to convert future amounts to a single present value amount based on current market expectations.

Cost: This approach is based on the amount that would be required to replace the service capacity of an asset (replacement cost).

The Company uses the following fair value hierarchy to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

Items Measured at Fair Value on a Recurring Basis

Except for derivative financial instruments (see Note 13) and pension plan assets (see Note 10), the Company has 0 material financial assets and liabilities that are carried at fair value at December 31, 2021 and 2020. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Items Measured at Fair Value on a Nonrecurring Basis

The Company measures certain assets and liabilities at fair value on a non-recurring basis. As these nonrecurring fair value measurements are generally determined using unobservable inputs, these fair value measurements are classified within Level 3 of the fair value hierarchy.  On July 1, the Company acquired B&E for $2,827. The purchase price was allocated to inventory (Level 2), property and equipment (Level 2) and other intangible assets (Level 3) based on their estimated fair values as of the acquisition date. As of December 31, 2021, and December 31, 2020, there were 0 other significant assets or liabilities measured at fair value on a non-recurring basis. 

Items Not Carried at Fair Value

The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs).  As of December 31, 2021, and 2020, the carrying values of the indebtedness under the Company’s Credit Agreement were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 9). Discount rates used to measure the fair value of Gentherm’s DEG Vietnam Loan are based on quoted swap rates. As of December 31, 2021, the carrying value of the DEG Vietnam Loan was $3,750, as compared to an estimated fair value of $3,778. As of December 31, 2020, the carrying value of the DEG Vietnam Loan was $6,250 as compared to an estimated fair value of $6,360.   

F-32


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 15 — Equity

Common Stock  

The Company is authorized to issue up to 59,991,000 shares, of which 55,000,000 shares shall be common stock, without par value, and 4,991,000 shall be Preferred Stock, without par value.  As of December 31, 2021, an aggregate of 33,008,185 shares of its common stock were issued and outstanding.  As of December 31, 2021, there are 0 preferred stock shares issued or outstanding. The Company’s common stock is listed on the Nasdaq Global Select Market under the symbol, “THRM”, and has the following rights and privileges:

Voting rights. All shares of the Company’s common stock have identical rights and privileges. With limited exceptions, holders of common stock are entitled to one vote for each outstanding share of common stock held of record by each shareholder on all matters properly submitted for the vote of the Company’s shareholders.

Dividend rights. Subject to applicable law, any contractual restrictions and the rights of the holders of outstanding preferred stock, if any, holders of common stock are entitled to receive ratably such dividends and other distributions that the Company’s Board of Directors, in its discretion, declares from time to time.

Liquidation rights. Upon the dissolution, liquidation or winding up of the Company, subject to the rights of the holders of outstanding preferred stock, if any, holders of common stock are entitled to receive ratably the assets of the Company available for distribution to the Company’s shareholders in proportion to the number of shares of common stock held by each shareholder.

Conversion, Redemption and Preemptive Rights. Holders of common stock have no conversion, redemption, sinking fund, preemptive, subscription or similar rights.

Stock Repurchase Program  

In December 2020, the Board of Directors of Gentherm Incorporated (“Board of Directors”) authorized a stock repurchase program (the “2020 Stock Repurchase Program”) to commence upon expiration of the prior stock repurchase program on December 15, 2020. Under the 2020 Stock Repurchase Program, the Company is authorized to repurchase up to $150,000 of its issued and outstanding common stock over a three-year period, expiring December 15, 2023.

Repurchases may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations. Any such repurchases may be executed using open market purchases, privately negotiated agreements or other transactions. Repurchases may be funded from cash on hand, available borrowings or proceeds from potential debt or other capital markets sources. During the year ended December 31, 2021, the Company repurchased approximately $20,000 of shares under the 2020 Stock Repurchase Program with an average price paid per share of $83.44. The 2020 Stock Repurchase Program had $130,000 repurchase authorization remaining as of December 31, 2021.

F-33


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 16 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the years ended December 31, 2021, 2020 and 2019 are as follows:

 

 

Defined

Benefit

Pension

Plans

 

 

Foreign

Currency

Translation

Adjustments

 

 

Commodity Hedge Derivatives

 

 

Foreign

Currency

Hedge

Derivatives

 

 

Total

 

Balance at December 31, 2020

 

$

(3,451

)

 

$

(12,637

)

 

$

 

 

$

1,106

 

 

$

(14,982

)

Other comprehensive income (loss) before reclassifications

 

 

512

 

 

 

(21,274

)

 

 

20

 

 

 

392

 

 

 

(20,350

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(71

)

 

 

(277

)

 

 

(4

)

 

 

(85

)

 

 

(437

)

Amounts reclassified from accumulated other comprehensive loss into net income

 

 

159

 

 

 

 

 

 

(14

)

a

 

(1,609

)

a

 

(1,464

)

Income taxes reclassified into net income

 

 

(42

)

 

 

 

 

 

3

 

 

 

350

 

 

 

311

 

Net current period other comprehensive income (loss)

 

 

558

 

 

 

(21,551

)

 

 

5

 

 

 

(952

)

 

 

(21,940

)

Balance at December 31, 2021

 

$

(2,893

)

 

$

(34,188

)

 

$

5

 

 

$

154

 

 

$

(36,922

)

(a)

The amounts reclassified from Accumulated other comprehensive income (loss) are included in Cost of sales.  See Note 13 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

 

 

Defined Benefit

Pension Plans

 

 

Foreign Currency

Translation

Adjustments

 

 

Foreign Currency

Hedge

Derivatives

 

 

Total

 

Balance at December 31, 2019

 

$

(3,371

)

 

$

(39,879

)

 

$

895

 

 

$

(42,355

)

Other comprehensive (loss) income before reclassifications

 

 

(328

)

 

 

27,147

 

 

 

(1,751

)

 

 

25,068

 

Income tax effect of other comprehensive (loss) income before reclassifications

 

 

117

 

 

 

95

 

 

 

381

 

 

 

593

 

Amounts reclassified from accumulated other comprehensive loss into net income

 

 

131

 

 

 

 

 

 

2,023

 

a

 

2,154

 

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

(442

)

 

 

(442

)

Net current period other comprehensive (loss) income

 

 

(80

)

 

 

27,242

 

 

 

211

 

 

 

27,373

 

Balance at December 31, 2020

 

$

(3,451

)

 

$

(12,637

)

 

$

1,106

 

 

$

(14,982

)

(a)

The amounts reclassified from Accumulated other comprehensive income (loss) are included in Cost of sales.  See Note 13 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

 

 

Defined Benefit

Pension Plans

 

 

Foreign Currency

Translation

Adjustments

 

 

Foreign Currency

Hedge

Derivatives

 

 

Total

 

Balance at December 31, 2018

 

$

(2,339

)

 

$

(37,157

)

 

$

(4

)

 

$

(39,500

)

Other comprehensive (loss) income before reclassifications

 

 

(1,264

)

 

 

(2,329

)

 

 

2,259

 

 

 

(1,334

)

Income tax effect of other comprehensive (loss) income before reclassifications

 

 

232

 

 

 

(393

)

 

 

(493

)

 

 

(654

)

Amounts reclassified from accumulated other comprehensive loss into net income

 

 

 

 

 

 

 

 

(1,108

)

a

 

(1,108

)

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

241

 

 

 

241

 

Net current period other comprehensive (loss) income

 

 

(1,032

)

 

 

(2,722

)

 

 

899

 

 

 

(2,855

)

Balance at December 31, 2019

 

$

(3,371

)

 

$

(39,879

)

 

$

895

 

 

$

(42,355

)

(a)

The amounts reclassified from Accumulated other comprehensive income (loss) are included in Cost of sales.  See Note 13 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

F-34


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

We expect all of the existing gains and losses related to foreign currency and commodity derivatives reported in Accumulated other comprehensive income (loss) as of December 31, 2021 to be reclassified into earnings during the twelve-month period ending December 31, 2022.

Note 17 Accounting for Stock Based Compensation

On May 16, 2013, the Compensation Committee of the Company’s Board of Directors (the “Board”) approved the Gentherm Incorporated 2013 Equity Incentive Plan (the “2013 Plan”), covering 3,500,000 shares of our Common Stock.  On May 19, 2017 theThe 2013 Plan was amended increasingon May 19, 2017 to increase the amountnumber of available shares by 2,000,000.2,000,000 and further amended on May 21, 2020 to increase the number of available shares by 2,450,000. The 2013 Plan permits the granting of various awards including stock options (including both nonqualified options and incentive options), stock appreciation rights (“SARs”), restricted stock and restricted stock units performance(“RSUs”), performance-based restricted stock units (“PSUs”) shares and certain other awards to employees, outside directors and consultants and advisors of the Company.  All shares of our Common Stock that remained available for issuance under the Amended and Restated 2006 Stock Incentive Plan (the “2006 Plan”) and the Gentherm Incorporated 2011 Equity Incentive Plan (the “2011 Plan), were reduced to zero; however, some options under the 2006 Plan are still outstanding.  As of December 31, 2018,2021, the Company had an aggregate of 1,567,5942,739,534 shares of Common Stock available to issue under the 2013 Plan.

All equity plans are administered by the Compensation Committee of the Board. The selection of participants, allotment of shares, determination of price and other conditions are determined by the Compensation Committee at its sole discretion, in order to attract and retain personnel instrumental to the success of the Company.  Stock options, for example, granted under such plans have lives for a period of up to ten years from the date of grant at an exercise price which is not less than the fair market value of the Common Stock on the date of the grant.

During the three yearthree-year period ended December 31, 2018,2021, the Company has outstanding stock options, stock appreciation rights (“SARs”),SARs, restricted stock awards and restricted stock units to employees, directors and consultants.  These awards become available to the recipient upon the satisfaction of a vesting condition, either based on a period of service or based on the performance of a specific achievement.  For equity basedequity-based awards with a service condition, the requisite service period typically ranges between three to fivefour years for employees and consultants and one year for directors. As of December 31, 2018,2021, there were 129,577 performance based restricted stock units319,336 PSUs outstanding. These awards cliff vest over a three-year period afterthree-years based on the Company’s achievement of either a target return on invested capital ratio (“ROIC”), as defined in the award agreement, for a specified fiscal year a target three year cumulative Adjusted EBITDA (“Adjusted EBITDA”), as defined in the award agreement, or the Company’s common stock market price returning a targetrelative total shareholder return (“TSR”), as defined in the award agreement, during a specific three-year measurement period. Approximately one-half of the performance based restricted stock units are paid based on the ROIC condition, while the other one-half are paid based on the TSR condition. In each case, awards will pay outbe earned at 50% of the target number of shares for achieving a minimum threshold or up to 200% of the target number of shares for exceeding the target.target, with a linear adjustment between threshold and target or between target and stretch performance goals. All other outstanding, unvested equity-based awards were service based. Equity-based award vesting may be accelerated at the discretion of the Board.Board under conditions specified in the 2013 plan.

Total unrecognized compensation cost related to nonvested options, restricted stock and SARs outstanding under allUnder FASB ASC Topic 718, the provisions of the PSUs that vest upon the achievement of relative TSR are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this portion award. A third party was engaged to complete a Monte Carlo simulation to account for the market condition.  That simulation takes into account the beginning stock price of our common stock, the expected volatilities for the relative TSR comparator group, the expected volatilities for the Company’s equity plans was $15,932stock price, correlation coefficients, the expected risk-free rate of return and $18,593the expected dividend yield of the Company and the comparator group.  The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of the actual future outcome of the relative TSR feature. The grant date fair value of the other PSUs and RSUs are calculated as the closing price of our common stock as quoted on Nasdaq on the grant date multiplied by the number of shares subject to the award. Each of ROIC and Adjusted EBITDA is considered a performance condition and the grant-date fair value for ROIC PSUs and Adjusted EBITDA PSUs corresponds with management's expectation of the probable outcome of the performance condition as of December 31, 2018 and 2017, respectively. That cost is expected to be recognized over a weighted average period of two years. Compensation expense for the years ended December 31, 2018, 2017 and 2016 was $12,177, $12,727 and $8,147, respectively.   No share-based payment arrangements expired during the three-year period ended December 31, 2018.  If Gentherm were to realize expired shared-based payment arrangements, they would be reported as a forfeit in the activity roll forward tables below.grant date.

F-28F-35


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 6 AccountingThe total recognized and unrecognized stock-based compensation expense is as follows:

Stock-Based Compensation Expense

 

2021

 

 

2020

 

 

2019

 

 

Unrecognized Stock-Based Compensation Expense at December 31, 2021

 

Options

 

$

482

 

 

$

836

 

 

$

885

 

 

$

-

 

Restricted Shares

 

 

1,198

 

 

 

1,495

 

 

 

1,600

 

 

 

309

 

Restricted Stock Units

 

 

4,594

 

 

 

3,137

 

 

 

1,751

 

 

 

7,423

 

Performance Based Units

 

 

5,535

 

 

 

3,361

 

 

 

2,017

 

 

 

8,572

 

Stock Appreciation Rights

 

 

2,721

 

 

 

5,494

 

 

 

2,336

 

 

 

-

 

Total Stock-Based Compensation

 

$

14,530

 

 

$

14,323

 

 

$

8,589

 

 

$

16,304

 

The related deferred tax benefit for Stock Based Compensation – (Continued)the years ended December 31, 2021, 2020 and 2019 was $2,725, $3,002, and $1,573, respectively. If Gentherm were to realize expired share-based payment arrangements, they would be reported as a forfeit in the activity roll forward tables below.

Stock Options

The following table summarizes stock option activity during the three-year periodyears ended December 31, 2018:2021, 2020 and 2019:

Options

 

Shares

 

 

Weighted-Average

Exercise Price

 

 

Weighted-Average

Remaining

Contractual Term

 

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2018

 

 

1,653,000

 

 

$

38.53

 

 

 

4.28

 

 

$

3,610

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(428,250

)

 

 

38.66

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(355,750

)

 

 

39.99

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

869,000

 

 

$

37.87

 

 

 

3.51

 

 

$

5,172

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(434,250

)

 

 

38.12

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,750

)

 

 

38.05

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

428,000

 

 

$

37.61

 

 

 

3.20

 

 

$

11,815

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(215,250

)

 

 

38.46

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,000

)

 

 

38.05

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

Exercisable at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

 

Options

  

Shares

 

 

Weighted-
Average
Exercise
Price

 

  

Weighted-
Average
Remaining
Contractual
Term

 

  

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2015

  

 

1,530,845

  

 

$

27.46

  

  

 

 

  

  

 

 

 

Granted

  

 

862,000

  

 

 

40.87

  

  

 

 

 

  

 

 

 

Exercised

  

 

(112,875

)

 

 

13.24

  

  

 

 

 

  

 

 

 

Forfeited

  

 

(176,500

)

 

 

39.32

  

  

 

 

 

  

 

 

 

Outstanding at December 31, 2016

  

 

2,103,470

  

 

$

32.72

  

  

 

4.86

 

 

$

12,265

 

Granted

  

 

808,500

  

 

 

37.23

  

  

 

 

 

  

 

 

 

Exercised

  

 

(202,328

)

 

 

13.62

  

  

 

 

 

  

 

 

 

Forfeited

  

 

(57,500

)

 

 

42.54

  

  

 

 

 

  

 

 

 

Outstanding at December 31, 2017

  

 

2,652,142

 

 

$

35.34

 

 

 

4.76

 

 

$

6,964

 

Granted

  

 

  

 

 

  

  

 

 

 

  

 

 

 

Exercised

  

 

(615,358

)

 

 

24.01

  

  

 

 

 

  

 

 

 

Forfeited

  

 

(383,784

)

 

 

39.59

  

  

 

 

 

  

 

 

 

Outstanding at December 31, 2018

  

 

1,653,000

 

 

 

38.53

 

 

 

4.28

 

 

$

3,610

 

Exercisable at December 31, 2016

  

 

675,152

 

 

$

21.40

 

 

 

3.45

 

 

$

9,646

 

Exercisable at December 31, 2017

  

 

984,374

 

 

$

29.84

 

 

 

3.44

 

 

$

6,534

 

Exercisable at December 31, 2018

  

 

788,125

 

 

$

38.15

 

 

 

3.71

 

 

$

2,200

 

There have been 0 stock options granted since the year ended December 31, 2017 and all options are currently vested. The fairtotal intrinsic value of each option is estimated onoptions exercised during the date of grant using the Black-Scholes option-pricing model in order to measure the compensation cost associated with the award. This model incorporates certain assumptions for inputs including a risk-free interest rate, expected dividend yield of the underlying Common Stock, expected option lifeyears ended December 31, 2021, 2020 and expected volatility in the market value of the underlying Common Stock. The following assumptions were used for options issued in the following periods:2019 was $8,269, $5,317 and $1,681, respectively.

 

  

2018

 

2017

 

2016

Expected volatility

  

NA

 

33%

 

37%

Weighted average expected volatility

  

NA

 

33%

 

37%

Expected lives

  

NA

 

3 yrs.

 

3 yrs.

Risk-free interest rate

  

NA

 

1.49-1.93%

 

0.90-1.07%

Expected dividend yield

  

none

 

none

 

none

NA – No new stock options were granted during 2018.

Expected volatilities are based on the historical volatility of the Company’s Common Stock. The Company uses historical exercise data and several other factors in developing an assumption for the expected lives of stock options, including the average holding period of outstanding options and their remaining terms.  The risk-free interest rate is based upon quoted market yields for United States Treasury debt securities. The expected dividend yield is based upon the Company’s history of having never issued a dividend, the limitations to issue a dividend under terms of the Credit Agreement and management’s current expectation regarding future dividends. We do not expect any of the options granted to be forfeited for purposes of computing fair value.

F-29F-36


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 6 Accounting for Stock Based Compensation – (Continued)

The weighted-average grant-date fair value of options granted during the year ended December 31, 2017 and 2016 was  $9.11 and $10.74, respectively. There were no stock options granted during the year ended December 31, 2018. The total intrinsic value of options exercised during the year ended December 31, 2018, 2017 and 2016 was $5,061, $4,715 and $2,456, respectively.

Restricted Stock Appreciation Rights

The following table summarizes restricted stock activity during the three-year period ended December 31, 2018:

 

Unvested Restricted Shares

  

Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Outstanding at December 31, 2015

  

 

179,026

 

 

$

34.92

 

Granted

  

 

141,784

 

 

 

39.73

 

Vested

  

 

(100,330

)

 

 

32.47

 

Forfeited

  

 

(9,999

)

 

 

40.99

 

Outstanding at December 31, 2016

  

 

210,481

 

 

$

39.02

 

Granted

  

 

237,542

 

 

 

37.30

 

Vested

  

 

(165,923

)

 

 

37.99

 

Forfeited

  

 

 

 

 

 

Outstanding at December 31, 2017

  

 

282,100

 

 

$

38.06

 

Granted

  

 

21,681

 

 

 

35.00

 

Vested

  

 

(130,684

)

 

 

38.62

 

Forfeited

  

 

(36,531

)

 

 

37.60

 

Outstanding at December 31, 2018

  

 

136,566

 

 

$

37.16

 

The compensation cost associated with restricted shares is estimated on the date of grant using quoted market prices (Level 1 input). The total fair value of restricted shares vested in 2018, 2017 and 2016 was $4,599, $6,006 and $3,865, respectively.

Restricted Stock Units

The following table summarizes restricted stock unit activity during the year ended December 31 2018:

 

 

 

 

 

 

Performance Based Awards

 

 

 

 

Unvested Restricted Stock Units

 

Time Vesting Shares

 

 

ROIC Target Shares

 

 

TSR Target Shares

 

 

Total

  

Outstanding at December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

86,392

 

 

 

64,785

 

 

 

64,792

 

 

 

215,969

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

86,392

 

 

 

64,785

 

 

 

64,792

 

 

 

215,969

 

No restricted stock units were granted prior to 2018.2,721

F-30

5,494

2,336

-

Total Stock-Based Compensation

$

14,530

$

14,323

$

8,589

$

16,304

The related deferred tax benefit for the years ended December 31, 2021, 2020 and 2019 was $2,725, $3,002, and $1,573, respectively. If Gentherm were to realize expired share-based payment arrangements, they would be reported as a forfeit in the activity roll forward tables below.

Stock Options

The following table summarizes stock option activity during the years ended December 31, 2021, 2020 and 2019:

Options

 

Shares

 

 

Weighted-Average

Exercise Price

 

 

Weighted-Average

Remaining

Contractual Term

 

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2018

 

 

1,653,000

 

 

$

38.53

 

 

 

4.28

 

 

$

3,610

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(428,250

)

 

 

38.66

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(355,750

)

 

 

39.99

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

869,000

 

 

$

37.87

 

 

 

3.51

 

 

$

5,172

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(434,250

)

 

 

38.12

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,750

)

 

 

38.05

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

428,000

 

 

$

37.61

 

 

 

3.20

 

 

$

11,815

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(215,250

)

 

 

38.46

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,000

)

 

 

38.05

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

Exercisable at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

There have been 0 stock options granted since the year ended December 31, 2017 and all options are currently vested. The total intrinsic value of options exercised during the years ended December 31, 2021, 2020 and 2019 was $8,269, $5,317 and $1,681, respectively.

F-36


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 6 Accounting for Stock Based Compensation – (Continued)

Stock Appreciation Rights

The following table summarizes SARs activity during the three-year period ended December 31, 2018:

 

Stock Appreciation Rights

  

Units

 

 

Weighted-
Average
Exercise
Price

 

  

Weighted-
Average
Remaining
Contractual
Term

 

  

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2015

  

 

1,049,850

 

 

$

34.61

 

 

 

 

 

 

 

 

 

Granted

  

 

244,000

 

 

 

40.64

 

 

 

 

 

 

 

 

 

Exercised

  

 

(18,750

)

 

 

24.28

 

 

 

 

 

 

 

 

 

Forfeited

  

 

(30,500

)

 

 

28.23

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

  

 

1,244,600

 

 

$

36.11

 

 

 

4.80

 

 

$

3,511

 

Granted

 

 

235,000

 

 

 

38.05

 

 

 

 

 

 

 

 

 

Exercised

 

 

(94,250

)

 

 

22.21

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(193,000

)

 

 

32.53

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2017

  

 

1,192,350

 

 

$

38.17

 

 

 

4.36

 

 

$

2,278

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(204,250

)

 

 

26.35

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

988,100

 

 

$

40.61

 

 

 

3.57

 

 

$

2,064

 

Exercisable at December 31, 2016

  

 

424,992

 

 

$

34.49

 

 

 

4.39

 

 

$

2,315

 

Exercisable at December 31, 2017

  

 

613,808

 

 

$

37.68

 

 

 

3.72

 

 

$

1,904

 

Exercisable at December 31, 2018

  

 

683,600

 

 

$

41.21

 

 

 

3.09

 

 

$

1,728

 

The total intrinsic value of SARs converted during the year ended December 31, 2018, 2017 and 2016 was $3,532, $1,495 and $261, respectively.

Note 7 Earnings Per Share

The Company’s diluted earnings per share give effect to all potential common shares outstanding during a period that do not have an anti-dilutive impact to the calculation. The following summarizes the shares included in the dilutive shares as disclosed in the statements of income:  

 

 

 

Year ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Weighted average number of shares for calculation of basic EPS – Common Stock

 

 

35,920,782

 

 

 

36,720,749

 

 

 

36,448,138

 

Stock options, restricted stock awards and restricted stock units under equity incentive plans

 

 

256,362

 

 

 

92,970

 

 

 

152,665

 

Weighted average number of shares for calculation of diluted EPS – Common Stock

 

 

36,177,144

 

 

 

36,813,719

 

 

 

36,600,803

 

The accompanying table represents Common Stock issuable upon the exercise of certain stock options and that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.2,721

 

 

  

Year ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Stock options outstanding for equity incentive plans

 

 

898,250

 

 

 

2,055,784

 

 

 

1,314,784

 

F-31


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 7 Earnings Per Share – (Continued)5,494

See Note 6 for information about the Company’s different equity incentive plans.

Note 8 Commitments and Contingencies  

The Company’s operating leases cover primarily buildings and underlying real estate, office equipment and automobiles. The Company has also entered into multiple year software subscription service agreements We do not have lease arrangements with related parties. A summary of lease and purchase commitments as of December 31, 2018, under all non-cancelable operating leases and service agreements with terms exceeding one year is as follows:

 

 

  

 

 

2019

  

$

7,530

  

2020

  

 

5,016

  

2021

  

 

2,468

  

2022

  

 

2,152

  

2023

  

 

1,532

  

2024 or later

  

 

4,021

  

Total

  

$

22,719

  

The Company does not have any outstanding capital lease agreements or purchase obligations that exceed one year. Rent expense under all of the Company’s operating leases was $8,366, $ 8,424 and $7,479 for 2018, 2017 and 2016, respectively.

We are subject to litigation from time to time in the ordinary course of our business; however, there is no current material pending litigation to which we are a party as of December 31, 2018 and 2017, respectively.  No material legal proceeding was terminated, settled or otherwise resolved during the fiscal year ended December 31, 2018 and 2017, respectively.

 

Note 9

2,336

-

Total Stock-Based Compensation

$

14,530

$

14,323

$

8,589

$

16,304

The related deferred tax benefit for the years ended December 31, 2021, 2020 and 2019 was $2,725, $3,002, and $1,573, respectively. If Gentherm were to realize expired share-based payment arrangements, they would be reported as a forfeit in the activity roll forward tables below.

Stock Options

The following table summarizes stock option activity during the years ended December 31, 2021, 2020 and 2019:

Options

 

Shares

 

 

Weighted-Average

Exercise Price

 

 

Weighted-Average

Remaining

Contractual Term

 

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2018

 

 

1,653,000

 

 

$

38.53

 

 

 

4.28

 

 

$

3,610

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(428,250

)

 

 

38.66

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(355,750

)

 

 

39.99

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

869,000

 

 

$

37.87

 

 

 

3.51

 

 

$

5,172

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(434,250

)

 

 

38.12

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,750

)

 

 

38.05

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

428,000

 

 

$

37.61

 

 

 

3.20

 

 

$

11,815

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(215,250

)

 

 

38.46

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,000

)

 

 

38.05

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

Exercisable at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

There have been 0 stock options granted since the year ended December 31, 2017 and all options are currently vested. The total intrinsic value of options exercised during the years ended December 31, 2021, 2020 and 2019 was $8,269, $5,317 and $1,681, respectively.

F-36


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Restricted Stock

The following table summarizes restricted stock activity during the years ended December 31, 2021, 2020 and 2019:

Unvested Restricted Shares

 

Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

Outstanding at December 31, 2018

 

 

136,566

 

 

$

37.16

 

Granted

 

 

19,920

 

 

 

40.16

 

Vested

 

 

(91,566

)

 

 

37.09

 

Forfeited

 

 

(30,000

)

 

 

38.05

 

Outstanding at December 31, 2019

 

 

34,920

 

 

$

38.31

 

Granted

 

 

32,406

 

 

 

39.96

 

Vested

 

 

(32,420

)

 

 

38.33

 

Forfeited

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

34,906

 

 

$

39.82

 

Granted

 

 

13,742

 

 

 

70.18

 

Vested

 

 

(37,272

)

 

 

41.70

 

Forfeited

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

11,376

 

 

$

70.33

 

The compensation cost associated with restricted shares is estimated on the date of grant using quoted market prices (Level 1 input). The total fair value of restricted shares vested in 2021, 2020 and 2019 was $1,554, $1,499 and $3,697, respectively.

RSUs

The following table summarizes restricted stock unit activity during the years ended December 31, 2021, 2020 and 2019:

Unvested Restricted Stock Units

 

Time Vesting

Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

Outstanding at December 31, 2018

 

 

86,392

 

 

$

42.53

 

Granted

 

 

107,391

 

 

 

40.99

 

Vested

 

 

(23,956

)

 

 

42.62

 

Forfeited

 

 

(28,086

)

 

 

39.88

 

Outstanding at December 31, 2019

 

 

141,741

 

 

$

42.16

 

Granted

 

 

132,864

 

 

 

34.41

 

Vested

 

 

(50,953

)

 

 

42.13

 

Forfeited

 

 

(14,747

)

 

 

39.16

 

Outstanding at December 31, 2020

 

 

208,905

 

 

$

37.26

 

Granted

 

 

93,539

 

 

 

79.79

 

Vested

 

 

(88,296

)

 

 

38.49

 

Forfeited

 

 

(20,522

)

 

 

48.76

 

Outstanding at December 31, 2021

 

 

193,626

 

 

$

56.02

 

The total intrinsic value of restricted stock units vested during the years ended December 31, 2021, 2020 and 2019 was $3,398, $2,214 and $1,000, respectively.

F-37


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

PSUs

The following table summarizes performance stock unit activity during the years ended December 31, 2021, 2020 and 2019:

Unvested Performance Stock Units

 

Relative TSR Target

Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

 

ROIC Target

Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

 

Adjusted EBITDA Target Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

 

Total

 

Outstanding at December 31, 2018

 

 

64,785

 

 

$

62.45

 

 

 

64,792

 

 

$

42.53

 

 

 

 

 

$

 

 

 

129,577

 

Granted

 

 

56,380

 

 

 

57.39

 

 

 

56,375

 

 

 

41.51

 

 

 

 

 

 

 

 

 

112,755

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(26,124

)

 

 

53.98

 

 

 

(26,128

)

 

 

39.41

 

 

 

 

 

 

 

 

 

(52,252

)

Outstanding at December 31, 2019

 

 

95,041

 

 

$

61.77

 

 

 

95,039

 

 

$

42.78

 

 

 

 

 

$

 

 

 

190,080

 

Granted

 

 

77,967

 

 

 

49.25

 

 

 

77,967

 

 

 

33.72

 

 

 

 

 

 

 

 

 

155,934

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(15,090

)

 

 

56.84

 

 

 

(15,090

)

 

 

39.96

 

 

 

 

 

 

 

 

 

(30,180

)

Outstanding at December 31, 2020

 

 

157,918

 

 

$

56.06

 

 

 

157,916

 

 

$

38.58

 

 

 

 

 

$

 

 

 

315,834

 

Granted

 

 

20,626

 

 

 

118.08

 

 

 

40,580

 

 

 

78.98

 

 

 

39,930

 

 

 

79.49

 

 

 

101,136

 

Performance Adjustment

 

 

30,828

 

 

 

69.18

 

 

 

(30,830

)

 

 

44.92

 

 

 

 

 

 

 

 

 

(2

)

Vested

 

 

(61,656

)

 

 

69.18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(61,656

)

Forfeited

 

 

(16,148

)

 

 

61.10

 

 

 

(17,374

)

 

 

44.32

 

 

 

(2,454

)

 

 

79.49

 

 

 

(35,976

)

Outstanding at December 31, 2021

 

 

131,568

 

 

$

62.09

 

 

 

150,292

 

 

$

47.52

 

 

 

37,476

 

 

$

79.49

 

 

 

319,336

 

The total intrinsic value of performance stock units vested during the years ended December 31, 2021, 2020 and 2019 was $4,265, $0 and $0, respectively.

SARs

The following table summarizes SARs activity during the years ended December 31, 2021, 2020 and 2019:

Stock Appreciation Rights

 

Shares

 

 

Weighted-Average

Exercise Price

 

 

Weighted-Average

Remaining

Contractual Term

 

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2018

 

 

988,100

 

 

$

40.61

 

 

 

3.57

 

 

$

2,064

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(179,500

)

 

 

32.84

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(254,350

)

 

 

42.63

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

554,250

 

 

$

39.41

 

 

 

2.84

 

 

$

2,981

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(342,150

)

 

 

38.22

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(40,500

)

 

 

44.39

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

171,600

 

 

$

40.60

 

 

 

2.44

 

 

$

4,224

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(116,000

)

 

 

40.34

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

55,600

 

 

$

41.15

 

 

 

1.28

 

 

$

2,544

 

Exercisable at December 31, 2021

 

 

55,600

 

 

$

41.15

 

 

 

1.28

 

 

$

2,544

 

There have been 0 SARs granted since the year ended December 31, 2017 and all SARs are currently vested. The total intrinsic value of SARs exercised during the years ended December 31, 2021, 2020 and 2019 was $4,301, $4,164 and $1,588, respectively.

F-38


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 18 Income Taxes

The income tax provisions were calculated based upon the following components of earnings before income tax for the years ended December 31, 2021, 2020 and 2019:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Earnings before income tax:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

(4,547

)

 

$

(11,374

)

 

$

74,531

 

Foreign

 

 

118,399

 

 

 

92,930

 

 

 

(15,380

)

Earnings before income tax

 

$

113,852

 

 

$

81,556

 

 

$

59,151

 

The components of the provision for income taxes for the years ended December 31, 2021, 2020 and 2019 are summarized as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Current income tax expense:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

1,944

 

 

$

784

 

 

$

262

 

State and local

 

 

234

 

 

 

83

 

 

 

94

 

Foreign

 

 

18,390

 

 

 

20,150

 

 

 

17,672

 

Total current income tax expense

 

$

20,568

 

 

 

21,017

 

 

 

18,028

 

Deferred income tax (benefit) expense:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(4,400

)

 

 

(2,302

)

 

 

(2,490

)

State and local

 

 

(91

)

 

 

32

 

 

 

(1

)

Foreign

 

 

4,341

 

 

 

3,119

 

 

 

(5,252

)

Total deferred (benefit) income tax expense

 

 

(150

)

 

 

849

 

 

 

(7,743

)

Total income tax expense

 

$

20,418

 

 

$

21,866

 

 

$

10,285

 

As of December 31, 2021, deferred U.S. income taxes have not been provided on the undistributed earnings of the Company’s foreign subsidiaries since these earnings will not be taxable upon repatriation to the United States. These earnings will be primarily treated as previously taxed income from either the one-time transition tax or global intangible low-taxed income (“GILTI”) provision, or they will be offset with a 100% dividend received deduction.  However, the Company continues to provide a deferred tax liability for foreign income and withholding tax that will be incurred with respect to the undistributed foreign earnings that are not indefinitely reinvested.

F-39


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The deferred tax assets and deferred tax liabilities and related valuation allowance were comprised of the following as of December 31, 2021 and 2020:

 

 

December 31,

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

$

25,610

 

 

$

22,658

 

Intangible assets

 

 

21,179

 

 

 

29,145

 

Research and development credits

 

 

9,736

 

 

 

10,773

 

Property and equipment

 

 

7,071

 

 

 

7,426

 

Valuation reserves and accrued liabilities

 

 

7,333

 

 

 

7,131

 

Capitalized Research and Development Costs

 

 

9,018

 

 

 

 

 

Stock compensation

 

 

3,832

 

 

 

4,200

 

Defined benefit obligation

 

 

1,466

 

 

 

1,974

 

Inventory

 

 

1,914

 

 

 

1,571

 

Other credits

 

 

10,158

 

 

 

12,068

 

Unrealized foreign currency exchange loss

 

 

 

 

 

1,431

 

Other

 

 

146

 

 

 

64

 

Total deferred tax asset

 

 

97,463

 

 

 

98,441

 

Valuation allowance

 

 

(16,090

)

 

 

(17,197

)

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Unrealized foreign currency exchange gains

 

$

(2,488

)

 

$

 

Undistributed profits of subsidiary

 

 

(6,676

)

 

 

(5,727

)

Property and equipment

 

 

(2,420

)

 

 

(2,758

)

Other

 

 

(1,428

)

 

 

(572

)

Total deferred tax liability

 

 

(13,012

)

 

 

(9,057

)

Net deferred tax asset

 

$

68,361

 

 

$

72,187

 

Reconciliations between the statutory Federal income tax rate and the effective rate of income tax expense for the years ended December 31, 2021, 2020 and 2019 are as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Statutory Federal income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Increase (decrease) resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

Change in valuation allowance

 

 

(1.2

)%

 

 

(0.4

)%

 

 

11.5

%

Effect of different tax rates of foreign jurisdictions

 

 

(5.2

)%

 

 

(4.7

)%

 

 

(24.8

)%

US taxes on foreign income, net of taxes paid credit

 

 

2.0

%

 

 

2.5

%

 

 

4.3

%

Tax credits & deductions related to R&D

 

 

(2.3

)%

 

 

(3.8

)%

 

 

(3.6

)%

Non-deductible expenses

 

 

1.7

%

 

 

2.1

%

 

 

3.4

%

Other foreign, state and local taxes

 

 

1.6

%

 

 

1.4

%

 

 

1.7

%

Tax effects of intercompany transfers

 

 

0.6

%

 

 

1.4

%

 

 

1.5

%

Undistributed profit of subsidiaries

 

 

1.0

%

 

 

0.9

%

 

 

1.2

%

Stock Option Compensation

 

 

(2.0

)%

 

 

(0.4

)%

 

 

1.0

%

Audit Settlements and Statute Expirations

 

 

0.0

%

 

 

3.9

%

 

 

0.6

%

Other

 

 

0.7

%

 

 

2.9

%

 

 

(0.4

)%

Effective rate

 

 

17.9

%

 

 

26.8

%

 

 

17.4

%

The Company has Net Operating Loss (“NOL”) carryforwards as follows:

Jurisdiction

 

Amount as of

December 31, 2021

 

 

Years of Expiration

U.S. state income tax

 

$

67,795

 

 

2022-2041

Foreign

 

$

199,153

 

 

Never

F-40


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

We have NOL carryforwards in various states associated with the benefits of the state dividends received reduction and foreign royalty exclusion.  The state NOL carryforwards generally expire at various dates from 2022 to 2041. We have concluded that there is not sufficient evidence these NOL carryforwards will be utilized, and thus have not recognized the benefit of these NOL carryforwards.

At December 31, 2021, certain non-U.S. subsidiaries had NOL carryforwards totaling $199,153 which have no expiration date.

The Company is subject to taxation in the United States and various state and foreign jurisdictions. As of December 31, 2021, the Company was no longer subject to U.S. Federal examinations by tax authorities for tax years before 2017 and was no longer subject to foreign examinations by tax authorities for tax years before 2014.

The Company currently benefits from tax holidays in various non-U.S. jurisdictions with expiration dates from 2024 – 2025.   The amount of corporate income tax savings realized by the Company as a result of the tax holidays during the current and prior years was immaterial as a result of operating losses previously generated.

At December 31, 2021, 2020 and 2019, the Company had total unrecognized tax benefits of $5,665, $4,967 and $3,795, respectively, all of which, if recognized, would affect the effective income tax rates. The reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Balance at beginning of year

 

$

4,967

 

 

$

3,795

 

 

$

2,819

 

Additions based on tax position related to current year

 

 

1,105

 

 

 

1,489

 

 

 

661

 

Additions based on tax position related to prior year

 

 

160

 

 

 

179

 

 

 

352

 

Reductions from settlements and statute of limitation expiration

 

 

(312

)

 

 

(650

)

 

 

 

Effect of foreign currency translation

 

 

(255

)

 

 

154

 

 

 

(37

)

Balance at end of year

 

$

5,665

 

 

$

4,967

 

 

$

3,795

 

The Company classifies income tax-related penalties and net interest as income tax expense.  In the years ended December 31, 2021, 2020 and 2019, income tax related interest and penalties were not material. It is reasonably possible that audit settlements, the conclusions of current examinations or the expiration of the statute of limitations in several jurisdictions could impact the Company’s unrecognized tax benefits.

Note 19 Segment Reporting

Segment information is used by management for making operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss. As discussed in Note 17, Gentherm acquired Etratech on November 1, 2017. The acquisition enhances key elements of our business strategy by greatly expanding our knowledge and capability to produce in-house electronic components for next generation intelligent thermal management products.

The Company’s reportable segments are as follows:

Automotive — this segment represents the design, development, manufacturing and sales of automotive climate comfort solutions, battery sub-systems, specializedsystems, automotive cable systems, battery performance solutions, and automotive thermal convenience products. All ofelectronic and software systems.

Medical — this segment represents the results from our activities with respect to electronics are also included in our Automotive segment because a majority of these activities relate to the manufacture of electronic components for our automotive products or the automotive products of third parties. Etratech’s operating results are included within Gentherm’s Automotive segment due to the concentration of Etratech’s product applicationspatient temperature management business within the automotive, recreational vehicle and marine industries.medical industry.

Industrial — the combined operating results of GPT, CSZ and Gentherm’s advanced research and development division.  We perform advanced research and development on thermal management systems, including those that utilize new proprietary comfort software algorithms, to enhance the efficiency and functionality of our automotive heating and cooling products. Unlike research and development that relates to a specific product application for a customer, advanced research and development activities affect products and technologies that aren’t currently generating product revenue. The segment includes government sponsored research projects. See Note 15 for information regarding the Industrial segment assets and liabilities classified as held for sale.

Reconciling Items — include corporate selling, general and administrative costs and acquisition transaction costs.

F-32


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 9 — Segment Reporting – (Continued)

The tables below present segment information about the reported product revenues and operating income of the Company for years ended December 31, 2018, 2017 and 2016. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of December 31, 2018, goodwill assigned to our Automotive and Industrial segments were $37,533 and $17,778, respectively.  Due to the classification GPT’s and CSZ-IC’s assets as held for sale, an additional $6,844 of goodwill is classified within assets held for sale on Gentherm’s consolidated balance sheet as of December 31, 2018. As of December 31, 2017, goodwill assigned to our Automotive and Industrial segments were $38,912 and $30,773, respectively.  

The Corporate categoryincludes unallocated costs related to our corporate headquarter activities, including selling, general and administrative costs and acquisition transaction costs, which do not meet the requirements for being classified as an operating segment.

F-41


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The tables below present segment information about the reported product revenues and operating income of the Company for years ended December 31, 2021, 2020 and 2019. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level.

 

 

Automotive

 

 

Medical

 

 

Corporate

 

 

Total

 

2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,004,633

 

 

$

41,517

 

 

$

 

 

$

1,046,150

 

Depreciation and amortization

 

 

35,389

 

 

 

2,460

 

 

 

931

 

 

 

38,780

 

Operating income (loss)

 

 

162,994

 

 

 

(1,829

)

 

 

(46,159

)

 

 

115,006

 

2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

869,998

 

 

$

43,100

 

 

$

 

 

$

913,098

 

Depreciation and amortization

 

 

37,662

 

 

 

2,366

 

 

 

1,086

 

 

 

41,114

 

Operating income (loss)

 

 

138,410

 

 

 

971

 

 

 

(50,164

)

 

 

89,217

 

2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

920,225

 

 

$

51,459

 

 

$

 

 

$

971,684

 

Depreciation and amortization

 

 

40,923

 

 

 

1,621

 

 

 

1,702

 

 

 

44,246

 

Operating income (loss)

 

 

141,206

 

 

 

(5,735

)

 

 

(51,211

)

 

 

84,260

 

Automotive and Medical segment product revenues by product category for each of the years ended December 31, 2021, 2020 and 2019 are as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Climate Control Seat

 

$

393,816

 

 

$

342,550

 

 

$

359,355

 

Seat Heaters

 

 

270,054

 

 

 

249,665

 

 

 

284,174

 

Steering Wheel Heaters

 

 

102,496

 

 

 

76,272

 

 

 

65,426

 

Automotive Cables

 

 

84,114

 

 

 

73,997

 

 

 

88,031

 

Battery Performance Solutions

 

 

69,594

 

 

 

50,901

 

 

 

41,498

 

Electronics

 

 

51,648

 

 

 

53,238

 

 

 

47,542

 

Other Automotive

 

 

32,911

 

 

 

23,375

 

 

 

34,199

 

Subtotal Automotive segment

 

 

1,004,633

 

 

 

869,998

 

 

 

920,225

 

Medical

 

 

41,517

 

 

 

43,100

 

 

 

36,860

 

GPT

 

 

 

 

 

 

 

 

11,181

 

CSZ-IC

 

 

 

 

 

 

 

 

3,418

 

Subtotal Medical segment

 

 

41,517

 

 

 

43,100

 

 

 

51,459

 

Total Company

 

$

1,046,150

 

 

$

913,098

 

 

$

971,684

 

F-42


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Revenue (based on shipment destination) by geographic area for each of the years ended December 31, 2021, 2020 and 2019 is as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

United States

 

$

404,466

 

 

$

377,577

 

 

$

440,316

 

China

 

 

142,816

 

 

 

101,039

 

 

 

71,461

 

South Korea

 

 

93,516

 

 

 

88,745

 

 

 

63,339

 

Germany

 

 

66,929

 

 

 

58,536

 

 

 

81,315

 

Japan

 

 

63,527

 

 

 

57,785

 

 

 

76,197

 

Romania

 

 

51,367

 

 

 

33,147

 

 

 

26,213

 

Other

 

 

223,529

 

 

 

196,269

 

 

 

212,843

 

Total Non-U.S.

 

 

641,684

 

 

 

535,521

 

 

 

531,368

 

Total Company

 

$

1,046,150

 

 

$

913,098

 

 

$

971,684

 

The table below lists the percentage of total product revenues generated from sales to customers which contributed 10% or more to the Company’s total consolidated product revenue for the years ended December 31, 2021, 2020 and 2019:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Lear

 

 

15

%

 

 

15

%

 

 

16

%

Adient

 

 

15

%

 

 

14

%

 

 

15

%

Property and equipment, net, for each of the geographic areas in which the Company operates as of December 31, 2021 and 2020 is as follows:

 

 

December 31,

 

Property and equipment, net

 

2021

 

 

2020

 

North Macedonia

 

$

32,682

 

 

$

36,925

 

China

 

 

25,411

 

 

 

20,375

 

Mexico

 

 

20,296

 

 

 

16,034

 

Vietnam

 

 

19,876

 

 

 

21,080

 

United States

 

 

19,222

 

 

 

19,011

 

Germany

 

 

16,174

 

 

 

15,641

 

Ukraine

 

 

9,539

 

 

 

9,034

 

Hungary

 

 

8,995

 

 

 

10,079

 

Other

 

 

3,075

 

 

 

4,402

 

Total

 

$

155,270

 

 

$

152,581

 

F-43


GENTHERM INCORPORATED

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended December 31, 2021, 2020 and 2019

(In thousands)

Description

 

Balance at

Beginning

of Period

 

 

Charged to

Costs and

Expenses

 

 

Other Activity

 

 

Deductions

from

Reserves

 

 

Balance at

End of

Period

 

Allowance for Doubtful Accounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2019

 

$

851

 

 

$

969

 

 

$

(8

)

 

$

(619

)

 

$

1,193

 

Year Ended December 31, 2020

 

 

1,193

 

 

 

1,298

 

 

 

33

 

 

 

(1,363

)

 

 

1,161

 

Year Ended December 31, 2021

 

 

1,161

 

 

 

1,066

 

 

 

(12

)

 

 

(816

)

 

 

1,399

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for Deferred Income Tax Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2019

 

$

9,977

 

 

$

7,830

 

 

$

(491

)

 

$

 

 

$

17,316

 

Year Ended December 31, 2020

 

 

17,316

 

 

 

 

 

 

139

 

 

 

(258

)

 

 

17,197

 

Year Ended December 31, 2021

 

 

17,197

 

 

 

357

 

 

 

(102

)

 

 

(1,362

)

 

 

16,090

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reserve for Inventory

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2019

 

$

6,270

 

 

$

1,679

 

 

$

(56

)

 

$

(1,820

)

 

$

6,073

 

Year Ended December 31, 2020

 

 

6,073

 

 

 

1,768

 

 

 

214

 

 

 

(914

)

 

 

7,141

 

Year Ended December 31, 2021

 

 

7,141

 

 

 

2,499

 

 

 

(134

)

 

 

(3,492

)

 

 

6,014

 


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  

Automotive

 

  

Industrial

 

  

Reconciling
Items

 

 

Consolidated
Total

 

2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

948,592

 

 

$

89,667

 

 

$

 

 

$

1,038,259

 

Depreciation and amortization

 

 

43,621

 

 

 

4,384

 

 

 

2,633

 

 

 

50,638

 

Operating income (loss)

 

 

152,051

 

 

 

(22,530

)

 

 

(56,733

)

 

 

72,788

 

2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

879,457

 

 

$

106,226

 

 

$

 

 

$

985,683

 

Depreciation and amortization

 

 

36,801

 

 

 

5,399

 

 

 

2,772

 

 

 

44,972

 

Operating income (loss)

 

 

166,378

 

 

 

(14,751

)

 

 

(54,529

)

 

 

97,098

 

2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

847,428

 

 

$

70,172

 

 

$

 

 

$

917,600

 

Depreciation and amortization

 

 

31,826

 

 

 

3,789

 

 

 

2,149

 

 

 

37,764

 

Operating income (loss)

 

 

174,027

 

 

 

(16,702

)

 

 

(51,206

)

 

 

106,119

 

Automotive

GENTHERM INCORPORATED

By:

/S/    Phillip Eyler

Phillip Eyler

Chief Executive Officer

Date:  February 17, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

Signature

Capacity

Date

/s/   PHILLIP EYLER 

Director, President and Industrial segment product revenues by product category for eachChief

February 17, 2022

PHILLIP EYLER

Executive Officer (Principal Executive Officer)

/s/    MATTEO ANVERSA

Executive Vice President, Chief

February 17, 2022

MATTEO ANVERSA

Financial Officer and Treasurer (Principal Financial Officer)

/s/    JENNIFER ZOLDOS

Chief Accounting Officer

February 17, 2022

JENNIFER ZOLDOS

(Principal Accounting Officer)

*

Director, Chairman of the years ended December 31, 2018, 2017 and 2016 are as follows:Board

 

 

 

2018

 

%

 

 

2017

 

%

 

 

2016

 

%

 

Climate Control Seat (CCS)

 

$

374,816

 

 

36

%

 

$

387,961

 

 

40

%

 

$

405,795

 

 

44

%

Seat Heaters

 

 

305,337

 

 

29

%

 

 

307,309

 

 

31

%

 

 

288,939

 

 

32

%

Steering Wheel Heaters

 

 

69,845

 

 

7

%

 

 

62,125

 

 

6

%

 

 

49,516

 

 

5

%

Automotive Cables

 

 

98,931

 

 

9

%

 

 

92,093

 

 

9

%

 

 

85,283

 

 

9

%

Battery Thermal Management (BTM) (1)

 

 

28,472

 

 

3

%

 

 

10,043

 

 

1

%

 

 

6,546

 

 

1

%

Etratech

 

 

54,267

 

 

5

%

 

 

8,398

 

 

1

%

 

 

 

 

0

%

Other Automotive

 

 

16,924

 

 

2

%

 

 

11,528

(2)

1

%

 

 

11,349

 

 

1

%

Subtotal Automotive

 

 

948,592

 

 

91

%

 

 

879,457

 

 

89

%

 

 

847,428

 

 

92

%

Remote Power Generation (GPT)

 

 

19,222

 

 

2

%

 

 

31,891

 

 

3

%

 

 

18,628

 

 

2

%

Cincinnati Sub-Zero Products (CSZ)

 

 

70,445

 

 

7

%

 

 

74,335

 

 

8

%

 

 

51,544

 

 

6

%

Subtotal Industrial

 

 

89,667

 

 

9

%

 

 

106,226

 

 

11

%

 

 

70,172

 

 

8

%

Total Company

 

$

1,038,259

 

 

100

%

 

$

985,683

 

 

100

%

 

$

917,600

 

 

100

%

(1)Battery Thermal Management or BTM product revenues include Gentherm’s automotive grade, low cost, heat resistant fans and blowers used by customer for battery cooling through ventilation and production level shipments of the advanced TED based active cool system which began during the fourth quarter of 2017.

(2)Includes $2.0 million rebate to customer during 2017.

February 17, 2022

F-33RONALD HUNDZINSKI


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 9 — Segment Reporting – (Continued)

The Industrial operating loss is net of reimbursement for developmental expenses of $1,117, $2,116 and $641 for the years ended 2018, 2017 and 2016, respectively. Reconciling items include selling, general and administrative costs of $42,857, $43,457 and $39,059, respectively, for the years ended December 31, 2018, 2017 and 2016 and acquisition costs of $0, $789 and $743 for the years ended December 31, 2018, 2017 and 2016, respectively.

Revenue (based on shipment destination) by geographic area is as follows:

 

 

 

2018

 

 

%

 

 

2017

 

 

%

 

 

2016

 

 

%

 

United States

 

$

488,926

 

 

 

47

%

 

$

454,669

 

 

 

46

%

 

$

449,065

 

 

 

49

%

China

 

 

93,628

 

 

 

9

%

 

 

93,645

 

 

 

9

%

 

 

80,493

 

 

 

9

%

Germany

 

 

88,366

 

 

 

9

%

 

 

71,768

 

 

 

7

%

 

 

70,258

 

 

 

8

%

Japan

 

 

62,633

 

 

 

6

%

 

 

57,467

 

 

 

6

%

 

 

45,103

 

 

 

5

%

South Korea

 

 

58,717

 

 

 

6

%

 

 

64,715

 

 

 

7

%

 

 

75,396

 

 

 

8

%

Canada

 

 

44,500

 

 

 

4

%

 

 

46,368

 

 

 

5

%

 

 

37,954

 

 

 

4

%

Czech Republic

 

 

42,665

 

 

 

4

%

 

 

38,828

 

 

 

4

%

 

 

38,164

 

 

 

4

%

United Kingdom

 

 

37,533

 

 

 

4

%

 

 

36,033

 

 

 

4

%

 

 

28,540

 

 

 

3

%

Romania

 

 

22,435

 

 

 

2

%

 

 

18,050

 

 

 

2

%

 

 

11,907

 

 

 

1

%

Other

 

 

98,856

 

 

 

9

%

 

 

104,320

 

 

 

10

%

 

 

80,720

 

 

 

9

%

Total Non U.S.

 

 

549,333

 

 

 

53

%

 

 

531,014

 

 

 

54

%

 

 

468,535

 

 

 

51

%

 

 

$

1,038,259

 

 

 

100

%

 

$

985,683

 

 

 

100

%

 

$

917,600

 

 

 

100

%

 

We rely on three customers, two domestic and one foreign, to derive a significant portion of our product revenues.  The table below lists the percentage of total product revenues generated from sales to these customers:

 

 

  

2018

 

  

2017

 

  

2016

 

Lear (domestic)

 

 

17

%

 

 

20

%

 

 

21

%

Adient (domestic)

 

 

16

%

 

 

18

%

 

 

21

%

Bosch (foreign)

 

 

8

%

 

 

8

%

 

 

8

%

 

Note 10 Pension and Other Post Retirement Benefit Plans

On August 8, 2008 the Company established The Executive Nonqualified Defined Benefit Plan of Gentherm Incorporated (the “Plan”), an unfunded executive pension plan, with an effective date of April 1, 2008. The Company’s former Chief Executive Officer, Daniel R. Coker, is the only participant in the Plan.

On May 10, 2017 the Company amended (the “Plan Amendment”) the Plan. Prior to the Plan Amendment, the Plan provided  for 15 annual retirement benefit payments of $300,000 each beginning January 1, 2018. Mr. Coker became fully vested in the benefits under the Benefit Plan on April 1, 2017. The Plan Amendment provided that if Mr. Coker continued to provide employment service to the Company through and including January 1, 2018, the fifteen annual retirement benefit payments would be increased to $342,000, otherwise the 15 annual retirement benefits would remain at $300,000.

On June 28, 2017, the same day a leader transition plan leading up to Mr. Coker’s retirement was announced, the Company entered into a Retirement Agreement with Mr. Coker (the “Retirement Agreement”).  The Retirement Agreement provided that if Mr. Coker’s retirement date was prior to January 1, 2018, the Company would amend the terms of the Plan, as amended, to accelerate the in-service vesting date to ensure an increase in the annual accrued benefit from $300,000 to $342,000.  Mr. Coker became fully vested in the incremental benefit, as described in the Plan Amendment, on December 4, 2017.

F-34


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 10 — Pension and Other Post Retirement Benefit Plans – (Continued)

The Company records a projected benefit obligation representing the present value of future plan benefits when earned by the participant. The following table sets forth the benefit obligation, amounts recognized in the Company’s financial statements and the principal assumptions used:

 

 

  

2018

 

  

2017

 

Change in projected benefit obligation:

  

 

 

 

  

 

 

 

Benefit obligation at beginning of year

  

$

4,218

  

  

$

3,419

  

Service cost

  

 

  

  

 

101

  

Interest cost

  

 

114

  

  

 

111

  

Actuarial (gain) loss

 

 

(158

)

 

 

78

 

Prior service cost

 

 

(342

)

 

 

509

 

Benefit obligation at end of year

  

$

3,832

 

  

$

4,218

 

*

 

The portion of the benefit obligation from the Plan expected to be paid in 2019 is classified as a current liability within accrued liabilities in the Company’s consolidated balance sheet.  The remaining portion is classified as a non-current liability within pension benefit obligations. Service and interest cost is included in selling, general and administrative expenses in the Company’s consolidated statements of income and actuarial gains and losses are included the Company’s consolidated balance sheet as part of accumulated other comprehensive income within shareholders’ equity. Actuarial gains or losses are amortized to selling, general and administrative expense in the Company’s consolidated statements of income based on the average future service life of the Plan using the corridor method. A discount rate assumption of 3.65%, 2.95% and 3.25% was used to determine the benefit obligation for the years ended December 31, 2018, 2017 and 2016, respectively.   A discount rate assumption of 2.95%, 3.25% and 3.40% was used to determine the net periodic service cost for years ended December 31, 2018, 2017 and 2016, respectively. Prior service costs reflect an increase to the projected benefit obligation as a result of the Plan Amendment, which retroactively increased benefits.  Prior service cost is included in selling, general and administrative expenses in the Company’s consolidated statements of income. We do not expect contributions to be paid to the Plan during the next fiscal year.Director

Although the Plan is not funded, the Company has established a separate trust having the sole purpose of paying benefits under the Plan. The only asset of the trust is a corporate-owned life insurance policy (“COLI”). The COLI is valued at fair value using quoted prices listed in active markets (Level 1 input based on the U.S. GAAP fair value hierarchy). The policy value of the COLI was $2,148 and $2,353 as of December 31, 2018 and 2017, respectively, and was included in other non-current assets.

Components of the Plan’s net periodic pension benefit cost for the years ended December 31, 2018, 2017 and 2016 are as follows:

 

 

  

2018

 

  

2017

 

 

2016

 

Service cost

  

$

  

  

$

101

  

  

$

387

 

Interest cost

  

 

114

  

  

 

111

  

  

 

98

 

Amortization of prior service cost

  

 

  

  

 

509

  

  

 

 

Net periodic benefit cost

  

$

114

  

  

$

721

  

  

$

485

 

February 17, 2022

SOPHIE DESORMIERE

 

F-35


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 10 — Pension and Other Post Retirement Benefit Plans – (Continued)

Pretax amounts recognized in other comprehensive income for the years ended December 31, 2018, 2017 and 2016 are as follows

 

 

  

2018

 

 

2017

 

2016

 

Actuarial Losses/(gains)

 

$

(158

)

 

$

78

 

$

36

 

Amortization of actuarial losses

 

 

 

 

 

 

 

 

Establish prior service cost

 

 

 

 

 

509

 

 

 

Amortization prior service cost

 

 

 

 

 

(509

)

 

 

 

 

$

(158

)

 

$

78

 

$

36

 

Tax expense of $73 was recognized in other comprehensive income related to the Plan for the year ended December 31, 2018, which included $40 due to the adoption of ASU 2018-02. See Note 13 for additional information about ASU 2018-02 and its impact in to Gentherm’s financial statements. Tax benefit of $26 was recognized in other comprehensive income related to the Plan for the year ended December 31, 2017. Tax expense of $14 was recognized in other comprehensive income related to the Plan for the year ended December 31, 2016.  

Pretax unrecognized actuarial losses recorded in accumulated other comprehensive loss not yet recognized in net periodic benefit cost were $222 and $380 as of December 31, 2018 and 2017, respectively.  No amount of pretax unrecognized actuarial loss recorded in accumulated other comprehensive income as of December 31, 2018 are expected to be recognized as components of net periodic benefit cost in the year ending December 31, 2019.  

Gentherm GmbH has an established defined benefit plan for retired and current members of its executive management team.

Gentherm GmbH records a projected benefit obligation representing the present value of future plan benefits when earned by the participant. The following table sets forth the benefit obligation and amounts recognized in the Company’s financial statements:

 

 

  

2018

 

 

2017

 

Change in projected benefit obligation:

 

 

 

 

 

 

 

 

Benefit obligation at beginning of year

 

$

7,927

 

 

$

7,326

 

Interest cost

 

 

147

 

 

 

130

 

Paid pension distributions

 

 

(292

)

 

 

(272

)

Actuarial (gains)/losses

 

 

114

 

 

 

(257

)

Exchange rate impact

 

 

(367

)

 

 

1,000

 

Benefit obligation at end of year

 

$

7,529

 

 

$

7,927

 

The following table sets forth the fair value of the plan assets for the periods ending December 31, 2018 and 2017:

 

 

  

2018

 

 

2017

 

Change in plan assets:

  

 

 

 

 

 

 

 

Plan assets at beginning of year

  

$

3,891

  

 

$

3,326

  

Actual return on plan assets

  

 

130

  

 

 

121

  

Contributions

  

 

292

  

 

 

272

  

Paid pension distributions

 

 

(292

)

 

 

(272

)

Actuarial losses

  

 

(30

)

 

 

(28

)

Exchange rate impact

  

 

(183

)

 

 

472

 

Plan assets at end of year

  

$

3,808

  

 

$

3,891

  

F-36


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 10 — Pension and Other Post Retirement Benefit Plans – (Continued)

The $3,720 and $4,036 net liability from the Gentherm GmbH plan as of December 31, 2018 and 2017, respectively, is classified as a noncurrent liability in pension benefit obligation.

Pretax amounts recognized in other comprehensive (loss) income for the years ended December 31, 2018, 2017 and 2016 are as follows:

 

 

  

2018

 

 

2017

 

2016

 

Actuarial (gains)/losses

 

$

143

 

 

$

(229

)

$

718

 

Amortization of actuarial losses

 

 

(73

)

 

 

(78

)

 

(48

)

Amortization of prior service cost

 

 

 

 

 

 

 

 

 

 

$

70

 

 

$

(307

)

$

670

 

Tax expense of $19 was recognized in other comprehensive income related to the Gentherm GmbH defined benefit plan for the year ended December 31, 2018.  Tax expense of $86 and tax benefit of $171 were recognized in other comprehensive income for the years ended December 31, 2017 and 2016, respectively.  *

Pretax unrecognized actuarial losses recorded in accumulated other comprehensive loss not yet recognized in net periodic benefit cost were $2,372 and $2,416 as of December 31, 2018 and 2017, respectively.  We expect $74 of pretax unrecognized actuarial loss recorded in accumulated other comprehensive income as of December 31, 2018 to be recognized as components of net periodic benefit cost in the year ending December 31, 2019.

Components of the Plan’s net periodic pension benefit cost for the years ended December 31, 2018, 2017 and 2016 are as follows:

 

 

  

2018

 

  

2017

 

 

2016

 

Interest cost

  

$

147

 

 

$

130

 

 

$

154

 

Return on plan assets

 

 

(130

)

 

 

(121

)

 

 

(125

)

Amortization of prior service cost

 

 

 

 

 

 

 

 

 

Amortization of actuarial loss (gains)

  

 

73

 

 

 

78

 

 

 

48

 

Net periodic benefit cost

  

$

90

 

 

$

87

 

 

$

77

 

The Gentherm GmbH defined benefit plan is underfunded by $3,720 and $4,036 as of December 31, 2018 and 2017, respectively. The net periodic benefit cost is included in selling, general and administrative expenses in the Company’s consolidated statements of income and actuarial gains and losses are included the Company’s consolidated balance sheet as part of accumulated other comprehensive income within shareholders’ equity. Actuarial gains or losses are amortized to selling, general and administrative expense in the Company’s consolidated statements of income using the corridor method. The following table describes the actuarial assumptions used to determine the benefit obligation and the net periodic service cost:Director

 

 

  

2018

 

 

2017

 

 

2016

 

Discount rate

  

 

2.04

%

 

 

1.93

%

 

 

1.69

%

Expected long term rate of return on plan assets

  

 

3.40

%

 

 

3.40

%

 

 

3.40

%

February 17, 2022

YVONNE HAO

 

F-37


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 10 — Pension and Other Post Retirement Benefit Plans – (Continued)

Plan assets are comprised of Gentherm GmbH’s pension insurance policies and are pledged to the beneficiaries of the plan. A market valuation technique, based on observable underlying insurance charges, is used to determine the fair value of the pension plan assets (Level 2). The expected return on plan assets assumption used to calculate Gentherm GmbH’s pension benefit obligation was determined using actual returns realized on plan assets in the prior year. We do not expect contributions to be paid to the Gentherm GmbH defined benefit plan during the next fiscal year.

The schedule of expected pension payments made to Gentherm GmbH defined benefit plan participants over the next 10 years is as follows:

 

Year

  

 

 

2019

  

$

287

  

2020

  

 

285

  

2021

  

 

283

  

2022

  

 

279

  

2023

  

 

290

  

2024 - 2028

  

 

1,344

  

Total

  

$

2,768

  

 

Gentherm has adopted a 401(k) plan to provide all eligible employees a means to accumulate retirement savings on a tax-advantaged basis, and eligible executive officers can participate in this plan on the same basis as other participants. Participants may defer specified portions of their compensation. On a discretionary basis, the Company matches a portion of the employee contributions.  The Plan also allows for additional discretionary contributions. Gentherm made $1,471, $1,396 and $1,289 in matching contributions to the 401(k) plan in 2018, 2017 and 2016, respectively.  

On December 31, 2018, Gentherm adopted the Gentherm Incorporated Deferred Compensation Plan (the “Management Plan”), effective January 1, 2019. The Management Plan’s purpose is to attract and retain a select group of management or highly compensated employees who will contribute significantly to the future business success of the Company by providing supplemental retirement income benefits. No contributions were made to the Management Plan as of December 31, 2018.

 

Note 11 Fair Value Measurement

The Company bases fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

F-38


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 11 Fair Value Measurement – (Continued)

Except for derivative instruments (see Note 12), pension liabilities, pension plan assets and a corporate owned life insurance policy (see Note 10), and assets and liabilities held for sale (see Note 15), the Company has no financial assets and liabilities that are carried at fair value at December 31, 2018 and 2017. The carrying amounts of financial instruments comprising cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs).

As of December 31, 2018 and 2017, the carrying values of the Company’s Credit Agreement indebtedness were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 5). Discount rates used to measure the fair value of Gentherm’s DEG Vietnam Loan and DEG China Loan are based on quoted swap rates.  As of December 31, 2018, the carrying values of the DEG Vietnam Loan and DEG China Loan were $11,250 and $913, respectively, as compared to an estimated fair value of $11,100 and $900, respectively.  As of December 31, 2017, the carrying value of the DEG Vietnam Loan and DEG China Loan were $13,750 and $1,919, as compared to an estimated fair value of $13,600 and $2,000, respectively.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable.  See Note 15 for information regarding impairment losses recognized on assets and liabilities classified as held for sale in 2018. As of December 31, 2017, the Company did not realize any changes to the fair value of these assets due to the non-occurrence of events or circumstances that could negatively impact their recoverability.

Note 12 — Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $33,250 and $29,273 outstanding at December 31, 2018 and 2017, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years.  We had copper commodity swap contracts with a notional value of $0 and $404 outstanding at December 31, 2018 and 2017, respectively.  

F-39


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

*

 

Note 12 — Derivative Financial Instruments – (Continued)Director

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated balance sheet.  When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated statement of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.  We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated statements of income. See Note 14 for the amount of unrealized loss associated with foreign currency derivatives and copper commodity derivatives reported in accumulated other comprehensive income as of December 31, 2017 that was reclassified into earnings during 2018. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative financial instruments in our consolidated balance sheet as of December 31, 2018 is as follows:

 

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

 

  

92

 

  

Current liabilities

 

$

 

 

$

92

 

Information related to the recurring fair value measurement of derivative financial instruments in our consolidated balance sheet as of December 31, 2017 is as follows:  February 17, 2022

David Heinzmann

 

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

 

  

141

 

  

Current liabilities

 

$

(1,050

)

 

$

(909

)

Commodity derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

  

  

$

72

  

  

 

 

 

 

 

 

$

72

 

 

F-40


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 12 — Derivative Financial Instruments – (Continued)

Information related to the effect of derivative instrument`s on our consolidated statements of income is as follows:  

 

 

 

Location

  

Year
Ended
December 31,
2018

 

 

Year
Ended
December 31,
2017

 

Foreign currency derivatives

 

Product Revenues

 

$

 

 

$

(3

)

 

 

Cost of sales

 

 

(444

)

 

 

2,209

 

 

 

Selling, general and administrative

 

 

75

 

 

 

(216

)

 

 

Other comprehensive income

 

 

1,096

 

 

 

302

 

 

 

Foreign currency gain

 

 

50

 

 

 

(112

)

Total foreign currency derivatives

 

 

 

$

777

 

 

$

2,180

 

Commodity derivatives

 

Cost of sales

 

$

145

 

 

$

202

 

 

 

Other comprehensive (loss) income

 

$

(218

)

 

$

54

 

Total commodity derivatives

 

 

 

$

(73

)

 

$

256

 

We did not incur any hedge ineffectiveness during the years ended December 31, 2018 and 2017.  

Note 13 — New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Revenue from Contracts with Customers

In May 2014, the FASB issued Accounting Standard Update (“ASU”) 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principal is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those good or services. Issuers are to use a five-step contract review model to ensure revenue is measured, recognized, and disclosed in accordance with this principle. The FASB issued several amendments to the update, including a one-year deferral of the original effective date, and new methods for identifying performance obligations that are intended to reduce the cost and complexity of compliance.

We adopted ASU 2014-09 and related amendments effective January 1, 2018 using the cumulative catch-up transition method, which required us to disclose the cumulative effect of initially applying the update recognized at the date of initial application. We elected to apply the guidance in ASU 2014-09 to contracts that were not completed at January 1, 2018.

The most significant impact from adoption of ASU 2014-09 occurred within our Automotive segment and relates to our accounting for production part purchase options that grant customers a material right to purchase additional parts under long-term supply agreements in the future. Due to the complexity of certain of our automotive supply contracts, the actual revenue recognition treatment for customer purchase options will depend on contract-specific terms and could vary from other contracts that are similar in nature. Revenue recognition related to goods and services reported in the Industrial segment remains substantially unchanged.

F-41


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 13 – New Accounting Pronouncements – (Continued)

The amount by which each financial statement line item was affected by application of ASU 2014-09 and related amendments during 2018 is as follows:

 

 

  

Revenue Based on Previously Effective Guidance

 

  

New Revenue Standard Adjustment

 

  

Revenue Based on New Revenue Standard

 

Year Ended December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,035,773

 

 

$

2,486

 

 

$

1,038,259

 

Income tax expense

 

 

16,727

 

 

 

507

 

 

 

16,220

 

Net income

 

 

39,920

 

 

 

1,979

 

 

 

41,899

 

Basic earnings per share

 

 

1.11

 

 

 

0.06

 

 

 

1.17

 

Diluted earnings per share

 

 

1.10

 

 

 

0.06

 

 

 

1.16

 

 

 

  

Revenue Based on Previously Effective Guidance

 

  

New Revenue Standard Adjustment

 

  

Revenue Based on New Revenue Standard

 

Balance Sheet December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net of allowance for doubtful accounts

 

$

166,858

 

 

$

 

 

$

166,858

 

Accrued liabilities(a)

 

$

64,211

 

 

$

1,597

 

 

$

65,808

 

Unearned revenue(a)

 

$

 

 

$

1,597

 

 

$

1,597

 

Deferred income taxes, net

 

$

62,522

 

 

$

325

 

 

$

62,847

 

Accumulated earnings

 

$

365,237

 

 

$

(1,272

)

 

$

363,965

 

*

 

a)

During 2018, unearned revenues associated with GPT and CSZ-IC were classified as liabilities held for sale.  As of December 31, 2018, 5,351 in unearned revenues associated with GPT and CSZ-IC were classified as liabilities held for sale.

Director

February 17, 2022

Adoption of ASU 2014-09 and related amendments had no impact to cash from or used in operating, investing or financing activities on our consolidated statements of cash flows.CHARLES KUMMETH

Statement of Cash Flows

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.”  ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company focused its evaluation on the following transactions to determine the effect ASU 2016-15 will have on the Company’s Consolidated Statements of Cash Flows:

 

1)

Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities.  Previously, Gentherm classified debt extinguishment payments within operating activities. 

 

2)

Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities up to the amount of the liability recognized at the acquisition date.  Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflows for operating activities.

3)

Cash receipts from the settlement of insurance claims, excluding those related to corporate-owned life insurance policies shall be classified on the basis of the related insurance coverage.  For example, proceeds received to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities.

*

Director

February 17, 2022

BETSY METER

 

4)

Cash receipts from the settlement of corporate-owned life insurance policies shall be classified as cash inflows from investing activities.

F-42


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 13 – New Accounting Pronouncements – (Continued)

We have adopted ASU 2016-15 and related amendments effective January 1, 2018. None of the cash receipt and cash payment transactions addressed by the update occurred during any of the periods presented in this report. Adoption of this update and related amendments did not have a material impact on the cash flows of the Company.

Income Taxes

In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” ASU 2016-16 modifies the current prohibition to recognize deferred income taxes from differences between the tax basis of assets in the buyer’s tax jurisdiction and their cost resulting from an intra-entity transfer from one tax-paying component to another tax-paying component of the same consolidated group.  Under current GAAP, deferred income taxes for intra-entity asset transfers are not recognized until the asset is sold to an outside party.  ASU 2016-16 allows entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs.

We adopted ASU 2016-16 and related amendments effective January 1, 2018 on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of such adoption date. As a result of the amendments in ASU 2016-16, a favorable adjustment of $31,645 was recorded directly to retained earnings.  The new deferred tax assets will be recognized ratably over the useful life of the applicable assets.

Accumulated Other Comprehensive Income

In February 2018, the FASB issued ASU 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” ASU 2018-02 provides a remedy to a narrow-scope financial reporting issue created by the Tax Act.  The Tax Act required entities to adjust deferred tax assets and liabilities to reflect the impact from newly enacted lower corporate income tax rates and recognize the effect in income from continuing operations.  This requirement applied to all deferred tax assets and liabilities, even those which arose from transactions originally recognized in other comprehensive income.  The amendments in ASU 2018-02 allow adjustments to deferred tax assets and liabilities due to newly enacted lower corporate income tax rates to be recognized in retained earnings, if those deferred tax balances arose from transactions originally recognized in other comprehensive income.  

Income tax effects are released from accumulated other comprehensive income and recorded against the deferred tax balance in the consolidated balance sheet when the underlying activity is realized.  

ASU 2018-02 is effective for annual and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update is permitted, including adoption in any interim period for which financial statements have not yet been issued. The amendments in ASU 2018-02 must be applied in the period of adoption or retrospectively to each period in which the effect of the change in U.S. federal corporate income tax rate in the Tax Act is recognized. We elected to early adopt ASU 2018-02 and related amendments effective January 1, 2018. An adjustment of $40 was recognized against retained earnings for effect of the change in the federal corporate income tax rate on deferred tax amounts. There are no related adjustments to the Company’s valuation allowance and no other income tax effects from the Tax Act on balances that remain in accumulated other comprehensive income were reclassified.  

Tax Act

In January 2018, the FASB released guidance on the accounting for tax on the global intangible low-taxed income (“GILTI”) provisions of the Tax Act. The GILTI provisions impose a tax on foreign income in excess of deemed return on tangible assets of foreign corporations. During the first quarter of 2018, the Company elected to treat any potential GILTI inclusions as a period cost.

F-43


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Note 13 – New Accounting Pronouncements – (Continued)

Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 modified the concept of impairment of goodwill to be a condition that exists when the carrying value of a reporting unit that includes goodwill exceeds its fair value. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill allocated to that reporting unit. Entities no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination.

ASU 2017-04 is effective for annual and any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-04 must be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company has adopted the accounting principles in ASU 2017-04 and applied them to our test for goodwill impairment. See Note 15 for information about the goodwill impairment loss recognized during 2018.

Recently Issued Accounting Pronouncements Not Yet Adopted

Derivatives and Hedging

In October 2018, the FASB issued ASU 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes.” ASU 2018-16 adds the OIS Rate based on SOFR to the list of eligible benchmark interest rates that can be used for hedge accounting purposes under Topic 815.  SOFR is a volume-weighted median interest rate that is calculated daily based on overnight transactions from the prior day’s trading activity in specified segments of the U.S. Treasury repo market. The designation of the OIS rate based on SOFR as a benchmark interest rate for hedge accounting purposes is in response to ongoing concerns about the sustainability of LIBOR and the Federal Reserve’s intent to have a suitable alternative to USD LIBOR that is more firmly based on actual transactions in a robust market. Prior to this update, the only eligible benchmark interest rates were the interest rates on direct Treasury obligations of the U.S. government (UST), the LIBOR swap rate, the OIS Rate based on the Fed Funds Effective Rate and the Securities Industry and Financial Markets Association (SIFMA) Municipal Swap Rate.

ASU 2018-16 is effective for annual and interim periods beginning after December 15, 2018.  Early adoption of the amendments in this update is permitted. The amendments in this update should be adopted on a prospective basis for qualifying new or redesigned hedging relationships entered into on or after the date of adoption.  While the Company has not executed any U.S. benchmark interest rate transactions in order to apply hedge accounting under Topic 815, we are currently in the process of determining the impact implementation of ASU 2018-16 will have on our strategy approach to the management of interest rate risk.

Cloud Computing Arrangements That Are Service Contracts

In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 provides guidance on when costs incurred to implement a hosting arrangement that is a service contract are and are not capitalized, aligning with the guidance for capitalizing implementation costs incurred to develop or obtain internal-use software. Entities must first determine the project stage of the implementation activity; depending on their nature, costs for implementation activities in the application development stage are capitalized and costs incurred during the preliminary project and post-implementation stages are expensed as the activities are performed. Capitalized implementation costs should be amortized over the term of the hosting arrangement on a straight-line basis and presented in the same line items in the consolidated statement of income as the expense for fees for the associated hosting arrangements.  Similarly, capitalized implementation costs should be presented in same line item in the balance sheet as prepaid fees for the associated hosting arrangement and cash flows from capitalized implementation costs should be classified in the same manner as cash flows for the fees for the associated hosting arrangement.

F-44


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

*

 

Note 13 – New Accounting Pronouncements – (Continued)Director

ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of the amendments in this update is permitted, including adoption in any interim period for which financial statements have not yet been issued. ASU 2018-15 permits two methods of adoption: prospectively to costs for activities performed on or after the date the entity first applies the content from the update, or retrospectively to all periods presented. We are currently in the process of determining the impact implementation of ASU 2018-15 will have on the Company’s financial statement note disclosures.

Retirement Benefits

In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” The amendments in ASU 2018-14 were developed using the concepts incorporated in the FASB’s Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018.  The amendments in this update remove the following disclosure requirements, among others, from Subtopic 715-20:

1)

The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year.February 17, 2022

BYRON SHAW

 

2)

The amount and timing of plan assets expected to be returned to the employer.

The following disclosure requirements were added to Subtopic 715-20:

 

1)

The weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates.

2)

An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period.

*

Director

February 17, 2022

ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update are permitted. Entities should apply the amendments in this update on a retrospective basis to all periods presented.  We are currently in the process of determining the impact implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.”  The amendments in ASU 2018-13 were developed using the concepts incorporated in the FASBs Concepts Statement, Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements, which were finalized in August 2018.  The amendments in this update remove the following disclosure requirements from Topic 820:

1)

The amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy.

2)

The policy for timing of transfer between levels.

3)

The valuation processes for Level 3 fair value measurements.

The following disclosure requirements were added to Topic 820:

1)

The changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period.

2)

The range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements.

F-45


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 13 – New Accounting Pronouncements – (Continued)

ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. Early adoption of disclosures that are removed is permitted, but adoption is delayed for the new additional disclosures until their effective date. The amendments in ASU 2018-13 that provide for new additional disclosure should be applied on a prospective basis, while all other amendments should be applied retrospectively to all periods presented upon their effective date. We are currently in the process of determining the impact implementation of ASU 2018-13 will have on the Company’s financial statement note disclosures.

Leases  

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).”  ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease.  While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases will be recognized on the balance sheet.  

ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted. The FASB has issued several amendments to ASU 2016-02, including ASU 2018-11, “Leases (Topic 842): Targeted Improvements” that introduced an additional transition method permitting an entity to initially apply the new lease standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption.  We expect elect this transition method.  

ASU 2016-02 includes optional practical expedients intended to reduce the cost and complexity to implement the new lease standard, such as an option to maintain the current lease classification for all existing lease arrangements and the option to use hindsight in evaluating lessee options to extend or terminate a lease. We expect to elect these practical expedients. The Company expects to add right-of-use assets and the corresponding liabilities to the consolidated balance sheet equal to approximately 1.5% to 2.5% of total assets as of the implementation date.  Any differences between the total carrying value of right-of-use assets and lease liabilities will be recognized as a reduction to the 2019 opening balance in retained earnings.


F-46


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 14 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the year ended December 31, 2018, December 31, 2017 and December 31, 2016 are as follows:

 

  

Defined Benefit Pension Plans

 

  

Foreign Currency Translation Adjustments

 

  

Commodity Hedge Derivatives

 

 

Foreign Currency Hedge Derivatives

 

 

 

 

Total

 

Balance at December 31, 2017

 

$

(2,366

)

 

$

(17,555

)

 

$

277

 

 

$

(800

)

 

$

(20,444

)

Cumulative effect of accounting change due to adoption of ASU 2018-02

 

 

(49

)

 

 

 

 

 

9

 

 

 

 

 

 

 

(40

 

)

Other comprehensive income (loss) before reclassifications

 

 

18

 

 

 

(19,212

)

 

 

 

 

 

1,342

 

 

 

 

(17,852

 

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(15

)

 

 

(390

)

 

 

 

 

 

(337

)

 

 

 

(742

 

)

Amounts reclassified from accumulated other comprehensive income (loss) into net income

 

 

73

 

 

 

 

 

 

(218

 

 

)

a

 

(246

)

 

 

a

 

 

 

(391

 

 

)

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

(68

)

 

 

37

 

 

 

(31

)

Net current period other comprehensive income (loss)

 

 

27

 

 

 

(19,602

)

 

 

(277

)

 

 

796

 

 

 

 

(19,056

 

)

Balance at December 31, 2018

 

$

(2,339

)

 

 

(37,157

)

 

 

 

 

 

(4

)

 

 

(39,500

)

(a)

The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.  See Note 12 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

 

  

Defined Benefit Pension Plans

 

  

Foreign Currency Translation Adjustments

 

  

Commodity Hedge Derivatives

 

 

Foreign Currency Hedge Derivatives

 

 

 

 

Total

 

Balance at December 31, 2016

 

$

(2,550

)

 

$

(65,762

)

 

$

241

 

 

$

(1,020

)

 

$

(69,091

)

Other comprehensive income (loss) before reclassifications

 

 

166

 

 

 

48,059

 

 

 

254

 

 

 

2,123

 

 

 

 

50,602

 

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(60

)

 

 

148

 

 

 

(93

)

 

 

(570

)

 

 

 

(575

 

)

Amounts reclassified from accumulated other comprehensive income (loss) into net income

 

 

78

 

 

 

 

 

 

(199

)

a

 

(1,822

 

 

)

 

 

a

 

 

 

(1,943

 

 

)

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

74

 

 

 

489

 

 

 

563

 

Net current period other comprehensive income (loss)

 

 

184

 

 

 

48,207

 

 

 

36

 

 

 

220

 

 

 

 

48,647

 

Balance at December 31, 2017

 

$

(2,366

)

 

$

(17,555

)

 

$

277

 

 

$

(800

)

 

$

(20,444

)

(a)

The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.  See Note 12 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

F-47


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 14 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss) – (Continued)

 

  

Defined Benefit Pension Plans

 

  

Foreign Currency Translation Adjustments

 

  

Commodity Hedge Derivatives

 

 

Foreign Currency Hedge Derivatives

 

 

 

 

Total

 

Balance at December 31, 2015

 

$

(2,060

)

 

$

(49,381

)

 

$

(229

)

 

$

 

 

$

(51,670

)

Other comprehensive income (loss) before reclassifications

 

 

(723

)

 

 

(16,678

)

 

 

154

 

 

 

(1,351

)

 

 

 

(18,598

 

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

185

 

 

 

297

 

 

 

(57

)

 

 

363

 

 

 

 

788

 

Amounts reclassified from accumulated other comprehensive income (loss) into net income

 

 

48

 

 

 

 

 

 

589

a

 

 

(44

)

 

 

a

 

 

 

593

 

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

(216

)

 

 

12

 

 

 

(204

)

Net current period other comprehensive income (loss)

 

 

(490

)

 

 

(16,381

)

 

 

470

 

 

 

(1,020

)

 

 

 

(17,421

)

Balance at December 31, 2016

 

$

(2,550

)

 

$

(65,762

)

 

$

241

 

 

$

(1,020

)

 

$

(69,091

)

(a)

The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.  See Note 12 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

We expect all of the existing gains and losses related to foreign currency and commodity derivatives reported in accumulated other comprehensive income as of December 31, 2018 to be reclassified into earnings during the twelve month period ending December 31, 2019.

Note 15 – Assets and Liabilities Held for Sale

During 2018, Gentherm determined GPT and CSZ-IC met the held for sale criteria and recorded an impairment on assets held for sale of $2,190 in impairment loss to adjust net book value to fair value less costs to sell. See Note 2 for information about the Company’s held for sale accounting policy, including a description of the criteria necessary for a disposal group to qualify for classification as held for sale. GPT and CSZ-IC did not meet the criteria to be classified as a discontinued operation.

F-48


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 15 – Assets and Liabilities Held for Sale – (Continued)

The assets and liabilities of the disposal group classified as held for sale as of December 31, 2018 are as follows:

Accounts receivable, less allowance of $96

$

10,868

 

Inventory, net

 

13,925

 

Prepaid expenses and other assets

 

263

 

Property and equipment, net

 

29,459

  

Goodwill

 

6,844

 

Other intangible assets, net

 

6,326

 

Deferred income tax assets

 

4,204

 

Other non-current assets

 

  

Impairment loss

 

(2,190

)

Total assets held for sale

$

69,699

 

 

 

 

 

Accounts payable

$

2,614

 

Accrued liabilities

 

10,448

 

Total liabilities held for sale

$

13,062

 

Losses before income taxes from GPT and CSZ-IC during 2018, including $2,190 in impairment loss recognized on held for sale assets, $6,151 in impairment loss on goodwill and $3,135 in impairment loss recognized on other intangible assets, were $15,747. Losses before income taxes from GPT and CSZ-IC during 2017 were $1,949. Management’s estimates used to record impairment expense are inherently uncertain and may change in future periods.

Note 16 – Unearned Revenue

Unearned revenue by segment was as follows:

 

December 31,

2018

 

 

December 31, 2017

 

Automotive

$

1,597

 

 

$

 

Industrial

 

 

 

 

4,889

 

Total

$

1,597

 

 

$

4,889

 

Changes in unearned revenue were as follows:

Year Ended December 31, 2018

  

 

 

Balance, beginning of period

$

4,889

  

Additions to unearned revenue

 

21,774

  

Reclassified to revenue

 

(19,677

)

Reclassified to liabilities held for sale

 

(5,351

)

Currency impacts

 

(38

)

Balance, end of period

$

1,597

 

Revenue allocated to remaining performance obligations represent contracted revenue that has not yet been recognized, which includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods.

F-49


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 17 — Etratech Acquisition

Etratech designs, develops, manufactures and sells electronic control modules and control systems to customers across a range of industries, including automotive, recreational vehicles and marine, HVAC systems and medical, amongst others.  Each function is part of an integrated, customer-focused process designed to exceed customer expectations for product quality, reliability and cost. Etratech’s global manufacturing footprint will enable us to provide customers with scalable and flexible manufacturing solutions across a variety of application and geographies.

Results of operations for Etratech are included in the Company’s consolidated financial statements beginning November 1, 2017.  Etratech contributed $8,398 in product revenues and a net loss of $510 for the year ended December 31, 2017.  

Purchase Price Allocation

The purchase price of $65,009, net of cash acquired of $670, has been allocated to the values of assets acquired and liabilities assumed as of November 1, 2017.  An appraisal by an independent third party valuation firm was completed to assist management in determining the fair value of acquired assets and assumed liabilities, including identifiable intangible assets. The fair values of acquired assets and assumed liabilities were determined using the cost approach that relied primarily internal sources of data to make assumptions that are not observable in the market (Level 3 inputs).  The purchase price allocation was finalized during the first quarter of 2018. The allocation as of November 1, 2017 was as follows:

 

 

 

 

 

Accounts receivable

 

$

12,654

 

Inventory

 

 

7,014

 

Prepaid expenses and other assets

 

 

535

 

Property and equipment

 

 

6,205

 

Customer relationships

 

 

24,774

 

Technology

 

 

8,588

 

Goodwill

 

 

14,881

 

Assumed liabilities

 

 

(9,642

)

 

 

 

 

 

Net assets acquired

 

 

65,009

 

Cash acquired

 

 

670

 

 

 

 

 

 

Purchase price

 

$

65,679

 

The gross contractual amount due of accounts receivable is $12,654, all of which was subsequently collected.  

Supplemental Pro Forma Information

The unaudited pro forma combined historical results including the amounts of Etratech revenue and earnings that would have been included in the Company’s consolidated statements of income had the acquisition date been January 1, 2017 or January 1, 2016 are as follows:

 

Twelve Months Ended
December 31,

 

 

2017

 

 

2016

 

Product revenues

$

1,032,273

 

 

$

966,355

 

Net income

$

35,911

 

 

$

77,577

 

Basic earnings per share

$

0.98

 

 

$

2.13

 

Diluted earnings per share

$

0.98

 

 

$

2.12

 

The pro forma information includes adjustments for the effect of the amortization of intangible assets recognized in the acquisition.  This pro forma information is not indicative of future operating results.

F-50


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 17 – Etratech Acquisition – (Continued)

Goodwill

We recorded goodwill of approximately $14,881 arising from the acquisition. The acquired goodwill represents intangible assets that do not qualify for separate recognition. It is estimated that approximately $8,787 of the goodwill recognized will not be deductible for income tax purposes.  

Intangible Assets

In conjunction with the acquisition, intangible assets of $33,362 were recorded. The Company’s estimate of the fair value of these assets at the time of the acquisition was determined with the assistance of an independent third-party valuation firm. As part of the estimated valuation, an estimated useful life for the assets was determined.

Intangible assets, net consisted of the following:

 

 

December 31, 2017

 

  

Gross Value

  

 

Accumulated
Amortization

 

  

Net Value

  

  

Useful Life

Customer relationships

 

$

24,774

 

 

$

358

 

 

$

24,416

 

 

8 -12 yrs

Technology

 

 

8,588

 

 

 

277

 

 

 

8,311

 

 

5 -6 yrs

Total

 

$

33,362

 

 

$

635

 

 

$

32,727

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization expense of $635 for the period November 1, 2017 through December 31, 2017 was recorded as follows:

 

 

Three Months Ended
December 31, 2017

 

Twelve Months Ended
December 31, 2017

 

Product revenues

 

$

358

 

$

358

 

Research and development expenses

 

 

277

 

 

277

 

Amortization expense for the prospective five years is as follows:

2018

 

$

3,769

 

2019

 

$

3,769

 

2020

 

$

3,769

 

2021

 

$

3,706

 

2022

 

$

3,278

 

Property, Plant & Equipment

Property and equipment consist of the following:

Asset category

 

Useful life

 

Amount

 

Leasehold improvements

 

10 yrs

 

$

342

 

Machinery and equipment

 

4-11 yrs

 

 

5,248

 

Furniture and fittings

 

4 yrs

 

 

230

 

Motor Vehicles

 

3 yrs

 

 

25

 

Computer hardware and software

 

1 yrs

 

 

360

 

 

 

 

 

 

 

 

 

 

 

 

$

6,205

 

F-51


GENTHERM INCORPORATED

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended December 31, 2018, 2017 and 2016

(In thousands)

Description

 

Balance at
Beginning
of Period

 

  

Charged to
Costs and
Expenses

 

 

Charged to
Other
Accounts

 

 

Deductions
from
Reserves

 

 

Balance at
End of
Period

 

Allowance for Doubtful Accounts

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2016

 

 

955

  

  

 

1,469

 

 

 

(270

)

 

 

(763

)

 

 

  1,391

 

Year Ended December 31, 2017

 

 

  1,391

 

 

 

1,239

 

 

 

51

 

 

 

(1,708

)

 

 

973

 

Year Ended December 31, 2018

 

 

973

 

 

 

1,005

 

 

 

(121

)

 

 

(1,006

)

 

 

851

 

 

Allowance for Deferred Income Tax Assets

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2016

 

 

13,418

  

  

 

5,706

 

 

 

180

 

 

 

 

 

 

19,304

 

Year Ended December 31, 2017

 

 

19,304

  

  

 

6,700

 

 

 

1,574

 

 

 

 

 

 

27,578

 

Year Ended December 31, 2018

 

 

27,578

  

  

 

 

 

 

(14,009

)

 

 

(3,592

)

 

 

9,977

 

 

Reserve for Inventory

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2016

 

 

4,308

  

  

 

876

 

 

 

(68

)

 

 

(326

)

 

 

4,790

 

Year Ended December 31, 2017

 

 

4,790

  

  

 

3,521

 

 

 

302

 

 

 

(726

)

 

 

7,887

 

Year Ended December 31, 2018

 

 

7,887

  

  

 

2,712

 

 

 

(1,047

)

 

 

(3,282

)

 

 

6,270

 

F-52


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

GENTHERM INCORPORATED

By:

/S/    Phillip Eyler

Phillip Eyler

Chief Executive Officer

Date:  February 26, 2019

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

Signature 

Capacity 

Date 

/s/   PHILLIP EYLER

Director, President and Chief

February 26, 2019

PHILLIP EYLER

Executive Officer (Principal Executive Officer)

/s/    MATTEO ANVERSA

Vice President of Finance, Chief

February 26, 2019

MATTEO ANVERSA

Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)

*

Director, Chairman of the Board

February 26, 2019

FRANCOIS CASTAING

*

Director

February 26, 2019

SOPHIE DESORMIERE

*

Director

February 26, 2019

MAURICE GUNDERSON

*

Director

February 26, 2019

YVONNE HAO

*

Director

February 26, 2019

RONALD HUNDZINSKI

*

Director

February 26, 2019

CHARLES KUMMETH

*

Director

February 26, 2019

BYRON SHAW

*

Director

February 26, 2019

JOHN STACEYJOHN STACEY

 

 

 

 

 

*By:

/s/ Phillip Eyler

 

Phillip Eyler, Attorney-in-Fact